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Abstract 
Mastitis is a major disease of dairy cattle worldwide. Breeding cattle for disease 
resistance is desirable in order to reduce the incidence of clinical and subclinical 
mastitis, to improve cow welfare and to reduce reliance on chemotherapeutic agents to 
control disease. 
The aim of this study was to develop and evaluate an in vitro proliferative response of 
peripheral blood mononuclear cells (PBM) isolated from Holstein-Friesian cattle, 
induced by formalin-killed Staphylococcus aureus, a major mastitis pathogen, as a 
potential indicator of resistance or susceptibility to mastitis. Different strains of S. 
aureus, isolated from cows with subclinical mastitis, and identified by restriction 
enzyme fragmentation pattern analysis, were shown to induce different levels of 
proliferation of PBM in vitro. One particular strain (strain A), induced the strongest 
proliferative response compared to the other strains tested and differences in the 
magnitude of the proliferative response, induced by S. aureus strain A, was noted 
among cows. Phenotypic analysis of PBM of cows, by flow cytometry, showed that 
normal proportions of cell sub-populations were present at the start of culture and that 
the proliferating cell population consisted mainly of T cells expressing CD4, CD8 or 
y8 markers. 
Proliferation of PBM of cows, induced by Staphylococcal Enterotoxin B (SEB), 
showed that the peak day of proliferation occurred 72 to 96 hours earlier in the 
presence ofSEB compared to in the presence of S. aureus strain A antigen. 
A statistically significant difference in the proliferative response induced by S. aureus 
strain A was seen in two progeny groups sired by two different commercial bulls, 
suggesting that genetic control of this response may be important in protection of the 
mammary glands against infection. The proliferative assay was, therefore, 
subsequently performed in bulls. 
Predicted Transmitting Abilities (PTA) for somatic cell counts (SCC) estimate the 
effect of the sires' genes on SCC, a measure of subclinical mastitis. Two groups of 
v 
five Holstein-Friesian bulls were selected on their extreme values of PTA for SCC 
:bulls with a high PTA for SCC have progeny with a higher than average SCC, while 
bulls with a low PTA for SCC have progeny with a lower than average SCC. The 
proliferative response, induced by S. aureus strain A, of these two groups of bulls, 
showed a strong negative (r=-0.7) and statistically significant (p<0.05) correlation with 
PT A for SCC. The proliferative assay was subsequently performed on 104 bulls 
selected randomly from all bulls kept by a commercial breeding company, however, 
no significant correlation was found between the proliferative response induced by S. 
aureus strain A and PTA for SCc. These results suggest that the proliferative assay 
might be useful in selecting bulls that have extreme values of PTA for SCC, rather 
than ranking bulls in general. 
Phenotypic analysis of PBM using Hotelling's T squared test, showed a significant 
difference (p<0.05) in the proportions of cell subpopulations between bulls and cows, 
although the biological significance ofthis has not been studied. 
Cloning and sequencing of the Major Histocompatability Complex (MHC) class II 
DQB exon 2 region, was carried out. Four previously published and one novel 
sequence were generated from 39 clones, from three of the bulls with low PTA for 
SCC and from one bull with high PTA for SCC. Characterisation of DQB exon 2 by 
PCR-RFLP was carried out, however, the enzymatic digestion patterns generated were 
too ambiguous to classify. 
PCR-RFLP was applied to DRB3 exon 2 of the ten bulls selected based on extreme 
PTA for SCc. It was found that four of the five bulls with low PTA for SCC and one 
of the five bulls with high PTA for SCC had RFLP patterns associated with allele 
DRB3.2 * 16 in other studies. It was also noted that all five bulls with a strong 
proliferative response induced by S. aureus strain A had RFLP patterns associated 
with allele DRB3.2*16, whereas all the bulls with a weak proliferative response 
induced by S. aureus strain A did not show this RFLP pattern. 
Numerous published studies have associated the occurrence of allele DRB3.2*16 in 
dairy cows with a reduction in SCc. The occurrence of allele DRB3.2*16 in the bulls 
with strong proliferative responses induced by S. aureus in vitro supports the 
vi 
hypothesis that there is potential to use the in vitro proliferative assay to predict 
subclinical mastitis caused by S. aureus in their progeny. 
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Chapter I 
Introduction 
1.1 General Background 
Mastitis is defined as inflammation of the mammary gland (Du Preez, 1987). Clinical 
mastitis can be categorised according to the severity of the infection into peracute, acute 
and mild cases (Schalm et at., 1971). Clinical signs include abnormalities of the udder 
such as heat, pain, redness and swelling, and abnormalities in milk including clots, 
abnormal colour and odour. Mediators of the immune system are produced in response to 
infections such as mastitis and can result in damage to the mammary secretory tissues 
(Milner et ai., 1996). A number of these mediators can lead to a reduction in milk quality 
as well as reduction in milk yield (Honkanen-Buzalski et al., 1981). Mastitis has been 
shown to increase pain perception in cows suffering from both mild and moderate cases 
of mastitis, compared to non-mastitic cows (Fitzpatrick et ai., 1998). Mastitis can also 
affect the cow subclinically and is much harder to diagnose than clinical disease. There 
may be no abnormalities of the udder or of the milk, however, an increase in the number 
of somatic cells present within milk, is used as an indicator of infection. 
Somatic cell counts (SCC) are recorded at the bulk tank level, providing a useful method 
of calculating the prevalence of subclinical mastitis in UK dairy herds (Holdaway et al., 
1996). With the disbandment of the Milk Marketing Board (MMB) in 1994, recording of 
SCC at a national level has ceased. The introduction of individual cow SCC recordings 
by milk purchasers now means that approximately 80% of dairy cows in the UK are 
recorded in this way (Mrode et at., 1998). Introduction of the EU hygiene directive 92/46 
in January 1998, set bulk milk somatic cell counts (BMSCC) at a maximum of 400,000 
cells/ml and set raw milk total bacterial count (TBC) at a maximum of 100,000 
bacterialrnl (Baines, 1996). On implementation of the new legislation, problems were 
forecast for the 10% of dairy farmers that had BMSCC consistently over 400,000 cells/rnl 
(Logue et al., 1995). 
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Enumeration of somatic cells in the milk of mastitic cows may give an indication of the 
type of pathogen causing the elevated levels. The number of somatic cells in a healthy 
gland is less than 100,000 cells/ml of milk. In subclinical mastitis, this figure may rise to 
approximately 500,000-1,000,000 cells/ml. In chronic intramammary infection (IMI), 
see may rise to approximately 4,000,000 cells/ml of milk. A chronic IMI of this nature 
can be caused by Staphylococcus aureus infection, while an IMI due to infection with 
coliforms may result in see in excess of 20,000,000 cells/ml of milk. The large increase 
in see due to infection by coli forms can often go undetected in a single milk sample due 
to the transient nature of infection caused by this pathogen (Hillerton, 1996). Successful 
treatment of mastitis has concentrated on elimination of clinical signs rather than 
bacteriological clearance from the mammary gland. The lack of complete bacteriological 
cure allows development of chronic IMI in some cases. Identification of the factors that 
. contribute to the incidence of mastitis helps in the development of effective control 
measures (Fox et al., 1995). 
Mastitis has severe economic and welfare implications for the dairy industry, and is noted 
as a major cause of mortality in adult dairy cows (Menzies et ai., 1995). The estimated 
average cost of a clinical case of mastitis is between £182-218 due to discarded milk, 
purchasing of antibiotics and veterinary bills (Kossaibati and Esslemont, 1997). With an 
average of 40 clinical cases per herd per annum, the annual bill for the United Kingdom 
has been estimated at approximately two hundred million pounds (Hillerton, 1998). 
The introduction of the Five Point Plan to dairy farms was designed to reduce the 
incidence of clinical mastitis (Dodd et al., 1969). The Five Point Plan suggested 1) 
annual checks on milking machinery, to prevent damage to the teat ends, 2) post milking 
teat dipping, to provide a protective barrier to the teat whilst the sphincter is still open, 3) 
correct use of dry cow therapy between calvings, 4) correct treatment for individual cases 
of mastitis and detailed recordings of cases and 5) culling of persistently infected animals 
that may jeopardise the health of the whole herd. 
At present the breeding of dairy cattle worldwide is predominantly based on profitability, 
which focuses on selection based on production traits. Unfortunately the genetic 
correlation between production traits, for example milk yield, and subclinical mastitis is 
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unfavourable, indicating that as milk yield increases, so does the incidence of mastitis 
(Mrode and Swanson, 1996; Biochard and Rupp, 1997). Inclusion of sec into current 
breeding programmes for dairy cows in addition to production traits, type traits and 
estimated longevity has been introduced recently (McGuirk, 1998). As a result, sires may 
now be selected that will result in their daughters having improved udder health through 
reduced Sec. The choice of see for inclusion into the current breeding programmes 
was due to see being reported as the most suitable single trait for the indirect selection 
for mastitis resistance, with a strong positive correlation (r=0.7) between mastitis and 
sec (Phillpsson et ai., 1995; Mrode and Swanson, 1996). 
1.2 Mastitis Pathogens 
Repeated isolation of Streptococcus agaiactiae and S. aureus from cases of mastitis made 
these the main bacterial pathogens responsible for IMI in the UK dairy herds during the 
1940's and 50's (Booth, 1997). Since then the types of pathogen isolated from cases of 
mastitis has changed with a lower incidence of contagious mastitis, an increase in the 
incidence of environmental mastitis mostly due to coliforms and the eradication of S. 
agaiactiae from well managed dairy herds (Hillerton, 1998). Mastitis in dairy herds is 
still attributed mostly to the pathogens Escherichia coli, Streptococcus uberis and S. 
aureus. Bacterial pathogens can be classified broadly into categories depending on the 
type of mastitis they cause, namely; environmental, summer or contagious (Blowey, 
1990; Smith and Hogan, 1993). 
1.2.1 Environmental mastitis 
The incidence of environmental mastitis in dairy herds has increased as cases attributable 
to contagious pathogens has reduced (Erskine et ai., 1988; Schukken et ai., 1991). Unlike 
the contagious pathogens, the transmission of environmental pathogens from cow to cow 
during milking is rare (Eberhart et ai., 1979). Faecal contamination has been identified as 
the major reservoir of environmental pathogens (Blowey, 1990), as well as bedding and 
soil (Risco et ai., 1999). 
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On average, 1 % of quarters of dairy cows will suffer from an IMI due to Gram negative 
bacteria, in comparison to approximately 35-50% of quarters due to Gram positive 
bacteria, (Paape et ai., 1986). Economically, most loss associated with environmental 
cases of mastitis is as a result of a reduction in milk production, with milk being 
discarded during infection, and a lack of response to treatment resulting in premature 
culling of animals (Smith and Hogan, 1993). 
Treatment of environmental mastitis is complex, the short duration of the infection 
(Todhunter et ai., 1991) and the high spontaneous cure rate (Bramley and Dodd, 1984), 
which has been reported as high as 70% (Cravens, 1987) makes antibiotic treatment 
inefficient. The use of pre-milking and post-milking teat dipping for prevention of 
environmental cases has proved largely ineffective (Wesen and Shultz, 1970). However 
it has been reported that after experimental challenge with S. uberis, there was a 67% 
reduction in new infections with pre-dipping compared to dry wiping (Rasmussen et ai., 
1991). As faecal contamination and bedding represent major reservoirs for environmental 
pathogens, as a preventative measure, post milking, cows should be prevented from 
returning directly to the stalls. At this time the teat canal is still open and is, therefore 
particularly vulnerable to bacterial penetration. 
Escherichia coli, S. uberis, Pseudomonas species, Bacillus species and yeasts are known 
to cause environmental mastitis (Todhunter et ai., 1991). 
1.2.1.1 Escherichia coli 
Escherichia coli infection normally results in clinical mastitis in dairy cows. Signs 
associated with E. coli mastitis can be classified as local, systemic, or toxic. Toxic 
mastitis accounts for between 10-15% of IMI caused by coliforms, with a survival rate of 
approximately 50% irrespective of the treatment given (Green et ai., 1997). 
Escherichia coli secretes lipopolysaccharide, an endotoxin, as a virulence factor during 
infection of the mammary gland (Carroll et ai., 1964). Lipopolysaccharide induces 
endotoxin shock syndrome, triggering the complement cascade, resulting in the 
development of a non-specific immune response (van Miert, 1991). Production of 
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endotoxin can result in the endogenous release of the hormone prostaglandin F2 (PGF2), 
(Smith, 1986). At certain levels PGF2 can result in abortion in dairy cattle through 
luteolysis (Giri et ai., 1991) and stimulation of uterine contractions. 
A reduction in national BMSCC was probably mostly due to a reduction in the prevalence 
of contagious mastitis however these herds still have a high incidence of clinical mastitis 
due to environmental pathogens (Oliver and Sordillo, 1988; Schukken et ai., 1990; Lam 
et ai., 1997). The increase in clinical mastitis incidence was reported to relate directly to 
impaired defence mechanisms in the cow (Kremer et ai., 1993; van Werven, 1999). As 
somatic cells are present within the mammary gland as a defence against invading 
pathogens, a very low SCC may predispose a cow to a higher risk of clinical mastitis 
(Suriyasathapom et ai., 2000). Contamination from bedding, damaged teats (Schukken et 
ai., 1991), nutritional deficiencies in vitamin E and selenium (Ndiweni and Finch, 1996) 
and the dry period have been implicated as causative factors in the incidence of E. coli 
mastitis (Erskine et al., 1988). 
The prevalence of cases of E. coli mastitis is lower than that associated with S. aureus 
incidence. The short duration of an E. coli infection results in transient increases in SCC, 
in comparison with the long duration of S. aureus infections resulting in chronic infection 
and persistently high SCc. An IMI caused by an environmental pathogen may be 
detected over a time period of between 2000-4000 milkings (Eberhart, 1977) compared to 
an IMI caused by a contagious pathogen which has a far greater chance of being detected 
by milking due to a persistently elevated SCC. 
1.2.2 Summer mastitis 
Relatively little is known about the transmission of pathogens and the causative factors 
that result in summer mastitis (Hillerton et ai., 1992). Cases of summer mastitis are 
related to the activity of the fly Hydrotaea irritans (Madsen et ai., 1991). Intramammary 
infections, classed as summer mastitis are prominent in dry cows and heifers during the 
summer months (Egan, 1990). The number of cases of summer mastitis are generally 
higher in younger animals (Hillerton, 1987), and have been reported to be in the range of 
39-54% in England and Wales (Berry, 1998). 
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Characteristics of summer mastitis include acute clinical signs (Hirvonen et ai., 1994), 
with a rancid smell from the gland caused by a purulent secretion (Bouman and Booth, 
1992). Signs can include toxaemia i.e. fever, depression, loss of appetite, and abortion, 
and in some cases, mortality (Webster, 1993). The impact of summer mastitis on the 
dairy herd is severe as infected quarters may be lost permanently in terms of milk 
production (Schalm et ai., 1971). Cases of summer mastitis in calving heifers is most 
detrimental as during the first pregnancy the mammary gland undergoes an exponential 
phase of growth and development that is important for milk production and subsequent 
lactations (Nickerson et ai., 1992). 
Treatment of summer mastitis has focused on the correct application of dry cow therapy, 
which has been reported to dramatically reduce its incidence. Effective fly control, 
adequate treatment of injured teats, and dry cow therapy have also been recommended as 
preventative measures for summer mastitis (Farm Animal Welfare-Council, 1997). 
Actinomyces pyogenes, Peptostreptococcus indolicus and Fusobacterium necrophorum 
have been isolated from cases of summer mastitis (Pyorala et ai, 1992). Experimental 
infection with these pathogens resulted in an acute response characteristic of summer 
mastitis (Vecht et ai., 1987). Streptococcus dysgaiactiae has also been isolated from 
cases of summer mastitis (Egan, 1986). 
1.2.3 Contagions Mastitis 
Within the dairy herd, transmission of contagious pathogens occurs primarily from cow to 
cow during routine milking (Bramley and Dodd, 1984). Hygiene within the dairy parlour 
should be meticulous. Dirty cloths used to wipe the teats prior to attachment of the 
clusters, dirty hands of dairy workers moving among animals udders and dirty clusters are 
all potential routes of infection for pathogenic micro-organisms (Webster, 1993). 
Contagious pathogens are able to survive on the outer surface of the mammary gland and 
by their opportunistic nature result in an 1MI (McDonald, 1984; Sutra and Poutrel, 1994). 
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Staphylococcus aureus, S. agalactiae, S. dysgalactiae and Mycobacterium bovis are 
classified as major contagious pathogens. 
1.2.3.1 Staphylococcus aureus 
Staphylococcus aureus has been classified as the most important of the contagious 
pathogens (Pederson et al., 1981; Bramley and Dodd, 1984). Staphylococcus aureus is 
the predominant cause of subclinical mastitis (Wilson and Richards, 1980), although this 
bacterium is also frequently associated with clinical mastitis (Wilesmith et al., 1986; 
Miltenburg et al., 1996), especially acute and occasionally peracute forms of the disease 
(Reid and Wilson, 1959). See section 1.4. 
1.2.3.2 Streptococcus agalactiae 
Streptococcus agalactiae has been classified as a Lancefield group B streptococcus 
(Schalm et al., 1971). Group B Streptococci are important pathogens of both humans and 
cattle (Facklam and Carey, 1985). Streptococcus agalactiae is an obligate udder 
pathogen and, therefore, for survival, must remain within the mammary gland 
environment (Schalm et al., 1971; Philpot, 1975; Blowey, 1990). As with S. aureus IMI, 
S. agalactiae has been reported as a cause of clinical mastitis (Risco et aI., 1999) but has 
also been reported as the causative agent in cases of subclinical mastitis. Streptococcus 
agalactiae results in a low-grade persistent infection with a low self-cure rate 
(Farnsworth, 1987). Lactic acid produced by S. agalactiae results in damage to the 
secretory tissue within the mammary gland (MacDonald, 1984). Variation among strains 
of S. agalactiae creates different levels of virulence, attributed to the ability of the 
bacteria to adhere to the mammary gland epithelium (Jain, 1979). 
Streptococcus agalactiae has, through successful antibiotic treatment, been eradicated 
from well-managed dairy herds over the past half century (Shpigel, 1994). Many 
penicillin-based antimicrobials are still effective in the treatment of S. agalactiae, for 
example Nafpenzal™ and SynuloxTM (The Veterinary Formulary: Handbook of 
Medicines used in Veterinary Practice). Aminoglycosides, which inhibit protein synthesis 
and possess bacteriostatic properties, are also effective in the treatment of S. agalactiae 
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(Hyatt et al., 1995). A comparison between the available systemic and intramammary 
treatments, indicated that systemic treatment was no more efficient in eliminating IMI 
(Tyler et al., 1992). Production of a vaccine directed against S. agalactiae has been 
largely ineffective. Vaccination with formalin-fixed S. agalactiae provided no protection 
against subsequent challenge with the bacteria (Yancey, 1993: Giraudo et al., 1997). 
Prevention of S. agalactiae mastitis by using pre-milking and post-milking teat dipping 
has received mixed reviews. Some studies report no reduction in the number of cases of 
S. agalactiae mastitis when pre-milking and post-milking teat dipping was administered 
(Bartlett et ai., 1992). In contrast, others reported that if used correctly within well-
managed herds, teat dipping has reduced but not eliminated S. agalactiae IMI (Sischo et 
al., 1993). 
1.2.3.3 Streptococcus dysgalactiae 
Transmission of S. dysgalactiae can occur during milking, however environmental 
sources of infection have also been reported (Prescott and Baggott, 1988; Risco et al., 
1999). Intramammary infection with S. dysgalactiae can result in cases of clinical 
mastitis (Todhunter et ai., 1995; Waage et al., 1999). Streptococcus dysgalactiae is most 
commonly isolated from cows during the dry period and from heifers (Thomas et al., 
1987; Bramley and Dodd, 1984). The sites of primary isolation of S. dysgalactiae are 
from skin lesions of the teat and from within the mammary gland (McDonald, 1984; 
Blowey, 1990). The prevalence of S. dysgalactiae in heifers suggests the existence of a 
reservoir other than the mammary gland, as these animals have yet to be exposed to the 
milking parlour environment, which may result in transmission of pathogens between 
animals (Aarestrup and Jensen, 1996). 
Establishment of an IMI with S. dysgalactiae involves adherence of the bacteria to the 
mammary gland epithelium and to extracellular matrix proteins in vitro (Filippsen et al., 
1990; Calvinho et al., 1996). An experimental infection in goats showed that S. 
dysgalactiae penetrated the alveolar epithelium, migrating to the interacinar tissue 
(Pattison and Smith, 1953), enabling the bacteria to evade the host's immune system 
(Calvinho and Oliver, 1998). 
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Effective treatment of S. dysgalactiae has been shown with dry cow therapy, penicillin 
and cephalosporins (Tyler et ai., 1992), however treatment with gentamicin and 
streptomycin has been ineffective due to antibiotic resistance (McDonald and McDonald, 
1976). Streptococcus dysgalactiae is considered to be less contagious than S. agalactiae. 
1.3 Genus Staphylococcus 
Staphylococci are spherical bacteria with a diameter range of O.5-1.5Jlm (Bisping and 
Amstberg, 1988). They are pyogenic, invasive, micro-organisms capable of causing 
diseases of the skin i.e. boils and impetigo; the central nervous system i.e. brain or 
epidural abscesses and the musculoskeletal system i.e. osteomyelitis (Schaechter, 1993). 
Staphylococcal species can cause mastitis in cattle, exudative epidermitis in swine and 
staphylococcosis in poultry (Anderson, 1983). Coagulase producing staphylococci are 
regarded as more pathogenic than non-coagulase producing strains and those 
staphylococci which produce carotenoid are regarded as more invasive than non-
pigmented strains (Schaechter, 1993). 
1.3.1 Staphylococcal Virulence Factors 
The production of virulence factors by bacteria help to establish the infection within the 
host as well as improving the bacteria's chances of survival (Forsgren, 1972; Y okornzo 
and Igarashi, 1991). Staphylococcal virulence factors possess a variety of functions that 
contribute to their pathogenicity (Sutra and Poutrel, 1994), (Table 1). 
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VIRULENCE EFFECT 
FACTOR 
LEUKOCIDINa,b edestruction / inhibition of white blood 
cells 
~-HEMOLYSINS edestruction / inhibition of red blood cells 
COAGULASEc ecoagulation of plasma therefore poor 
penetration by phagocytes 
CATALASE ereduction in killing by neutrophils 
HYALURONIDASE edestruction of hyaluronic acid between 
cells which results in further spreading 
~-LACT AMASE edestruction of ~-lactam rings 
DNAse edestruction of DNA 
LlPASES edestructiqn of lipids 
PROTEINASES edestruction of proteins 
PROTEIN AfJ eactivation of classical complement 
pathway in the absence of adherence to 
antibody 
PEPTIDOGL YCANe, r ecomplement activation 
TEICHOIC ACID ecomplement activation 
eadherence to mucosal cells 
a TOXINg,h ebinds to cell membrane resulting in 
hexameric pores 
eemptying of cytoplasmic components 
epromotion of bacterial growth 
~ TOXINh,i eoedema and influx of neutrophils 
epromotion of bacterial growth 
Table 1: Virulence factors associated with staphylococci: Loeffler and Norcross, 1987; b) 
Soboll, 1971; c) Kirby, 1944; d) Postle et ai., 1978; e) Kowalski and Berman, 1971; f) 
Adlam and Easmon, 1983; g) Bhakdi and Tranum-Jensen, 1991; h) Sutra and Poutrel, 
1994; i) Ward et al., 1979. 
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1.4 Staphylococcus aureus 
Staphylococcus aureus is a Gram positive, catalase producing, coccus. The production of 
coagulase allows identification of S. aureus from other staphylococci. Different biotypes 
of S. aureus have evolved and adapted for survival in different host species (Aarestrup et 
al., 1995). Biotype A is associated with humans, B with pigs and poultry, C with cattle 
(Matsunga et al., 1993) and D with hares. These groups are not mutually exclusive as 
biotype A has been reported to be able to colonise the skin of cattle (Hajek and Marsalek, 
1971). 
Staphylococcus aureus is the predominant cause of subclinical mastitis (Wilson and 
Richards, 1980), where SCC acts as an indicator of infection. Persistently elevated SCC 
indicates chronic infection characteristic of S. aureus (Holdaway et al., 1996). 
Staphylococcus aureus is also frequently associated with clinical mastitis (Wilesmith et 
al., 1986; Miltenburg et al., 1996), especially peracute and acute mastitis (Reid and 
Wilson, 1959). Signs of peracute mastitis are characterised by systemic upset including, 
pyrexia, anorexia and grossly abnormal milk, which resembles bloodstained serous fluid 
(Webster, 1993). 
1.4.1 Virulence Factors associated with Staphylococcus aureus 
The route of infection has been reported to effect the development of an IMI. An 
intramammary infection caused by a strain of S. aureus present on the outer skin of the 
mammary gland was shown to require large numbers of bacteria to migrate into the 
mammary gland to develop an inflammatory response (Blowey et ai., 1992). Inoculation 
of bacteria directly into the gland requires far fewer numbers to develop an inflammatory 
response (Anderson, 1986). Production of extracellular substances such as exotoxins and 
enzymes, contribute to the pathogenicity of S. aureus (Kotzin et al., 1993; Lee, 1996). 
Staphylococcal enterotoxins (SE) and Toxic Shock Syndrome Toxin-l (TSST1) are 
extracellular metabolites produced during bacterial growth (Czop and Bergdoll, 1974) 
and secreted by certain strains of S. aureus (Yokomizo et al., 1995). These SE can be 
subdivided into SEA, SEB, SED, SEE and SEC. SEC is further divided into subtypes 
SEC}, SEC2 and SEC3 due to serological differences (Kenny et al., 1993). Recently, 
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three new SE have been identified: SEG, SEH and SEI (Munson et ai., 1998; Li et ai., 
1999). Amino acid homology divides the enterotoxins into two groups, SEA, SED and 
SEE in one with SEB and SECI-3 in another (AI-Daccak et ai., 1998). Staphylococcal 
enterotoxins can cause food poisoning in humans (Miller et ai., 1978) and TSSTI can 
result in tampon related toxic shock (Todd et ai., 1978). Strains of S. aureus producing 
both SE and TSSTI have been identified in bovine mastitis (Yokomizo and Igarashi, 
1991). The estimates of enterotoxigenic strains of S. aureus in ruminants has been 
reported previously as in the range of 4-19% of isolates (Olsen et ai., 1970; Harvey and 
Gilmour, 1985; Abbar et al., 1986; Orden et al., 1992). Bovine S. aureus isolates are 
reported to frequently produce more than one toxin, especially SEC, SED and TSST-l 
(Ferens et aI., 1998). Enterotoxins are extremely heat stable, thus persisting potentially 
during the pasteurisation process. Milk heat treated for 15 minutes at between 77-82°C, 
condensed and finally spray dried showed detectable levels of enterotoxin on examination 
ten years later (Batish et al., 1990). Others have also shown detectable amount of SEA 
and SED post-pasteurisation (Tatini et aI., 1971). 
1.4.2 Antibiotic therapy 
Treatment of S. aureus IMI is problematic (Owens and Watts, 1987). It has been reported 
that despite the number of studies carried out to investigate the problems associated with 
antimicrobial therapy for S. aureus infection, little has been resolved (Ziv et al., 1995). 
Treatment of IMI due to S. aureus with dry cow therapy does not always result in 
elimination of the pathogen from the mammary gland (Nickerson et al., 1999), although 
some success has been reported (Clegg et aI., 1975; Cummins and McCaskey, 1987; Sol 
et al., 1994). The lack of success in the treatment of IMI caused by S. aureus may be as a 
result of fibrosis, and abscessation of the infected tissue (Nickerson and Heald, 1981). 
The tough outer layer of the abscess acts as an impervious barrier preventing the 
infiltration of phagocytes and penetration of antibiotics (Sears and Heider, 1981; Makaya, 
1996). The ability of S. aureus to persist intracellularly within macrophages, neutrophils 
and epithelial cells (Sandholm and Mattila, 1985) also helps to prevent destruction by the 
host's immune system. Production of ~-lactamase by S. aureus can result in antibiotic 
resistance, thus enabling the bacteria to persist within the hosts environment (Owens, 
1988; Aarestrup and Jensen, 1998). The antibiotics administered in dry cow therapy are 
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designed to be in contact with the bacteria for prolonged periods, possibly encouraging 
the development of antibiotic-resistant strains (Osteras et ai., 1999). Levels of antibiotic 
resistant S. aureus are increasing, with estimates suggesting that >70% of human S. 
aureus strains are resistant (Wiedemann and Kresken, 1984; Cormican and Jones, 1996), 
and approximately 12% of S. aureus strains associated with bovine mastitis showing 
resistance (National Veterinary Laboratories, 1996). However in the Scandinavian 
countries where administration of antibiotic treatment is only performed by the 
veterinarian, approximately 94% of S. aureus strains are still sensitive to penicillin in 
vitro (Nilsson et ai., 1997). 
1.4.3 Antibiotic Residues 
Antibiotic residues in milk and meat products are concerns for the respective industries. 
Allergic reactions to antibiotics such as penicillin can occur at very low doses 
(Zimmerman, 1959), which make antibiotic residues unacceptable (Ziv et ai., 1973). 
Contamination of processed dairy products with antibiotics has been reported to reduce 
the quality of these products (McEwan et ai., 1991). Milk contaminated by antibiotics 
(>0.005 international units, IU), results in a purchase price of 1 pll rather than the normal 
value of 18p/1 for uncontaminated milk (Beard, personal communication). Antibiotic 
contamination results mainly from failure to withhold the milk of animals receiving 
antibiotic treatment or receiving dry cow therapy (Booth and Harding, 1986). Antibiotic 
failures have also been suggested as a result of natural inhibitors present in the milk i.e. 
colostrum and lactoferrin (VanEenennaam et ai., 1993) creating false positives. 
1.4.4 Vaccination 
Vaccine development for prevention of S. aureus has proved largely ineffective. Many S. 
aureus bacterins are available, however, their efficacy has not been proven by field trials 
or substantiated in publications. One commercial bacterin was shown to increase the 
number of spontaneous cures rate and significantly reduce the SCC of infected animals 
(Pankey et ai., 1985), while the incidence of new IMI and clinical mastitis remained 
unchanged. Vaccines based on staphylococcal toxoids and pseudocapsular materials have 
been shown to provide protection against clinical mastitis under experimental challenge 
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conditions (Watson, 1992). The reduction in clinical mastitis and new IMI following 
vaccination was also confirmed by others (Nickerson et al., 1993; Watson et al., 1996). 
1.5 Anatomical Defences of the Mammary Gland 
The outer epithelial layer of the teat is the mammary glands first line of defence against 
opportunistic pathogens. This layer of tough dead cells, comprised of stratified squamous 
epithelium, is impregnated with keratin, a waxy substance that possesses bacteriostatic 
properties. These bacteriostatic properties are esterified and non-esterified fatty acids, 
including palmitoleic acid and linoleic acid (Bitman et al., 1988). The waxy structure of 
keratin prevents pathogens migrating from the outer layer of skin into the gland cistern, 
which may result in an IMI (Hibbitt et al., 1969). If the external layer of skin is 
compromised i.e. chapped or cracked, colonisation of inner dermal layers by 
opportunistic pathogens could result in an IMI. The streak canal is also lined with 
squamous epithelium containing keratin. Studies have shown removal of teat canal 
keratin resulted in an 84% infection rate when challenged via the mammary gland with S. 
agalactiae, compared with a 27% infection rate in control quarters containing keratin 
(Schultze and Bramley, 1985). Cationic proteins in the streak canal disrupt the osmotic 
balance of invading bacteria's cell wall resulting in cell lysis. The sphincter muscle at the 
teat end creates an impervious barrier against potential pathogens. During milking when 
the sphincter muscle is relaxed to allow milk ejaculation, it is at this time that the streak 
canal is vulnerable to penetration by opportunistic pathogens. Implementation of pre-and 
post-milking teat dipping, to remove any micro-organisms prior to and after milking from 
the surface of the teat may help prevent colonisation of the udder by pathogens at this 
vulnerable time (Dodd et al., 1969; Pankey et al., 1983; Pankey, 1989). 
1.6 Dietary defence 
Basic dairy management can help protect the mammary gland if essential nutritional 
elements are included in the cows diet. Vitamin A and E, selenium, ~-carotene, zinc and 
copper all contribute to the maintenance of the dairy cow's immune system. 
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1.6.1 Vitamin E and Selenium 
Deficiencies in selenium and vitamin E reported in rats and goats have been shown to 
result in impairment of neutrophil bactericidal activities, and reduction in the production 
of chemotactic properties by macrophages (Gairola and Tai, 1985; Aziz and Klesius, 
1986). 
Severe vitamin E and selenium deficiencies are associated primarily with calves and 
borderline deficiencies occur more frequently in adult cattle. Selenium is found naturally 
within the soil, therefore uptake by the animal is indirect (McKenzie et al., 1998). 
Enhancement of neutrophil migration, production of chemotactic factors and improved T 
cell proliferation induced by mitogenic stimuli have been reported in cows on vitamin E 
and selenium supplemented diets (Ndiweni and Finch, 1999). Both vitamin E and 
selenium have been shown to protect against hydrogen peroxide and oxygen free radicals 
that result in damage to healthy secretory tissue (Hogan et al., 1993). A reduction in 
lymphocyte transformation has been observed in sheep deficient in vitamin E and 
selenium (Turner and Finch, 1990) and cattle (Cipriano et al., 1982), as well as an 
increase in incidence, severity and duration of IMI (Smith et ai., 1984; Weiss et ai., 1990; 
Hogan et al., 1993). 
1.6.2 Vitamin A and Beta-carotene 
Supplementation with vitamin A and a precursor, ~-carotene, during the periparturient 
period has been shown to improve mammary gland health and is essential for the growth 
and maintenance of ruminant epithelial cells (Daniel et al., 1991). Improvement of 
phagocytosis and intracellular killing as a result of vitamin A supplementation is limited 
(Tjoelker et ai., 1988a). A reduction in blastogenic T cell response has been reported in 
animals deficient in vitamin A, whilst B cell responses remain unaltered (Tjoelker et al., 
1988b). 
Beta-carotene, the precursor for vitamin A, has been shown to increase T helper cell 
numbers by 30% whilst T cytotoxic and T suppressor levels remained unchanged 
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(Alexander et ai., 1985). Improved neutrophil function due to ~-carotene has also been 
reported, as shown by improved bactericidal activity prior to drying off (Chew, 1993). 
1.6.3 Zinc 
Low levels of zinc in dietary nutrition have been shown to reduce the overall T cell 
numbers (Wirth et ai., 1984). A zinc deficit may alter keratin composition present within 
the teat canal, subsequently rendering the udder vulnerable to infection, as well as 
increasing SCc. 
1.6.4 Copper 
Impairment of the immune system, due to a lack of copper, results in clinical signs 
associated with dietary deficiency (Koller et ai., 1987), elevated incidences of IMI, due to 
a reduction in response to acute inflammation (Harmon et ai, 1994) and a reduction in 
intracellular killing (Babu and Failla, 1990). 
1.7 Humoral Immunity - non specific 
1.7.1 Lactoferrin 
Lactoferrin is an iron binding protein found in milk (Gordon et ai., 1962) and in the 
granules of neutrophils (Masson and Heremans, 1966). This chelating protein starves 
bacteria such as staphylococci and coliforms of iron, an essential element for bacterial 
growth (Bishop et ai., 1976). Lactoferrin has also been shown to work in conjunction 
with IgGl in the inhibition of E. coli and Klebsiella pneumoniae (Oliver and Bushe, 
1987). In a normal, healthy, gland lactoferrin concentrations are relatively low, recorded 
as between 0.1-0.3mglml of milk (Oliver and Smith, 1982). Levels are seen to rise at 
drying off and reach 20-30mglml of milk between three to 30 days involution (Harmon et 
al., 1975). During an IMI levels of lactoferrin in milk are elevated, suggesting a possible 
role in the defence of the udder, which may arise through modulation and control of 
lymphocytes, macrophages and neutrophil function (Sanchez and Watts, 1999). 
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1.7.2 Complement 
Complement is a set of approximately 30 heat labile proteins capable of lysing micro-
organisms and cells (Klein and Horejsi, 1999), with receptors found on the surfaces of 
neutrophils, eosinophils, macrophages, monocytes and gastrointestinal epithelial cells. In 
a normal healthy gland, complement levels are relatively low, with higher levels reported 
in colostrum. Levels of complement have been reported as significantly increased during 
and IMI with the production of Protein A by S. aureus shown to activate the classical 
complement cascade. The antibacterial properties of complement are thought to have a 
minimal role within the udder (Reiter et al., 1983). 
1.7.3 Lysozyme 
The enzyme, lysozyme, can cleave peptidoglycan from the cell wall of Gram positive and 
Gram negative bacteria (Reiter, 1978). Digestion of the peptidoglycan may occur 
immediately, resulting in destruction of the micro-organism, or alternatively, additional 
enzymes maybe required for the destruction of the outer cell wall to expose the 
underlying peptidoglycan. It has been suggested that lysozyme may enhance lactoferrin 
binding, contributing to the defence of the mammary gland against pathogenic organisms. 
The concentration of lysozyme in the mammary gland of cows has been reported as 300 
times lower than those of human breast milk (Chandran et al., 1964), which may suggest 
that cattle have an ineffective concentration of lysozyme to deal with invading micro-
organisms. 
1.7.4 Lactoperoxidase thiocyanate hydrogen peroxide system 
The lactoperoxidase thiocyanate hydrogen peroxide system has been shown to elicit 
bacterostatic effects on Gram positive (S. aureus) and bactericidal effects on Gram 
negative bacteria (coliforms), (Outteridge and Lees, 1988). Neutrophils produce large 
amounts of hydrogen peroxide during the respiratory burst due to alterations in the plasma 
membrane (Paape et al., 1991). In a healthy animal, levels of lactoperoxidase are low 
within the udder, and if the animal is suffering from nutritional stress, a further reduction 
has been observed in the levels of this enzyme (Sordillo et al., 1997). 
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1.7.5 Cytokines 
Cytokines are important in the specific and non-specific humoral immune system in 
cattle. These proteins have a potent biological effect at picomolar to nanomolar levels, 
and are produced by a variety of immune and non-immune cells. The primary role of 
human peripheral blood monocytes involves the regulation of the synthesis and secretion 
of biologically active molecules, such as cytokines (Alderson et ai., 1991). Their 
interactions as individual cytokines and in combination with others can be synergistic, 
additive or antagonistic, spanning mUltiple cell targets (Lawman et ai., 1987), with certain 
cytokines stimulating cells directly (Tosato and Jones, 1990; Cheung et ai., 1991). There 
have been greater than 30 bovine cytokines identified by their regulatory activities, many 
of which affect the cells present within the mammary gland (Table 2), (Sordillo et ai., 
1997). To date there have been more than 80 cytokines characterised in humans 
(Oppenheim, 1994). 
CYTOKINE EFFECT 
G-CS~ 
-increase in milk somatic cell counts 
GM-CSFb 
-enhanced neutrophil activity 
IFN-y -enhanced neutrophil phagocytosis and 
bacteriostatic/cidal activity 
IL_1d,e 
-increase in neutrophil numbers 
-no alteration in mononuclear cell proliferation 
IL_2f, g 
-increase in plasma cell numbers 
-enhanced lymphocyte cytotoxicity and 
bacteriostatic/cidal activity 
Table 2: Cytokines and theIr vanous effects on the immune system; a) Kehrli et ai., 
1991; b) Sordillo et ai., 1992; c) Sordillo et ai., 1991; d) Daley et ai., 1991; e) Torre et 
ai., 1992; f) Nickerson et ai., 1989; g) Sordillo et ai., 1991 
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1.7.5.1 Interleukin-l 
Interleukin-l (IL-l) is an inflammatory cytokine, that has been reported to contribute to 
the amplification of the host's inflammatory response and to aid in the restoration of 
damaged tissue (Neta and Oppenheim, 1988). Interleukin-l is secreted by a variety of 
nucleated cells and along with IL-6, tumour necrosis factor (TNF)-a, and TNF-~, is 
highly pleiotropic (Dinarello, 1989; Beutler and Cerami, 1989; Hirano et ai., 1990). 
Intramammary infusion with recombinant (rb) bovine (Bo) IL-l ~ was reported to increase 
SCC and enhance the production of superoxide by milk neutrophils (Daley et ai., 1993), 
although an improvement in phagocytosis was not evident. Elevated levels of IL-l have 
been reported in response to intramammary infusion with endotoxin (Shuster et ai., 
1993), suggesting that the production of this cytokine precedes, or is concurrent with, 
leucocytic influx and systemic response. 
1.7.5.2 Interleukin-2 
Interleukin-2 (IL-2) is the best characterised of the bovine cytokines. Primarily produced 
by T helper cells, IL-2 effector function can lead to clonal expansion of T cells, growth 
and development of the B cell population, activation of natural killer (NK) cells (Swain, 
1991) and induction of T cytotoxic activity (Caligiuri et ai., 1990). Interleukin 2 can 
initiate an increase in thymocyte proliferation (Lawman et ai., 1987) as well as the 
enhancement of bactericidal activity, MHC II expression and neutrophil infiltration 
(Sordillo et ai., 1991). Colostrum collected from the mammary gland during the final 
week of gestation indicated very low levels of IL-2 (Sordillo et ai., 1992), correlating 
with the increased susceptibility of the mammary gland to infection during this time. 
Initially difficulty in purifying large quantities of bovine IL-2 hindered studies looking at 
the potential use of this cytokine in treating mastitis, however the production of rbIL-2 
has since removed these constrictions (Cerretti et ai., 1986; Price et ai., 1987). Research 
has shown that treatment of milk mononuclear cells with rbIL-2 enhanced the 
proliferative response induced by mitogenic stimulus at a concentration that when 
challenged previously in the absence of rbIL-2 was not sufficient to induce a proliferative 
response (Torre et ai., 1992). In vivo studies administering rbIL-2 by the intramammary 
route via surgically implanted mini osmotic pumps resulted in an increase in the total 
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number of lymphocytes, macrophages and IgG bearing plasma cells (Nickerson et ai., 
1989). The data from the previously published studies suggests the potential of using 
rbIL-2 as a therapeutic agent in the prevention or reduction of IMI (Torre et ai., 1992). 
1.7.5.3 Granulocyte-Colony Stimulating Factor 
Granulocyte-Colony Stimulating Factor (G-CSF) is one of a group of colony stimulating 
factors, required for development, differentiation and survival of phagocytes and 
granulocytes (Sordillo et ai., 1997). The primary secretory cells of G-CSF include 
monocytes, fibroblasts and endothelial cells (Fukunaga et ai., 1990). Administration of 
rbG-CSF subcutaneously to cows led to a two to five fold augmentation in the number of 
peripheral blood neutrophils (Kehrli et ai., 1991). 
1.7.5.4 Granulocyte Macrophage-Colony Stimulating Factor 
Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) has been reported to 
induce the development of granulocytes and macrophages from hematopoietic stem cells 
(Metcalf et ai., 1985). The primary secretory cells of GM-CSF include macrophages, T 
lymphocytes, fibroblasts and endothelial cells (Gearing et ai., 1989). Intramammary 
infusion with rbGM-CSF did not result in an influx of cells into the mammary gland, 
however it was noted that neutrophils were stimulated to produce superoxide via the 
respiratory burst (Daley et ai., 1993; Tao et ai., 1993). Administration of rbGM-CSF to 
cattle has been shown to significantly enhance the bactericidal and chemotactic properties 
of neutrophils in peripheral blood and the mammary gland (Sordillo et ai., 1992). 
Recombinant GM-CSF has also been reported previously to prevent apoptosis of bovine 
peripheral blood neutrophils during in vitro culture (Colotta et ai., 1992). The ability of 
rbGM-CSF to stimulate peripheral blood and mammary gland neutrophils and 
enhancement of the bactericidal and chemotactic properties suggests treatment with this 
cytokine may induce a more efficient immune response towards invading pathogens 
(Sordillo et ai., 1992). 
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1.7.5.5 Interferon-y 
Interferons (IFN) were discovered in the 1950s, and are characterised by the ability to 
induce an antiviral status in vitro. Interferon-y belongs to the second class of IFN, and is 
derived from T lymphocytes and NK cells (Aguet et al., 1988). This cytokine has many 
immunomodulatory properties and has been shown to improve antibody dependent cell 
cytotoxicity, NK activity and T lymphocyte cytotoxic ability. A reduction in the severity 
of clinical signs and levels of mortality were reported in cattle challenged with Bovine 
Herpes Virus and subsequently treated with IFN-y (Babuik et al., 1987). Treatment of 
immunosuppressed cattle with IFN-y improved neutrophil function even compared to 
normal non-immunosuppressed cattle (Roth and Frank, 1989). Interferon-y has been 
reported to be involved in the regulation of MHC II expression on cell surfaces, as well as 
the regulation of complement receptors on monocytes and macrophages (Bielefeldt 
Ohmann et ai., 1986). A reversal of the suppressive effects of milk on mammary gland 
neutrophils was reported in vitro following treatment with IFN-y (Sordillo et al., 1991). 
The significant enhancement of neutrophil function as a result of treatment with IFN-y 
may improve mammary gland defences against pathogens such as S. aureus. 
1.8 Humoral immunity - specific 
Immunoglobulins (Ig) are involved in humoral immunity and the acquired immune 
system. Secretion of Ig occurs primarily from B-Iymphocytes that have been stimulated 
and have matured into antibody secreting cells. There are five isotypes of Ig namely; 
IgM, IgA, IgD, IgG and 19B, with IgG further subdivided into IgGl and IgG2• 
Immunoglobulin G is the predominant isotype in the serum of cattle compared to humans 
where IgA predominates (Lascelles, 1979). 
Ruminant neonates are born devoid of Ig acquiring the required Ig from their mother's 
colostrum (Howe, 1921; Aschaffenberg, 1949). The transfer of Ig from the mother's 
colostrum to the calf is different to humans, where Ig absorption takes place in utero via 
the placenta (Butler, 1974; Brambell, 1970). Colostral Ig is a concentrated source of 
serum antibodies (Dixon et al., 1961), which is transferred from the maternal serum to the 
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colostrum, which the calves suckle (Sasaki et at., 1976; Watson and Lascelles, 1973). 
Colostral IgM and IgA are both derived from maternal serum and synthesised locally 
within the mammary gland of cattle (Newby and Bourne, 1977). In humans and mice 
most synthesis of Ig occurs locally rather than from transportation from serum (Drife et 
at., 1976). 
The transfer of Ig from serum to the mammary gland was suggested to arise from 
leakage/transudation, a mechanism which would be viable during severe cases of mastitis 
or during the dry period, but would not be functional in a normal healthy gland (Linzell 
and Peaker, 1974). The single layer of cells at the periphery of the mammary gland 
consists of milk producing secretory cells, mainly alveoli and ducts (Mackenzie and 
Lascelles, 1968), which is responsible for the specific transportation of Ig to the 
mammary gland (Brandon et ai., 1971) 
Levels of Ig are not constant in the mammary gland and have been reported to increase 
during colostrogenesis and infection (Musoke et ai., 1987), with concentrations in the 
mammary gland during parturition far exceeding those in serum (Concha et at., 1980). 
For neonate absorption of Ig from colostrum the first 24 to 30 hours postpartum are the 
most critical (Deutsch and Smith, 1957). A delay in suckling can result in a reduction in 
Ig absorption and an increased susceptibility to infection (Gay, 1965). 
The four main isotypes thought to be associated with defence against mastitis are IgGI , 
IgG2, IgA and IgM (Butler, 1974; Spiegelberg, 1974). Both IgD and IgE are present in 
small quantities within the mammary secretions but are not associated with protection. 
Immunoglobulin GI , IgG2 and IgM act as bacterial opsonins, improving phagocytosis by 
macrophages and neutrophils by direct binding of bacteria to the cell surface or via the 
C3b component of complement (Smits et at., 1996). Immunoglobulin A provides a better 
defence as it has enhanced resistance to proteolytic enzymatic degradation that may 
enhance its survival in the mammary gland (Underdown and Dorrington, 1974). 
Immunoglobulin A's enhanced resistance to proteolytic enzymatic degradation may also 
prevent bacterial colonisation through agglutination and toxin neutralisation (Musoke et 
at., 1987). 
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1.9 Cell mediated immunity 
Somatic cells present in milk represent immune cells in the mammary gland and comprise 
neutrophils, macrophages, lymphocytes and epithelial cells. The percentages of each cell 
type present are dependant on a number of factors, including, stage of lactation, whether 
the mammary gland is healthy or infected, and if infected what degree of inflammation is 
present. Macrophages are the predominant cell type in the healthy mammary gland, 
followed by neutrophils, lymphocytes and epithelial cells (Miller et ai., 1991). During 
early and late lactation, neutrophils increase in number and the lymphocyte population 
decreases (McDonald and Anderson, 1981). Cell numbers present within the gland 
increase rapidly within hours of an IMI, rising from <105 to >106 cells per ml (Paape et 
ai., 1981). The initial response mounted by the immune system to an IMI should be quick 
and efficient to minimise damage and prevent establishment of a chronic infection. 
1.9.1 Neutrophils 
Neutrophils are part of the immune system's first line of defence against infection (Paape 
et ai., 1991), and have been shown to play an important role in cattle in the defence 
against E. coli (Hill, 1981) and S. aureus mastitis (Schalm, 1976). Activation of 
neutrophils leads to diapedesis of cells to the site of inflammation, and subsequently the 
destruction of pathogens via phagocytosis, enzymatic degradation and oxidative burst 
metabolism (Spitznagel, 1983). The ability to respond to invading pathogens varies 
between neutrophils present in blood and those in milk, with peripheral blood neutrophils 
being more effective phagocytes than mammary gland neutrophils (Kent and Newbould, 
1969). The presence of cytokines at the site of inflammation has been shown to enhance 
neutrophil function (Steinbeck et ai., 1989) whereas stress (Kelley, 1980) and viral 
pathogens (Abramson and Mills, 1988) have been reported to impair the phagocytic 
properties of neutrophils. During late pregnancy, calving and early lactation cows have 
been shown to be affected by physical and metabolic stress (Kehrli et aI., 1989a). The 
rate of IMI increases during this period and coincides with reported immunosuppression 
and a reduction in bactericidal activity of neutrophils (Gilbert et ai., 1993). Neutrophil 
function is known to effect the incidence of mastitis, but has also been reported to effect 
the severity of the IMI (Craven et ai., 1985). 
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Temporary disruption of the epithelial cells, followed by resealing of the tight junctions, 
permits neutrophils to migrate from peripheral blood into the mammary gland (Lin et aI., 
1995). Epithelial cells and tight junctions are reported to restrict neutrophil diapedesis 
from blood to the mammary gland (Evans et al., 1983). Migration of neutrophils to the 
site of infection is dependant on energy resources, which are required for effective 
phagocytosis (Newbould, 1973). The mammary gland energy sources required for the 
effective phagocytosis are at their lowest when the cow is most susceptible to an IMI. A 
reduction in neutrophil function has also been reported due to the ingestion of fat and 
casein present in the milk (Paape and Guildry, 1977). To overcome the problems 
associated with the mammary gland a large number of neutrophils are required to tackle 
an IMI (Schultze and Paape, 1984). Neutrophils have been reported as contributing 90% 
of total leukocytes during an IMI (Sordillo et aI., 1987). Ideally neutrophil migration to 
the site of inflammation should be quick, as extended periods of diapedesis can result in 
damage of the mammary parenchyma tissue, which contribute to a reduction in milk yield 
(Sordillo and Nickerson, 1988). 
1.9.2 Dendritic cells 
Dendritic cells are the most potent stimulators of T cell proliferation (Steinman and 
Witmer, 1978). Although present in very low numbers they form an extensive network 
that pervades the entire body. During circulation, they acquire the capacity to process and 
present antigen, express MHC class IT and MHC class I and co-stimulatory molecules 
(Engering et al., 1998; Sunshine et aI., 1983; Hayashi et aI., 2000). They are 
morphologically distinct from other cells and lack the classical markers associated with T 
and B cells (Steinman and Cohn, 1973). The MAb, CC21, has been used to identify a 
subpopulation of PBM expressing the B cell marker and has been shown to stain cells 
around the follicles of the lymphoid tissue of cattle with dendritic cell morphology 
(Naessens and Howard, 1991). It is not known whether these dendritic cells express 
antigen passively or acquired from other cells as hypothesised in humans. Bacterial 
products i.e. LPS and inflammatory stimuli e.g. TNF induce the maturation of dendritic 
cells (Watts 1997b; Cella et al., 1999). Maturation of the dendritic cells alters the 
functional state and within 10-20 hours biosynthesis of MHC class IT is upregulated and 
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maintains a high endocytic capacity (Pieters, 2000). This ensures that dendritic cells 
retain a high capacity for peptide loading (Pierre et ai., 1997). Production of LPS and 
TNF also induce migration of dendritic cells towards lymphoid tissue (Adema et ai., 
1997). Down-regulation of endocytosis and MHC class II recycling during migration 
ensures the peptides derived from the pathogen are not replaced as well as stabilising the 
half life of the dendritic cell (Cella et ai., 1997). This pathway of events results in potent 
antigen presenting cell (APC) in the lymphoid tissue where immunologically naIve T 
cells can be stimulated (Banchereau and Steinman, 1998). 
1.10 Lymphocytes 
There are two main sets of lymphocytes, namely T and B lymphocytes, with many 
subsets, sub-subsets and clones identified by expressed cell surface markers. These 
different sets and subsets enable the immune system to process different antigens from 
various sources (Grey and Chesnut, 1985; Cooper, 1987; von Boehmer, 1988). B-
lymphocytes respond to externally presented antigen, for once the antigen becomes 
internalised, the antibodies produced by the B lymphocytes are largely ineffective. T 
lymphocytes respond to internalised antigenic peptides presented on the surface of APC, 
in association with MHC molecules (Swain, 1983). For an optimal immune response, 
both Band T lymphocytes are required (Beckmann and Levitt, 1984). 
1.10.1 T lymphocytes 
Lymphocytes originate from pluripotent stem cells within bone marrow. These 
pluripotent stem cells differentiate into lymphoid stem cells and further develop into pre-
T and pre-B-Iymphocytes. After differentiation from lymphoid stem cells, T cells are 
educated as to the differences between self and non-self antigen within the thymus, an 
absolute requirement for differentiation (Bill and Palmer, 1989; Shortman et ai., 1991; 
Marrack and Kappler, 1997). Children suffering from DiGeorge syndrome, lack mature T 
cells as a result of an athymic condition, and fail to induce a proliferative response when 
stimulated by mitogens (Markert et ai., 1998). The survival of naIve T cells present in the 
thymus without antigenic stimulus is dependant on the expression of MHC molecules 
(Sprent et ai., 1990; Tough and Sprent, 1994; Takeda et ai., 1996; Rooke et ai., 1997). 
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The MHC molecules and self peptide present in the thymus in combination result in 
either survival or elimination of the immature T cell (Jameson et al., 1995). In mammals, 
puberty triggers a reduction in size of the thymus known as thymic involution (Steinmann 
and Mullerhermelink, 1984), which scales down the requirement for T cell education as 
the residual population mature and develop into memory cells. The thymus was believed 
to be largely ineffective by the onset of puberty, however further studies have now shown 
that the thymus continues to participate in lymphocyte development throughout adult life 
(Bertho et al., 1997). 
T lymphocytes can be characterised by immunological markers present on their cell 
surface. The T cell receptor (TCR), is a cell surface marker which has been studied 
extensively in mice and humans since the molecular structure was unveiled (Yanagi et aI., 
1984; Hendrick et al., 1985). The TCR is a transmembrane molecule composed of two 
chains linked via a disulphide bond that can be combined as a~ or yo (Pereira et al., 
1997). Many similarities exist between a~ and yo chains in function, structure and 
association with CD3 (Bank et al., 1986; Borst et al., 1987; Van Neerven et al., 1990). 
Each T cell clone has a unique TCR that is non-covalently associated on the surface of the 
T cell with a complex of transmembrane polypeptides, CD3. The CD3 complex 
comprises three molecules y, 0, and E and is required for T cell development (Tanaka et 
al., 1995), as well as assembly and efficient surface expression of the TCR (Exley et al., 
1995). The CD3 complex and TCR are tightly associated with zeta (t;), a molecule 
composed of two identical chains. The CD3 complex is T cell specific unlike t;, however 
neither bind antigen directly but rather act as signal transducers initiating signal relay to 
the T cell molecule once the antigen has bound to the TCR (Wegener et al., 1992). 
1.10.1.1 T lymphocytes expressing the a~ TCR 
Once the lineage of the TCR has been established, a~ T cells develop into T helper 
(CD4+ T cells), (Baldwin et aI., 1986), T cytotoxic or T suppressor cells (CD8+ T cells), 
(Chan et al., 1998), each with different regulatory immunological functions (Ellis et al., 
1986). Expression of CD4 and CD8 on the T cell surface strengthens the bond that exists 
between the T cell and the APe. This bond is important due to the low affinity of MHC-
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antigenic peptide complex binding to the TCR. The CD4 + T cell binds to the invariant 
portion of the MHC class II molecule (Glass et al., 1991), and the CD8+ T cell bonds to 
the invariant portion of the MHC class I molecule (Sordillo et al., 1997). The affinity of 
CD4+ T cells for MHC class II and CD8+ T cells for MHC class I is known as MHC 
restriction (Zinkemagel and Doherty, 1979). 
T cells expressing the CD8 cell surface marker have been identified in large numbers 
within the paracortex of lymph nodes, discrete Peyers Patches and periarteriolar T-
dependant areas of the tonsils (Ellis et al., 1986; Morrison et ai., 1988). CD8+ T cells 
have also been identified in the red pulp of the spleen of young calves and in the 
epithelium of the gut mucosa of cattle (Parsons et al., 1989; Naggi and Babiuk, 1989). 
Phenotypic identification of CD8+ T cells can be achieved by staining with monoclonal 
antibodies as described in humans (Johnson, 1989) and cattle (Ellis et al., 1986). 
CD8+ molecules have been associated with two types of regulatory T cell; T suppressor 
and T cytotoxic cells (VonBoehmer, 1988). T suppressor cells generate a negative 
feedback loop for the immune system, downregulating the responses of both T and B 
cells, ensuring the immune response is self-limiting and not damaging (Chin and Hay, 
1980; Callard et al., 1982; Cooper, 1987). T suppressor cells secrete 1I..--4, a cytokine 
associated with a Th2-type immune response, whiCh has been shown to shift the immune 
response induced from a Thl-type response to a Th2-type response (Hsieh et al., 1992; 
Mocci and Coffman, 1995). The shift in the type of Th response is carried out by 
differential expression of chemokine receptors on the cell surface of T suppressor cells 
(Kim et al., 1998; Sallusto et ai., 1998). T cytotoxic cells have been reported to initiate 
the destruction of infected or altered host cells mediated by cell lysis through the release 
of cytotoxic granules that contain perforin monomers (Fong and Mosmann, 1990). The 
granules create homopolymeric pores resulting in rapid osmotic lysis of the infected cell 
(Liu et al., 1995). T cytotoxic cells also function as effective scavengers, removing old or 
damaged secretory cells that may impair immune function (Taylor et al., 1994). 
T cells expressing the CD4 cell surface marker have been identified in the organised 
lymphoid tissue of the paracortex of the lymph nodes, the peri arteriolar region of the 
spleen, and the interfollicular area of the discrete Peyers Patches and tonsils (Parsons et 
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ai., 1989). CD4+ T cells are also located in the non organised lymphoid tissue of the gut 
mucosa in the lamina propria, but unlike CD8+ T cells have not been identified in the 
epithelium (Parsons et ai., 1989). CD4+ T cells are classified as regulatory T cells (Fong 
and Mossman, 1990). Once stimulated by antigen, CD4+ T cells can induce 
responsiveness in both T and B-lymphocytes (Sattentau and Weiss, 1988; Mazerolles et 
ai., 1991; Gaubin et ai., 1996). The induction of a response may result in the maturation 
of B cells into antibody producing plasma cells (Semple et ai., 1993). CD4+ T cells have 
been reported as essential in responding to helminth infection in humans, and in directing 
the host's immune response towards the infectious agent (Romagnani, 1994). CD4+ T 
cells are important in the development of a fully functional immune response, as 
differentiation of B cells into memory cells is usually T helper cell dependant (Rouse et 
ai., 1982). 
In human and murine immune systems, T helper cells are divided into further subsets. T 
helper cells originate as ThO-type cells then differentiate into Th1- or Th2-type cells 
(Mosmann et ai., 1986; Cherwinski et ai., 1987). Characterisation of Th1-type and Th2-
type cells can be achieved by their cytokine profiles (Abbas et ai., 1996; Seder and Paul, 
1994; Mosmann et ai., 1986). Production of lL-12 by monocytes and macrophages, and 
production of INF-y by natural killer cells, trigger differentiation of the precursor ThO-
type cell to the Th1-type cell (Tam et ai., 1999). Interleukin-4 production from 
unconventional natural killer cells as well as basophils, eosinophils and mast cells, 
triggers differentiation of the precursor ThO-type cell to the Th2-type cell (Powrie and 
Coffman, 1993). 
Prior to differentiation, the precursor ThO-type cell secretes lL-2, lL-3, lL-4, lFN-yand 
TNF-B (Gurish et ai., 1992). Classically Th1-type cells produce both lL-2 and lFN-y, 
which are reported to promote cellular responses induced by intracellular pathogens, in 
particular mycobacterial infections (Cher and Mosmann, 1987; Fong and Mosmann, 
1989). This cellular response requires activation of cell mediated defence mechanisms 
and the induction of specific immunity. The presence of Th1-type cells has also been 
associated with the development of immediate hypersensitivity and allergic responses. 
Th2-type cells are characterised by the production of lL-4, lL-5 and lL-lO and have been 
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associated with the regulation of Ig isotype produced by B cells (Coffman and Carty, 
1986). 
There is no absolute restriction to which Th-type of response develops, however, 
detrimental shifts from Th I-type to a Th2-type have been reported with respect to some 
viral infections and allergic conditions (Mosmann and Sad, 1996; Carter and Dutton, 
1996). It has been noted in patients infected with HIV, a shift from Thl-type to Th2-type 
has been correlated with disease progression (Clerici and Shearer, 1994). The shift from 
Th I-type to Th2-type has also been reported to be detrimental to those suffering from 
atopic disorders such as asthma (Gelfand et ai., 1996; Leung, 1997). Staphylococcal 
superantigens (SAg), which are known cytokine stimulators, have also been implicated in 
detrimental shifts in Th-type (Campbell et at., 1999). The expression of Thl cytokines 
has been reported to enhance anti-viral immunity against Hepatitis B and anti-tumour 
immunity against human melanoma (Van Elsas et at., 1997; Chow et at., 1998). 
Promotion of a Th I-type immune response has been suggested as beneficial in 
enhancement of the immune response induced by certain bacterial infections (O'Sullivan 
et ai., 1995; Greenberger et at., 1996; O'Suilleanbhain et ai., 1996). Conversion of Thl-
type cells to Th2-type cells may elicit a protective role in the down-regulation of TNF-a, 
preventing its overproduction and subsequent tissue damage. Interleukin-4 and ll..,-1O, 
both Th2-type cytokines, are potent anti-inflammatories that can suppress the production 
of pro-inflammatory cytokines, therefore, reducing the risk of possible tissue damage 
(Zhou et at., 1994; Clarke et ai., 1998). Production of ll...-4 has been reported to modulate 
the balance between an inflammatory and an immune response induced by bacterial 
infection in pigs (Zhou et at., 1994). Not all cYtokine production can be classified as 
either Thl-type or Th2-type as production of ll...-3 and GM-CSF is common to both Th-
types (Gurish et at., 1992). 
1.10.1.2 T lymphocytes expressing the "(8 TCR 
Expression of the cell surface markers CD4 and CD8, which act as co-receptors 
promoting signal transduction, do vary between y8 and a~ T cells (Gay et at., 1987; Rudd 
et ai., 1988; Veillette et at., 1989; Newell et ai., 1990). Expression of the cell surface 
markers CD4 and CD8 on y8 T cells is not usual (Haas et ai., 1993; Zorbas and Scollay, 
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1993). Expression of MHC molecules is not an absolute requirement for the development 
of y8 T cells, and has no effect on the number of y8 T cells (Correa et al., 1992; Bigby et 
al., 1993), unlike T cells bearing the a~ TCR, as reported in mice. Although cells 
expressing the a~ TCR and the y8 TCR differ in the chains of their TCR they do share the 
same composition of cluster of molecules known as CD3. The CD3 is responsible for 
signal transduction (Bank et aI., 1986; Borst et aI., 1987; Van Neerven et al., 1990), as 
well as function of the T lymphocytes (Hanby-Plarida et al., 1996). Large numbers of y8 
T cells have been identified in peripheral blood, in the gut, and at the epithelial surfaces, 
with lower numbers reported in the lymph node, thymus and spleen (Mackay et al., 1988). 
The lower numbers of y8 T cells reported in the lymph node, thymus and spleen suggests 
that this population does not readily re-circulate. Expression of L-selectin on the cell 
surface of y8 T cells suggests that they are able to migrate from peripheral blood into the 
lymph node via high endothelial venules (HEV) , (Mackay et aI., 1988; Howard et al., 
1992). Sequentially, the afferent lymph, peripheral blood and the efferent lymph 
contribute the largest number of y8 T cells present in the lymph node in sheep (Mackay et 
al., 1990). The location of the y8 T cells suggests that those present in the lymph nodes 
were extracted by endothelium in peripheral tissue as opposed to the HEV of lymph 
nodes. Examination of lymph node sections showed that the entry of y8 T cells was via 
the afferent lymph (Mackay et al., 1988). 
When y8 T cells are induced by antigenic stimuli the response is similar to that of a T 
cytotoxic cell. Cytokine production by activated y8 T cells is dependent on the type of 
antigenic stimulus. Stimulation of murine peritoneal y8 T cells with Listeria 
monocytogenes, showed a pattern of cytokine production that was characteristic of a Thl 
type response (Ferrick et al., 1995). However on stimulation of the same cells with a 
different antigen, Nippostrongylus brasiliensis, the pattern of cytokine production was 
characteristic of a Th2 type response (Ferrick et al., 1995). The in vitro culture of y8 T 
cells with IL-2 has been shown to induce the destruction of malignant breast carcinoma 
cells (Miescher et al., 1990). y8 T cells have also been reported to play an important role 
against challenge from bacterial pathogens (Mackay and Hein, 1991). 
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The addition of yo T cells to a mixed lymphocyte reaction resulted in a disproportionate 
proliferation (Clevers et ai., 1990). When yo T cells were depleted in vivo, the antibody 
response generated towards intravenously administered human type 0 erythrocytes 
increased (Howard et ai., 1989). The combination of these effector functions has resulted 
in speculation that yo T cells are associated with the regulation of response induced by 
antigen in other subsets of lymphocytes. It has also been suggested that yo T cells may 
possess cytolytic activity but this has still to be established (Mackay, 1988; O'Reilly and 
Splitter, 1991). 
T cells expressing the yo TCR are a major subpopulation in cattle (Wyatt et ai., 1996). 
Levels of yo T cells expressing the WCl cell surface marker are considerably lower 
within secondary lymphoid tissue and mammary gland secretions (3-8%), (Park et ai., 
1992; Wyatt et ai., 1994), but higher in the tissue of the gut and the skin (McClure et ai., 
1989; Howard et ai., 1992). Levels of yo T cells lacking expression of the WCI cell 
surface marker represent a small percentage of the circulating lymphocyte population, 
between 2-5%. A large proportion of those cells lacking the expression of the WCl cell 
surface marker are present in the spleen, mammary gland and its secretions, as well as the 
gut epithelium (Wyatt et ai., 1994 and 1995; MacHugh et ai., 1997). These two disparate 
subpopulations have been reported in cattle and pigs (Binns, 1994; Licence et ai., 1995). 
The first subset express cell surface markers similar to those of yo T cells in other species 
namely WCl, CD2, CD5, CD6 and they may, or may not, express CD8 (Davis et ai., 
1996). Expression of CD6 has been reported to enhance T cell responsiveness (Yang et 
ai., 1996). The second subset lacks expression of WCl, CD2, CD6 and CD8 but does 
express the CD5 cell surface marker (Clevers et ai., 1990). Expression of CD5 on both 
subsets of bovine yo T cells is unlike humans where CD5 is expressed on only one of the 
subsets (Spour et ai., 1990). The proportion of yo T cells in the peripheral blood of 
adolescent ruminants has been reported as approximately 40% in three week old lambs 
(Washington et ai., 1992) and 27% in three week old calves (Clevers et ai., 1990). Levels 
are shown to decrease too less than 15% in adults (Tizard, 1992). The reduction in yo T 
cell numbers due to age is in direct contrast to the pattern observed with CD4+ T cells 
(Mackay et ai., 1990; Howard et ai., 1991; Mason and Powrie, 1990). 
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About 60% of the lymphocytes present in the skin of cattle have been identified as 
expressing the y8 cell surface marker (Mackay and Hein, 1991), as well as having been 
identified in the epithelial tissues of cattle (Wijngaard et ai., 1992). As has been 
suggested in other species (Janeway et ai., 1988), the function of y8 T cells identified in 
the skin of ruminants may be the protection of the epithelial surfaces (Hein and Mackay, 
1991; Morrow-Tesch et ai., 1996). 
1.10.1.3 Expression of naIve/memory phenotype on T lymphocytes 
Expression of a cell surface marker, CD45, was first identified through the production of 
a mouse anti-human monoclonal antibody, which was able to identify CD4+ T cells that 
could respond to mitogenic stimulus but not soluble antigen and vice versa (Morimoto et 
ai., 1985). These T cells were named CD45RA and further studies identified a lower 
molecular weight (MW) isoform of the CD45 cell surface marker, named CD45RO 
(Smith et ai., 1986). 
CD45 is a membrane protein tyrosine phosphatase (Tonks et ai., 1988) expressed on all 
nucleated haematopoetic cells in various isoforms (Kong et ai., 1995a). The requirement 
for CD45 has been reported for T and B cell activation after antigenic stimulation (Pingel 
and Thomas, 1989; Chan et ai., 1994; Justement et ai., 1994). This result was confirmed 
by the addition of anti-CD45 MAb, which resulted in the loss of ability by B cells to 
respond to stimuli, which initiates cross-linkage of the BCR (Gruber et ai., 1989). 
B cells lacking the expression of CD45 can produce normal levels of antibody after 
antigenic challenge and maintain the ability to switch Ig class with CD4+ T cells 
assistance (Kong et ai., 1995a). This suggests that expression of CD45 is not an absolute 
requirement for B cell development or signal transduction involving surface Ig. However 
mice lacking CD45 expression do exhibit impaired T cell development and function 
(Kishihara et ai., 1993; Kong et ai., 1995b). 
In mammals expression of the higher MW isoform of CD45 can result in 
unresponsiveness or low levels of response when challenged after vaccination with a 
specific antigen. The isoforms associated with this unresponsiveness were identified 
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using MAb in humans and rodents and classified as CD45RAlRBIRC (Streuli et ai., 
1987; Streuli et ai., 1988; Johnson et ai., 1989). A similar state of unresponsiveness is 
reflected in cattle and sheep in association with the high MW CD45, where high MW 
CD45 are mainly CD45RBIRA respectively (Mackay et ai., 1990; Howard et ai., 1991). 
From studies carried out in humans, it was suggested that T cells expressing the high MW 
isoform of CD45 were naive in terms of antigenic exposure (RA) and those T cells 
expressing the low MW isoform of CD45 were memory T cells (RO), (Terry et ai., 1988). 
Expression of the isoforms is not mutually exclusive, and the presence of both CD45RA 
and RO has been observed on a small subset of T cells in humans (Mason and Powrie, 
1990). Dual expression may suggest that this subset of T cells has a function that is 
distinct from that of other CD45RO+ T cells, or that it may be an intermediate phenotype, 
which develops during alteration in activation status (Bell and Sparshott, 1990; Sparshott 
et ai., 1991; Michie et ai., 1992). Persistent exposure to antigenic stimulus has also been 
suggested as a potential explanation for dual expression of CD45RA and RO (Salmon et 
ai., 1994). 
Approximately 10% of bovine T cells have been shown to be double positive for 
CD45RAlRO, which is consistent with the results published in humans (Bembridge et al., 
1995). Bovine CD4+ T cells have been reported to express a higher percentage of 
CD45RO molecules than CD8+ T cells (Akbar et ai., 1993). Expression of the CD45RO 
isoform is positively correlated with age, for as the animal matures the level of CD45RO+ 
T cells increases (Sanders et ai., 1988; Beverly, 1990; Hannet et ai., 1992). This is not 
unexpected for as the cattle mature, their exposure to antigenic stimuli will increase. 
Expression of CD45RO is not restricted to CD4+ and CD8+ T cells. yo T cells in mice 
have been reported to uniformly express the CD45RO isoform parallel with CD25 
(Capone et ai., 1998), the receptor ligand for IL-2. The expression of these two cell 
surface molecules suggests an activated phenotype. 
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1.10.2 B Lymphocytes 
Band T lymphocytes are derived from the same cell lineage, originating from pluripotent 
stem cells. These pluripotent stem cells differentiate into lymphoid stem cells and further 
develop into pre-T and pre-B lymphocytes. The maturation of immature B cells creates 
plasma cells, which are capable of producing antibody. Antibody producing B cells are 
educated within the bone marrow and Peyers patches and B cells have also been 
identified in the cortex of the lymph nodes and the marginal zone of the spleen 
(VonBoehmer and Kisielow, 1990). B cells respond to external antigen through the 
production of antigen specific antibody (Morafo et at., 1999). 
Generation of an antibody response is a two-stage process. Initial cell to cell contact 
between the B cell and the Th cell in addition to co-stimulation by adhesion molecules is 
required, followed by stimulation of the B cell by cytokines secreted from the Th cell 
population (Hermann et at., 1995). Promotion of B cell proliferation and polyc1onal Ig 
secretion is associated with a Th I-type response, although this does not result in antigen 
specific antibody formation (Mosmann et at., 1986; Cherwinski et at., 1987; Reiner and 
Seder, 1995). A Th2 type response results in up-regulation of IgG1, IgA and IgE (Tam et 
at., 1999). The final stage in the maturation of the B cell into an antibody secreting 
plasma cell takes place after re-circulation (Pierce et at., 1979; Husband, 1982). 
B cells possess a B cell receptor (BCR), which is comprised of different glycoproteins 
and functions much like the TCR. The BCR initiates antigen specific signals from the B 
cells and also processes and presents antigen through phagocytosis and proteolysis similar 
to conventional APC (Butler, 1998). A unique feature of the BCR is that, unlike the 
TCR, they can bind antigen, which is not present on the surface of an APC, after internal 
processing (Klein and Horejsi, 1999). 
Interaction between the BCR and antigenic peptide must be accompanied by co-
stimulation to trigger the immune response and result in the production of antibody. Co-
stimulation between the B cell surface involves CD40 (van Kooten and Banchereau, 
1997) and its ligand, CD40L on the surface of activated T cells, which are predominately 
CD4+ (Roy et at., 1993; Banchereau et at., 1994; Foy et at., 1996). The interaction 
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between CD40 and CD40L enhances B cell proliferation, antibody production and Ig 
isotype switching and is essential for the development of an antibody mediated response 
towards T cell antigens (Durie et ai., 1994). Studies carried out in vivo reported that the 
interaction between CD40 and CD40L was able to initiate the development of a humoral 
response (Allen et ai., 1990) as well as the transient activation of macrophages (Stout et 
ai., 1996). The interaction between CD40 and CD40L has also been shown to be 
essential for the production of bcl-2 a molecule known to promote B cell survival by 
preventing apoptosis (Liu et ai., 1991). The expression of bcl-2 is restricted to memory B 
cells, with only 5% of maturing B cells developing into plasma cells and the rest being 
deleted by apoptosis (Parry et ai., 1994). 
It has been suggested that a reduction in the expression of CD40L may affect the 
efficiency of T and B cell responses. In neonates whose T cells expressed low levels of 
CD40L (Nonoyama et ai., 1995; Durandy et ai., 1995; Flamand et ai., 1998) the 
development of a specific antibody response was slower. Cytokine expression in these 
neonates also preferentially promoted a Th2-type response (Barrios et ai., 1996; Kovarik 
and Siegrist, 1998). The expression of CD40L is regulated via transcriptional and post-
translational mechanisms, resulting in limited expression time on activated T cells (Graf 
et ai., 1995). The level of expression of CD40L on T cells has been reported to limit the 
rate and magnitude of the specific antibody response (Perez-Melgosa et ai., 1999). 
Various studies have been carried out to remove CD40L as the limiting factor in the 
process of antigen presentation and recognition. Addition of an anti-CD40 antibody to 
the culture, which mimics CD40L, resulted in successful presentation and recognition of 
antigen (Flamand et ai., 1998). Other studies have altered the type of cell presenting the 
antigen to dendritic cells thus eliminating the requirement for CD40L in the presentation 
of antigen (Ridge et ai., 1998). 
1.10.3 Co-stimulatory and Adhesion Molecules 
The expression of CD4 and CD8 on the cell surface of a~ T cells aids the adhesion of the 
T cell to the APC during presentation of the antigenic peptide. Other co-stimulatory and 
adhesion molecules are expressed on the surface of T cells, which participate in the 
process of antigen presentation and recognition. 
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1.10.3.1 CD28 and B7 Interaction 
Expression of the CD28 molecule is essential for T cell activation and induction of an 
immune response (Allison, 1994; DeBenedette et ai., 1997). The expression of the ligand 
B7 binds the CD28 molecule to the surface of the APC. B7 exists as two molecules; B7.1 
(CD80), (Freedman et ai., 1987; Freeman et ai., 1991; Croft et aI., 1994) and B7.2 
(CD86), (Azuma et ai., 1993; Freeman et ai., 1993). Cloning of B7.1 and B7.2 has been 
successful and the existence of another molecule, B7.3, has also been suggested 
(Boussiotis et ai., 1996). The interaction between CD28 and B7 sends a signal to the T 
cell, which amplifies the signal transmitted via the MHC-peptide-TCR complex 
interaction. The interaction between CD28 and B7 is essential for the production of IL-2 
from unprimed T cells (Lindstein et ai., 1989; Linsley et ai., 1991; Harding et ai., 1992; 
Norton et ai., 1992; Harding-and Allison, 1993; Linsley and Ledbetter, 1993). Production 
of IL-2 has been reported to activate macrophages and enhance their microbicidal activity 
(O'Suilleabhain et ai., 1996). Regulation of the co-stimulation between B.7 and CD28 
has also been reported to be mediated by IL-lO (Tam et aI., 1999). Production of IL-lO 
results in the up-regulation of B7.1 in monocytes, paralleled by a down regulation of B7.2 
in monocytes, Langerhans and dendritic cells (Buelens et ai., 1995; Kawamura and Furue, 
1995; Creery et ai., 1996). Whether B7.1 and B7.2 induce identical, or different, gene 
effector programmes involved is unclear (Freeman et aI., 1995). 
1.10.3.2 CTLA-4 and B7 Interaction 
CTLA-4 is a co-stimulatory molecule expressed on the cell surface of T cells. This co-
stimulatory molecule has affinity for the B7 ligand expressed on the cell surface of the 
APC (Linsley et aI., 1990; Linsley et aI., 1991). The interaction between CTLA-4 and B7 
may result in a down-regulation of the signal sent from the T cell to the MHC-peptide-
TCR complex, resulting in a reduction in the production of IL-2 (Krummel and Allison, 
1995; Krummel and Allison, 1996; Chambers et ai., 1996; Boussiotis et ai., 1996; 
Sperling and Bluestone, 1996; Waterhouse et ai., 1996). 
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1.10.3.3 CD2 and Lymphocyte Function associated Antigen Interaction 
The adhesion marker, CD2, is a pan T cell marker expressed on surface of T cells. CD2 
has affinity for its ligand, Lymphocyte Function associated Antigen (LF A), which is 
expressed on many different cell types (Dustin et ai., 1987). The interaction between 
CD2 and LF A contributes to the overall binding affinity of T cell to APC (Arnauot, 
1990). The LFA ligand has also been reported to take part in the trans-endothelial 
migration of T cells (Oppenheimer-Marks, 1991), and the multi-step extravasation of 
lymphocytes. 
1.10.3.4 IntraCellular Adhesion Molecule-1 
Intracellular Adhesion Molecule-1 (ICAM-l), is an Ig receptor and adhesion molecule, 
which mediates firm adhesion and transmigration of neutrophils (Sakamoto et ai., 1997; 
Morland et ai., 1997), and T cells to hepatic endothelial cells in vitro (Yoong et ai., 
1998). Expression of ICAM-1 has been noted on macrophages and cortical epithelial 
cells (Dustin et ai., 1986; Singer et ai., 1990). The presence of ICAM-1 has been shown 
to enhance antigen recognition of T cells through the interaction of T cell and APC 
(Dustin et ai., 1986; Dustin and Springer, 1991). 
1.10.4 Proportion of Lymphocytes present in peripheral blood and in the mammary 
gland of cattle 
Percentages of lymphocytes in the peripheral system have been shown to vary within 
different species depending on the subject's age. In humans, children up to 16 years of 
age have approximately 34-57% circulating T cells and 15-42% B cells. As humans 
mature the percentage of lymphocytes fluctuate, and in adults approximately 56-83% are 
T cells and 8-21 % are B cells (Bhat et ai., 1992). 
In adult cows it has been reported that 46-75% of T cells were CD2+ (Davis et ai., 1988; 
Baldwin et ai., 1988), and that approximately 23-35% of those were CD4+ (Baldwin et 
ai., 1986), and 9-26% were CD8+ (Ellis et ai., 1986; MacHugh and Sopp, 1991). 
Expression of the CD5 cell surface marker has been reported on approximately 70% of T 
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cells (Rabinovsky and Yang, 1986) and 16-35% on B cells (Yang et ai., 1997). The high 
levels of CD5+ T cells in adult cows is not unexpected as CD5 is a mature cell surface 
marker reported on CD2+, CD4+, CD8+ and y8 T cells (Yang et al., 1995). Expression of 
MHC class IT molecules that are involved in presentation of antigenic peptide to CD4+ T 
cells, has been reported as 19-28% of peripheral blood lymphocytes in cattle (Taylor et 
al., 1993), and also as 30-50% of peripheral blood lymphocytes in cattle (Tizard, 1992). 
Variation in CD4/CD8 T cell ratios in peripheral blood has been noted among species 
during lactation, CD4+ T cells predominate in goats (Ismail et ai., 1996a) where as in 
lactating pigs (Chabaudie et al., 1993), and mice (Ismail et al., 1996b) CD8+ T cells 
predominate. 
Approximately 5% of peripheral blood lymphocytes in adult cattle are y8 T cells. In 
young ruminants, y8 T cell expression is much greater with levels reported as 
approximately 26% of the peripheral blood lymphocyte population in calves aged three 
weeks, and 40% in lambs aged four weeks (Clevers et al., 1990). Work carried out by 
Ayoub and Yang (1996) reported a rapid increase in the number of CD4+, CD8+ and y8 T 
cells in newborn calves, which peaked at six to eight months of age. As the calves aged, 
the levels of CD4 + and CD8+ T cells decreased to a point then remained unchanged. The 
y8 T cell population however continued to decrease as the calves aged, results which are 
supported by work previously published in sheep (Hein, 1994). As well as y8 T cell 
numbers altering with age, alteration in lymphocyte numbers can also be attributed to 
disease status. A two-fold increase in B cell numbers was reported in cows suffering 
from lymphocytosis (Muscoplilt et al., 1974). 
In cattle, it has also been reported that during lactation, CD8+ T cells are predominant in 
milk, a reversal of the situation reported in the peripheral system (Park et ai., 1992). As 
the days in lactation increased an increase in the proportion of CD4+ T cells in the 
mammary gland was reported (Taylor et al., 1994). Lymphocyte numbers have been 
shown to be highest during late lactation, in particular T cells (Park et al., 1992). Levels 
of CD8+ T cells remain fairly constant throughout lactation but numbers of CD4+ T cells 
start very low and increase throughout lactation (Asai et al., 1998). 
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The type of milk, as well as the stage of lactation may also affect the types of cells 
present. Work carried out by Concha et al. (1996), showed that stripping and residual 
milk did not differ significantly in the proportion of CD2, CD4 and CD8 expressing T 
cells, but both did differ significantly from mid lactation milk in CD2 and CD4 T cell 
numbers. A reduction in T cells was observed during the peri parturient period compared 
with during lactation. Numbers increased during the dry period (Asai et al., 1998). 
During the dry period the population dynamics of cells within the mammary gland alters 
considerably (Lee et al., 1980; Jensen and Eberhart, 1981), with the most dramatic 
fluctuations seen in macrophages and neutrophils (Wilson et al., 1986). 
Induction of a proliferative response induced by antigen in vitro is representative of 
cellular immunocompetence (Kristensson et al., 1994). Bovine mammary gland 
lymphocytes isolated from foremilk are hyporesponsive when cultured in vitro (Smith and 
Schultz, 1977; Nonnecke and Kehrli, 1985; Park et al., 1993). The state of 
hyporesponsiveness exhibited by mammary gland lymphocytes has been suggested as an 
effect of increased numbers of macrophages (Collins and Oldham, 1986). Others have 
reported no improvement in proliferative response when macrophage numbers were 
reduced (Concha et al., 1996). Although a reduction in responsiveness has been noted 
between mammary gland lymphocytes and PBL, mammary gland lymphocytes still 
possess the ability to respond to mitogenic stimuli (Nonnecke and Kehrli, 1985), 
allogenic histocompatibility antigens (Parmely et al., 1976), and virus infected cells (Kohl 
et al., 1981). 
Parturition and lactation have been reported to effect the type of cells present in the 
mammary gland and their function. The postpartum period in cattle is associated with 
higher incidence of mastitis and a reduction in immunological response (Oliver and 
Sordillo, 1988; Sordillo et al., 1997). The reduction in immunological response has been 
reported to affect phagocytosis, cellular proliferation, antibody production and secretion 
of inflammatory mediators such as cytokines (Harp and Nonnecke, 1986; Nagahata et al., 
1992; Ishikawa et al., 1994; Detilleux et al., 1995). 
Development of an inflammatory response is a main requirement for elimination of a 
bacterial pathogen (Hill, 1981). Neutrophils act as the host's primary line of defence 
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against invading pathogens. Impaired neutrophil function in cattle during early lactation 
can result in an increased susceptibility to disease (Guildry et ai., 1975; Kehrli et ai., 
1989a) and has been reported as essential in the prevention of staphylococcal infections 
(Lee, 1996). 
During the postpartum period a reduction in the proportion of lymphocytes has been 
reported in peripheral blood, mammary secretions and mammary parenchyma (Shafer-
Weaver et ai., 1996; Van Kampen and Mallard, 1997; Yang et ai., 1997). A reduction in 
the total number of lymphocytes and a reduction in the proportion of CD4+ T cells has 
been used to indicate a compromised immune function in humans (Fahey et ai., 1984; 
Kalish and Schlossman, 1985). The number of CD4+ T cells has been reported to differ 
significantly in cows before and after parturition and in cows in mid-lactation (Harp et ai., 
1991). During the postpartum period, T cells expressing CD4 secrete low levels of ll..r2 
and IFN-y, both Th1-type cytokines. Both of these cytokines are reported to stimulate up-
regulation of MHC class IT molecules on the surface of mammary epithelial cells 
(Fitzpatrick et ai., 1992) and to activate and enhance the microbicidal activity of 
macrophages (Paul and Seder, 1994). T cells expressing CD4 during the postpartum 
period have been identified as expressing mRNA transcripts for Th2 type cytokines 
(Shafer-Weaver et ai., 1999). During the postpartum-period the reduction in both IL-2 
and IFN-y was positively correlated with an increased incidence of mastitis in dairy cows 
(Shafer-Weaver et ai., 1999). Neutrophil and lymphocyte function, phagocytosis, cellular 
proliferation and antibody production are all reduced in the mammary gland during the 
postpartum period (Harp and Nonnecke, 1986; Kehrli et ai., 1989b; Detilleux et ai., 
1995). The presence of hormones such as oestrogen and progesterone, has been 
suggested as a possible mechanism of immunosuppression in the mammary gland during 
the postpartum period (Roth et ai., 1982; Blalock, 1994). The elevated levels of these 
hormones present during the postpartum period may alter the type of cytokines secreted 
from Th1-type to Th2-type (Rook et ai., 1994). The imbalance between Th1-type and 
Th2-type cells and the cytokines they produce has been linked to disease susceptibility 
(Clerici and Shearer, 1994; Romagnani, 1994; Carter et ai., 1996). The expression of T 
suppressor cells dominates that of T cytotoxic cells during the postpartum period 
compared to the proportions present mid to late lactation (Shafer Weaver et ai., 1997). 
The presence of T suppressor cells during the postpartum period has been reported to 
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reduce the responsiveness of CD4+ T cells present in the mammary gland (Shafer Weaver 
and Sordillo, 1997). The presence of T suppressor cells in peripheral blood and the 
mammary gland during the postpartum period has resulted in a reduction of ll.,-2 and IFN-
y (Park et ai., 1993; Sordillo et ai., 1991). 
The immunosuppression reported in the mammary gland during the postpartum period 
was reversed during mid to late lactation. During mid to late lactation an increase in the 
levels of ll.,-2 and IFN-y in the mammary gland and in peripheral blood, due to the large 
proportion of Thl-type CD4+ T cells was reported (Ishikawa et ai., 1994; Shafer-Weaver 
et ai., 1996; Sordillo et ai., 1991). 
Monocytes present in peripheral blood are the precursors for macrophages, which are 
responsible for non-specific cellular immunity (Durum et ai., 1984). Macrophages in 
cattle are known to reside as Kupffer cells in the lining of the sinusoids of the liver, 
microglia in the brain, alveolar macrophages in the alveoli of the lung and those present 
in lymphoid and mammary gland tissue (Bielefeldt Ohmann et ai., 1986; Bryan et ai., 
1988). Pulmonary intravascular macrophages account for a large number of macrophages 
in cattle and other species and are involved in the clearance of blood borne bacterial 
pathogens and particulate debris (Winker et ai., 1988). 
Mammary gland macrophages ingest fat and casein indiscriminately from the milk. This 
results in fat globules within the cytoplasm of macrophages, which allows distinction 
between those present in the peripheral system and those in the mammary gland, as their 
cytoplasm appears foamy (Jenson and Eberhart, 1975). Non-specific ingestion of fat by 
macrophages has been shown to result in a reduction in phagocytic capability of 
mammary gland macrophages, and is particularly compromised prior to calving. 
Macrophages contain phagocytic and antibacterial properties (Higginbotham and Pruett, 
1994), which are functional whilst they are resting but once activated become more 
aggressive, capable of ingesting bacteria, cellular debris and milk components (Sordillo 
and Nickerson, 1988). An important product of macrophage activation is the prompt 
release of ll.,-I, ll..,-6 and TNF-a, which can trigger acute phase and inflammatory 
responses (Politis et ai., 1991). Macrophages contribute to cell mediated immunity, 
acting as APC involved in processing and presenting antigen to lymphocytes (Nickerson, 
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1985) and have been reported to be the predominant cell type in a healthy lactating 
mammary gland (Lee et ai., 1980; Jensen and Eberhart, 1981; Concha and Holmberg, 
1990). Presentation of antigen by peripheral blood macrophages occurs in association 
with MHC class II expressed on their cell surface (Weaver and Unanue, 1990; Sordillo et 
ai., 1997), and has also been reported in macrophages within the mammary gland 
(Fitzpatrick, 1992). Macrophages also express ligands for co-stimulation with T cell 
markers (Ding and Shevach, 1996). These ligands can be expressed (Oyaizu et ai., 1997) 
or secreted (Kiener et ai., 1997). The macrophage population, like lymphocytes, divides 
into two subsets effected by the presence of various cytokines. The two subsets differ 
phenotypically and have been reported to develop as a result of antagonistic induction 
pathways (Orlikowsky et ai., 1996; Orlikowsky et ai., 1997+ 
; Kummerle-Deschner et ai., 1998). 
1.11 Initiation of an Immune Response 
A dual signal model was first suggested to try and explain why lymphocytes once they 
have encountered an antigenic stimulus, either induce an immune response or remain 
unresponsive (Bretsher and Cohn, 1970). The first signal was described as being induced 
by the coupling of the antigen receptor to antigen, which if not backed up by a second 
signal would result in unresponsiveness. The primary signal is now recognised as the 
engagement of the TCR with the MHC-antigenic peptide complex. Various suggestions 
have been made as to the nature of the second signal. Some of these include the 
interaction previously described between B7.1 (Freeman et ai., 1989; 1991), or B7.2 
(Azuma et ai., 1993; Freeman et ai., 1993; Hathcock et ai., 1993; Ranger et ai., 1996). 
The interaction between CD28 (June et ai., 1990), and CTLA-4 (Linsley et ai., 1991b); 
the interaction between CD28 and CD2 (Meuer et ai., 1984; Kato et ai., 1992; Holter et 
ai., 1996); the interaction between CD28 and ICAM-l (Kuhlman et ai., 1991; Dubey et 
ai., 1995; Cai et ai., 1996; Deeths and Mescher, 1997); and the interaction between CD28 
and LFA-3 (Parra et ai., 1997). Cytokines, for example IL-l (Williams et ai., 1985; 
Houssiau et ai., 1988; Houssiau et ai., 1989; Vink et ai., 1990; Holsti et ai., 1994), IL-2, 
IL-6 (Houssiau et ai., 1988; Houssiau et ai., 1989; Vink et ai., 1990; Holsti et ai., 1994; 
Joseph et ai., 1998) and TNF-a (Vella et ai., 1997; Joseph et ai., 1998), have also been 
suggested as candidates for initiation of the second signal. Recent studies have reported 
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that if the primary signal relayed to the T cell is exceptionally strong, the requirement for 
the second signal to initiate the immune response may be obsolete (Goldstein et ai., 1998; 
Luxembourg et ai., 1998). Others have dismissed this theory and reported that CD8+ T 
cells, whose response is based upon a single signal, die rapidly if no secondary signal 
follows (Sepulveda et ai., 1999). Work showing that the interaction between CD28 and 
B7, as well as providing a secondary stimulatory signal for induction of an immune 
response, also provided a survival signal for those CD8+ T cells, supports the theory for a 
dual signal (Sperling et ai., 1996). The age and maturity of the cell being induced must 
be taken into account as it has been suggested that fewer TCR-ligand interactions and co-
stimulatory molecules are required by mature effector cells when compared to immature 
effector cells (Dubey et ai., 1996). 
1.11.1 Cell cycle events 
The recognition of antigenic peptide by lymphocytes by virtue of cell surface markers 
results in proliferation and differentiation of cells. Differentiation produces clones of 
cells with corresponding receptors to the antigenic determinant or epitope (Benjamini et 
ai., 1996). This mechanism is more commonly described as clonal selection (Klein and 
Horejski, 1999). 
Resting lymphocytes appear as a homogenous population with a low RNA and DNA 
content and are referred to as Go cells (Kristensen et ai., 1982). On stimulation the Go 
cells transform into the G1 phase of their cell cycle, which is characterised by an increase 
in RNA synthesis (Darzynkiewicz et ai., 1976; Stadler et ai., 1980). Once an increase in 
DNA synthesis is detectable the lymphocytes have entered into the S phase of their cell 
cycle. On completion of DNA-synthesis the lymphocytes progress to an interphase 
known as the G2 phase (Klein and Horejski, 1999). From the G2 phase the lymphocytes 
undergo mitosis (M phase) and subsequently return to the Go phase (Kristensen et ai., 
1982). It has also been suggested that lymphocytes undergoing mitosis go directly to the 
G1 phase of their cell cycle during the logarithmic growth phase. It has been 
demonstrated previously in mice and humans that an ll..-2 signal in addition to the 
activation signal is required for T cell proliferation (Baker et ai., 1980; Gillis et ai., 
1980). The ll..-2 is responsible for completion of the cycle involving RNA synthesis and 
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proliferation (Kristnesen et ai., 1981). T cells have been reported previously to secrete 
IL-2 after binding mitogen or antigen to the cell membrane and after receiving a signal 
from IL-l secreted from adherent cells (Smith et ai., 1980). 
1.11.2 Re-circulation 
Large proportions of lymphocytes, which reside in the central lymphoid organs namely 
bone marrow and thymus, and in the secondary lymphoid organs of the lymph nodes (LN) 
and spleen remain within these sites. Approximately 10% of lymphocytes in adult 
animals are able to migrate from peripheral blood to tissue and then into the lymph nodes 
(Trnka and Cahill, 1980). This mechanism is known as re-circulation (Gowans and 
Knight, 1964). Re-circulation, prior to elucidation of the mechanism involved, was 
believed to occur randomly. A model in sheep depicted T cells homing in tissue specific 
streams towards the gut (Cahill et ai., 1976). The ability of lymphocytes to re-circulate is 
an inherent trait important in foetal development for long term development of immunity 
(Pearson et ai., 1970). The thymus contributes to the determination of tissue-specific T 
cell re-circulation, as well as contact with antigen in foetal development (Washington et 
ai., 1994; Kimpton et ai., 1995). 
Initial attachment of lymphocytes to vascular endothelial cells is an absolute requirement 
for cells that leave the periphery and enter the surrounding tissue (Janeway and Golstein, 
1992; Springer, 1994). The attachment of lymphocytes to endothelial cells is regulated by 
cell surface molecules expressed on lymphocytes and on the endothelium of the target 
tissue. Adhesion molecules are essential for the re-circulation of lymphocytes to the 
lymphatic organs or effector sites (Springer, 1994; Picker, 1994; Springer, 1995). After 
adhesion to the vascular endothelium, rolling of the leucocyte on endothelial cells in post 
capillary venules or HEV of peripheral lymph nodes or mucosal tissue of the gut is 
mediated by expression of selectin or integrin (Ley and Tedder, 1995; Bargatze et ai., 
1995). The majority of lymphocytes and HEV interactions have been studied in humans 
and mice, using the methodology associated with the binding of MAb to tissue sections or 
monocultures to provide enlightenment as to the mechanisms involved (Kishimoto et ai., 
1989; Dustin and Springer, 1991; Picker and Butcher, 1992). The production of MAb for 
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ruminant species now makes it possible to study lymphocyte re-circulation and homing in 
these animals (Trnka and Cahill, 1980; Miyasaka and Trnka, 1986; Pearson et aI., 1976). 
Lymphocyte entry into the LN from peripheral blood is predominately via post capillary 
venules (PCV), (Harp et al., 1990; Kraal and Mebius, 1997), which are distinguished 
morphologically from HEV but function in a similar manner. Approximately 10% of the 
total lymphocyte population is transported to the LN via the afferent lymph, and 
transported from the LN via the efferent lymph (Binns, 1988). 
Endothelial cells express adhesion molecules with complementary ligands expressed on 
the surface of the circulating T cells (Jutila et al., 1989). One such ligand is CD62, 
known as L-selectin and regarded as a homing receptor. L-selectin has been well 
conserved throughout mammalian evolution with expression reported in sheep (Mackay 
et al., 1992), and cattle (Howard et al., 1984). L-selectin promotes binding of 
lymphocytes to the HEV on endothelial surfaces and permits diapedesis of lymphocytes 
into the LN. Lymphocytes deficient in L-selectin have been shown to be unable to 
migrate to the peripheral nodes (Arbones et al., 1994; Steeber et al., 1996; Tang et al., 
1998). Another such adhesion molecule is ICAM-l, which has been shown to mediate 
firm adhesion and transmigration of neutrophils (Sakamoto et al., 1997; Morland et al., 
1997) and T cells to hepatic endothelial cells in vitro (Yoong et al., 1998). Lymphocyte 
Function associated Antigen has been reported to aid in the trans-endothelial migration of 
T cells (Oppenheimer-Marks et al., 1991), and in the multi-step extravasation of 
lymphocytes (Picker et al., 1990). 
The uterus of the sheep provides an environment where foreign antigen and memory T 
cells are prevented from entering the tissues and, therefore, the homing patterns of T cells 
can be followed and distinguished between naIve and memory T cells (Pearson et al., 
1976; Cahill and Trnka, 1980). From studies using the ovine uterus, lymphocytes have 
been reported to begin re-circulating 75 days into the gestation period, migrating from 
peripheral blood and entering the tissue, during which time their growth is exponential 
(Cole and Morris, 1973). 
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The immunological development that takes place in the thymus, spleen, lymph node and 
Peyers patches in human foetal development is very similar to that reported in sheep 
during that period. By way of comparison, at the time of birth, rats and mice have 
inadequately developed lymphoid organs. The similarity between human and sheep 
development makes the sheep model useful for determining different stages of human 
immunological development (Kimpton et al., 1995). At approximately day 80 in the 
gestation period, the foetal sheep thymus is fully developed as identified by 
immunohistological and cellular appearance (Mackay et al., 1986; Maddox et al., 1987; 
Kimpton et al., 1995). 
Re-circulation of lymphocytes in the sheep foetus is comparable with numbers of 
lymphocytes present in the postnatal immune system (Kimpton et al., 1989; Kimpton et 
al., 1990; Kimpton et al., 1995). Transportation of cells from the thymus in the postnatal 
animal approximates to 1 % of thymocytes per day and has been reported in mice (Scollay 
et al., 1980), pigs (Binns et al., 1988) and humans (Miyasaka et al., 1990). Re-circulation 
in humans of lymphocytes approximates too roughly that reported for other species under 
non-inflammatory conditions. Of these lymphocytes, CD4+ T cells more actively re-
circulate than CD8+ T cells (Lemaire et al., 1998). 
1.11.3 Lymphocyte Homing 
T cells expressing a memory phenotype preferentially re-circulate to the site of initial 
antigenic stimulus; termed lymphocyte homing (Mackay et al., 1992; Picker and Butcher, 
1992). It has been reported that T cells expressing the memory phenotype re-circulate 
more actively in the gut when compared to other non-lymphoid sites (Lemaire et al., 
1998). Non-lymphoid sites that have shown T memory cell re-circulation included 
intestinal mucosa, skin, pulmonary tissue and joints (Mackay et al., 1992; Picker and 
Butcher, 1992; Butcher and Picker, 1996). The migratory pathways associated with naIve 
and memory T cells are distinct. Memory T cells migrate preferentially through non-
lymphoid tissue, whereas naIve T cells are transported via HEV in the LN. The 
development of the distinct pathways for memory and naIve T cells is regulated by 
exposure to antigen (Butcher and Picker, 1996; Mackay, 1993). 
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As a result of antigenic challenge, a dramatic reduction in migration of cells, termed 
shutdown, from within the LN during the initial hours post challenge has been reported 
(Hall and Morris, 1967). The reduction in the migration of cells coincides with an influx 
of lymphocytes into the LN, mediated by an increase in blood flow to the stimulated node 
(Cahill et ai., 1976). The lymphocytes that migrate from within the LN during antigenic 
challenge, amplify and disseminate the immune response to the whole body (Hall et ai., 
1967), highlighting the necessity for an efficient lymphatic system to circulate memory 
and effector cells. 
The existence of a common mucosal immune system has been demonstrated in 
monogastric species such as pigs (Harp and Moon, 1988). Priming of immune cells with 
antigen via the gastrointestinal route lead to antigen-specific immune cells being present 
in the mammary gland (Goldblum et ai., 1975; Parmely and Beer, 1977; Kortbeeklacobs 
and Van der Donk, 1981). The existence of a common mucosal immune system, known 
as the entero-mammary link, is less functional in ruminants (Chang et ai., 1981; Moon 
and MacDonald, 1983). The less functional entero-mammary link was highlighted in 
cattle when radiolabeled mammary LN lymphocytes localised in the node of origin 
(mammary LN) and a peripheral node (prescapular LN) (Harp et ai., 1988). However, 
very few of the radiolabeled cells localised in the intestinal mesenteric node, as 
previously reported in sheep (Harp and Moon, 1987). 
1.12 Major Histocompatibility Complex 
The murine MHC, named H-2 (Snell, 1958) was discovered by the recognition of 
molecules present on lymphocytes which resembled a blood group antigen. Twenty years 
later, the chicken B complex (Briles et ai., 1950), followed by the human leucocyte 
antigen system (HLA; Klein, 1986) were reported. The MHC was recognised as the 
major locus controlling the rejection of foreign transplantation tissue in chickens 
(Schierman and Nordskog, 1961) and humans (Tiercy et ai., 1991) as well as influencing 
susceptibility to autoimmune diseases (Gregersen et ai., 1987; Thomson, 1988). The 
MHC has now been described in mammalian, avian, amphibian, domestic species (Klein 
and Figueroa, 1986), pigs (Vailman et aI., 1970), and cattle, where it is termed the Bovine 
Leucocyte Antigen System (BoLA), (Amorena and Stone, 1978). Definition of BoLA 
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was carried out using antisera that had been raised from recipients of skin grafts and 
mUltiparous cows (Spooner et ai., 1978; Spooner et ai., 1979). 
The location of the MHC varies among species, the munne H-2 is located on 
chromosome 17, HLA on chromosome 6 of man (Korman et ai., 1985), and BoLA on the 
short arm of chromosome 23, identified by use of in situ hybridisation. Within the MHC 
there are three different regions, class I, class II, and class ill. In both the HLA and BoLA 
system, the chromosomal organisation is in the order of centromere: class II genes first, 
separated from class I genes by class ill in the middle (Peel man et ai., 1996). 
The region between class II and class ill appears conserved in humans, pigs and mice 
(Lunney, 1994), unlike the region between class I and class ill, which appears more 
variable (Bahram et ai., 1994). The class ill genes are less variable and show 
conservation in mammalian species. Information on MHC class ill genes in horses, cattle 
and goats is limited, with the organisation suggested as similar to that in humans 
(Cameron et ai., 1990). The location of structural genes required for serum complement 
components have been reported in the MHC class ill region (Hood et ai., 1983), with 
their function reported as unrelated to that of class I and class II genes (Klein et ai., 1986) 
It was first observed in the 1960s that mice and guinea pigs could be categorised as high 
or low immune responders based on antibody production induced by a synthetic 
polypeptide (Paul et ai., 1968; McDevitt and Benacerraf, 1968), and that the ability to 
respond to antigenic stimulus was possibly due to the presence of immune response genes 
(McDevitt et ai., 1972). These immune response genes were categorised as MHC class II, 
and the MHC molecules identified by classic serology were defined as MHC class I. 
The MHC is regarded as a major gene in immune responsiveness (Falconer, 1989). MHC 
genes encode highly polymorphic cell surface molecules, which present antigenic 
peptides to T lymphocytes (Allen et ai., 1987). High and low antibody responder lines of 
mice were created by selective breeding to antigen of different specificity's (Biozzi et ai., 
1979). Immune responsiveness was shown to be under polygenic control, with MHC-
linked genes playing a partial and irregular role (Biozzi et ai., 1979). After seven 
generations of selective breeding the differences between the high and low antibody titre 
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lines was calculated to be the effect of alleles at four independent loci (Cabrera et at., 
1982). One line of responder mice in particular with a high antibody titre carry a MHC 
class II with a specific B-chain sequence, which renders those mice susceptible to chronic 
relapsing experimental allergic encephalomyelitis (Liu et at., 1993). In humans the 
alteration of the HLA-DQ B-chain sequence is associated with insulin-dependant diabetes 
mellitus (Tait and Harrison, 1991). Greater than 10% of differences in immune 
responsiveness towards various antigens can be attributed to MHC in mice (Biozzi et at., 
1974), and cattle (Mallard et at., 1989). 
It is well established that cellular and humoral immune responses are influenced through 
the MHC, in presentation of simple antigens (Benacerraf and Germain, 1978; Klein, 
1986) and in disease susceptibility. Presentation of antigenic peptides to lymphocytes 
usually takes place in the presence of a MHC molecule for the induction of an immune 
response. Antigenic peptides are joined to a respective class of MHC molecule 
depending on the responding lymphocyte type. Further work revealed the crystallised 
complex of the TCR coupled to peptide embedded in the MHC molecule (Garcia et at., 
1996). The ability of lymphocytes to recognise non-self antigen in conjunction with self-
MHC molecules is known as MHC restriction (Zinkemagel and Doherty, 1974). Major 
Histocompatibility Complex restriction was first described with regards to MHC class II 
in the guinea pig (Shvach and Rosenthal, 1973) and has been defined in mice (Shreffler 
and David, 1975) and humans (Bergholtz and Thorsby, 1978). In general, MHC class I 
molecules present antigenic peptides to T cytotoxic lymphocytes, expressing the CD8 cell 
surface molecule and are expressed on the surface of all nucleated cells. In contrast MHC 
class II molecules present antigenic peptides to T helper lymphocytes, expressing the CD4 
cell surface molecule (Batra et at., 1989; Parham and Ohta, 1996) and are expressed on 
the cell surface of macrophages, dendritic cells, B lymphocytes and some epithelial cells 
(Wiman et at., 1976). Expression of MHC class II molecules have also been identified on 
the surface of activated lymphocytes (Seeg et at., 1982). During the latter stage of the 
immune response, T cytotoxic cells have been identified as expressing MHC class II 
molecules (York and Rock, 1996). This may result in a down-regulation of the immune 
response resulting in the prevention of antigen presentation to T helper lymphocytes 
(Braakman et ai., 1987). 
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The manner in which antigen is processed is dependant on which class of MHC molecule 
is expressed. Endogenous antigen is processed by cells expressing MHC class I (Moore 
et ai., 1988) and exogenous antigen is processed by cells expressing MHC class IT (Lamb 
et ai., 1982; Hanke et ai., 1985). 
1.12.1 Major Histocompatibility Complex class I 
Major Histocompatibility Complex class I molecules are integral cell surface 
glycoproteins. Expression of MHC class I has been identified on all nucleated somatic 
cells (York and Rock, 1996). The heavy chains of the MHC class I molecules are bound 
non-covalently to ~2-rnicroglobulin (Madden, 1995). Beta 2-micoglobulin although not 
encoded for by the MHC, is thought to provide structural stability for the MHC class I 
molecule (Townsend et ai., 1990; Elliott et ai., 1991). The MHC class I genes are 
receptors for endogenous antigen to be processed and presented to the immune system 
(Moore et ai., 1988). 
Ubiquitin, a small stable protein, attaches the target pathogen to a proteosome, a complex 
of different proteases (Englehart, 1994), with different peptidase activity. The 
proteosome unfolds the target pathogen and during this process releases the ubiquitin. 
Generation of antigenic peptides from the whole target pathogen transpires at the centre 
of the proteosome. The antigenic peptides generated are attached to transporter proteins, 
Transporter for Antigen Processing-1 (TAP 1) and T AP2, which prevent further 
degradation by the proteosome. Antigenic peptides are delivered via the TAP molecule 
across the cytoplasm and into the lumen of the endoplasmic reticulum (ER). In TAP 
deficient cell lines accumulation of MHC class I molecules within the ER can result in 
unstable heterodimeric complexes (Tan et ai., 1997) effecting the presentation of 
antigenic peptides to cytotoxic T lymphocytes (Powis et ai., 1991; Spies and DeMars, 
1991). In the lumen of the ER peptide fragments are coupled to MHC class I molecules, 
which are bound non-covalently to ~2-microglobulin (Heemels and Ploegh, 1995). The 
peptides are loaded into the MHC binding groove, to form a peptide-MHC complex and 
transported from the ER to the cell surface for recognition by T cytotoxic lymphocytes. 
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Studies characterising the crystallised structure of the HLA class I molecule reported 
antigenic peptides presented in a groove formed by the al and a2 domain (Bjorkman et 
at., 1987). The structure of the groove was reported as an ala2 unit, supported by a ~ 
pleated sheet floor containing eight strands bounded by two a helices, one from aI, and 
one from a2 (Brown et at., 1993; Stem et ai., 1994). Once the structure had been 
detailed, the groove was renamed as the peptide binding groove. More detailed 
examination of the peptide binding groove revealed the presence of pockets (Garrett et 
at., 1989), reported to house anchor residues involved in peptide recognition (Saper et ai., 
1991). It was reported that polymorphic amino acid residues present in the HLA heavy 
chain created the pocket structure (Madden et at., 1992). The class I peptide binding 
groove is restricted to binding peptides of eight to nine amino acids in length (Rotzschke 
et at., 1990; van Bleek and Nathenson, 1990; Falk et ai., 1991). This is due to the peptide 
binding grooves structure being closed at both ends (van Bleek and Natheson, 1990; 
Schumacher et at., 1991; Falk et ai., 1991; Madden et at., 1991). Following expression 
on the cell surface a portion of the MHC class I molecules are endocytosed, either being 
recycled back to the plasma membrane or retained intracellularly and degraded (Reid and 
Watts, 1990). This level of regulation of MHC class I ensures a constant level of 
expression is maintained. 
1.12.2 Major Histocompatibility Complex class II 
Major Histocompatibility Complex class II genes reside in the D locus of BoLA (Groenen 
et at., 1990). Restriction Enzyme Fragmentation Pattern (REFP) analysis (Andersson, 
1988) and characterisation of cloned MHC class II genes (Groenen et at., 1990) resulted 
in mapping studies, which reported that the order of genes in the BoLA system was 
similar to those in the HLA system (Bensaid et ai., 1991). 
Major Histocompatibility Complex class II molecules, like MHC class I molecules, are 
cell surface glycoproteins (Klein, 1986), and exist as dimers composed of an a and ~­
chain. Expression of BoLA-MHC class II molecules has been reported on classical APC 
such as B cells (Lewin et ai., 1985), monocytes (Taylor et at., 1993), and alveolar 
macrophages (Ohmann et at., 1986). Expression has also been noted on other cell types 
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including, activated T lymphocytes (Taylor et ai., 1993), mammary epithelial (Fitzpatrick 
et ai., 1992) and bronchial epithelial cells (Spurzem et ai., 1992). 
There are 12 loci in the class II region of BoLA, with two sub-regions in the MHC class 
II; class IIa and class lIb. These two sub-regions are approximately 15 centimorgans 
apart, identified previously by genetic mapping (Andersson, 1988; van Eijk et ai., 1992). 
The DQ and DR genes present in sub-region IIa of BoLA are in tight linkage 
disequilibrium, where there are only a few exceptions of DQA alleles that are not 
associated with the same DQB alleles (Sigurdardottir et ai., 1988). Linkage 
disequilibrium generates haplotypes or combinations of allelic variants of genes located 
on one chromosome. The gap between the subregions of class IIa and class lIb has 
created a hot spot for intra-MHC recombination, which alter haplotypes normally 
inherited as a complete unit (Andersson, 1988). The genes residing in the MHC class IIa 
region are DRA, DRBl, DRB2, DRB3, DQA, and DQB. In this sub-region, the function 
of these genes has been well studied (Davies et ai., 1994b). The genes residing in the 
MHC class lIb region are DY A, DYB, DIB, DOB and DNA. Much less is known of the 
function of these genes within this group (Andersson and Rask, 1988). 
Cellular intemalisation of exogenous antigen is contained within endosomal or lysosomal 
vesicles (Werdelin, 1987; Wubbolts et ai., 1997). These vesicles contain proteases and 
peptidases, which provide an extremely acidic environment (pH-4) for degradation of the 
antigen into peptides of various lengths (Allen, 1987). Synthesis of the MHC class II 
dimer molecule takes place in the ribosomes of the rough endoplasmic reticulum (RER), 
where association with an invariant (Ii) chain prevents peptide binding at this stage. The 
MHC class II molecule and Ii complex are transported via the Golgi and trans-Golgi 
network to the cell surface. En route to the cell surface the vesicles containing the MHC 
class II molecules intercept the acid vesicles containing the peptide. When the MHC 
class II molecules and peptide fuse the Ii chain degrades and the MHC and peptide 
complex is transported to the cell surface for presentation to CD4+ T lymphocytes. The 
loading of MHC class II molecule with peptide occurs via the endocytic pathway. 
The antigen binding groove of MHC class II molecules comprises eight strands of anti-
parallel ~ sheets for the floor and two anti-parallel helical regions create the sides (Brown 
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et aI., 1993; Stem et al., 1994). The antigen binding groove of MHC class II molecule is 
open ended (Rudensky et al., 1991) and can accommodate peptides up to 34 amino acids 
in length (Chicz et aI., 1993). The MHC class II peptide binding groove is restricted also 
as peptides with a minimum of eight or nine amino acids are required (Sinigaglia and 
Hammer, 1994). The MHC class II binding groove lacks the amino acid chains, which 
act as a lid on the class I groove (Chicz et al., 1993). Attachment of peptide in the MHC 
class II binding groove occurs preferentially in the middle of the cleft allowing longer 
peptides to bind (Engelhart, 1994). 
1.12.2.1 Major Histocompatibility Complex class IIa DOB 
A high degree of polymorphism in the MHC class IIa loci was identified by the use of 
human probes and RFLP (Andersson, 1986; Sigurdardottir et al., 1988). Polymorphisms 
differ between the MHC and proteins as the number of alleles and number of amino acid 
replacements at a single locus is often very high in the MHC, with amino acid 
substitutions reported to be in excess of 10% (Schenning et al., 1984; Trowsdale and 
Kelly, 1985). Both DQA and DQB, especially in exon 2 (Ballingall et al., 1997) loci 
have been shown to be highly polymorphic with 31 DQA (Davies et aI., 1994) and 37 
DQB alleles (Davies et al., 1997) identified by RFLP. The DRA locus however does not 
exhibit the same level of polymorphisms and has been reported as monomorphic (Aida et 
ai., 1995). Recent studies have reported the possible identification of another DQA locus 
(Ballingall et ai., 1997). Complexity of bound MHC repertoire of peptides is still largely 
unknown. It has been estimated that in excess of 2000 peptides can bind to the murine 
MHC class II-lAd region, which is the equivalent to the DQ region in humans (Englehart, 
1994). A study carried out by Chicz et al. (1993) reported greater than 200 peptides 
presented by each of the HLA-DR alleles they investigated. One hypothesis for the 
existence of polymorphisms at the MHC locus is that some alleles may be favourable for 
protection to one disease whilst other alleles may be favourable for resistance to another 
disease (Biozzi et al., 1979). 
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1.12.2.2 Major Histocompatibility Complex class ITa DRB 
Three DRB loci have been reported, DRB 1 has been reported as an unexpressed 
pseudogene, DRB2 is poorly expressed (Burke et ai., 1991; Russell et ai., 1994) but does 
express polymorphic properties (Mugglicockett and Stone, 1991). The DRB3 locus is 
expressed and is highly polymorphic (Sigurdardottir et ai., 1988). The DRB3 locus has 
also been reported to possess functional restriction elements (Burke et ai., 1991; Fraser et 
ai., 1996). Numerous haplotypes have been associated with the HLA-DRB locus, 
whereas BoLA-DRB3 has been reported as well-conserved (Sigurdardottir et ai., 1991), 
adding to the possible functional importance of this locus in cattle. Genetic 
polymorphisms are predominately within exon 2 of DRB3, which has been reported to 
encode the antigen-binding site (Ellegren et ai., 1993). DRB3, in particular alleles from 
ex on 2, have been associated with traits involved in immunity, somatic cell score and 
mastitis incidence (Dietz et ai., 1997b). 
1.12.3 Major Histocompatibility Complex and disease 
Resistance to infection can be partially determined by genetics (Gavora and Spencer, 
1983). Farmers select animals based on production traits: however higher yielding 
animals are associated with increased health costs (Jones et ai., 1994). Selection of 
animals for improved health traits can be problematic due to low heritability of some 
traits and limited availability of records of disease incidence (Starkenburg et ai., 1997). 
The association between the MHC and infectious disease has been best defined by 
Marek's disease in chickens (Briles et ai., 1977; Hepkema et ai., 1993). Many B 
haplotypes have been associated with specificity of immune response and resistance to 
specific diseases (Kean et ai., 1994). The index used to gauge immune responsiveness 
combines humoral, cellular and reticuloendothelial aspects of the immune system (Kean 
et ai., 1994). In chickens, the B haplotype, B21, has been shown to improve resistance to 
Marek's disease, as were the B2 and B6 haplotypes (Briles et ai., 1980). The B21 
haplotype, as well as improved resistance, has been shown to promote increased antibody 
production (Martin et ai., 1990). The B19 haplotype has been reported to increase 
susceptibility to the disease as did the haplotypes B3, B5, B13 and B15 (Briles et ai., 1980). 
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Association between the MHC and subclinical bovine leukaemia virus infections (Lewin, 
1988) and equine sarcoids (Lazary et al., 1985; Meredith et al., 1986) have also been 
reported. 
Associations among production traits, health traits, and MHC class I alleles in cattle have 
been reported. These include percentage milk fat (Hines et al., 1986), protein yield (Batra 
et al., 1989), ketosis (Mejdell et al., 1994), a reduction in the number of cases of mastitis 
and health costs attributed to increased milk yield and high fat content (Weigel et al., 
1990). Parasitic infection, determined by faecal worm egg counts (Stear et al., 1988), and 
tick infestation (Stear et al., 1989) have also been associated with MHC class I alleles. 
MHC class I genes have also been shown to have an association with the incidence of 
clinical mastitis (Oddgeirsson et al., 1988; Mejdell et al., 1994; Schukken et aI., 1994) 
and the susceptibility or resistance to mastitis (Solbu, 1983; Spooner et al 1988). The 
identification of allele BoLA-A14 has been linked to low SCC (Weigel et al., 1990), to 
resistance to enzootic bovine leucosis (Lewin and Bernoco, 1986) and late seroconversion 
in those cattle infected with enzootic leucosis (Lewin and Bernoco, 1986; Palmer et al., 
1987). The effect elicited by this one allele highlights the fact that selection for a single 
trait may affect many other traits. 
At least 170 BoLA-A-DRB3 haplotypes have been identified within the major breeds 
associated with both dairy and beef production (Lewin, 1996). Variation in haplotype 
among breeds was noted, however, detection of ancestral haplotypes was also observed. 
These ancestral haplotypes permit elucidation of the evolutionary relationship among 
breeds of cattle and relates them to the migratory patterns of humans over the years 
(MacHugh et al., 1994). 
Associations between BoLA MHC class IT alleles and bull breeding values have been 
shown with respect to clinical mastitis, ketosis, retention of the placenta and milk fever 
(Lunden et al., 1991). In one study in cattle, it was reported that allele DRB3.2*16 
increased the susceptibility to mastitis as estimated by an increase in SCC (Dietz et al., 
1997a). In the same study, alleles DRB3.2*11, 12, 23 were suggested to improve 
resistance to clinical mastitis. Other studies have contradicted this previous work by 
reporting an association between allele DRB3.2*16 and a reduction in SCS in Holstein 
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cows in their first lactation (Sharif et ai., 1998a) and second lactation (Starkenburg et ai., 
1997). Allele DRB3.2*23 reported previously to reduce the incidence of clinical mastitis 
was reported by others to increase the severity of the incidence of coliform mastitis 
(Sharif et ai., 1998a). 
Evidence of heritability associated with immune response and the MHC has been reported 
previously in pigs (Mallard et ai., 1992) and in cattle (Detilleux et ai., 1994). The 
association in cattle has been reported with respect to BoLA class I alleles and 
measurable parameters of non-specific immunity (Weigel et ai., 1991). A significant 
association was also reported previously between immune parameters of BoLA MHC 
class IT DRB alleles (Dietz et ai., 1997b). The suggestion from the study carried out by 
Dietz et ai. (1997b) was that further studies were required to determine the interaction 
between the MHC class IT alleles and the traits of innate and adaptive immunity. 
Mastitis is a multi-factorial disease with complex aetiology (Anderson, 1983). Variation 
in susceptibility due to causative agent, environmental factors, genetics and the 
interaction of all of the above will contribute to the risk of an individual animal suffering 
from an IMI. Resistance or susceptibility to clinical mastitis by BoLA has been shown to 
vary among breeds. In Norwegian Red cattle, BoLA-All has been linked to 
susceptibility to clinical mastitis, whereas in Holstein and Danish Black Pied cattle, it has 
been linked to resistance to clinical mastitis (Weigel et ai., 1990), and low SCC, 
respectively (Aarestrup et ai., 1995). Levels of BoLA-MHC class IT expression present 
on PBM has been shown to vary depending on the reproductive cycle. Levels of MHC 
class IT on the monocytes of cows were shown to be highest prior to parturition and after 
parturition, with levels falling after calving (Van Kampen and Mallard, 1997). Selection 
of haplotypes for resistance to a particular disease, making the animals homozygous at the 
MHC loci would create holes in the peptide-binding repertoire (Lewin et ai., 1999). The 
implementation of haplocide, homozygosity at the MHC loci, may result in animals 
resistant to one pathogen and susceptible to another (Lewin, 1989). The complex 
aetiology of mastitis makes it very difficult to achieve absolute resistance to any 
infectious agent in an outbred species even in the well characterised MHC linked resistant 
loci in Marek's disease (Briles et ai., 1977). 
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1.12.4 Methods of Detection of Major Histocompatibility Complex Polymorphisms 
Various methods for characterisation of polymorphisms in BoLA MHC class II genes and 
products have been described. For detection of protein polymorphisms, serology (Emery 
et al., 1987; Williams et al., 1991) and one-dimensional isoelectric focusing have been 
used (Watkins et al., 1989; Glass et al., 1992). To elucidate the genetic organisation of 
the class II genes RFLP (Sigurdardottir et al., 1988), DNA sequence analysis (Groenen et 
al., 1990; Bernoco et al., 1991; Sigurdardottir et al., 1991; Davis et al., 1997), and allele 
specific oligonucleotide (ASO) hybridisation have been used (Sitte et al., 1995). 
Availability of HLA sequence data on genes within the MHC allowed the development of 
a PCR based technique leading to sequence based HLA typing methods (Saiki et al., 
1988). These techniques used single stranded oligonucleotides and restriction 
endonucleases (PCR-RFLP), (Maeda et al., 1989; Dekker and Easteal, 1990; Uryu et al., 
1990) for identification of polymorph isms in PCR amplified products from the HLA-
MHC class II. 
1.12.4.1 Polymerase Chain Reaction-Restriction Fragment Length Polymorphism 
The combination of PCR and RFLP techniques saw the development of an extremely 
powerful tool for the determination of genetic polymorphisms in the functional domain of 
BoLA-DRB3 (van Eijk et al., 1992; Russell et ai., 1997), combining simplicity and speed 
(Mallard et al., 1999). The use of PCR-RFLP permitted analysis of multiple samples and 
animals identifying important allelic patterns in the ~ 1 domain by enzymatic degradation 
(Maeda et al., 1989; Dekker and Easteal, 1990; Uryu et al., 1990). A possible drawback 
of PCR-RFLP when looking at heterozygotes is preferential allele amplification, which 
results from mismatching in the regions where the primers used for amplification anneal. 
Unwanted products of PCR which form when complementary strands of DNA pair up are 
known as heteroduplexes, and out-compete the oligonucleotides for hybridisation with 
their template strand. The interference of heteroduplexes is restricted to those that form 
during the final annealing step within the PCR, as others formed prior to this will 
dissociate. Work carried out by Van Eijk et al. (1992) used PCR-RFLP to successfully 
characterise 14 alleles which had been previously identified by DNA sequencing 
(Sigurdardottir et al., 1991). 
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1.12.4.2 Advances in Methodology for the Detection of MHC Polymorphisms 
The development of microsatellite haplotyping (Ellegren et ai., 1993) has reported a 
technique that is as powerful as PCR-RFLP, and extremely useful in large scale MHC 
disease association studies related to outbred populations as well as paternity testing (van 
Haeringen et ai., 1999). Denaturing Gradient Gel Electrophoresis (DGGE) has been 
reported as having an increased sensitivity and specificity for identification of new BoLA 
alleles (Aldridge et ai., 1998). The technique is rapid and allows sequencing without the 
requirement for cloning, and is applicable to other gene loci (Myers et ai., 1988; Weber, 
1991; Lessa, 1993). 
1.13 Dairy Cattle Breeding 
Improvement in management practices has resulted in a significant reduction in the 
incidence of clinical and subclinical mastitis in the UK (Booth, 1988). Increasing costs 
associated with treatment of cases of mastitis and implementation of milk quality 
penalties has resulted in a need to breed cows that have a lower incidence of mastitis and 
lower SCc. It has been calculated that an increase of 100,000 cells/ml milk over an 
average BMSCC of 200,000 cells/ml milk results in a 2.5% reduction in milk yield 
(Edmondson, 1995). As well as the production benefits associated with breeding for 
lower SCC, inclusion of SCC in breeding programmes has the potential for improved 
control of subclinical and clinical mastitis (Coffey et ai., 1986). 
Presently, selection of dairy cattle for breeding worldwide is based mainly on 
profitability. The selection of dairy cattle in the UK utilises two indices; Profit Index 
Number (PIN) and Index of Total Economic Merit (ITEM). The PIN is a genetic index 
with economic weighting, which incorporates production traits including milk yield, and 
percentage of milk solids (Animal Data Centre, Fox Talbot House, Chippenham, 
Wiltshire). The PIN reflects the expected rise in revenue for each daughter's lactation, 
compared to an animal with a PIN value of zero. These calculations are based on 
expected future prices for milk, quota, transportation and feed requirements (Holstein-
Friesian Society, www.hfs-gbi.org). 
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The ITEM, introduced for dairy cows and bulls in the UK in 1995 (Veerkamp et ai., 
1995), includes production traits as in the PIN, and the main type traits associated with 
longevity, namely udder depth, teat length, angularity and hoof angle (Brotherstone and 
Hill, 1991). Clearance of the udder from the ground and tighter fore udder attachment 
have been correlated to a reduction in log SCC, somatic cell score (SCS), and 
subsequently a reduction in the incidence of clinical mastitis (Rogers et ai., 1991; Lund 
and Jensen, 1996; Boettcher et ai., 1998). The traits included in the ITEM have also been 
associated with lameness in cattle as well as contributing to economic profit and 
longevity (Rogers, 1993). Estimation of type traits is carried out using multi-trait linear 
models (Brotherstone and Hill, 1991; Jairath et ai., 1998), or alternatively the threshold 
model (Gianola, 1982) for higher estimates of heritability than the linear model (Weller 
and Ron, 1992). 
More recently, the Profitable Life Index (PLn has been published. This index assesses 
longevity through direct measurements utilising those type traits, which directly affect the 
life span of dairy cows (Brotherstone et ai., 1997). Low milk production, poor 
reproduction and a high incidence of mastitis have been cited as the top three reasons for 
premature culling from the dairy herd (Allaire et ai., 1977). Enhanced longevity or herd 
life of dairy cattle is of economic importance (Rendel and Robertson, 1950), as it is 
associated with a reduction in culling (van Arendonk, 1985) and reduces the costs 
associated with purchasing and raising replacement animals (Boettcher et ai., 1999). It 
has been estimated that longevity accounts for 25-70% of the economic value attributed 
to milk production (Allaire and Gibson, 1992; Weller and Ron, 1992). 
Selection of dairy cattle based on production traits has been extremely successful, 
resulting on average in an improved annual yield of approximately 2-3% (Honkenboken, 
1987). However selection for improved udder health has been sacrificed for 
improvement in production traits (Rogers et ai., 1998). Studies have shown that selection 
for increased milk yield may result in tissue damage in the mammary gland resulting in a 
reduction in milk yield (Mrode et ai., 1998). Recent studies have reported a reduction in 
milk yield of 1.29kglday in young cows and 2.04kg/day in older cows with each 10glO 
increase in SCC (Koldeweij et ai., 1999). The damage sustained by mammary tissue may 
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lead to an increase in susceptibility to subclinical mastitis (Arriens et ai., 1994). An 
unfavourable genetic correlation has been reported between protein yield and udder health 
in Danish and Swedish Holstein cattle (Emanuelson et ai., 1988; Shultz et ai., 1993; 
Rogers et ai., 1998). An unfavourable genetic correlation has also been reported between 
production traits, and subclinical and clinical mastitis (Mrode and Swanson, 1996; Poso 
and Mantysaari, 1996; Biochard and Rupp, 1997), as well as high milking speed and 
subclinical SCC (Seykora and McDaniel, 1986; Boettcher et ai., 1998). The genetic 
correlation between productive life, longevity, and udder conformation traits, especially 
with regard to clinical rather than subclinical mastitis is favourable (Shook, 1989; Rogers 
et ai., 1991; Boettcher et ai., 1992). Improvement in disease resistance, in addition to 
benefiting general animal health and welfare, has been shown to enhance the efficiency of 
vaccine administration (Lamont, 1989). 
Selection of traits for inclusion in breeding programmes should carry sufficient genetic 
variability and heritability as well as provide economic benefit. The traits for inclusion 
should be measurable at a low or reasonable cost to maximise economic gain. Around 
80% of the UK dairy farms, as well as recording BMSCC, have already opted to record 
individual cow SCC on a monthly basis (Mrode and Swanson, 1996). Research is being 
undertaken to assess the economic and welfare importance of including SCC proofs 
breeding programmes (McGuirk, 1998). It has been suggested that inclusion of PTA for 
SCC into the PIN would be of most benefit, where SCC could be directly compared and 
contrasted with production and other traits (Animal Data Centre). 
Genetic variation associated with disease resistance in dairy cattle, with direct relevance 
to mastitis has been reviewed as early as 1952 (Legates and Grinnells). Direct selection 
of animals, which possess enhanced disease resistance with regard to mastitis, is 
hampered by the lack of accurate and standard recording of clinical mastitis incidence. 
Collection of data is both difficult and costly (Mrode et ai., 1998), and presently there is 
no routine data collection for clinical mastitis incidence within the UK. The heritability 
of clinical mastitis based on direct selection is estimated at approximately four percent 
(Mrode and Swanson, 1996). 
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Many of the traits used for selection of dairy cows are heritable. By definition, 
heritability of a trait, is the percentage of the observed variation attributed to genetics, or 
the proportion of the difference among individuals that should be transmitted to their 
progeny. The definition could also encompass the reliability associated with an 
individual's phenotype in predicting genetic merit for the quantitative trait in question 
(Hohenboken et aI., 1987). Type traits and production traits are classed as highly 
heritable, with udder traits classed as moderately heritable (Ashwell et aI., 1996). In 
comparison with type traits and production traits, health traits, such as foot angle and feet 
and leg scores are classed as having relatively low heritability (Starkenburg et aI., 1997). 
Lack of data on disease incidence restricts their potential for use in genetic improvement 
of dairy cattle (Starkenburg et aI., 1997). 
The low heritability of clinical mastitis and the lack of reliable and available data have 
resulted in selection of animals with improved disease resistance based on indirect 
methods. Udder type traits, teat structure, SCC and SCS have been identified as traits 
that allow for selection of improved udder health (Seykora and McDaniel, 1986; 
Emanuelson et aI., 1988; Rogers, 1993; Philipsson et aI., 1995). 
Somatic cell counts are considered the most suitable single trait for indirect selection of 
animals for mastitis resistance. A positive link between the level of SCC and clinical 
mastitis has resulted in this trait being classed as a genetic marker of disease resistance 
(Aarestrup et aI., 1995; Ashwell et aI., 1996; Dietz et aI., 1997a). The strong positive 
correlation between mastitis and SCC has been reported as 0.7 (Phillpsson et aI., 1995; 
Mrode and Swanson, 1996). 
Variations in heritability estimates of SCC are reported among breeds. Heritability 
estimates for SCC in Holstein-Friesians approximate to 11 % (Schultz et aI., 1990; Rogers 
et aI., 1991; Da et aI., 1992), greater than those reported for Ayrshires, Guernseys and 
Jerseys (Schults et aI., 1995). Variation between lactations was reported as minimal, 
suggesting that the occurrence of genetic and residual variation was similar across parity 
(Monardes and Hayes, 1985; Reents et aI., 1995). Other researches have reported 
improvements in heritability as parity increased (Coffey et aI., 1986) whilst others 
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reported reductions in heritability with increasing lactations, based on a reduction in sire 
variance and an increase in residual variation (Banos and Shook, 1990). 
In February 1998, the Animal Data eentre published predicted transmitting ability (PTA) 
data for sec. Predicted transmitting abilities reflect the effect of sire genes on the trait 
being measured. In terms of sire PTA for see they express the genetic merit of 
individual bulls and the predicted impact they are likely to exert on see of their 
daughters (McGuirk, 1998). Sire PTA for see is calculated from the mean lactational 
records of their daughters. Each daughter included in the evaluation requires see 
records for her first three lactations with a minimum of six test records from each 
lactation. An animal model, similar to that used for evaluation of production traits in the 
UK was used to measure the genetic potential of see as an indicator of resistance or 
susceptibility to mastitis (Animal Data eentre, 1996). The data generated from monthly 
milk sec records was highly skewed, requiring a logarithmic transformation of the data 
prior to statistical analysis. Logarithmic transformation of the data resulted in normal 
distribution of the data allowing the use of statistical methodology. Various logarithmic 
transformations have been carried out for example transformation to loge (Heuven et ai., 
1988), log2 or 10glO (Weller et ai., 1992; Da et ai., 1992). A review carried out by Mrode 
and Swanson (1996) reported no effect due to type of logarithmic transformation carried 
out on estimates of genetic parameters. 
Almost all PTA for see fall between +/-25%, with 86% bulls and 96% cows being +/-
12% (Mrode et ai., 1998). A negative PTA for see indicates that a bull should transmit 
a reduction in see to his progeny and, conversely, a positive PTA for see should result 
in a bull transmitting an increase in see to his progeny. Estimation of PTA for sec 
based on progeny testing provides an accurate prediction of a sire's genetic merit if 
sufficient daughters are recorded. Using monthly see records to calculate this effect of 
sire reflects the on-farm situation, as data is based on commercial herds under typical 
management conditions. 
Unfortunately, progeny testing schemes are both labour and cost intensive with a 
minimum of four years to generate reliable data. The development of new methods for 
evaluating a bull' s potential as a sire are needed to eliminate the bulls which would 
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normally be removed from AI programmes after the four years of progeny testing much 
earlier. This would reduce costs associated with rearing as well as improving the quality 
of daughters produced by the bull selected for AI. 
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Aim of the current study 
The aim of the current study is to develop an in vitro immunological assay to measure the 
proliferative response of PBM induced by Staphylococcus aureus in Holstein-Friesian 
cattle and to identify the proportion of cell types present in peripheral blood mononuclear 
cells (PBM) and in the proliferating cell population. 
At present in the UK, progeny testing schemes are carried out to evaluate bulls' potential 
as sires. This method is both labour and cost intensive with a minimum of four years 
required to generate reliable data. The aim of the current study is to identify an in vitro 
immunological assay that may be used as a means of identifying individual bulls with 
strong immune responses induced by S. aureus, a contagious mastitis pathogen. The 
hypothesis to be tested is that bulls with strong in vitro proliferative responses induced by 
S. aureus may have daughters that have low somatic cell counts due to increased 
resistance to intramammary infection with S. aureus. The development of an 
immunological marker that could be measured in blood and that would identify 
resistance/susceptibility to mastitis pathogens would potentially reduce the time 
associated with progeny testing and increase the efficiency of bull selection. 
In addition to testing the association between the proliferative response in bulls and their 
Predicted Transmitting Ability (PTA) for somatic cell count (SCC), the aim of the current 
study is to look for associations between the proliferative response, or PTA for SCC, and 
Major Histocompatibility Complex class IT alleles by DNA cloning and sequencing of 
exon 2 and Polymerase Chain Reaction-Restriction Fragment Length Polymorphism. 
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Chapter II 
Materials and Methods 
2.1 Animals 
Over a four-year period, the proliferative response of peripheral blood mononuclear cells 
(PBM) to antigen was measured in 30 Holstein-Friesian cows from a commercial dairy 
herd. 
In addition ten cows were selected as two progeny groups, five were sired by bull A and 
five were sired by bull B. These bulls were commercial artificial insemination (An dairy 
bulls, whose semen was purchased from Scottish Livestock Services. None of the cows 
were suffering from, or were recorded as having any recent cases of mastitis and all were 
in general good health. 
The proliferative assay was also performed on bulls from four bull breeding 
establishments owned by Genus Ltd. These bulls were selected by age, as only those 
aged four years and above have PTA data for SCC, available from progeny testing. Ten 
bulls were chosen to represent extremes of the PTA for SCC: five bulls had the lowest 
PTA for SCC and five bulls had the highest PTA for SCC. A further 103 bulls were 
selected at random to represent the population of bulls held in bull breeding 
establishments owned by Genus Ltd. A random sample of 50 bulls from the total 103 
bulls was re-sampled to test the repeatability of the in vitro proliferation assay. 
2.2 Cell isolation 
2.2.1 Isolation of peripheral blood mononuclear cells 
Peripheral blood was collected either from the jugular or coccygeal vein of cattle into 
sterile ten millilitres (ml) heparinised vacutainers (Becton Dickinson UK Ltd., Cowley, 
Oxford). Twenty mls of blood was mixed with ten mls Hanks Balanced Salt Solution 
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(HBSS) without calcium chloride and magnesium sulphate (Gibco and Sigma) in a SOml 
polystyrene tube (Sterilin, Bibby Sterilin Ltd, Staffordshire). This mixture was underlaid 
with 20ml of ficoll-isopaque, density 1.077g/l (Sigma). Samples were centrifuged for 40 
minutes at 800g at 20°C with the brake off. The cells present at the interface between the 
ficoll-isopaque and media were aspirated using sterile plastic pastettes and washed twice 
in HBSS for ten minutes at 600g at 20°C. Cell pellets were re-suspended in two mls of 
complete BME media containing 2% autologous serum, with cell numbers counted using 
white cell counting fluid (WCCF) as described later. 
2.2.2 Isolation of peripheral T lymphocytes using miniMACS separation 
Peripheral blood mononuclear cells, isolated by density centrifugation as described later, 
were counted using White Cell Counting Fluid (WCCF). Thirty million cells were 
incubated with an anti bovine MHC class II MAb, JL-A21 , (ECACC) diluted 1:4 and then 
mixed gently and incubated for one hour on ice. After primary incubation, the cells were 
washed in two ml of sterile phosphate buffered saline (PBS) for ten minutes at 600g. 
This centrifugation step was repeated twice more. Goat anti~mouse IgG microbeads 
(Miltenyi Biotech, Surrey) at a 1:4 dilution were added to the cell pellet and incubated for 
30 minutes at 4°C. MiniMACS MS column (Miltenyi Biotech) with a cell capacity of 
107 , was attached to the magnetic stand. Five hundred microlitres (~.tl) of sterile PBS was 
allowed to run through the column, followed by the total volume of labelled cells. Cells 
were washed through with SOOul of sterile PBS and this was collected at the bottom in a 
separate bijou and deemed the MHC class II-negative fraction. One ml of PBS was 
washed though the column and collected into a separate bijou, and was classified as the 
wash fraction. The miniMACS column was then removed from the magnetic stand. One 
ml of PBS was forced through with a plunger, this procedure was repeated, to ensure 
removal of all bound cells from column, and was deemed the MHC class II-positive 
fraction. All fractions were counted using WCCF to ensure that most of the cells had 
been eluted by this method of positive selection. The positive fraction contained the cells 
used as the APC population, and the negative fraction contained the cells used as the 
responding lymphocyte population in the in vitro proliferation assay as described later. 
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2.2.3 Isolation of total peripheral blood leucocytes 
Peripheral blood was collected either from the jugular or coccygeal veins of cattle into 
sterile ten mls heparinised vacutainers (Becton Dickinson UK Ltd.). Two mls of blood 
was mixed with 40mls of Erythrolyse (Serotec), to lyse the red blood cell population, in a 
50ml polystyrene tube (Sterilin, Bibby Sterilin Ltd). Samples were mixed thoroughly, 
incubated at room temperature for ten minutes then centrifuged for ten minutes at 600g at 
20°C. The supernatants were discarded and the cell pellets washed twice in HBSS 
without calcium chloride and magnesium sulphate (Gibco and Sigma) for ten minutes at 
600g at 20°C. Cell pellets were re-suspended in two mls of complete BME media 
containing 2% autologous serum, with cell numbers counted using WCCF as described 
later. 
2.3.4 Isolation of milk mononuclear cells 
Cows' teats were washed with warm water then cleaned further with cotton, wool soaked 
in methanol. The first few draws of foremilk were discarded, as this sample is 
unrepresentative of cell numbers present in the milk. Between 800ml and 1000mi of milk 
was collected either through hand stripping of all four quarters or by machine milking 
into an individual jar. One hundred rnls of milk was diluted 50:50 with sterile PBS 
(lOmM at pH 7.4, Sigma) supplemented with 15mM ethylenediaminetetraacetic acid 
(EDTA, Sigma) and 20% acid citrate dextrose (ACD) in polypropylene tubes (Nalgene 
Nunc International, Fisher Scientific Ltd, Leicestershire). Samples were centrifuged for 
30 minutes at 900g at +20°C. The remaining samples were stored at +4°C as only four 
samples could be centrifuged at anyone time. Cell pellets were transferred to sterile 
50rnl tubes (Sterilin) and made up to 50ml with PBSIEDTAlACD. Samples were 
centrifuged for 15 minutes at 600g at +20°C, the cell pellets were re-suspended, 
PBSIEDT AI ACD added and centrifuged as above to remove as much milk fat and debris 
as possible. The cell pellets were re-suspended in 30ml PBSIEDT AI ACD and underlaid 
with 20ml ficoll-isopaque, density 1.077g1l (Sigma) and centrifuged for 40 minutes at 
800g at +20°C with the brake off. The layer of mononuclear cells present at the interface 
was aspirated and washed twice in PBSIEDT AI ACD. Cell pellets were washed and re-
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suspended in one or two mls of PBSIEDT AI ACD and cell viability was assessed using 
trypan blue as described later (Sigma). 
2.3.5 Isolation of total milk leucocytes 
Cells were isolated from whole milk as described for the isolation of milk mononuclear 
cells. The isolated cell pellet was not underlaid with ficoll-isopaque. Cell pellets were 
then transferred to sterile 50ml tubes (Sterilin) and made up to 50ml with 
PBSIEDTAlACD. Samples were centrifuged for 15 minutes at 600g at +20°C, the cell 
pellets were re-suspended, PBSIEDT AI ACD added and centrifuged as above to remove 
as much milk fat and debris as possible. The cell pellets were washed twice in 
PBSIEDTAlACD. Cell pellets were washed and re-suspended in one or two mls of 
PBSIEDTAlACD and cell viability was assessed using trypan blue as described later 
(Sigma). 
2.3 Counting and assessment of viability of cell preparations 
2.3.1 Preparation of white cell counting fluid for estimation of peripheral blood 
mononuclear cell numbers 
White cell counting fluid a 2% solution of acetic acid (BDH, Poole, Dorset) in distilled 
water with gentian violet for colour staining was used to perform cell counts on the PBM 
cell population. White cell counting fluid results in the lysis of erythrocytes permitting 
counting of the remaining leucocytes to be carried out accurately. Fifty JlI of cell 
suspension was diluted in 450JlI of WCCF, then mounted and counted on a Neubauer 
haemocytometer (Weber Scientific International Ltd., Hamilton, USA). 
2.3.2 Preparation of trypan blue for estimation of viability of peripheral blood 
mononuclear cells 
Trypan blue (Sigma, Poole Dorset) was used to assess the viability of both milk and PBM 
cell populations. Fifty JlI of cell suspension was mixed 1: 1 with trypan blue, viability and 
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cell numbers were assessed and counted on a Neubauer haemocytometer (Weber 
Scientific International Ltd.). 
2.4 Identification of subclinical mastitis 
2.4.1 Estimation of the infection status of milk using the California Mastitis Test 
The California Mastitis Test (CMT, Genus Animal Health, Llanelli, Wales) permitted 
rapid semi-quantitative evaluation of cell counts in milk. The teats and udder were 
washed with warm water and dried with separate disposable towels. The first two or 
three draws of foremilk were stripped out and discarded. Approximately five to ten mls 
of milk, from each quarter was added to the four individual paddles of the CMT test tray. 
The same volume of CMT reagent was added to the milk. The test tray was swirled in a 
horizontal circular movement for five to ten seconds to ensure adequate mixing. A 
negative result indicated a low SCC with the mixture of milk and CMT reagent moving 
freely. A trace result indicated a slight increase in SCC, with the viscosity of the liquid 
altering and becoming less mobile. A positive result represented a high SCC, the 
viscosity of the mixture increased, characteristic of a gel rather than a liquid. 
2.4.2 Somatic cell counting 
Twenty mls of milk was sent to the Glasgow University Yeterinary School (GUYS) 
haematology laboratory to determine SCCllitre of whole milk. Cells were fixed initially 
with Somafix® (Coulter Electronics, Luton) for 25 minutes at 56°C. Samples were 
allowed to cool to +20°C, then diluted 1/100 with Somaton® (Coulter) and heated for 12 
minutes at +80°C. The samples were allowed to cool again to +20°C. The cells were 
counted on a Coulter counter, model ZF (Coulter). This acted as a gold standard for SCC, 
allowing an estimation of the proportion of cells isolated following the milk mononuclear 
cell isolation technique. 
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2.5 Phenotyping of peripheral blood mononuclear and milk mononuclear cells 
Peripheral blood cells, PBM, milk polymorphonuclear cells and milk mononuclear cells 
were isolated as described previously. The cell pellet was re-suspended in four mls 
HBSS without calcium chloride and magnesium sulphate (Sigma) in a 50ml tube 
(Sterilin) and 0.4% paraformaldehyde (Sigma) was added to the cells at a ratio of 1: 1 
vol/vol. Samples were mixed and incubated for four minutes at +20°C. The samples 
were made up to 50ml with sterile PBS (Sigma) supplemented with 1 % bovine serum 
albumin (BSA, Sigma) and 0.1 % sodium azide (Sigma). Samples were centrifuged for 
ten minutes at 600g at +4°C. The supernatants were discarded and the cell pellets re-
suspended in 50rnl of PBS/BSNsodium azide and the above centrifugation step repeated 
to remove any remaining debris. Cell pellets were re-suspended in three rnIs of 
PBS/BSNsodium azide and transferred to a five mls tube (Falcon 2054, Becton 
Dickinson UK Ltd.). Samples were centrifuged for five minutes at 200g at +4°C. Once 
the supernatant was discarded, the lip of each tube was carefully blotted dry to remove 
any excess liquid. The cell pellets were re-suspended and the above centrifugation step 
repeated in fresh PBS/BSNsodium azide. The supernatants were decanted and one rnl of 
PBS/BSNsodium azide added. Cell counts were carried out using trypan blue (Sigma) as 
described before and 0.5x106 cells added to one tube for each monoclonal antibody 
(MAb) used. The primary MAb were added to the cell pellet at a dilution of 1/10 in 
PBS/BSNsodium azide. Tubes were mixed gently and incubated for 30 minutes at +4°C. 
Three mls of PBS/BSNsodium azide was added and the samples centrifuged for five 
minutes at 200g at +4°C, the cell pellets were re-suspended and the centrifugation 
repeated twice to remove any unbound primary antibody. The secondary antibody, rabbit 
anti-mouse fluorescein isothiocyanate (FITC, Dako NS, Denmark) was added at 1:15 
dilution in PBS/BSNsodium azide and incubated for 40 minutes at +40C. The cells were 
re-suspended in PBS/BSNsodium azide and centrifuged twice as described above. Five 
hundred JlI of 1 % paraformaldehyde was added to each tube containing cells. Samples 
were stored at +4°C wrapped in tin foil and analysed by flow cytometry within two days 
of cell isolation. 
All MAb used for flow cytometry and anti-MHC class II inhibition studies were ali quoted 
and stored at -20°C until required. The MAb used during the course of this study were all 
70 
purchased from the European Collection of Animal Cell Culture (ECACC, Salisbury, 
Wiltshire). 
2.5.1 Anti-BoCD2 
The cell surface protein molecule CD2 is found expressed on T lymphocytes, thymocytes, 
and natural killer (NK) cells and is regarded as a pan T cell marker. In addition to acting 
as a marker for T cells expressing a alB T cell receptors (TCR), it is also been reported on 
r/8 peripheral T cells in humans (Inghirami et ai., 1990), yet it has not been reported on 
r/8 peripheral T cells in cattle (Clevers et ai., 1990). BoCD2 acts as an adherence 
molecule and on interaction with its ligand LFA-3 (CD58), enhances the binding of T 
cells to other cells. The CD2 marker has been reported previously on approximately 40-
60% bovine peripheral blood T cells (Asai et ai., 1998). The cell line IL-A21 was used to 
generate the monoclonal antibody (MAb) which is directed against BoCD2 (ECACC). 
The antibody class of this MAb was IgG. 
2.5.2 Anti-BoCD4 
BoCD4 is expressed on the cell surface of T helper lymphocytes. Functionally BoCD4+ 
cells are co-receptors for MHC class II molecules, present on the surface of antigen 
presenting cells (APC). The interaction between CD4, MHC class II and the TCR 
improves T cell binding to the APC. Cells expressing CD4 also partake in signal 
transduction, whereby a signal is passed from the APC via the receptor into the 
lymphocyte (Benjamin et ai., 1996). CD4+ T cells account for approximately 15-35% of 
PBM in cattle (Bensaid and Hadam, 1991). Cell line AFRC IAH-CC30 produces the 
MAb CC30, which is directed against BoCD4+ cells (ECACC). The antibody class of 
this MAb was IgG. 
2.5.3 Anti-BoCD8 
BoCD8 is expressed on the cell surface of T cytotoxic cells. T cytotoxic cells are 
responsible for elimination of cells infected with intracellular pathogens. BoCD8 acts as 
a co-receptor for MHC class I molecules, which as described previously, enhance binding 
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of APC and lymphocytes binding. CD8+ T cells account for approximately 11-22% of 
PBM in cattle (Taylor et ai., 1994; Shafer-Weaver et ai., 1999). MAb CC58 derived from 
cell line AFRC IAH-CC58 was used for the detection of BoCD8 (ECACC). The 
antibody class of this MAb was IgG. 
2.5.4 Anti-monocyte 
Monocytes, present in peripheral blood, are the immature precursor of macrophages, prior 
to their migration into tissue. Monocytes account for approximately 20% of PBM in 
cattle (Shafer-Weaver et ai., 1999). Cell line IL-A24 was used to raise the MAb directed 
against bovine myeloid cells. This MAb reacts with bovine granulocytes and monocytes 
and some differentiated mononuclear phagocytes (ECACC). The antibody class of this 
MAb was IgG. 
2.5.5 Anti-BoCD21 
BoCD21, formerly WC3, was renamed due to similarities in size and cellular distribution 
as the human CD21 molecule (Naessen and Howard, 1991). It is expressed on the surface 
of follicular dendritic and B cells. B-Iymphocytes are essentially responsible for the 
production of antibodies to extracellular pathogens, and possess the ability to function as 
APC. CD21 can act as a co-stimulatory molecule for B cell activation as well as 
enhancing signal transduction post antigen binding. B cells represent approximately 16-
21 % total lymphocyte numbers in cattle (Park et ai., 1992). Cell line AFRC IAH-CC21 
was used to raise the antibody directed against the surface CD21 molecule (ECACC). 
The antibody class of this MAb was IgG. 
2.5.6 Anti-BoWCI 
The cell surface marker WCl is expressed on y/8 T cells (Mackay et ai., 1991). y/8 T 
cells generally lack those cell surface markers associated with a~ T cells and their 
phenotype has been reported as CD2-ICD4-ICD8-. This molecule remains defined as a 
workshop cluster, WC, as no CD homologue has yet been found. These cells represent 
approximately 1-3% of human and mouse peripheral T cells, however in young 
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ruminants, approximately 27% of T cells express a ,,{/O TCR with some individual animals 
having greater than 50% of cells expressing "{/O+ TCR (Clevers et ai., 1990). In adult 
ruminants the number of ,,{/O T cells declines to approximately 5-10% of PBM (Clevers et 
ai., 1990). The function of ,,{/O T cells still remains unclear, although results from in vivo 
depletion studies suggest that this cell population may have a role to play in control of 
proliferation of other lymphocytes (Howard et ai., 1989). It has not been fully established 
if they may also have a cytolytic role in the immune system (Mackay, 1988). Cell line 
AFRC IAH-CC15 was used to produce the MAb CC15, which is directed against BoWC1 
(ECACC). The antibody class of this MAb was IgG. 
2.5.7 Anti-MHC class II 
The response of T cells to antigenic stimuli has been described as MHC restricted 
(Zinkernagel and Doherty, 1974). This cell surface molecule is of vital importance in 
antigen presentation to the TCR on the corresponding lymphocyte. Only antigenic 
peptides expressed in association with a MHC molecule will be recognised by the TCR 
and its co-stimulatory molecule either CD4 or CD8. CD4+ T cells recognise antigen in 
association with MHC class II molecules and conversely CD8+ T cells recognise MHC 
class I molecules. MHC class II molecules are expressed on the surfaces of B cells, 
dendritic and thymic epithelial cells (Wiman et ai., 1976), however activated T cells, 
macrophages and endothelial cells can be induced to express these molecules on their 
surface (Sleeg et ai., 1982). Cell line IL-A21 was used to raise this monomorphic 
antibody directed against Bovine MHC class II molecules (ECACC). The antibody class 
of this MAb was IgG. 
2.5.8 Control antibody 
The MAb MIL-4, which detects porcine granulocytes (Haverson et ai., 1994), was used as 
a control antibody to ensure that no non-specific binding of the secondary fluorescent 
MAb was occurring. The antibody class of this MAb was IgG. 
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2.6 In vitro culture 
2.6.1 Preparation of autologous serum for in vitro culture of peripheral blood 
mononuclear cells 
Twenty mls of blood was collected either from the jugular or coccygeal vein by 
vacutainer (Becton Dickinson UK Ltd.), from each individual cow. The samples were 
allowed to clot at +20oe then incubated for 30 minutes at +37°e, followed by a further 30 
minutes at +4°e, to improve clot retraction. The samples were then centrifuged for 20 
minutes at 1300g, the serum collected by aspiration was heat inactivated for 30 minutes at 
+56°C. Sera were stored at -20oe until required. 
2.6.2 Preparation of media for in vitro culture of peripheral blood mononuclear cells 
Basal media, Eagles (BME, Gibco, Life Technologies Ltd., Paisley) with Earles salts and 
without L-glutamine (Gibco) was used for all antigen specific experiments. The media 
was supplemented with 2mM L-glutamine (Gibco), 20mM Hepes (Gibco), 
50~gl50units/ml of streptomycin/penicillin (Gibco) and 2% heat inactivated autologous 
serum as described previously. 
2.7 Preparation of antigen for in vitro culture 
2.7.1 Isolation of Staphylococcus aureus from naturally occurring subclinical 
mastitis cases 
Milk samples were taken from four adult Friesian dairy cows with subclinical mastitis, 
detected by the presence of high Sec. These cows were identified initially as having 
Iesee (>400,000 cells/ml) through routine monthly milk sampling. Infected quarters 
were subsequently identified as having IQSee (>600,000 cells/ml). 
Routine bacteriological examination of milk samples from infected quarters resulted in 
isolation of S. aureus. For determination of bacterial strains present, three rnIs of milk 
was diluted in 17mls sterile distilled water (Baxters Healthcare Ltd., Baillieston). 
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Samples were centrifuged for 20 minutes at 4500g. Cell pellets were re-suspended in 
100J.ll lauryl broth then 50ul was streaked onto Columbia blood and Mannitol salt agar 
plates (Oxoid Ltd. Ltd., Basingstoke). The agar plates were incubated overnight at +37°C. 
Fifteen to 20 individual colonies were tested using a coagulase slide test (Rapidec 
bioMerieux, France) and DNA fingerprinting. Genomic fingerprinting resulted in one 
strain of S. aureus, designated as strain A being isolated from the two cows from farm A. 
Colonies isolated from the cows originating from farm B, belonged to a single strain 
different to those from farm A, designated strain B. After identification, both strains were 
subcultured onto Columbia blood agar (Oxoid Ltd.) and incubated for 18 to 24 hours at 
+37°C. Single colonies were inoculated into ten mls of brain heart infusion (BHI) broth 
and incubated for 18-24 hours at +37°C, 360JlI of bacterial suspension from the BHI broth 
was added to 60JlI of glycerol in a 1.5ml micro-centrifuge tube. The glycerol stocks were 
mixed thoroughly then stored until further batches of bacterial antigen were required at -
20°C. The bacterial suspension was then centrifuged for 15 minutes at 1000g, re-
suspended, and washed four times in sterile PBS to remove any growth medium or by-
products. Bacterial cell pellets were inactivated by incubation with constant stirring in 
2% formalin for 48 hours at +4°C. To remove any traces of formalin, the pellets were 
washed four times in sterile PBS. The cell pellets were re-suspended, aliquoted and 
stored until required at -20°C. The fixed bacterial suspensions were streaked on to sheep 
blood agar (Oxoid Ltd.) for four days at +37°C, to ensure no bacterial growth occurred. 
2.7.2 Preparation of Staphylococcus aureus from glycerol stocks 
A single loop of S. aureus glycerol stock was streaked onto a sheep blood agar plate 
(Oxoid Ltd.), and incubated for 18-24 hours at +37°C. A single colony from the sheep 
blood agar plate was inoculated into 200ml of BHI broth and incubated for 18-24 hours at 
+37°C. The suspension was then treated as before. 
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2.7.3 Collection of milk samples from cull cows 
The udders of 14 cows sent to the abattoir under the BSE cull scheme were selected at 
random. The age of these animals was not known although it may be assumed that they 
were older than 30 months and that they were mature cows. The teats were washed with 
an antibacterial compound (Hibiscrub, Zeneca Ltd, UK) diluted in warm water, then 
cleaned with methanol-soaked cotton wool. The condition of the selected udders varied 
considerably. Some of the udders showed obvious signs of abscessation, whilst others 
appeared visually normal. The first draw of milk from the teat was discarded then a ten 
rnl milk sample was collected in a sterile universal (Sterilin) from one quarter only. 
These samples were collected as a possible source of additional strains of S. aureus, for 
use in the in vitro proliferation assay. 
2.7.4 Bacteriological examination of milk samples 
The milk samples obtained from the cull cows were streaked aseptically onto 
MacConkeys, chocolate, sheep blood and horse blood agar plates (Oxoid Ltd.). 
MacConkeys and sheep blood plates were incubated aerobically at +37°C, chocolate 
plates were incubated in the CO2 incubator and horse blood plates were incubated 
anaerobically (Don Whitley, Mark 3 anaerobic workstation). After a 24-hour incubation, 
plates were checked for growth and those samples identified as staphylococci had single 
colonies removed and streaked onto fresh sheep blood agar plates. A single colony from 
each of the possible staphylococci was smeared onto DNAse sensitive agar (Oxoid Ltd.), 
allowing identification of staphylococci as a genus rather than indivioual strains. After 24 
hours incubation, 10% hydrochloric acid was added to the DNAse plates, a transparent 
halo appeared around DNAse producing colonies. Non-DNAse producing bacteria were 
discarded at this point. Those isolates identified as DNAse producers were identified 
further by API staphylococcal strips (bioMerieux). Interpretation of the API 
staphylococcal strips creates a five-digit profile number, which can be used to determine 
the strain of the bacterium using the API profile index. The API profile index documents 
micro-organisms that have previously been identified. Once positively identified as S. 
aureus, colonies were maintained on Dorset egg slopes and prepared as described 
previously for use in in vitro culture. 
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2.7.5 Estimation of Staphylococcus aureus concentration 
An aliquot of formalin fixed S. aureus was sent to GUVS haematology laboratory to 
determine bacterial cell numbers per ml of PBS. The bacterial cell preparation was 
allowed to settle prior to counting to eliminate the chance of floating cells being 
recounted. The estimation of bacterial cell numbers was carried out in a Neubauer 
haemocytometer (Weber Scientific International Ltd.) under X400 magnification. 
2.7.6 Genomic fingerprinting of staphylococci 
Sheep Blood agar plates (Oxoid Ltd.) were streaked aseptically with S. aureus and 
incubated aerobically overnight at +37°C. Ten mls of BHI broth (Oxoid Ltd.) was 
inoculated with a single colony from the streak plate and incubated once again overnight 
under the same conditions. The broth was centrifuged for ten minutes at 2000g. The 
supernatants were discarded and the pellets re-suspended in three mls of tris EDT A NaCI 
(TES) and subsequently divided into one ml aliquots. Samples were micro-centrifuged 
for 30 seconds at 140g and the supernatants discarded. The pellets were re-suspended in 
200lli of TES supplemented with 50mM sucrose (Sigma). Six percent lysostaphin 
(1000units/ml, Sigma) and 31 % lysozyme (40mg/ml, Sigma) were added and the samples 
vortex mixed, followed by incubation for 30 minutes at +37°C. Fifteen microlitres of 
20% SDS was added, and the micro-centrifuge tubes inverted, gently, approximately a 
dozen times. Thirteen percent proteinase K (50mg/ml, Boehringer Mannheim) was added 
and the solution was sheared twice through a 25-gauge needle, at a constant rate. 
Samples were then incubated for two hours at +37°C. Twenty percent TElO was added to 
make the aqueous layer less viscous plus 50% of 1: 1 (vol:vol) phenol: chloroform 
(Sigma). The samples were mixed then centrifuged for ten minutes at 140g. The upper 
aqueous layer was aspirated and transferred to a sterile micro-centrifuge tube, which 
contained 500lli of isopropanol (Sigma). The samples were left for approximately one 
hour at +20°C, then centrifuged for ten minutes at 140g and the supernatants discarded. 
One hundred III of TElO was added and the samples left to re-dissolve at +20°C. The 
triplicate samples were pooled and approximately 10% of 7.5M ammonium acetate and 
60% of 95% ethanol were added. The samples were mixed and stored overnight at -20°C. 
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The samples were centrifuged for ten minutes at 140g, to pellet the DNA, the 
supernatants were discarded and the pellets re-suspended in 300lli TEIO to which 6% of 
freshly prepared RNAse (lOmg/ml, Sigma) was added. The samples were incubated for 
one hour at +37°C and 60% of 1: 1 (vol:vol) phenol chloroform (Sigma) was added and 
the samples were mixed then centrifuged for ten minutes at 140g. In a fresh 1.5m1 micro-
centrifuge tube, 500lli isopropanol (Sigma) was added, to which the upper aqueous layer 
was transferred and allowed to stand for one hour at +20°C. The samples were 
centrifuged for ten minutes at 140g and once re-suspended in 300lli TE lO, 10% of 7.5M 
ammonium acetate (Sigma) and 60% of 95% ethanol were added. Samples were stored 
overnight at -20°C. The samples were centrifuged for ten minutes at 140g and the 
supernatants discarded. The DNA pellets were re-suspended in 60111 TE and the samples 
were digested further using restriction enzymes. To each reaction tube five III of lOX 
buffer, two III Hha I enzyme (Gibco) and 15-201l1 of DNA was added. The total reaction 
volume was made up to 50111 with sterile water (Baxters). Three controls were set up 
with the following enzymes, either two III of Kpn I, Pst I or Hha I (Gibco) plus two III of 
bacteriophage A DNA (Gibco), five III of the appropriated buffer supplied with the 
enzyme (Kpn I: react 4, Hha 1 and Pst I: react 2), and the final reaction volume was made 
up to 50111 with sterile water (Baxters). The tubes were mixed and incubated for four 
hours in the +37°C water bath. 
2.7.7 Gel electrophoresis of restriction digests 
Agarose powder (Bioline) was mixed with IX TBE buffer to make a 0.8% gel, ethidium 
bromide was not added prior to the gel setting. The gel was run overnight in IX TBE 
buffer at 25mA using a DNA subcell powerpack (Biorad, Biorad Laboratories Ltd., 
Hemel Hempstead) to maintain a constant current and to allow clear separation of the 
digested fragments. Fifty III of restriction digest was mixed with five III of loading 
buffer, as described previously (Sigma). Approximately 40111 of both sample and control 
mixtures were loaded into individual wells. 
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2.7.8 Ethidium bromide staining of genomic gel 
The gel was removed from the gel tank, transferred to a plastic tupperware dish and 
immersed in one litre of IX TBE containing 3% ethidium bromide solution (stock 
solution lOmglml). The Tupperware was placed on a plate rocker (Luckham 4RT rocking 
table, Denley Instruments, UK) for one hour on its lowest setting. The gel was destained 
using normal tap water for 20 minutes on the plate rocker. The restriction digest products 
were visualised under UV light and Polaroid pictures were taken with the exposure time 
increased to two minutes on the Polaroid T224 land camera (Sigma). It was important to 
include the wells of the gel in any photographs that were taken to allow the results to be 
digitised at a later date. 
2.7.9 Digitisation of Restriction Enzyme Fragmentation Pattern Results 
Interpretation of electrophoretic gels was a skill-intensive task. Digitisation of gel 
photographs was an objective yet flexible technique that allowed the accurate assessment 
of electrophoretic data. Data was stored in numerical form (molecular weight of 
restriction fragments). The graphical output was used to present the data in a familiar 
format, which allowed visual comparisons with the original gel photograph. Digitisation 
of REFP isolates allowed comparisons of restriction fragments generated by the different 
strains of S. aureus. Strains were analysed using a commercially available programme 
(Platt and Sullivan, 1992) with restriction digested A DNA using enzymes Kpn I and Pst I 
as calibration controls. 
2.7.10 Detection of Staphylococcal Enterotoxins (SE) using Reverse Passive Latex 
Agglutination (RPLA) 
A single colony of S. aureus was added to ten mls of tryptone soya broth (Oxoid Ltd.) and 
incubated for 18-24 hours at +37°C in an orbital shaker. The samples were centrifuged 
for 20 minutes at 900g at +4°C. The supernatant was retained for the detection of SE. 
The diluents, anti-SE antibody, which consists of polystyrene particles coated in purified 
antiserum of the various SE, and latex solutions were supplied as part of the toxin 
detection kit (TD900, Oxoid Ltd.). The used of a latex control ruled out non-specific 
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agglutination between sample and the anti-SE antibody. Each sample to be tested was 
added to five rows and eight wells on a microtitre V well plate. Twenty-five /-11 of diluent 
was added to each well, 25/-11 of sample supernatant was added to the first well of each 
row. Once mixed 25/-11 was taken from well one and serial dilutions carried out until well 
seven, well eight contained only diluent as a negative control. To every well of rows one 
to five, 25/-11 of anti-SEA or SEB or SEC or SED or latex control was added respectively. 
Samples were mixed thoroughly prior to an adhesive clear cover being fixed to the top of 
each plate to eliminate evaporation. The plates were left on a sheet of black card for 18-
24 hours at +20°C, on a vibration free surface. 
As defined in the working instructions (Oxoid Ltd.), if SE was present in the sample the 
latex particles formed a lattice structure, and once settled on the bottom of the V well 
plate they formed a diffuse layer. If SE was absent there was no cross linkage and 
therefore a tight pinhead formed at the bottom of the plate. Results were scored visuillly 
from negative to three plus depending on the level of agglutination. 
The RPLA method was also used for the detection of Toxic Shock Syndrome Toxin-1 
(TSST-1), using a TSST-1 detection kit (TD940, Oxoid Ltd.). One difference in the 
methodology being that the first two wells of each row had sample supernatant added and 
the serial dilutions subsequently started from well two leaving well one at the original 
concentration. Incubation times, conditions and interpretation of results were, otherwise, 
as described for SET-RPLA. 
2.8 In vitro proliferation assays induced by antigen and enterotoxin 
2.8.1 In vitro proliferation assays of peripheral blood mononuclear cells induced by 
Staphylococcus aureus 
Peripheral blood mononuclear cells were isolated from heparinised blood, as described 
previously. Proliferative responses to particulate and soluble antigens were assayed in 
two ml volumes in 24 well tissue culture grade flat bottomed plates (Nunclon™, Nunc). 
Each test well contained one ml of PBM at a final concentration of 2x106/ml and one ml 
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of antigen at an optimal dilution, in complete media containing 2% autologous serum. 
Control wells contained the same concentration of PBM, and in replace of antigen, one 
ml of complete media containing 2% autologous serum was added. Culture plates were 
incubated at +37°C with 5% C02 and 100% humidity for up to 11 days. At specific time 
points during culture, wells were sampled and cells pulsed with 3H-thymidine as 
described below. 
Each well of the in vitro cell culture was mixed thoroughly by pipetting prior to 100J,.l1 
being transferred to a fresh 96 well plate, in triplicate (Coming Costar Corporation, 
Cambridge). One microcurie of methyl-tritiated eH) thymidine (5mCi, Amersham 
International plc, Buckinghamshire) in 20J,.l1 of complete media was added to each well. 
The plates were incubated for six hours at +37°C with 5% CO2 and 100% humidity. 
Samples were harvested onto GFC bonded unifilter plates (Canberra Packard, Berkshire) 
using a filtermat 196™ (Canberra Packard) and dried for at least one hour at +65°C. Once 
dried, the filtermats were sealed on the under side and ten J,.ll of Microscint OTM (Canberra 
Packard) was added to each well of the filtermat. A clear seal was adhered to the top of 
the filter plate to prevent spillage of the radioactive scintillation fluid. The 3H-thymidine 
incorporated into the newly synthesised DNA of the proliferating cells was measured by 
liquid scintillation counting using a Topcount Microplate Scintillation and Luminescence 
Counter™ (Canberra Packard). The data produced was recorded as counts per minute 
(cpm), and means of the triplicate wells were calculated. Stimulation indices (SI) were 
calculated by dividing the cpm of the wells with antigen by the cpm of the wells in the 
absence of antigen. 
2.8.2 In vitro proliferation assays of peripheral blood mononuclear cells induced by 
Staphylococcal Enterotoxin B 
The in vitro culture of PBM and Staphylococcal Enterotoxin B (SEB, Sigma) was 
designed to study the difference in the kinetics of the proliferative response when 
stimulated by antigen or staphylococcal enterotoxin. Staphylococcal Enterotoxin B from 
S. aureus was diluted in sterile water (Baxters) to a stock concentration of lug/mi. 
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Staphylococcal Enterotoxin A content was estimated to be ~ 0.25%, as per data sheet 
(Sigma). The stock solution of SEB was aliquoted and stored at -20°C until required. 
Peripheral blood mononuclear cells isolated by density centrifugation were diluted in 
complete media with 2% autologous serum as described previously, at a final 
concentration of 2x 1 06 cells/rnl media. Staphylococcal Enterotoxin B (Sigma) was added 
at dilutions ranging from 1:100 to 1:1,000,000. Cultures were incubated under the same 
conditions and pulsed with 3H-thymidine as described previously. 
2.8.3 In vitro proliferation assays of peripheral blood mononuclear cells induced by 
recall antigen 
After the peak day of proliferation, day 10 or 11, the cells were removed from the 24 well 
plate and transferred to a 50rnl centrifuge tube (Sterilin). The empty wells were washed 
with complete media heated to +37°C, to ensure no cells remained in the wells. The cells 
were then centrifuged twice in warm complete media for ten minutes at 600g to remove 
any antigen and debris. The cell pellets were re-suspended in a small volume of complete 
media and cell numbers and viability were assessed using Trypan Blue (Sigma). The 
cells were re-cultured in 24 well plates in two ml volumes at varying cell concentrations. 
Irradiated PBM were added as a source of fresh antigen presenting cells, and antigen 
concentrations remained as in the primary culture. The ratio of PBM: APC: antigen was 
lx106:0.5x106:1x104• Again the culture was incubated at +37°C with 5% CO2 and 100% 
humidity. After 24, 48 and 72 hours the culture was pulsed with 3H-thymidine as 
described previously. 
2.8.3.1 Preparation of antigen presenting cells for in vitro proliferation assays of 
peripheral blood mononuclear cells to recall antigen 
Additional APC were required, as the number of cells expressing the monocyte marker 
fall dramatically post in vitro primary stimulation. Irradiation of the APC removes the 
ability of the cells to proliferate but not the ability to present antigen to the responding 
lymphocyte population. Peripheral blood collected in EDT A-coated vacutainers (Becton 
Dickenson UK Ltd.) was irradiated with 5000rads in the central position of the C060 
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source (Glass et ai., 1991). Once irradiated, blood was diluted in HBSS without calcium 
carbonate and magnesium sulphate (Sigma) and underlaid using ficoll-isopaque 1. 077 gil 
(Sigma) as described previously. The cells aspirated from the interface were washed and 
used as antigen presenting cells (APC) at ratios of 1:2 and 1:8 respectively to the 
responding cell population. 
2.8.4 In vitro proliferation assays of peripheral blood mononuclear cells induced by 
antigenic stimuli in the presence of anti-MHC class II monoclonal antibody 
To determine if the proliferative ability of PBM of cows induced by S. aureus strain A 
was dependent on MHC class II for processing and presentation of antigen, an anti-MHC 
class II MAb, IL-A21, was added to PBM and S. aureus strain A during the culture in 
vitro. Peripheral blood mononuclear cells were isolated from heparinised blood, as 
described previously. The proliferative responses of PBM induced by S. aureus strain A 
in the presence and absence of anti-MHC class II MAb (IL-A21) at dilutions of 1:5 and 
1: 10 was recorded. The test wells were set up as described previously for in vitro 
proliferation of PBM induced by S. aureus strain A. Culture plates were incubated at 
+37°C with 5% C02 and 100% humidity for up to 11 days. At specific time points during 
culture, wells were sampled and cells pulsed with 3H-thymidine as described previously. 
2.9 DNA isolation 
2.9.1 DNA extraction from peripheral blood cells 
Ten rnIs of blood was taken from either the jugular or coccygeal veins into an EDT A-
coated vacutainer (Becton Dickinson UK Ltd.). The whole blood was transferred to a 
50ml centrifuge tube (Sterilin) containing 40ml of nucleic lysis mix. After a gentle mix, 
the tubes were submerged in ice for ten minutes to improve cell lysis. Samples were 
centrifuged for ten minutes at 1900g at +200 C. The supernatants were discarded and the 
tube rims blotted with absorbent tissue to remove excess liquid. Cell pellets were re-
suspended in three mls of nucleic lysis mix, 6% sodium-Iauryl-sulphate (SDS, Sigma) and 
1.6% proteinase K (Boehringer Mannheim). The samples were then incubated overnight 
at +37°C or for two hours at +55°C. To aid precipitation of the DNA, one rnl of 6M NaCI 
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was added and each sample shaken vigorously. Samples were further centrifuged for ten 
minutes at 1900g at +200 C. The supernatants were transferred to sterile 15ml centrifuge 
tubes (Sterilin), to which three ml of 1: 1 (vol:vol) phenol chloroform (Sigma) was added. 
The tubes were inverted to ensure proper mixing and then centrifuged as before. Tubes 
were removed carefully from the centrifuge so as not to disturb the interface. The upper 
aqueous layers were transferred to 30ml sterile universals and care was taken to prevent 
aspiration of the bottom fraction, which contained unwanted protein. One hundred 
percent ethanol was added to each universal at approximately three times the volume of 
the top fraction, the contents were mixed and the precipitated DNA was spooled out using 
a heat sealed glass pipette. The spooled out DNA was re-suspended in 300J.t1 of sterile 
water (Baxters) in screw cap tubes (Starstedt Ltd., Leicester). If the DNA did not 
precipitate out immediately, one tenth of the original volume of the upper aqueous layer 
of sodium acetate (Sigma) was added and incubated for one hour at -20°C. Finally the 
DNA was allowed to redissolve for approximately one hour at +20°C and stored at -20°C 
until required. 
2.9.2 Estimation of DNA concentration by spectrophotometry 
One f.11 of stock DNA was added to 99f.11 of sterile water (Baxters). One hundred f.11 of 
sterile water (Baxters) was used as a blank for the spectrophotometer. Optical density of 
the samples was determined at wavelengths of 260nm, 280nm and 320nm. 
Concentrations of DNA per sample was determined using the following equation. 
DNA concentration (f.1g/f.1I) = nucleic acid reading x dilution 
working DNA concentration 
The working concentration of DNA for future use was O.5f.1g/f.11, stock samples were 
diluted with sterile water if necessary. Ten mls of the O.5f.1g/f.11 DNA stock was 
transferred to O.5ml micro-centrifuge tubes to prevent repeated freeze-thawing of stock 
samples. 
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2.10 Cloning and sequencing of MHC class II DOB region 
2.10.1 Polymerase Chain Reaction amplification of MHC class II DQB alleles 
To avoid contamination with extragenous template, the work area was decontaminated by 
depurination. Surfaces and pipettes were wiped sequentially with IN HCI, IN NaOH, 
and finally, Tris buffer as a neutralising agent. The surfaces and pipettes were rinsed with 
distilled water and wiped down with 100% ethanol. A master mix, enough for all 
samples, was made up to avoid contamination of stock PCR solutions. For each sample 
five I.d of PCR enzyme buffer, one J.11 dNTP, nine J.11 of OAJ.1M LA40, 5' 
(TCCCCCGCAGAGGA TTTCGT) and 12J.11 of OAJ.1M LA41, 3' 
(AT AGAA TTCACCT(AIT)GCC GCTGCCAGGT), primers published previously for 
MHC class IT in cattle (Sigurdardottir et aI., 1992) were used. The master mix was 
vortexed and irradiated by ultra violet light (UV) for five minutes, prior to addition of 
DNA and DNA polymerase (Dynazyme, Flowgen, Novara Group Ltd., Leicestershire) to 
each sample to eliminate possible contaminants. One J.1g of genomic DNA plus 0.25J.11 of 
DNA polymerase was added to the above master mix, and the total reaction volume made 
up to 50J.11 with sterile water (Baxters). A negative control containing no DNA was set up 
as part of a standard protocol. Two drops of mineral oil (Sigma) were added to each 
micro-centrifuge tube prior to loading onto a 480 thermal cycler (Perkin Elmer, 
Birchwood Science Park North, Cheshire) to prevent evaporation of the sample. PCR 
amplification involved an initial hot start for five minutes at +95°C straight from ice, 
followed by 30 cycles for one minute at +94°C, for one minute at +65°C, for one minute at 
+ 72°C and a final extension for 30 minutes at + 72°C. 
Gel electrophoresis of the PCR products was carried out as follows. Agarose powder 
(molecular grade, Bioline, The Edge Business Centre, London) was mixed with IX tris 
boric acid EDT A (TBE) buffer to make a 1.5% gel. The gels were run in submarine 
agarose gel units (Hoefer Scientific Instruments, San Francisco) with IX TBE as the 
running buffer at 100 volts. Prior to the gel setting, five mls of ethidium bromide 
(lOmg/ml, Sigma) was added to the dissolved agarose for visualisation of product bands 
under UV light. Ten J.11 of PCR product was taken from below the oil layer and mixed 
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with five III of loading buffer (Sigma), which consisted of 40% sucrose and 1 % 
bromophenol blue. Twelve III of this mixture was loaded into each well and eight III of a 
100 base pair (bp) marker (Gibco) was loaded to allow estimation of size of the PCR 
product. The desired product size was approximately 300bp (Sigurdardottir et at., 1992; 
Nasir et at., 1997). Once the bromophenol blue had run approximately half the length of 
the gel, it was removed and analysed under UV light on a transilluminator T2201 
(Sigma), connected to a Polaroid MP4 land camera to allow photographs to be taken and 
results retained in picture and negative form. 
2.10.2 Molecular cloning of MHC class II DQB alleles 
The 300bp product generated by PCR amplification was used in conjunction with 
Novagen PT7 Blue Perfectly Blunt™ cloning kit (Novagen, Inc., 601 Science Drive, 
Madison). The PCR product was removed from beneath the mineral oil layer and 
transferred to a 500lli micro-centrifuge tube. The PCR product was mixed 1: 1 (vol:vol) 
with chloroform then centrifuged for two minutes at 140g in a micro-centrifuge tube 5402 
micro-centrifuge (Micro-centrifuge tube, MCQuilken and Co., Polmadie Ave, Glasgow). 
The top aqueous layer was removed and run through Qiaquick PCR purification kit 
(Qiagen, Boundary Court, Crawley) to inactivate residual enzyme, dNTP, and any double 
stranded DNA that may be present within the PCR product that would prevent successful 
cloning. Twenty-two nanograms of amplified product were mixed with five III of an end 
conversion mix (Novagen). The total volume was made up to ten III with nuclease-free 
water provided as part of the kit, forming the end conversion reaction. Samples were 
incubated for 40 minutes at +22°C, as these were amplified with polymerases that lacked 
3'----75' activity. To localise the kinases at the bottom of the tube, the samples were 
centrifuged briefly for 30 seconds at 140g in a micro-centrifuge. The samples were 
subsequently heated for ten minutes to + 75°C to terminate the reaction and stop the 
kinases reducing the vector backgrounds. To prevent inactivation of the ligase enzyme, 
samples were cooled on ice for two minutes, followed by centrifugation to collect any 
condensation that had formed on the tube walls. The ligation reaction involved 
combining the blunt phosphorylated insert to the blunt dephosphorylated pT7 Blue vector. 
One III of T4 DNA ligase (4U) and one III of pT7 Blue vector (SOngful) were added to the 
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ten J.11 of the end conversion reaction. Samples were mixed gently with a pipette tip and 
incubated overnight at +22°C. One J.11 of the ligation reaction mixture was used in the 
transformation reaction to create recombinants. Twenty J.11 of Novablue E. coli competent 
cells were removed from the -70°C freezer and transferred directly onto ice. The cells 
had been previously aliquoted into pre-chilled micro-centrifuge tubes to eliminate a 
reduction in transformation efficiencies due to repeated freeze thawing. One J.11 of the 
ligation reaction was added to the cells. Samples were stirred gently and incubated for a 
further 30 minutes on ice. The samples were heated for exactly 40 seconds to +42°C, 
followed by a further incubation for two minutes on ice. Eighty J.11 of SOC media 
(Novagen), which had been allowed to warm to +20oC, was added and the total volume 
transferred to a 20ml universal (Sterilin). Samples were transferred to an orbital shaker to 
improve the cloning efficiency, for one hour at +37°C with the lids slackened slightly to 
allow aeration. A further 170J.11 of SOC was added to the cells. Two LB broth agar plates 
which had been previously seeded with, 50J.1g1ml carbenicillin (Sigma), 15J.1g1ml 
tetracycline (Sigma), 70J.1g/ml Xgal (5-Bromo-4-chloro-3-indolyl beta-D-
galactopyranoside, Gibco) and 80J.1M IPTG (Isopropyl beta-D-thiogalactopyranoside, 
Gibco), were spread with either 80J.11 or 50J.11 of the transformation mixture. The different 
volumes of the transformation mixture were spread to ensure single colonies would be 
obtainable in the case of blanket coverage of the plate or under growth of the spread cells. 
Spread plates were incubated inverted overnight at +37°C, under aerobic conditions. The 
presence of Xgal and IPTG allowed for selection of recombinants with a white phenotype 
and non-recombinants that possessed a blue phenotype. Enhancement of the blue 
phenotype can be achieved by incubating the streak plates for 30 minutes at +4°C 
(Novagen). Approximately ten single white colonies, of medium size, were picked off 
the agar plates under aseptic conditions and inoculated individually into three mls of LB 
broth in a 50ml centrifuge tube. The LB broth contained 100mglml carbenicillin and 
15mglml tetracycline, which were added post-autoclaving. The lids of the tubes were 
slackened and placed into the orbital shaker overnight at +37°C. The samples were 
checked the following morning visually for signs of growth indicated by cloudiness. Any 
colonies, which had not grown, were returned to the orbital shaker until later on the same 
day. Twenty J.11 of the cell culture was transferred to a 0.5ml micro-centrifuge tube for 
PCR to check for the presence of an insert. Three hundred and sixty J.11 of cell culture was 
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mixed with 60lll of glycerol to provide a glycerol stock should samples be required for 
further sequence analysis. To check for the presence of the insert, 20111 of the sample was 
heated for five minutes at +9SoC, followed by centrifugation for two minutes at 140g. 
Ten III of the supernatant was mixed with 10mM dNTP mix, Spmol/Ill T7, Spmoi/Ill U 19, 
IX buffer (lOX), 30111 nuclease free water and O.31l1 of DNA polymerase (Dynazyme). 
The mastermix was irradiated prior to DNA and DNA polymerase (Dynazyme) being 
added. Finally two drops of mineral oil (Sigma) was added to the top of the tube. 
Samples were amplified for 3S cycles for one minute at +94°C, for two minutes at + 72°C 
and a final extension for five minutes at + 72°C. Samples were run out on a I.S% agarose 
gel as described previously. Once the presence of the 4S0bp insert was confirmed 
samples were subjected to further purification using Wizard TM Minipreps DNA 
purification kit (Promega Ltd., Chilworth Research Centre, Southampton) as described 
below, to remove any residual dNTP, enzyme, and primers. 
2.10.3 Purification of clones for commercial sequencing 
Purification involved using the Wizard™ Minipreps DNA purification kit (Promega). 
Broth samples were centrifuged for ten minutes at 1200g and the supernatants discarded. 
Two hundred III of cell re-suspension solution was added to the cell pellets and 
transferred to a I.Srnl micro-centrifuge tube. Two hundred III of cell lysis solution was 
added and the micro-centrifuge tube continually inverted until the solution cleared. To 
this, 200lli of neutralising solution was added, and the micro-centrifuge tube was again 
inverted. The sample was centrifuged for five minutes at 140g and the supernatant was 
transferred to a fresh two ml micro-centrifuge tube. 
Plasmid purification of the clones was carried out as follows. One rnl of the Wizard 
minipreps DNA purification resin was added to the supernatant sample and mixed by 
inverting the micro-centrifuge tube. The plunger from a three ml syringe was removed 
prior to the attachment of the miniprep column, to ensure the membrane was not 
damaged. The resin / DNA mix was pipetted into the syringe, the plunger replaced and 
the solution pushed through slowly. The syringe was detached from the column prior to 
removal of the plunger. Once the plunger was removed the column was reattached and 
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two mls of column wash was added and pushed gently through. The membrane within 
the column was centrifuged for two minutes at 140g to dry the resin retained. For elution 
of the DNA from the membrane, S0J.11 of sterile water (Baxters), that had been preheated 
to +5SoC, was added direct to the column and allowed to stand for two minutes followed 
by centrifugation for a further 20 seconds. The plasmid DNA collected was stored at -
20°C. These samples were then sent to Cambridge Bioscience (Cambridge Bioscience 
Ltd., Cambridge) for commercial sequencing. 
2.11 Polymerase Chain Reaction-Restriction Fragment Length Polymorphism 
2.11.1 Polymerase Chain Reaction amplification of MHC class II DQB exon 2 alleles 
for analysis by Restriction Fragment Length Polymorphism. 
Polymerase Chain Reaction amplification of BoLA MHC class IT DQB exon 2 was 
carried out using DNA isolated from peripheral blood by standard methods as described 
previously. To avoid contamination of stock PCR solutions, a master mix, enough for all 
samples was made up. This master mix contained per sample five J.11 of lOX PCR bu~fer, 
1.5JlI SOmM Mg CI, one J.11 lOmM dNTP, one J.11 2SpmollJ.11 DQBEX2fwd, 
S'(GGGCC[TA]GTGTTA [CT] TTCAC [CT] AA)3', and one J.11 2SpmollJ.11 
DQBEX2rev, S'(TTGT[GT] TCTGCACACC [CG]TGTCC)3', primers published 
previously for MHC class IT in cattle (Russell, 2000) were used. To avoid contamination 
with extraneous template the work area was decontaminated by depurination as described 
previously. The master mix was vortexed and irradiated by UV light for five minutes, 
prior to addition of DNA and DNA polymerase (Dynazyme) to each sample to eliminate 
possible contaminants. One J.1g of genomic DNA plus 0.SJ.11 of DNA polymerase was 
added to the above master mix, and the total reaction volume made up to SOJlI with sterile 
water (Baxters). A negative control containing no DNA was set up as part of a standard 
protocol. Polymerase Chain Reaction amplification involved an initial hot start for three 
minutes at +94°C straight from ice, followed by 30 cycles for one minute at +94°C, for 
one minute at +S7°C, for three minutes at + 72°C and a final extension for five minutes at 
+72°C. 
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Gel electrophoresis of the PCR products was carried out as follows. Briefly, ten JlI of the 
50JlI PCR reaction was mixed with five JlI of loading buffer (Sigma) and run on a 1.5% 
agarose gel. The expected size of the PCR product generated was 214bp in length. The 
product was analysed under UV light on a transilluminator T2201 (Sigma), to ensure the 
DQB fragment of the correct size had been amplified. 
2.11.2 Polymerase Chain Reaction amplification of MHC class II DRB alleles for 
analysis by Restriction Fragment Length Polymorphism. 
The same basic principle for generation of a PCR product was used to amplify the MHC 
class II second ex on in DRB3. Unlike DQB, PCR amplification of DRB3 ex on 2 
involved a hemi-nested PCR, whereby the product of a first stage amplification is used to 
generate the final product using one nested on first stage products. In the first stage, one 
JlI of 5pmol/I.Ll HL030, 5'(ATCCTCTCTCTGCAGCACATTTCC)3' and one JlI of 
5pmol/JlI HL031, 5'(TTTAAATTCGCGCTCACCACGCCGCT)3' (van Eijk et ai., 
1992), were added with the DNA and other PCR reagents. PCR amplification involved 
an initial hot start for four minutes at +94°C straight from ice, followed by 15 cycles for 
one minute at +94°C, for two minutes at +60°C, for one minute at + 72°C and a final 
extension for five minutes at + 72°C. The first stage PCR product was not run out on an 
agarose gel, as a 15 cycle amplification would not generate enough product to visualise by 
ethidium bromide staining. 
For the second stage amplification, two JlI of the first stage product was added to one JlI 
of 25pmol/JlI HL030, 5'(ATCCTCTCTCTGCAGCACATTTCC)3', and one JlI of 
25pmol/JlI HL032, 5'(TCGCCGCTGCACAGTGAAACTCTC) 3' (van Eijk et ai., 
1992), and made up to 50JlI with the other PCR reagents. PCR amplification involved 30 
cycles at +94°C for one minute, +65°C for 30 seconds and a final extension at + 72°C for 
five minutes. The PCR product generated was anticipated to be 284bp in length. Gel 
electrophoresis was carried out as described previously. 
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2.11.3 Restriction Fragment Length Polymorphism enzymatic digestion of MHC 
class II DQB and DRB3 exon 2 Polymerase Chain Reaction products. 
The products of the DQB and DRB3 PCR amplification were divided into three I5J..lI 
aliquots and transferred into 0.5ml micro-centrifuge tubes. For the DQB samples, the 
three enzymes used were Rsa I, Rae III and Brs I. To ten J..lI of PCR product, 0.5J..lI of one 
of the enzymes was added to 4.5J..lI IX enzyme buffer. The samples containing Rsa I and 
Rae III were incubated for eight to ten hours at +37°C. The samples containing Brs I 
were incubated for eight to ten hours at +65°C. The samples were then transferred 
directly onto ice prior to analysis on a polyacrylamide gel. 
For the DRB3 samples, the three enzymes used were Rsa I, Rae III and Bst YI. To ten J..lI 
of PCR product, 0.5J..lI of one of the enzymes was added to 4.5J..lI IX enzyme buffer. The 
samples containing Rsa I and Rae III were incubated for eight to ten hours at +37°C. The 
samples containing Bst YI were incubated for eight to ten hours at +50°C. The samples 
were then transferred directly onto ice prior to analysis on a polyacrylamide gel. 
2.11.4 Visualisation of Restriction Fragment Length Polymorphism by gel 
electrophoresis 
Fifteen mIs of 40% acrylamide (Easigel, Scotlab, Coatbridge) was mixed with 100J..lI of n, 
n, n', n' -tetramethylethylelediamine (TEMED), ten mIs of lOX TBE, 100J..lI of 25% 
ammonium persulphate and made up to 100ml with distilled water, to give a final 
concentration of 6% polyacrylamide. The solution was mixed thoroughly and poured 
slowly between the two glass plates to ensure no air bubbles formed. Once set, the wells 
were flushed out with the buffer used to run the gel prior to samples being loaded. The 
enzymatic digestion products were mixed with bromophenol blue (Sigma) and run along 
with a pBR3221Rae III (Sigma) and 20/l00bp ladder size standards mixed, to allow easier 
determination of fragment sizes. The gel was run in IX TBE buffer at 400volts/60mA 
until the bromophenol blue was almost at the bottom. 
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Once the run was complete, the gels were stained in 100Jlglml ethidium bromide for 15-
30 minutes. The gels were then rinsed in tap water to remove excess ethidium bromide, 
before visualisation of the digestion patterns under UV light. Digital images of the gels 
were recorded and printed using a Bio-Rad Gel Doc 1000 system running multi-analyst 
software. 
2.11.S Analysis of Restriction Fragment Length Polymorphism generated by 
Polymerase Chain Reaction 
The RFLP patterns generated were compared with previously published patterns, which 
were already attributed to sequenced alleles by prediction of restriction sites (van Eijk et 
ai., 1992; Gelhaus et ai., 1995, appendix D). 
2.12 Statistical analysis 
2.12.1 Correlation 
The correlation coefficient was calculated using a general linear mixed model (SAS, 
Cary, North Carolina) where the model used was: 
Stimulation Index (SI) mean = mean (SIl + SI2 + SI3 + SI4) 
LogS I mean = lOglO (SI mean + 1) 
2.12.2 Repeatability 
Repeatability used the statistical model: 
Where Jl is the common mean, Uk is the effect of the individual and elan is the 
environmental deviation of the Mth measurement. 
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Repeatability was calculated as: 
Where R is the permanent environmental effect plus the genetic effects; w is the variation 
between individuals and e is the variation within individuals 
2.12.3 T test 
A two-tailed unpaired T test was used to compare the means of two independent groups 
of observations and was calculated as: 
Xl -X2 
t = --r==============:= 
S2(_1 +_1 J 
n l n2 
Where n is the number of observations, x is the sample mean and s is the estimated 
standard deviation. 
A two tailed paired T test was used to compare the means of two related groups of 
observations and was calculated as: 
d d 
SE(J) = Sd..Jn 
Where n is the number of pairs in the sample, d is the mean of the difference in the 
sample, SEC d) is the estimate of the standard error of the differences and Sd is the 
estimate of the standard deviation of the differences 
The difference in the proportion of cell subpopulations between bulls and cows was tested 
using Hotelling's T square test (Minitab, Release 13 for Windows). 
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2.12.4 Hardy-Weinberg equation 
The probability of the MHC DRB3.2*16 RFLP type being identified in all five bulls 
chosen as having the strongest proliferative response induced by S. aureus strain A was 
calculated assuming a gene frequency of 0.1 (KeIrn et ai., 1997; Sharif et ai., 1998b) and 
the Hardy-Weinberg principle that an allele p will be carried by p2 homozygotes and 2pq 
heterozygotes. Allele frequencies of p and q can be calculated as follows: 
p2 + 2pq +q2 = 1, where 
0.01 + 0.18 + 0.81 = 1 
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Chapter III 
Results 
3.1 Restriction Enzyme Fragmentation Pattern Analysis 
Staphylococcus aureus strains A, C and F, used to induce the proliferative response of 
PBM isolated from cows and bulls, were characterised by REFP analysis. Two further 
isolates, strains D and E, which were not used to induce the in vitro proliferative response 
were also characterised by REFP analysis to demonstrate the variation in strains of S. 
aureus present in the dairy cow's environment. The S. aureus strains A, C, D and E were 
all isolated from the mammary gland. The S. aureus strains C and D were isolated from 
the mammary gland of the same cow but from different quarters. The S. aureus strain F 
was isolated from the vagina of the same cow as strains C and D. 
The band patterns generated following enzymatic digestion highlighted genomic 
differences between the strains. Differences in patterns were seen between strains 
isolated from the vagina (strain F) and the mammary gland, but also among isolates from 
different mammary glands (strain A, C, D, and E), (Figure: 1). 
Digestion of the isolates generated a variety of fragment sizes. For S. aureus strain A, 
isolated from the mammary gland, sizes ranged from 8.36kilobases (kb) to 4.38kb (Figure 
1: lane 1). Staphylococcus aureus strain C, isolated from the mammary gland, sizes 
ranged from 8.36kb to 4.47kb (Figure 1: lane 2). Staphylococcus aureus strain D, isolated 
from the mammary gland, sizes ranged from 8.63kb to 4.47kb (Figure 1: lane 3). 
Staphylococcus aureus strain E, isolated from the mammary gland, sizes ranged from 
8.63kb to 4.38kb (Figure 1: lane 4). 
Digestion of strain F, isolated from the vagina of same cow as mammary isolates C and 
D, generated fragment sizes that ranged from 26.37 to 4.36kb (Figure 1:lane 4). 
Estimation of the band sizes was performed using enzymatic standards, Kpn I, Pst I and 
Hha 1. These were run simultaneously with the S. aureus isolates. Lambda DNA 
incubated with Kpn I generated fragments of 30.04kb and 18.21kb (Figure 1: lane 9). 
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Lambda DNA incubated with Pst I generated fragments of 14. 13kb, 11.95kb, 4.61kb, 
4.42kb, 4.27kb and 3.68kb (Figure 1: lane 10). 
Analysis of the fragmentation patterns showed individual bands for S. aureus strain A, 
isolated from the mammary gland, of sizes; 8.63kb, 7.68kb, 6. 13kb, 5.79kb, 5.5kb, 
5.03kb, 4.9kb, 4.73kb, 4.69kb, 4.58kb, 4.49kb, 4.43kb and 4.38kb (Figure 2: lane 1). 
Estimation of the band sizes generated by the REFP showed that S. aureus strains C and 
D, isolated from the mammary gland of the same cow but different quarters were identical 
with sizes of; 8.63kb, 7.68kb, 6.62kb, 5.92kb, 5.82kb, 5.49kb, 4.9kb, 4.83kb, 4.72kb, 
4.59kb, 4.49kb and 4.47kb (Figure 2: lanes 2 and 3 respectively), for S. aureus strain E, 
isolated from the mammary gland; 8.36kb, 7.68kb, 6. 13kb, 6. 19kb, 5.45kb, 4.93kb, 
4.67kb, 4.57kb, 4.38kb (Figure 2: lane 4). Estimation of the band sizes generated by 
REFP showed that S. aureus strain F although isolated from the vagina of the same cow 
as strain C and D was unique with sizes of; 26.37kb, 12.47kb, 8.75kb, 7.64kb, 6.55kb, 
5.53kb, 5.3kb, 4.96kb, 4.82kb, 4.65kb, 4.55kb and 4.36kb (Figure 2: lane 5). 
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Lanes: 1 2 3 4 5 9 10 
Figure 1: Results of restriction enzymatic digestion of various strains of S. aureus with 
Hha I. Lane 1: S. aureus strain A isolated from the mammary gland, lane 2: S. aureus 
strain C isolated from the mammary gland, lane 3: S. aureus strain D isolated from the 
mammary gland, lane 4: S. aureus strain E isolated from the vagina and lane 5 shows S. 
aureus strain F isolated from the mammary gland. Lambda DNA controls were digested 
with Kpn I and Pst I lanes 9 and 10 respectively. 
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Figure 2: Graphical output of digitised image of figure 1, results of restriction enzymatic 
digestion of various strains of S. aureus with Hha I. Lane 1: S. aureus strain A isolated 
from the mammary gland, lane 2: S. aureus strain C isolated from the mammary gland, 
lane 3: S. aureus strain D isolated from the mammary gland, lane 4: S. aureus strain E 
isolated from the mammary gland, and lane 5: S. aureus strain F isolated from the vagina. 
Lambda DNA controls were digested with Kpn I and Pst I and the fragment sizes used on 
the left and right hand side of the digitised image. 
98 
3.2 Detection of Staphylococcal Enterotoxins (SE) using Reverse Passive Latex 
Agglutination (RPLA) 
Investigation of enterotoxin production from S. aureus strains A, C, D and F, used to 
induce the proliferative response of PBM in vitro, was undertaken. The results would 
allow comparison of strain phenotype and genotype, as pre-determined by REFP analysis, 
and provide additional information on the strains of S. aureus used to induce the 
proliferative response of PBM in vitro. 
Four isolates confirmed as S. aureus, three of which were isolated from the mammary 
gland (strains A, C, and D) and one of which was isolated from the vagina (strain F), by 
use of selective and differential media, coagulase testing and serotyping were tested for 
enterotoxin and TSST1 production using RPLA toxin detection kits (Oxoid; Matsunaga et 
ai., 1993). 
Results showed variation in the types of enterotoxin produced by the four different strains 
of S. aureus. Enterotoxin production varied among mammary isolates and between the 
mammary and vaginal isolates. Strain A, isolated from the mammary gland, produced 
SED only (Table: 1), this differed from the other two mammary isolates, strains C and D, 
which produced SEC and TSST1 (Table: 1). The results from strain C and D supports 
those reported in the REFP genomic analysis, which showed that these two strains had 
identical restriction enzyme digestion patterns. Strain F, isolated from the vagina, 
although originating from the same cow as strain C and D, produced two different 
enterotoxins, SEA and SEB (Table: 1). 
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Staphylococcal enterotoxin SEA SEB SEC SED TSSTI 
s. aureus strain 
strain A 
- - - + -
mammary 
strain C 
- - + - + 
mammary 
strain D 
- - + - + 
mammary 
strain F + + - - -
vaginal 
Table 3: Results of RPLA toxin detection of three mammary gland strains and one 
vaginal strain of S. aureus. Staphylococcus aureus strain A was isolated from the 
mammary gland of a cow from a different farm from strains C, D and F. Staphylococcus 
aureus strain C and D were isolated from the same mammary gland but different quarters 
of the same cow. Staphylococcus aureus strain F was isolated from the vagina of the 
same cow as strains C and D. 
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3.3 In vitro proliferation of peripheral blood mononuclear cells 
Modification of the antigen presentation assay described by Fitzpatrick (1992) during the 
current study attempted to isolate a pure population of peripheral T cells using 
miniMACS. Cell yield for this technique was in the range of 85-95% of the total number 
of cells loaded onto the column. Incubation of an anti-CD2 MAb with PBM prior to 
loading onto the column resulted in positive selection where the labelled T cell 
population was retained in the column until removed from the magnetic stand when the 
positive fraction was eluted. Cell viability of the positive fraction was poor at 50-60%. 
When T cells isolated by positive selection, at various concentrations were cultured in 
vitro with S. aureus strain A and fresh irradiated APC at varying ratios to the T cell 
population, they failed to proliferate. A possible explanation for the lack of proliferative 
response induced by S. aureus strain A was that positive selection of T cell may have 
damaged the isolated cells, altering their functional capabilities. Peripheral blood 
mononuclear cells were subsequently labelled with an anti-MHC class II MAb, which 
retained the APC population within the column and allowed the negative fraction to pass 
through. When T cells isolated by negative selection were culture in vitro with fresh 
irradiated APC and induced by S. aureus strain A, again, they failed to proliferate. 
As a result of the failure to induce T cells isolated by positive and negative rniniMACS 
selection to proliferate in vitro, development of the current study led to total blood 
mononuclear cells being isolated by centrifugation with media of a specific density. The 
isolated PBM population were then use as the responding cell population in the current in 
vitro proliferation assay induced by S. aureus. 
Peripheral blood mononuclear cells were isolated from six cows, by density 
centrifugation using ficoll-isopaque (density 1.077gfl). To determine the optimal 
concentrations of formalin-killed whole S. aureus strain A and PBM that would induce 
maximal proliferative responses, a range of S. aureus strain A and PBM concentrations 
were employed. Staphylococcus aureus strain A at a stock concentration of 1.4x 108 
bacteria/ml complete media was diluted 1:100-1:800, and concentrations of PBM ranged 
from 1.0-4.0x 106 PBMlml complete media. These initial experiments resulted in a final 
dilution of S. aureus strain A as 1 :300 (0.5x 106 bacteria/ml complete media) and a final 
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concentration of 2.0x106 PBMlml complete media being chosen (Table: 4). The 
proliferative response was measured over an eleven-day period of culture in vitro. 
PBM concentration 1.0xl06/m 2.0xl06/m 4.0xl06/m 
I I I 
S. aureus dilution 
1:100 0 0+/-2 0+/-1 
1:200 8+/-3 14+/-20 12+/-10 
1:300 30+/-11 70+/-25 45+/-15 
1:400 25+/-6 55+/-10 50+/-8 
1:500 18+/-4 40+/-9 30+/-7 
1:600 5+/-2 29+/-13 10+/-3 
1:700 3+/-2 20+/-14 15+/-5 
1:800 9+/-3 20+/-7 10+/-4 
Table 4: The mean proliferative response (SI+/-SD) of PBM isolated from Holstein-
Friesian cows (n=6) at concentrations ranging from 1.0-4.0x106PBMlml, induced by 
Staphylococcus aureus strain A at dilutions ranging from 1:100-1:800 from a stock 
concentration of 1.4 xI 08bacterialml. 
Incubation of peripheral blood mononuclear cells at a concentration of 2.0x 106 PBMlml 
in the presence of S. aureus strain A, at a dilution of 1: 100 (1.4x106 bacterialml), failed to 
induce a proliferative response throughout the in vitro culture period. Staphylococcus 
aureus strain A at dilutions of 1 :300 (0.5x 1 06 bacterialmI), 1 :500 (O.3x 106 bacterialml), 
and 1 :800 (0.18x 106 bacterialmI), induced a proliferative response with the day of peak 
proliferation measured on day 7 of culture (Figure: 3). Results presented in the current 
study have been expressed as SI and counts per minute to illustrate the extent of the 
proliferative response induced by the S. aureus strain A. 
Peripheral blood mononuclear cells, in the absence of S. aureus strain A, had a very low 
background proliferation. Results showed that the mean proliferative response eH-
thymidine incorporation +/-SD) of PBM cultured in the absence of S. aureus strain A was; 
407+/-207 cpm on day 5, 336+/-94 cpm on day 7,436+/-143 cpm on day 9, and 363+/-102 
cpm on day 11 (n=4). A proliferative response above the background levels was apparent 
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in the presence of S. aureus strain A from day five of culture. The proliferative response 
continued to increase at day seven, peaked at day nine, and had begun to diminish by day 
eleven. The mean proliferative response eH-thymidine incorporation +/-SD) of PBM 
induced by S. aureus strain A was; 10,452+/-11,515 cpm on day 5, 13,606+/-17,677 cpm 
on day 7,23,278+/-17,598 cpm on day 9, and 10,100+/-6,266 cpm on day 11 (Figure: 4). 
Variation in the magnitude of the proliferative response of PBM at a concentration of 
2.0x106 PBMlrnl, induced by S. aureus strain A at a concentration of 0.5x106bacterialrnl, 
was apparent among individual animals (n=21), (Figure: 5). As can be noted from figure 
5, there was little response detected between days two and four of in vitro culture. 
Variation in the response induced by the S. aureus strain A was seen among animals with 
some cows showing an increase in proliferation to a peak on day 9, with the day of peak 
proliferative response occurring later in some cows. The mean proliferative response 
(SI+/-SD) of PBM induced by S. aureus strain A was; 0 on day 2; 9+/-4 on day 3; 1+/-1 on 
day 4; 35+/-30 on day 5; 12+/-9 on day 6; 45+/-37 on day 7; 34+/-26 on day 8; 61+/-53 on 
day 9; 36+/-44 on day 10 and 22+/-20 on day 11 (Figure: 6). The SI on day 9, the day of 
peak proliferation, ranged from 0 to 164. 
To investigate if different strains of S. aureus resulted in different kinetics associated with 
a proliferative response, two strains of S. aureus, strain A and strain B, characterised by 
genomic fingerprinting, were isolated and used to induce proliferation of PBM in vitro. 
The S. aureus strain A was isolated from a case of subclinical mastitis on one farm, and 
the S. aureus strain B was isolated from a case of subclinical mastitis on another farm. 
Variation in the proliferative response of PBM to S. aureus strain A and strain B at 
concentrations ranging from 1.4-0.14 x106 bacterialml was measured in the same cows 
and a representative result for one cow shown in Figure 7. Results showed that the 
proliferative response induced by S. aureus strain A was stronger than that induced by S. 
aureus strain B at concentrations of 0.5x 106 bacterialml, 0.35x 106 bacterialml, 0.14x 106 
bacterialml (n=4). However, as shown previously with S. aureus strain A, S. aureus 
strain B at a concentration of l.4xl06bacterialrnl, failed to induce a proliferative response 
throughout the culture period. Results showed the mean proliferative response (SI+/-SD) 
of PBM induced by S. aureus strain A at the previously chosen optimal dilution of 
0.5x106 bacterialml was; 49+/-43 on day 5, 94+/-59 on day 7, 75+/-20 on day 9, and 45+/-
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29 on day 11. The mean proliferative response (SI+/-SD) of PBM induced by S. aureus 
strain B was; 1+/-2 on day 5, 1+/-1 on day 7, 1+/-1 on day 9, and 2+/-1 on day 11. The day 
of peak: proliferation was day 7 of culture for S. aureus strain A. The difference in 
proliferative response in cows (n=4) between strain A and strain B was highly significant 
(p<O.OI). 
The within assay repeatability of the proliferative response induced by S. aureus strain A, 
measured as SI, was shown to be 99.0% on day 5, 87.0% on day 7, 99.0% on day 9, 
99.8% on day 11 and 92.0% (n=4), (Figure: 8). When statistical analysis was carried out 
on log-transformed SI the within assay repeatability was shown to be 99.8% on day 5; 
98.3% on day 7; 96.1 % on day 9; 98.6% on day 11 and 98.4%, with p=O.OI for all days 
tested. 
Considerable variation in the proliferative response of PBM of cows, kept in the same 
environmental conditions, to S. aureus strain A, suggested that the difference in ability to 
induce a proliferative response may be under genetic control. To investigate the 
hypothesis, ten cows from a commercial dairy herd were chosen. The cows were sired by 
one of two commercial Holstein-Friesian bulls; five were sired by bull A and five were 
sired by bull B. The mean proliferative response (SI+/-SD) induced by S. aureus strain A 
of the progeny sired by bull A was, 13+/-14 on day 7; 17+/-27 on day 9; and 11+/-16 on 
day 11. The mean proliferative response (SI+/-SD) induced by S. aureus strain A of the 
progeny sired by bull B was, 41+/-45 on day 7; 77+/-69 on day 9; and 20+/-19 on day 11. 
Results showed that on day 9 the mean proliferative response of the progeny of sire B was 
significantly higher than the mean proliferative response of the progeny of sire A 
(p=0.03), (Figure: 9). On day 7 and day 11 of culture, the proliferative response of 
progeny of sire B was again greater than that of the progeny of sire A, but did not reach 
statistical significance (day 7: p=0.08, and day 11: p=0.19), (Figure: 10). The between 
assay repeatability of the proliferative response induced by S. aureus strain A in these ten 
cows, measured as SI, was shown to be 79% for all days tested. 
The variation in the proliferative response of PBM in cows induced by the two strains of 
S. aureus, strain A and strain B, resulted in investigation of the proliferative response 
induced by further strains of S. aureus isolated from the mammary gland and from 
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different areas of the cows' anatomy. Staphylococcus aureus strain C, was isolated from 
the mammary gland, whilst S. aureus strain F, was isolated from the vagina of the same 
cow. The isolate from the mammary gland, strain C, allowed a direct comparison of the 
ability of three different S. aureus strains, A, Band C, all originating from the mammary 
gland of different cows to induce a proliferative response. The vaginal isolate allowed 
comparison of the ability of two different strains of S. aureus isolated from different 
mucosal sites in a single animal, strain C and strain F. The concentration of each strain of 
S. aureus used to induce a proliferative response was 0.5x106 bacteria/ml. 
Results showed the proliferative response of PBM (n=8) induced by S. aureus at a 
concentration of 0.5x 106 bacteria/ml, was again greatest for S. aureus strain F, the vaginal 
strain (Figure: 11). The mean proliferative response (SI+I-SD) of S. aureus strain A, at a 
concentration of 0.5x 106 bacteria/ml, isolated from the mammary gland, was; 2+1-1 on day 
2; 29+1-40 on day 4; 45+1-74 on day 6; 40+1-54 on day 8; and 27+1-32 on day 10. The 
mean proliferative response (SI+I-SD) of S. aureus strain C, at a concentration of 0.5x106 
bacteria/mI, isolated from the mammary gland, was; 2+1-1 on day 2; 5+1-2 on day 4; 1+/-1 
on day 6; 0 on day 8; and 0+1-1 on day 10. The mean proliferative response (SI+I-SD) of 
S. aureus strain D, at a concentration of 0.5x106 bacteria/ml, isolated from the vagina, 
was; 1+/-1 on day 2; 38+1-50 on day 4; 86+1-137 on day 6; 34+/-43 on day 8; and 12+1-11 
on day 10. The day of peak proliferation was day six rather than day four. 
The response of PBM induced by different strains of S. aureus highlighted the variation 
in the ability of different strains isolated from a common site, the mammary gland, strain 
A, strain B and strain C, to induce a proliferative response. Similarly, S. aureus strains 
isolated from the same animal, but from different mucosal sites, strain F and strain C, also 
showed different abilities to induce proliferation of PBM. 
Whole bacterial formalin-fixed S. aureus was purchased from Sigma (Staphylococcus 
aureus Wood 46 strain), a non-protein A producing strain. The proliferative response of 
PBM induced by S. aureus Wood 46 strain was measured in cows (n=4). Dilutions of the 
S. aureus Wood 46 strain ranged from 1: 100-1: 1,000,000. Variation in proliferative 
response of PBM induced by S. aureus Wood 46 strain was noted at the various dilutions 
(Figure: 12). Peak proliferation of PBM induced by S. aureus Wood 46 strain was at 
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dilutions of 1: 1,000 or 1: 10,000. The mean proliferative response (SI+I-SD) of PBM 
induced by S. aureus Wood 46 strain (1:1,000) was; 18+/-22 on day 3; 61+/-91 on day 5; 
58+1-65 on day 8 and 30+1-36 on day 10. The mean proliferative response (SI+I-SD) 
induced by S. aureus Wood 46 strain (1:10,000) was; 14+/-19 on day 3; 48+1-78 on day 5; 
47+1-34 on day 8 and 39+1-38 on day 10. Variation among animals in the proliferative 
response induced by S. aureus Wood 46 strain was noted, as found previously with S. 
aureus strain A, C and D, with some animals generating a higher proliferative response 
than others (Figure: 13). It can be seen (Figure: 13) that cow 1 had a higher proliferative 
response induced by the S. aureus Wood 46 Strain At both dilutions of 1: 1,000 and 
1: 10,000 compared to cows 2, 3 and 4. The day of peak proliferation for cow 1 was day 
five compared to day eight for cows 2, 3 and 4. 
Generally, as was noted with the other strains of S. aureus tested, those animals with a 
strong proliferative response induced by one dilution of S. aureus also showed a strong 
proliferative response at the other dilutions tested. 
The proliferative response of PBM to staphylococcal enterotoxin B was measured in cows 
(n=3). Enterotoxin B is one of a number of exoproteins secreted by strains of S. aureus 
that has been shown to induce a mitogenic polyc1onal T cell response. To demonstrate 
that the kinetics of the proliferative response of PBM, induced by S. aureus in the current 
study were induced by an antigenic stimulus rather than a mitogenic stimulus, PBM, at 
the predetermined optimal concentration, were incubated with SEB (Sigma) at dilutions 
ranging from 1: 100-1: 100,000. The mean proliferative response (SI+I-SD) induced by 
SEB at a dilution of 1:100 was; 41+/-14 on day 2; 63+/-43 on day 4; 2+1-4 on day 6; and 0 
on day 8. The mean proliferative response (SI+I-SD) induced by SEB at a dilution of 
1: 1000 was; 43+1-10 on day 2; 54+1-34 on day 4; 10+1-8 on day 6; and 1+1-2 on day 8. The 
mean proliferative response (SI+I-SD) induced by SEB at a dilution of 1: 10,000 was; 40+1-
8 on day 2; 49+1-32 on day 4; 9+1-5 on day 6; and 1+1-2 on day 8. The mean proliferative 
response (SI+I-SD) induced SEB at a dilution of 1:100,000 was; 32+1-13 on day 2; 46+1-25 
on day 4; 8+1-4 on day 6; and 1+/-2 on day 8. Results showed that a strong proliferative 
response induced by all dilutions of SEB was detectable on day 2 of culture. The day of 
peak proliferation for all dilutions of SEB was day 4, by day 6 the proliferative response 
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induced by the SEB had begun to decline and by day 8 the response was negligible (data 
not shown), (Figure: 14). 
As was reported when studying the different strains of S. aureus, variation in proliferative 
response of PBM induced by SEB was observed among cows (Figure: 15). The 
magnitude of the proliferative response induced by SEB on day 4 was greater in cow 3 
compared to cows 1 and 2, which had quite similar levels of response. The results show 
clear differences in the kinetics of the proliferative response of PBM of cows induced by 
antigen and SEB when S. aureus strain A was added to the culture at a concentration of 
0.5x106 bacteria/mI, peak proliferation occurred at day 7 or day 9. In contrast, when SEB 
was added to the culture peak proliferation occurred much earlier on day 4. 
In vivo, cell proliferation, induced by mammary gland pathogens would probably occur in 
cells found within the local mammary gland environment, including the interstitial tissue, 
and possibly in cells in the alveoli or gland cistern of the udder. To investigate the 
possible effect of milk on the proliferative response of PBM induced by SEB, an 
experiment was designed where proliferation induced by SEB was compared in the 
presence and absence of complete media containing 7% and 14% normal filtered milk. 
Peripheral blood mononuclear cells and SEB were also cultured in the presence of the 
same dilutions of filtered milk from a mastitic cow, which had been identified as being 
infected with S. aureus by routine bacteriology. Staphylococcal Enterotoxin B was used 
at a dilution of 1: 10,000. Results showed that the day of peak proliferation in the 
presence of SEB was on day three, which confirmed the difference in kinetics of 
proliferative response, induced by SEB and S. aureus as shown previously. The mean 
proliferative response (SI+/-SD) of PBM induced by SEB was; 2+/-2 on day 1; 69+/-47 on 
day 2; 162+/-156 on day 3; 107 +/-95 on day 4; and 18+/-19 on day 5. The mean 
proliferative response (SI+/-SD) induced by SEB in 14% normal milk was; 0 on day 1; 
8+/-3 on day 2; 28+/-18 on day 3; 28+/-30 on day 4; and 10+/-6 on day 5. The mean 
proliferative response (SI+/-SD) of PBM induced by SEB in 7% normal milk was; 1+/-1 
on day 1; 19+/-1 on day 2; 33+/-5 on day 3; 108+/-161 on day 4; and 38+/-56 on day 5 
(n=3). Using a paired T test, the presence of 14% normal milk in the culture system 
significantly reduced the proliferative response of PBM of cows induced by SEB 
compared to the proliferative response induced by SEB in the absence of milk (p=0.025). 
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Again using a paired T test, a similar trend could also be seen in the proliferative response 
induced by SEB in the presence of 7% normal milk, however this was not statistically 
significant (p=0.28), (Figure: 16). Incubation of PBM in the presence of milk infected 
with S. aureus, as determined by routine bacteriology, induced no proliferative response 
over background when added to the in vitro culture at concentrations of 7% and 14%. 
Presentation of antigen to CD4+ cells is dependent on expression of MHC class II on 
antigen presenting cells. To determine if the proliferative ability of PBM of cows induced 
by S. aureus strain A was dependent on MHC class II, an anti-MHC class II MAb, IL-
A21, was added to PBM and S. aureus strain A during culture in vitro. Dilutions of the 
anti-MHC class II used were 1:5 and 1: 10. The mean proliferative response (SI+I-SD) of 
PBM of cows induced by S. aureus strain A was; 4+1-1 on day 2; 66+/-61 on day 4; 225+1-
111 on day 6; 81+1-31 on day 8; and 75+1-27 on day 10. The mean proliferative response 
(SI+I-SD) of PBM of cows induced by S. aureus strain A in the presence of anti-MHC 
class II (1:5) was; 1+1-1 on day 2; 29+1-16 on day 4; 138+/-91 on day 6; 81+1-61 on day 8; 
and 19+1-18 on day 10. The mean proliferative response (SI+I-SD) of PBM of cows 
induced by S. aureus strain A in the presence of anti-MHC class II (1: 10) was; 3+1-1 on 
day 2; 45+1-28 on day 4; 182+1-90 on day 6; 105+1-43 on day 8 and 31+1-9 on day 10 
(Figure: 17). Results showed that the proliferative response of PBM induced by S. aureus 
strain A was significantly reduced in the presence of anti-MHC class II at a dilution of 1:5 
(p=0.05) on day 6 of culture (n=5). A similar trend in reduction of proliferative response 
of PBM was also seen in the presence of anti-MHC class II at a dilution of 1: 10 on day 6 
of culture, however this was not statistically significant (p=0.06). 
During the course of the study, additional stocks of S. aureus strain A were required for 
use in the proliferative assay. Variation in the ability of two newly prepared batches of S. 
aureus strain A and the original batch to generate a proliferative response of PBM of 
cows (n=8) was noted. The comparison was based on the S. aureus strain A at the 
original concentration of 0.5x 106 bacteria/ml that was chosen from the primary results. 
The mean proliferative response (SI+I-SD) of PBM induced by the second batch of S. 
aureus strain A at a concentration of 0.5x 106 bacteria/ml was; 1 +1-1 on day 2; 4+1-3 on day 
4; 3+1-5 on day 6; 22+1-15 on day 8 and 14+1-12 on day 10. The mean proliferative 
response (SI+I-SD) of PBM induced by the third batch of S. aureus strain A at a 
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concentration of 0.5x106 bacteria/ml was 1+/-2 on day 2; 4+/-4 on day 4; 9+/-11 on day 6; 
11 +/-19 on day 8 and 6+/-1 on day 10. These were compared with the mean proliferative 
response (SI+/-SD) of PBM induced by the original strain A at a concentration of 0.5x106 
bacteria/ml (n=21), (Figure: 18). The day of peak proliferation for the newly prepared 
batches of S. aureus strain A at a concentration of 0.5x106bacteria/ml was slightly later, 
measured on day 10 of culture, whereas the day of peak proliferation of the original batch 
was day 8 of culture. 
The initial concentration of bacteria present in the newly prepared batches of S. aureus 
strain A was greater than that of the original batch. Titration experiments were carried 
out to determine the optimum concentration of the new batches of S. aureus strain A. 
Concentrations ranged from 0.35-5x108 bacteria/ml. Results of the titration experiments 
showed at a concentration of 5x 108 bacteria/ml, S. aureus strain A failed to induce a 
proliferative response in PBM of cows. The mean proliferative response (SI+/-SD) of 
PBM induced by S. aureus strain A, at a concentration of 2.5x108 bacteria/rnl was; 40+/-
42 on day 2; 59+/-157 on day 4; 9+/-15 on day 6; 8+/-14 on day 8 and 3+/-3 on day 10. The 
mean proliferative response (SI+/-SD) of PBM induced by S. aureus strain A, at a 
concentration of l.4x 1 08 bacteria/rnl was; 48+/-42 on day 2; 219+/-240 on day 4; 35+/-28 
on day 6; 20+/-22 on day 8 and 8+/-8 on day 10. The mean proliferative response (SI+/-
SD) of PBM induced by S. aureus strain A, at a concentration of 0.7x108 bacteria/ml was; 
32+/-29 on day 2; 158+/-194 on day 4; 71+/-66 on day 6; 44+/-49 on day 8 and 21+/-32 on 
day 10. The mean proliferative response (SI+/-SD) of PBM induced by S. aureus strain 
A, at a concentration of 0.35x108 bacteria/ml was; 17+/-13 on day 2; 87+/-35 on day 4; 
113+/-76 on day 6; 87+/-98 on day 8 and 29+/-24 on day 10 (n=9), (Figure: 19). These 
results showed that the optimal dilution of S. aureus strain A altered from 0.5x 106 
bacteria/rnl to either 1.4x108 bacteria/ml or 0.7x108 bacteria/ml, and that the day of peak 
proliferation had changed compared to the original batch. The alteration was from peak 
proliferation occurring on day eight or nine to the day of peak proliferation to day four at 
a concentration of 1.4x 108 bacteria/ml (Figure: 20), and either day four or day six at a 
concentration of 0.7x108 bacteria/ml (Figure: 21). As the concentration of S. aureus 
strain A reduced, the day of peak proliferation occurred later. Variation in the 
proliferative response of PBM induced by S. aureus strain A among cows at the new 
concentrations studied was noted. In general, cows with a strong proliferative response of 
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PBM induced by S. aureus strain A had similar responses at the other concentrations of S. 
aureus strain A tested. This can be seen in figures 20, 21 and 22, at concentrations of 
1.4x108 bacteria/ml, 0.7x108 bacteria/ml and 0.35x108 bacteria/ml in cows 2, 3 and 4, 
which responded better than the other cows to the S. aureus strain A. 
The variation in proliferative response induced by the original batch of S. aureus strain A 
at a concentration of 0.5x106 bacteria/rnl in cows led to investigation of the effect of sire 
on the proliferative response induced by S. aureus strain A in two progeny groups. The 
significant difference between the progeny groups sired by two different bulls led to 
investigation of the proliferative response of PBM of Holstein-Friesian dairy bulls 
induced by S. aureus strain A. Initially, ten bulls were selected from the list of UK 
artificial insemination bulls owned by Genus Ltd. Plc. These bulls were chosen based 
upon available information for PTA for see, and they represented the extremes within 
the population: five bulls were chosen as having the lowest PTA for see, and five were 
chosen as having the highest PTA for Sec. The PTA for see, recorded in 1997, for the 
ten extreme Holstein-Friesian bulls ranged from -12.9 (a mean reduction of 12.9% in 
see in the daughters of that sire, compared to the mean of the population), to +19.6 (a 
mean increase of 19.6% in see in the daughters of that sire, compared to the mean of the 
population). The PTA for see data is not static and as more daughters and more 
lactation records are generated these are incorporated into the data set from which PTA 
for see is calculated. As more data is included the reliability of the PTA for see value 
increases, adding power to the predicted increase or decrease in progeny see. The PTA 
for see in 1998 for the same ten Holstein-Friesian bulls ranged from -23 to +35, and in 
1999 the PTA for see ranged from -2 to +23. Two of the bulls did not have PTA for 
see available in November 1999 (Figure: 23). The reliabilities for the 1997 values for 
PTA for see ranged from 36% to 94%, for the 1998 values, from 49% to 98%, and for 
the 1999, from 49% to 98%. In addition to the PTA for see data on the ten extreme 
bulls in 1997, PTA for the production traits of milk, fat and protein were available (Table: 
5). On comparison of the bulls with low PTA for see with the group of bulls with high 
PTA for see it was noted that PTA for milk (p=0.7), fat (p=0.96) and protein (p=0.81) 
was not affected by the PTA for Sec. This indicates that selection of sires with a low 
PTA for see should not result in reduced milk yield, fat or protein content in their 
progeny. 
110 
PREDIeTED TRANSMITTING ABILITIES 1997 
BULL SI see MILK (kg) FAT (kg) PROTEIN (kg) 
A 37 -12.9 504 21.5 N/A 
B 736 -12.2 544 15 .5 19.2 
C 516 -8 .1 666 26.3 21.9 
D 12 -7.8 242 2.3 11 .2 
E 75 -5 .8 520 12.4 14.8 
F 38 10.6 653 14.3 16.1 
G 5 12.0 645 18.7 15.6 
H 16 12.9 474 14.3 17.8 
I 8 13 .6 678 26.6 19.7 
J 11 19.6 273 5.7 11 .2 
... Table 5: Predicted Transmitting AbilitIes of see, milk, fat and protem m 1997 and the 
proliferative response (SI) induced by S. aureus strain A for the five bulls recorded as 
having the lowest PTA for see (coloured blue) and for the five bulls recorded as having 
the highest PTA for see (coloured red) 
The proliferative response (Sl) of PBM isolated from the initial ten bulls induced by S. 
aureus strain A ranks bull A as having the lowest PTA for see in 1997, and bull J as 
having the highest PTA for see in 1997 (Figure: 24). The range of SI for those bulls 
selected as having the lowest PTA for see in 1997 was; 12 to 726 on day 9, and the 
range of SI for those bulls selected as having the highest PTA for sec in 1997 was; 5 to 
38 on day 9. There was a strong negative correlation (r= -0.7) between the log SI and 
PTA for sec in 1997. Results showed that the proliferative response of PBM of bulls 
induced by S. aureus strain A was statistically significant between the two groups of bulls 
(p=O.05), with the regression of response on see proof also being significant (p=0.05). 
The results however were not dichotomous but bimodal and overlapping. Bull D, 
recorded as having a low PTA for sec, showed a weak proliferative response induced by 
S. aureus strain A, and bull F, recorded as having a high PTA for sec, showed a strong 
proliferative response induc(fd by S. aureus strain A (Figure: 24). The within assay 
repeatability based on log SI was shown to be 97% for these ten bulls (p=0.03). 
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The strong negative correlation between SI and PTA for see in 1997 in the extreme ten 
bulls resulted in the study being extended. One hundred and three Holstein-Friesian dairy 
bulls were sampled and the proliferative response of the PBM induced by S. aureus strain 
A at a concentration of 0.5x 106bacteria/ml was measured. These bulls were sufficiently 
old to have generated sufficient daughters to undergo progeny testing. A total of 59 
proofs for PTA for see were available in 1998 when the 103 bulls were first sampled, 
the mean +I-SD for PTA for see at that time was 4.8+1-6.0. The range of PTA for see 
was from -7.5 to 22.6. The following year in 1999, more proofs for PTA for see 
became available, a total of 98, and the mean +I-SD altered to 4.9+1-8.4. The range of 
PTA for see was from -12.0 to 27.0. The alteration in proofs for PTA for see is due to 
the bulls maturing, increasing in the number of daughter lactation records on which the 
PTA for see is based and improving the reliability. On statistical analysis of the 
different years for PTA for see there was shown to be a good correlation between the 
data sets (r=0.75), this is not surprising as the data sets are not independent. Analysis of 
the 1998 PTA for see in relation to proliferative response of the 103 bulls induced by S. 
aureus strain A (mean log SI) resulted in a correlation (r=) of -0.07. Analysis of the 1999 
PTA for see in relation to immunological response of the 103 bulls induced by S. aureus 
strain A (mean log SI) resulted in a correlation (r=) of -0.01. Both of these results show 
that the significant negative correlation found in the ten extreme bulls (r=-0.7) was not 
present in the randomly selected sample of 103 bulls. 
Variation in the proliferative response of PBM of Holstein-Friesian bulls induced by S. 
aureus strain A was noted among animals with SI ranging from 131 to 0 on day nine of 
culture (Figure: 25). The most extreme SI value was 131, followed by the next highest SI 
value of 49. Thirty-four of those bulls sampled failed to generate a proliferative response 
induced by S. aureus strain A. From the sample population of 103 Holstein-Friesian 
bulls, 53 were resampled to test between assay repeatability. Additionally nine bulls were 
sampled for a third time and six bulls were sampled for a fourth time. The mean 
proliferative response (SI+I-SD) of PBM induced by S. aureus strain A for the bulls tested 
once was 9+/-16; the SI ranged from 0 to 31. The mean proliferative response (SI+I-SD) 
of PBM induced by S. aureus strain A for the bulls tested twice was 7+1-12; the SI ranged 
from 0 to 48. The mean proliferative response (SI+I-SD) of PBM induced by S. aureus 
112 
strain A for the bulls tested three times was 8+1-12; the SI ranged from 0 to 33. The mean 
proliferative response (SI+I-SD) of PBM induced by S. aureus strain A for the bulls tested 
four times was 6+1-5; the SI ranged from 0 to 14. Variation in the proliferative response 
of PBM induced by S. aureus strain A was noted among those bulls, which were sampled 
on more than one occasion. The proliferative response (SI) of PBM induced by S. aureus 
strain A of the bulls sampled on four occasions range was; bull one: 5 to 45; bull two: 4 
to 14; bull three: 0 to 5; bull four: 5 to 15; bull five: 2 to 32 and for bull six: 2 to 30 
(Figure: 26). 
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Figure 3: Representative proliferative response (51) of PBM isolated from a Holstein-Friesian 
cow at a concentration of 2x106/ml induced by Staphylococcus aureus strain A at 
concentrations ranging from 0.18-1.4x1 06 bacteria/ml 
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Figure 4: Mean proliferative response (cpm+/-SO) of PBM at a concentration of 2x106 /ml 
isolated from Holstein-Friesian cows (n=4) induced by Staphylococcus aureus strain A at 
a concentration of 0.Sx1 06 bacteria/ml and in the absence of bacteria 
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Figure 5: Proliferative response (SI) of PBM at a concentration of 2.0x106/ml isolated from 
Holstein-Friesian cows (n=21) induced by Staphylococcus aureus strain A at a 
concentration of 0.5x1 06 bacteria/ml 
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Figure 6: Mean proliferative response (51+1-50) of PBM at a concentration of 2.0x106/ml isolated 
from Holstein-Friesian cows (n=21) induced by Staphylococcus aureus strain A at a 
concentration of 0.5x106 bacterialm I 
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Figure 7: Representative proliferative response (51) of PBM isolated from a Holstein-Friesian 
cow at a concentration of 2x1 06/ml induced by Staphylococcus aureus strain A and strain B at 
concentrations ranging from 0.14-1.40x1 06 bacteria/ml 
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Figure 8: Within assay repeatability of the proliferative response (81) of PBM at a concentration of 
2x106/ml isolated from Holstein-Friesian cows (n=4) induced by Staphylococcus aureus strain A at a 
concentration of 0.5x1 06 bacteria/ml (a= assay well 1; b= assay well 2) 
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Figure 9: Variation in the proliferative response (51+1-50) of PBM at a concentration of 2x106/ml isolated 
from Holstein-Friesian cows (n=10) sired by two different bulls, induced by Staphylococcus aureus 
strain A at a concentration of 0.5x106 bacterialml 
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Figure 10: Variation in the proliferative response (51+/-50) of PBM at a concentration of 2x106/ml 
isolated from Holstein-Friesian cows (n=10) sired by two different bulls induced by Staphylococcus 
aureus strain A at a concentration of 0.5x1 06 bacteria/ml 
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Figure 11: Variation in the proliferative response (51+/-50) of PBM at a concentration of 2x106/ml 
isolated from Holstein-Friesian cows (n=8) induced by different strains of Staphylococcus aureus at 
a concentration of O.5x106 bacterialml 
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Figure 12: Variation in the proliferative response (81+/-80) of PBM at a concentration of 
2x106/ml isolated from Holstein-Friesian cows (n=4) induced by Staphylococcus aureus 
Wood 46 strain at dilutions ranging from 1: 1 00-1: 1,000,000 
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Figure 13: Variation in proliferative response (51) of PBM at a concentration of 2x106/ml 
isolated from Holstein-Friesian cows (n=4) induced by Staphylococcus aureus Wood 46 
strain at dilutions of 1:1,000 (a) and 1:10,000 (b) 
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Figure 14: Variation in the proliferative response (SI+/-SD) of PBM at a concentration of 
2x106/ml isolated from Holstein-Friesian cows (n=3) induced by SEB at dilutions ranging 
from 1 :100-1 :100,000 
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Figure 15: Variation in proliferative response (SI) of PBM at a concentration of 2x106/ml 
among Holstein-Friesian cows (n=3) induced by SEB at a dilution of 1 :10,000 
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Figure 16: Alteration in the proliferative response (51+/-50) of PBM at a concentration of 
2x106/ml isolated from Holstein-Friesian cows (n=3) induced by SEB at a dilution of 1 :10,000 
when cultured in the presence of 7% and 14% normal filtered milk 
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Figure 17: Alteration in the proliferative response (51+/-50) of PBM at a concentration of 2x106/ml 
isolated from Holstein-Friesian cows (n=3) induced by Staphylococcus aureus strain A at a 
concentration of 0.5x106 bacterialml in the presence of anti-MHC II (IL-A21) at dilutions of 1:5 and 
1 :10 
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Figure 18: Variation in proliferative response (51+1-50) of PBM at a concentration of 2x1 06/ml 
isolated from Holstein-Friesian cows (original batch: n=21; batches 2 and 3: n=8) induced by 
different batches of Staphylococcus aureus strain A at a concentration of 
0.5x106 bacterialml 
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Figure 19: Variation in proliferative response (51+1-50) of PBM at a concentration of 2x106/ml 
isolated from Holstein-Friesian cows (n=9) induced by Staphylococcus aureus strain A at 
concentrations ranging from O.35-5x108 bacterialml 
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Figure 20: Variation in proliferative response (81) of PBM at a concentration of 2x106/mI among 
Holstein-Friesian cows (n=9) induced by Staphylococcus aureus strain A at a concentration of 
1.4x108 bacterialm I 
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Figure 21: Variation in proliferative response (51) of PBM at a concentration of 2x106/ml among 
Holstein-Friesian cows (n=9) to Staphylococcus aureus strain A at a concentration of O.7x108 
bacterialm I 
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Figure 22: Variation in proliferative response (51) of PBM at a concentration of 2x106/ml among 
Holstein-Friesian cows (n=9) to Staphylococcus aureus strain A at a concentration of O.35x108 
bacteria/ml 
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Figure 23: Alteration in the PTA for see of Holstein-Friesian bulls (n=10) for 1997, 1998 and 
1999 
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Figure 24: Proliferative response (51) of PBM on day 9 of culture at a concentration of 2x106/ml isolated 
from Holstein-Friesian bulls (n=10) induced by Staphylococcus aureus strain A at a concentration of 
0.5x106 bacteria/mi. Bulls are ranked from lowest to highest PTA for see from left to right for year 1997 
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Figure 25: Variation in the proliferative response (51) of PBM on day 9 of in vitro culture at a 
concentration of 2x106/ml isolated from Holstein-Friesian bulls (n=103) induced by 
Staphylococcus aureus strain A at a concentration of 0.5x1 06 bacteria/ml 
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Figure 26: Variation in the proliferative response (51) of PBM on day 9 of in vitro culture at a 
concentration of 2x106/ml isolated from Holstein-Friesian bulls (n=6) induced by 
Staphylococcus aureus strain A at a concentration of O.5x106 bacteria/ml sampled on four 
separate occasions 
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3.4 Phenotyping of peripheral blood mononuclear cells and total blood leucocytes 
The phenotyping studies on PBM isolated from cows showed that the mean percentage 
(+I-SD) of cells expressing CD4 was 26+1-8%; expressing CD8 was 16+/-10%; expressing 
'Yo was 7+1-4%; expressing the B cell marker was 17+/8%; expressing the monocyte 
marker was 38+1-17% (n=IO), and expressing MHC class IT was 34+1-9% (n=8), (Figure 
27). 
Considerable variation in the percentage of different cell phenotypes was observed among 
cows. The percentages of stained cells ranged from 16 to 44% for CD4+ cells; 7 to 41 % 
for CD8+ cells; 1 to 17% for 'Y0+ cells; 9 to 39% for cells expressing the B cell marker; 12 
to 61 % for cells expressing the monocyte marker; and 23 to 49% for MHC class n+ cells 
(Figure 28). 
The phenotyping studies on the PBM isolated from bulls showed that the mean 
percentage +I-SD of cells expressing CD4 was 17+1-3%, expressing CD8 was 7+1-3%, 
expressing 'Yo was 1+1-0.5%, expressing the B cell marker was 10+1-3%, expressing the 
monocyte marker was 0.5+1-0.5%, and expressing MHC class IT was 32+1-12% (n=IO), 
(Figure: 29). 
Analysis of these results using Hotelling's T square test showed a statistically significant 
difference in the proportions of cell subpopulations between cows and bulls (p<0.05). 
As was noted in cows, considerable variation In the percentage of different cell 
phenotypes was observed among bulls. The percentage of stained cells isolated from the 
bulls ranged from; 11 to 23% for CD4+ cells; 2 to 15% for CD8+ cells; 1 to 2% for 'Y0+ 
cells; 6 to 18% for cells expressing the B cell marker; 0.6 to 1 % for cells expressing the 
monocyte marker; and 16 to 55% for MHC class IT + cells (Figure: 30). 
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Density centrifugation allows the separation of mononuclear cells from whole blood by 
retention of cells of a specific density at the interface between the density centrifugation 
media and the diluted blood sample. Media of various densities are available, and the one 
most commonly used for isolation of PBM in cattle is ficoll-isopaque, with a density of 
1.077g1l. (Shafer-Weaver, 1997; McCole et ai., 1998; Asai et ai., 1998). To ensure that 
certain cell subtypes in bulls were not being lost due to the density of the centrifugation 
media chosen, ficoll-isopaque with a greater density of 1.083g1l, was used to isolate the 
cells from whole blood collected from bulls. The mean cell yield (+I-SD) with ficoll-
isopaque of density 1.077g1l was 8+1-2x10s cells/ml whole blood, and with ficoll-isopaque 
of density 1.083g1l was 13+/-4xlOs cells/ml whole blood (n=5). Using a paired T test the 
difference in cell yield between the two media was shown to be significantly different 
(p=0.01) indicating that some cell loss was occurring when ficoll-isopaque of the lower 
density was used. 
The phenotype of cells isolated from the two density media was then compared. The 
phenotyping studies on the PBM isolated from bulls with ficoll-isopaque of density 
1.077g/l showed that the mean percentage +I-SD of cells expressing CD4 was 19+1-6%, 
expressing CD8 was 6+1-2%, expressing y8 was 1+1-0.4%, expressing the B cell marker 
was 10+1-3%, expressing the monocyte marker was 0.6+1-0.6%, and expressing MHC 
class II was 37+1-11 % (n=5). The phenotyping studies on the PBM isolated from bulls 
with ficoll-isopaque of density 1.083g1l showed that the mean percentage +I-SD of cells 
expressing CD4 was 6+1-3%, expressing CD8 was 2+1-1 %, expressing y8 was 0.9+1-0.7%, 
expressing the B cell marker was 3+1-2%, expressing the monocyte marker was 0.4+1-
0.3%, and expressing MHC class II was 13+1-8% (n=5), (Figure: 31). Results indicated 
that the percentage of stained cells with all monoclonal antibodies employed were lower 
from the samples separated with ficoll-isopaque of density 1.083g1l, compared to those 
samples separated with ficoll-isopaque of density 1.077g1l. Using a paired T test a 
statistically significant reduction in the proportion of PBM expressing CD4 (p=0.01), 
CD8 (p=0.03), the y8 marker (p=0.02), expressing the B cell marker (p=0.006), and MHC 
class II (p=0.004) was reported. There was shown to be no statistically significant 
difference in the expression of the monocyte marker (p=0.47) between PBM isolated by 
ficoll-isopaque of density 1.077g/l and 1.083g/l. 
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In further experiments with ficoll-isopaque of density 1.077gll, PBM were aspirated from 
the interface of the diluted blood sample. The red blood cell pellet at the bottom of the 
centrifuge tube was treated with a red cell lysis buffer and the cells remaining were then 
phenotyped. This approach was to ensure that certain cell subtypes were not being lost 
due to the media of lower density, which may have resulted in cells being deposited into 
the pellet below. Results showed very few stained cells were present within the cell 
pellet, with only 5% of CD4+cells, 1% of CDS+cells, 1% of y'f/ cells, 2% of cells 
expressing the B cell marker, O.S% of cells expressing the monocyte marker, and 7% of 
MHC class :I:t cells being detected (n=2). 
Results of the phenotyping studies carried out in bulls on the cell pellet, after 
centrifugation with a ficoll-isopaque of density 1.077gll, showed that the percentage of 
stained cells was approximately IS% of the total cells. Seventy two percent of the cell 
population that comprised the cell pellet was unlabelled. Isolation of PBM from bulls by 
centrifugation with ficoll-isopaque of density 1.0S3g1l resulted in approximately SO-90% 
of the cells from the cell pellet being unlabelled. One explanation may be that these two 
unlabelled cell populations are the same cells. Those present within the cell pellet may 
have been deposited through the less dense ficoll-isopaque (1.077gll), while these cells 
may be retained at the interface of the higher density ficoll-isopaque (1.0S3g1l). 
The methodology of density centrifugation to isolate mononuclear cells from whole blood 
may result in a proportion of cell lysis, consequently some differential cell loss may 
occur. To test this, PBM isolated by density centrifugation and PBM isolated from whole 
blood treated with Erythrolyse (Serotec), a red cell lysis buffer, from cows were compared 
(n=2). The whole blood treated with the lysis buffer produced a cell pellet that still 
contained neutrophils, whereas the cell pellet produced by density centrifugation 
contained only mononuclear cells. Results indicated that the percentage of cells 
expressing CD4, CDS, cell expressing the B cell marker, cells expressing the monocyte 
marker, and MHC class IT were lower in whole blood compared with cells isolated by 
centrifugation with media of density 1.077 gil. In samples where cells were isolated by 
density centrifugation the percentage of cells expressing CD4 was 31 %; CDS was 10%; 
the B cell marker was 11 %; the monocyte marker was 24%; and MHC class IT was 36%. 
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In samples where cells were isolated by use of the red blood cell lysis buffer the mean 
percentage of cells expressing CD4 was 21 %; CD8 was 5%; the B cell marker was 3%; 
the monocyte marker was 3%; and MHC class IT was 26%. The proportion of cells 
expressing yo was similar in both samples, the proportion of cells expressing yo isolated 
by centrifugation with a density media (1.077g/l) was 2% compared to 3% of the cells 
isolated by red blood cell lysis (Figure: 32). In normal blood, lymphocytes account for 
approximately 70% of cells and neutrophils for approximately the remaining 30% 
(Sordillo et ai., 1997). The difference in percentage of stained cells between cells 
isolated by density centrifugation and those isolated by red blood cell lysis buffer is 
expected due to the neutrophil population altering the proportion of mononuclear cells 
identified. 
During the current study PBM isolated from cows and induced by S. aureus strain A in 
vitro were removed on day nine of culture, the day of peak proliferation, to identify those 
cells that were proliferating in response to S. aureus strain A. The phenotyping studies on 
the responding PBM isolated from cows on day nine of the in vitro proliferation assay 
showed that 53+/-8% of cells expressed CD4, 21+/-5% of cells expressed CD8, 13+/-4% of 
cells expressed the yo cell marker, 11+/-4% of cells expressed the B cell marker, and that 
1+/-1 % of cells expressed the monocyte marker (Figure: 33). 
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Figure 27: Mean percentage of PBM (+1-50) isolated from Holstein-Friesian cows (n=10) by ficoll· 
isopaque of density 1.077g/l expressing C04 (CC30), C08 (CC58), yo (CC15), B cell marker 
(CC21), monocyte marker (IL-A24), and MHC class II (IL-A21) 
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Figure 28: Variation in the percentage of PBM isolated from Holstein-Friesian cows (n=10) by ficoll-
isopaque of density 1.077g/l expressing CD4 (CC30), CD8 (CC58), 'Yo (CC15), B cell marker (CC21), 
monocyte marker (IL-A24), and MHC class II (IL-A21) 
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Figure 29: Mean percentage of PBM (+1-50) isolated from Holstein-Friesian bulls (n=10) by ficoll-
isopaque of density 1.077g/l expressing C04 (CC30), C08 (CC58), yo (CC15), B cell marker 
(CC21), monocyte marker (IL-A24), and MHC class II (IL-A21) 
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Figure 30: Variation in the percentage of PBM isolated from Holstein-Friesian bulls (n=10) by 
ficoll-isopaque of density 1.077g/l expressing CD4 (CC30), CDS (CCSS), yo (CC1S), B cell 
marker (CC21), monocyte marker (IL-A24), and MHC class II (IL-A21) 
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Figure 31: Variation in the percentage of PBM (+1-50) isolated from Holstein-Friesian bulls 
(n=5) by ficoll-isopaque of density 1.077gl and 1.083g/l expressing C04 (CC30), C08 (CC58), 
y<> (CC15), B cell marker (CC21), monocyte marker (IL-A24) 
and MHC class II (IL-A21) 
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Figure 32: Variation between the percentage of PBM isolated with ficoll-isopaque of density 1.077g/l and 
total blood leucocytes from Holstein-Friesian cows (n=2) expressing CD4 (CC30), CDS (CC5S), yo (CC15), B 
cell marker (CC21), monocyte marker (IL-A24) and MHC class II (IL-A21) 
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Figure 33,: Mean percentage of PBM (+1-50) from Holstein-Friesian cows (n=5) isolated on day nine of the in vitrl 
proliferation assay expressing C04 (CC30), C08 (CC58), yo (CC15), B cell marker (CC21), and the mononcyte 
marker (IL-A24) 
3.5 Phenotyping of milk mononuclear cells and total milk leucocytes 
The expression of MHC class II molecules on mononuclear cells isolated from milk by 
centrifugation with media of density 1.077g/1 was investigated in Holstein-Friesian cows 
with either high SCC (>400,000 cells/ml milk for three consecutive months prior to 
sampling) or low SCC «150,000 cells/ml milk for the month prior to sampling). 
The mean percentage (+I-SD) of mononuclear cells expressing MHC class II isolated by 
ficoll-isopaque of density 1.077g/l from cows with high SCC was 39+1-21 % (n=12). The 
mean percentage (+I-SD) of mononuclear cells expressing MHC class II isolated from 
cows with low SCC was 32+1-10% (n=9). 
Considerable variation in the percentage of mononuclear cells expressing MHC class II 
was observed among cows with either high or low SCC. The percentage of mononuclear 
cells expressing MHC class II from cows with high SCC ranged from 12% to 86%. The 
percentage of mononuclear cells expressing MHC class II from cows with low SCC 
ranged from 18% to 49% (Figure: 34). Using an unpaired T test, although considerable 
variation in the percentage of mononuclear cells expressing MHC class II was observed 
among cows with either high or low SCC no significant difference (p=0.32) in expression 
was reported. 
Isolation of milk cells by centrifugation using media of density 1. 077 gil results in 
isolation of a mononuclear cell population, with polymorphonuclear cells being excluded 
by this method of isolation. Whole milk was centrifuged in the absence of density media 
to allow isolation of a total milk leucocyte population. The mean percentage (+I-SD) of 
total milk leucocytes expressing MHC class II from cows with high SCC was 13+1-10% 
(n=6). The mean percentage (+I-SD) of total milk leucocytes expressing MHC class II 
from cows with low SCC was 10+1-15% (n=6). 
Considerable variation in the percentage of total milk leucocytes expressing MHC class II 
was observed among cows with either high or low SCc. The percentage of total milk 
leucocytes expressing MHC class II in cows with high SCC ranged from 2% to 29%. The 
percentage of total milk leucocytes expressing MHC class II in cows with low SCC 
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ranged from 1 % to 39% (Figure: 35). Using an unpaired T test a significant difference in 
the expression of MHC class II in cows with a high SCC was noted between milk 
mononuclear cells isolated by ficoll-isopaque of density 1.077g/l and total milk 
leucocytes (p=0.004), (Figure: 36). Again using an unpaired T test a significant 
difference in the expression of MHC class II in cows with a low SCC was noted between 
milk mononuclear cells isolated by ficoll-isopaque of density 1.077g/l and total milk 
leucocytes (p=O.Ol), (Figure: 36). 
The total milk leucocytes isolated from cows with either high SCC or low SCC were 
stained to examine the expression of CD4 and CD8 molecules, in addition to MHC class 
II molecules. The mean percentage (+I-SD) of total milk leucocytes expressing CD4 and 
CD8 isolated from cows with high SCC was 21+1-12% and 17+1-17% respectively (n=9). 
The mean percentage (+I-SD) of total milk leucocytes expressing CD4 and CD8 isolated 
from cows with low SCC was 16+1-13% and 8+1-9% respectively (n=6). 
As in previous results, considerable variation in the percentage of total milk leucocytes 
expressing CD4 and CD8 was observed among cows with either high or low SCC. The 
percentage of leucocytes from milk expressing CD4 in cows with high SCC ranged from 
6% to 47% and CD8 from 1% to 47%. The percentage of leucocytes from milk 
expressing CD4 in cows with low SCC ranged from 7% to 43% and CD8 from 0% to 
26% (Figure: 37). From these results using an unpaired T test it was shown that there was 
no significant difference in the expression of CD4 (p=0.56) and CD8 (p=0.23) on total 
milk leucocytes from cows with high and low SCC. 
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Figure 34: Variation in the percentage of milk mononuclear cells expressing MHC class II 
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Figure 35: Variation in the percentage of total milk leucocytes expressing MHC class II (IL-A21) isolated 
from Holstein-Friesian cows with either high SCC (>400,OOOcells/ml) or low SCC «150,OOOcells/ml) 
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Figure 36: Comparison between the expression of MHC class II (IL-A21) on milk mononuclear cells 
isolated by ficoll-isopaque of density 1.077g/l and total milk leucocytes from Holstein-Friesian cows 
with either high SCC (>400,000cells/ml) or low SCC «150,000cells/ml) 
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Figure 37: Variation in the percentage total milk leucocytes expressing CD4 (CC30) and CD8 
(CC58) isolated from Holstein-Friesian cows with either high SCC (>400,OOOcelis/ml), (n=9) 
or low SCC «150,OOOcelis/ml), (n=6) 
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3.6 Blunt End Cloning of MHC class II-DOB exon 2 of Holstein-Friesian Bulls 
Polymerase Chain Reaction (PCR) amplification and sequence analysis of cloned 
products of the MHC DQB ex on 2 loci were performed in four bulls; three of the bulls 
(bulls A, C, and E) were from the group with the lowest PTA for SCC, and one bull (bull 
F), was from the group with the highest PTA for SCC. PCR amplification using 
oligonucleotide primers LA40/41 (Sigurdardottir et al., 1992), successfully generated an 
amplimer of the expected molecular size (284bp) from all four subjects. Following blunt 
end cloning of the PCR products, commercial sequencing was carried out; a total of 39 
clones were sequenced bi-directionally; ten clones each from bulls C and E, eight clones 
from bull A, and 11 clones from bull F. Not all of the clones sent for DNA sequencing 
were generated by a single PCR amplification. 
Sequence analysis of the 39 clones, identified the presence of four different sequences. 
Only one of the sequences identified appeared to be novel compared to all other 
sequences identified previously within the DQB ex on 2 locus in cattle (Figure: 38). The 
alleles identified were compared to DQB*1001 previously identified in Holstein-Friesian 
cattle (Nasir et aI., 1996). The most commonly identified sequence was DQB*1-3 (25 of 
39 clones) and all bulls examined had this sequence. All of the eight clones of Bull A 
sent for sequencing were identified as DQB*1-3. The clones generated by bull C resulted 
in identification of two sequences, DQB*1-3 and NB25, reported previously in Japanese 
Black cattle (Dikiniene and Aida, 1995). Bull E also generated two sequences from the 
clones produced, namely DQB*1-3 and a new sequence SM381O. This latter sequence 
was found to have 98% homology to allele DQB*I-3. Bull F, the only bull with a high 
PTA for SCC, generated three sequences from the clones produced, namely DQB*1-3, 
DQB* 17 and NB25. Usually only two sequences should be identified, one from each 
parent, however locus duplication is a phenomenon that has been previously recorded in 
BoLA DQB (Sigurdardottir et al., 1992; Xu et al., 1994; Marello et al., 1995). The 
frequent cloning and sequencing of the allele DQB * 1.3 stimulated the development of the 
current study to utilise the methodology of PCR-RFLP for DQB analysis. 
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Figure 38: Sequence analysis ofa total of39 cloned products of the MHC class II DQB exon 2. 
Three previously published sequences were identified; DQB*1-3, NB25, NB17 and one novel sequen(;\,; ; s M38 10. 
Sequence data was compared to allele DRB* 1 001 previously identified in Holstein-Friesian cattle (Nasir et ai., 1997) 
3.7 Restriction Fragment Length Polymorphism enzymatic digestion of MHC class 
II DRB3 and DOB exon 2 Polymerase Chain Reaction Products. 
MHC class II DRB3 
Following two-step PCR amplification, a product of 284bp was generated that 
corresponded to the MHC class II DRB3 ex on 2. Cleavage of the PCR product with 
restriction endonucleases Rsa I, Bst YI and Rae III resulted in bands of various base pair 
sizes being visible. Selection of Rsa I, Bst YI and Rae III as the restriction enzymes was 
by the method of Van Eijk et al (1992), who showed these three enzymes could 
distinguish all of the BoLA-DRB3 alleles sequenced previously by Sigurdardottir et al. 
(1991). In Figure 39 the restriction enzyme digestion patterns of BoLA DRB3 exon 2 of 
one bull with the lowest PTA for SCC in 1997 tbull C) and three bulls with the highest 
PTA for SCC in 1997 (bulls F, Hand J) by Rsa I and Rae III are shown. In Figure 40 the 
restriction enzyme digestion patterns of BoLA DRB3 exon 2 of one bull with the lowest 
PTA for SCC in 1997 (bull C) and three bulls with the highest PTA for SCC in 1997 
(bulls F, Hand J) by Bst YI are shown. In Figure 41 the restriction enzyme digestion 
patterns of BoLA DRB3 ex on 2 of four bulls with the lowest PTA for SCC in 1997 (bulls 
A, B, D and E) and two bulls with the highest PTA for SCC in 1997 (bulls G and I) by 
Rsa I and Rae III are shown. In Figure 42 the restriction enzyme digestion patterns of 
BoLA DRB3 ex on 2 of one bull with the lowest PTA for SCC in 1997 (bull C) and three 
bulls with the highest PTA for SCC in 1997 (bulls F, Hand J) by Bst YI are shown. The 
band sizes generated by digestion with restriction endonucleases were estimated for bulls 
with the lowest PTA for SCC and for bulls with the highest PTA for SCC (Table: 6). 
Estimation of band sizes was made in correspondence with a standard digest rather than 
against molecular weight markers. 
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Restriction Enzyme Rsa I BstYI Hae III 
Bulls with the lowest 
PTA for sec 
A 180, 104,93, 78, 284 190, 167,65,52, 
63,50 29 
B 180, 104,93, 78, 284 219,190,65,29 
63,50 
C 284, 93, 78, 63, 284 190, 167,65,48, 
50 29 
D 180, 111, 104, 284 219,190,65 
54,50,39,30 
E 140,93, 78, 63, 284,199,85 190, 167,65,52, 
54,50,39 29 
Bulls with the highest 
PTA for sec 
F 180, 104,93, 78, 284 190,167,65,52,29 
63,50 
G 180, 140, 104,39 284, 199, 112,87, 167,65,52 
85 
H 180, 111, 104,69 284 219,167,65,52 
I 180, 104 284 167,65,52 
J 180, 141, 111, 284,199,85 167,65,52 
104,69,54,50,39 
Table 6: Estimated band sizes generated by restriction enzyme digestion of the peR 
product of DRB ex on 2 with Rsa I, Bst YI and Hae ill in bulls with the lowest PTA for 
see (n=5) and in bulls with the highest PTA for see (n=5) 
The combination of restriction band sizes of Rsa I, Bst YI and Hae ill identified above 
can be related to a restriction digestion pattern (appendix D: Van Eijk et ai., 1992; 
Gelhaus et al., 1995; www.rLbbsrc.ac.uk. bola). The restriction digestion patterns can 
subsequently be related to a DRB3.2* type. The restriction digestion patterns and 
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corresponding DRB3.2*type for the bulls with the lowest and highest PTA for see are 
detailed in Table 7. 
Bulls with the lowest PTA Restriction Digestion DRB3.2* 
ForSee Pattern 
A jbd 16 
nba 23 
B jbd 16 
nbb 24 
e jbd 16 
obf 27 
D nbb 24 
bbb 03 
E jbd 16 
faa 08 
Bulls with the highest PTA 
ForSee 
F jbd 16 
nba 23 
G nba 23 
gea 11 
H mba 22 
nbb 24 
I nba 23 
faa 08 
J mba 22 
fba 10 
maa 32 
hba 13 
gaa 51 
Table 7: The relationship between the restriction enzyme digest pattern of the peR 
product of DRB exon 2 generated by Rsa I, Bst YI and Hae III to the DRB3.2*type in 
bulls with the lowest PTA for see (n=5) and in bulls with the highest PTA for see 
(n=5) in 1997. 
The bulls A, B, e, D, E, F, G and H generated two restriction patterns indicating that they 
are heterozygous for DRB3*2. Bull I generated only one restriction pattern suggesting 
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that this particular animal is homozygous for DRB3*2. From the band sizes generated by 
restriction digestion bull J has generated three possible pairs of restriction patterns. 
Further investigation would be required to identify the expressed restriction pattern pair. 
From the patterns created by restriction digest the corresponding DRB3.2*type can be 
related to previously sequenced and published alleles. From the ten bulls selected for 
their extreme PTA for see, 26 previously sequenced DRB3 alleles were identified. The 
maximum number of alleles expected from ten animals is 20. The DRB3.2*type however 
is not an absolute classification, some DRB3.2*types are associated with more than one 
sequenced allele. More detailed investigation into the characterisation of the allelic 
sequences is required to permit absolute classification of restriction enzyme pattern to 
allele. The establishment of a DRB3.2*type permits rapid typing of a large number of 
individuals, from which interesting animals maybe selected and investigated in greater 
detail. The sequenced alleles present in the bulls with the lowest and highest PTA for 
see are detailed in Table 8. 
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Bulls with the lowest DRB3.2* type Sequenced DRB3* alleles 
PTA for sec 
A 16 1501,1502,4301 
23 2702,2703,2705,2706,2707 
B 16 1501,1502,4301 
24 0101,0102 
C 16 1501,1502,4301 
27 14011, 14012,3101 
D 24 0101,0102 
03 1001, 1002 
E 16 1501,1502,4301 
08 1201 
Bulls with the highest 
PTA for sec 
F 16 1501,1502,4301 
23 2702,2703,2705,2706,2707 
G 23 2702,2703,2705,2706,2707 
11 0901,0902,1202 
H 22 1101 
24 0101,0102 
I 23 2702,2703,2705,2706,2707 
08 1201 
J 22 1101 
10 1601, 1602 
32 2401 
13 0401 
51 4201 
Table 8: The relationship between the DRB3.2*type and previously sequenced DRB3 
alleles in bulls with the lowest PTA for sec (n=5) and in bulls with the highest PTA for 
sec (n=5) 
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A difference in the frequency of each of the alleles was noticed on further examination of 
the data. DRB3.2*16 was identified in four of the bulls with low PTA for sec (bulls A, 
B, e, and E), and one of the bulls with high PTA for sec (bull F). DRB3.2*23 was 
identified in one of the bulls with low PTA for sec (bull A), and three of the bulls with 
high PTA for sec (bulls F, G and I). DRB3.2*24 was identified in two of the bulls with 
low PTA for sec (bulls B and D), and one of the bulls with high PTA for sec (bull H). 
DRB3.2*22 was only identified in two bulls with high PTA for sec (bulls Hand J). 
DRB3.2*03 was identified only in one bull which had low PTA for sec (bull D). 
DRB3.2*11 was identified only in one bull which had high PTA for sec (bull G). 
DRB3.2*27 was identified only in one bull which had a low PTA for sec (bull C). 
Finally, DRB3.2*1O, DRB3.2*32, DRB3.2*13 and DRB3.2*51 were identified only in 
one bull, which had a high PTA for sec (bull J), (Table: 9). 
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Bulls A B C D E F G H I J 
DRB3.2* 
types 
16 • • • • 
"" 
23 • 
"" "" "" 
24 • • 
"" 
08 • 
"" 
03 • 
11 • 
22 • • 
27 • 
10 • 
32 • 
13 • 
51 • 
Table 9: Relationship between bulls with the lowest PTA for see and bulls with the 
highest PTA for see and previously characterised DRB3.2*types identified by restriction 
digestion with Rsa I, Bst YI and Hae III: 
• bulls with the lowest PTA for see as recorded in 1997 
'" bulls with the highest PTA for see as recorded in 1997 
• DRB3.2*types present exclusively in bulls with high or low PTA for see. 
The relationship between bulls with the lowest PTA for see and bulls with the highest 
PT A for see and previously identified DRB3 alleles are presented in Table 10. 
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Bulls A B C D E F G H I J 
DRB3 
alleles 
*1501 • • • • ... 
*1502 • • • • ... 
*4301 • • • • ... 
*2701 • ... ... ... 
*2702 • ... ... ... 
*2703 • ... ... ... 
*2704 • ... ... ... 
*2705 • ... ... ... 
*2706 • ... ... ... 
*2707 • ... ... ... 
*0101 • • ... 
*0102 • • ... 
*14011 • 
*14012 • 
*3101 • 
*1201 • ... 
*1001 • 
*1002 • 
*0901 • 
*0902 • 
*1202 • 
*1101 • • 
*1601 • 
*1602 • 
*2401 • 
*0401 • 
*4201 • 
Table 10: Relationship between bulls with the lowest PTA for see and bulls with the 
highest PTA for see and previously characterised DRB3 alleles 
• bulls with the lowest PTA for see as recorded in 1997 
... bulls with the highest PTA for see as recorded in 1997 
• alleles present exclusively in bulls with the lowest or highest PTA for sec. 
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A difference in the frequency of the RFLP types associated with immunological response 
measured was noticed on examination of the data. DRB3.2*16 was identified in all five 
of the bulls with a strong immunological response induced by S. aureus strain A in vitro 
(bulls A, B, C, E, and F). DRB3.2*23 was identified in two of the bulls with a strong 
immunological response induced by S. aureus strain A in vitro (bulls A and F), and two 
of the bulls with a weak: immunological response induced by S. aureus strain A in vitro 
(bulls G and n. DRB3.2*24 was identified in one of the bulls with a strong 
immunological response induced by S. aureus strain A in vitro (bull B), and two of the 
bulls with a weak: immunological response induced by S. aureus strain A in vitro (bulls D 
and H). DRB3.2*22 was only identified in two bulls which had weak immunological 
responses induced by S. aureus strain A in vitro (bulls Hand J). DRB3.2*03 was 
identified only in one bull which had a weak: immunological response induced by S. 
aureus strain A in vitro (bull D). DRB3.2*11 was identified only in one bull which had a 
weak: immunological response induced by S. aureus strain A in vitro (bull G). 
DRB3.2*27 was identified only in one bull which had a strong immunological response 
induced by S. aureus strain A in vitro (bull C). Finally, DRB3.2* 10, DRB3.2*32, 
DRB3.2*51, were identified only in one bull which had a low immunological response 
induced by S. aureus strain A in vitro (bull J), (Table: 11). 
Assuming a gene frequency (p) of 0.1 for DRB3.2*16, and using the Hardy-Weinberg 
equation: p2 + 2pq + q2 = 1 where 0.01 + 0.18 + 0.81 = 1 it was estimated that the 
probability of a bull being either homozygous or heterozygous for DRB3.2*16 was 0.01 + 
0.18 = 0.19. The probability of five bulls being selected at random and being 
homozygous or heterozygous for DRB3.2*16 was estimated, therefore, as 0.195 = 
0.00025. 
However further investigation of the ten bulls ranked on extremes of PTA for SCC 
showed that there was some overlap in their paternal and maternal grandsires (Table 12). 
The presence of common grands ires means that the association of DRB3.2*16 and 
proliferative response induced by S. aureus strain A cannot be regarded as random. 
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Bulls A B C D E F G H I J 
DRB3.2* type 
16 • • • • ... • 
23 • • ... ... 
24 • • ... 
08 ... ... 
03 • 
11 • 
22 • • 
27 • 
10 • 
32 • 
13 • 
51 • 
Table 11: Relationship between bulls with strong immunological response and bulls with 
weak immunological response and previously characterised DRB3.2*types identified by 
restriction digestion with Rsa I, Bst YI and Hae III. 
• bulls with strong immunological response induced by S. aureus strain A in vitro 
'" bulls with weak immunological response induced by S. aureus strain A in vitro 
• DRB3.2* types present exclusively in bulls with strong or weak immunological 
response induced by S. aureus strain A in vitro. 
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Grandsire Paternal Maternal 
Bulls 
A I II 
B II V 
C III V 
D III IV 
E III IV 
F II IV 
G IV VI 
H IV VII 
I IV IV 
J IV II 
Table 12: Relationship between bulls with strong immunological response and bulls with 
weak immunological response and their paternal and maternal grandsires. There are a 
total of seven (I-VII) different grandsires in different combinations associated with these 
ten bulls 
_ bulls with strong immunological response induced by S. aureus strain A in vitro 
_ bulls with weak immunological response induced by S. aureus strain A in vitro 
The relationship between bulls with strong immunological response induced by S. aureus 
strain A in vitro and bulls with weak immunological response induced by S. aureus strain 
A in vitro and previously identified DRB3 alleles 1 presented in Table 13. 
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Bulls A B C n E F G H [ J 
DRB3 alleles 
*1501 • • • oft • 
*1502 • • • oft • 
*4301 • • • oft • 
*2701 • • oft oft 
*2702 • • oft oft 
*2703 • • oft oft 
*2704 • • oft oft 
*2705 • • oft oft 
*2706 • • oft oft 
*2707 • • oft oft 
*0101 • • oft 
*0102 • • oft 
*14011 • 
*14012 • 
*3101 • 
*1201 oft oft 
*1001 • 
*1002 • 
*0901 • 
*0902 • 
*1202 • 
*1101 • • 
*1601 • 
*1602 • 
*2401 • 
*0401 • 
*4201 • 
Table 13: Relationship between bulls with strong immunological response and bulls with 
weak immunological response to previously characterised DRB3 alleles. 
• bulls with strong immunological response induced by S. aureus strain A in vitro 
oft bulls with weak immunological response induced by S. aureus strain A in vitro 
• alleles present exclusively in bulls with strong or weak immunological response 
induced by S. aureus strain A in vitro. 
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Lanes: 1 2 3 4 5 6 7 8 9 10 11 12 13 
Figure 39: Restriction digest patterns of BoLA DRB3 exon 2 of one bull with the lowest 
PTA for SCC in 1997 (bull C) and three bulls with the highest PTA for SCC in 1997 
(bulls F, Hand J) obtained by digestion with the enzymes Rsa I (lanes 3-6) and Rae III 
(lanes 8-11). Lanes 1 and 12 are Rae III control digest of pBR322 (Sigma). Lanes 2 and 
13 are molecular weight markers of 20bp and 100bp. Lane 3: bull J, lane 4: bull F, lane 
5: bull C, lane 6: bull H, lane 8: bull J, lane 9: bull F, lane 10: bull C, lane 11: bull H. 
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Lanes: 1234567 
Figure 40: Restriction digest patterns of BoLA DRB3 exon 2 of one bull with the lowest 
PTA for SCC in 1997 (bull C) and three bulls with the highest PTA for SCC in 1997 
(bulls F, Hand J) obtained by digestion with the enzymes Est YI (lanes 2-5). Lane 6 is 
Hae ill control digest of pBR322 (Sigma). Lanes 1 and 7 are molecular weight markers 
of 20bp and lOObp. Lane 2: bull J, lane 3: bull F, lane 4: bull C, lane 5: bull H. 
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Lanes: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Figure 41: Restriction digest patterns of BoLA DRB3 ex on 2 of four bulls with the 
lowest PTA for see in 1997 (bulls A, B, D and E) and two of the bulls recorded as 
having the highest PTA for see in 1997 (bulls G and I) obtained by digestion with the 
enzymes Rsa I (lanes 3-8) and Rae III (lanes 10-15). Lanes 2, 9 and 16 are Rae III 
control digest of pBR322 (Sigma). Lane 1 is molecular weight markers of 20bp and 
100bp. Lane 3: bull G, lane 4: bull E, lane 5: bull D, lane 6: bull B, lane 7: bull I, lane 8: 
bull A, lane 10: bull G, lane 11: bull E. lane 12: bull D, lane 13: bull B, lane 14: bull I, 
lane 15: bull A. 
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Lanes: 123456789 
Figure 42: Restriction digest patterns of BoLA DRB3 ex on 2 of four bulls with the 
lowest PTA for see in 1997 (bulls A, B, D and E) and two bulls with the highest PTA 
for see in 1997 (bulls G and I) obtained by digestion with the enzymes Bst YI (lanes 2-
7). Lanes 1 and 8 are Hae III control digest of pBR322 (Sigma). Lane 9 is molecular 
weight markers of 20bp and lOObp. Lane 2, bull A, lane 3: bull I, lane 4: bull B, lane 5: 
bull D, lane 6: bull E, lane 7: bull G. 
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MHC class II DQB2 
Following peR amplification a 214bp product was generated which corresponded to the 
MHe class IT DQB ex on 2 region. After enzymatic digestion of the peR product with 
Rsa I, Brs I and Hae ill, RFLP banding patterns were visible. In Figure 43 the restriction 
enzyme digestion patterns of BoLA DQB exon 2 of four bulls with the lowest PTA for 
see in 1997 (bulls A, B, D and E) and two bulls with the highest PTA for see in 1997 
(bulls G and I) by Rsa I and Hae ill are shown. In Figure 44 the restriction enzyme 
digestion patterns of BoLA DQB exon 2 of four bulls with the lowest PTA for see in 
1997 (bulls A, B, D and E) and two bulls with the highest PTA for see in 1997 (bulls G 
and I) by Bst YI are shown. These patterns, although relatively clean, were generally too 
complex to be resolved unambiguously as allelic patterns. Due to the clean nature of the 
bands, the results cannot simply be dismissed as being caused by partial digestion or non-
specific peR. The number of bands present may be created by the presence of multiple 
alleles. The presence of multiple alleles was detected in most animals and suggests the 
phenomenon of gene duplication, which can be problematic for analytical purposes. 
Rather than dismiss the restriction banding patterns of the DQB2 as too complex for 
analysis, the current study reported similarities in banding patterns among animals. Bulls 
A and D, both with low PTA for see, and bulls E and I, one with low PTA for see and 
the other with high PTA for see respectively, showed similarities in their Rsa I patterns. 
Two bulls with low PTA for see (bulls D and E) and one bull with high PTA for see 
(bulls I), showed similarities in their Hae ill patterns, bulls A and D, both with low PTA 
for see, showed similarities in their Brs I patterns. Similarities were also noted in the 
banding patterns of the MHe class IT DRB3 among animals. Bulls A and B, both with 
low PTA for see, bulls D and I, one with low PTA for see and the other with high PTA 
for see respectively, and bulls e and F, one with low PTA for see and the other with 
high PTA for see respectively showed similarities in their Rsa I patterns. Bulls A and I, 
one with low PTA for see and the other with high PTA for see respectively, bulls B 
and D, both with low PTA for see, and bulls e and F, one with low PTA for see and 
the other with high PTA for see respectively, showed similarities in their Hae ill 
patterns. 
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Again with respect to immunological response, similarity in banding patterns of MHC 
class IT DQB2 was seen among animals. Bulls A and D, both with a strong 
immunological response induced by S. aureus strain A in vitro, and bulls E and lone with 
a strong immunological response induced by S. aureus strain A in vitro and the other with 
a weak immunological response induced by S. aureus strain A in vitro, showed 
similarities in their Rsa I patterns. Bulls D, with a weak immunological response induced 
by S. aureus strain A in vitro and bulls E and I, which had strong immunological response 
induced by S. aureus strain A in vitro, showed similarities in their Hae ill patterns. Bulls 
A and D, both with a strong immunological response induced by S. aureus strain A in 
vitro, showed similarities in their Brs I patterns. 
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Lanes: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Figure 43: Restriction digest patterns of BoLA DQB exon 2 of four bulls with the lowest 
PTA for see in 1997 (bulls A, B, D and E) and two bull with the highest PTA for see 
in 1997 (bulls G and 1) obtained by digestion with the enzymes Rsa I (lanes 3-8) and Hae 
ill (lanes 10-15). Lanes 2, 9 and 16 are Hae ill control digest of pBR322 (Sigma). Lane 
1 is molecular weight markers of 20bp and 100bp. Lane 3: bull A, lane 4: bull I, lane 5: 
bull B, lane 6: bull D, lane 7: bull E, lane 8: bull G, lane 10: bull A, lane 11: bull I, lane 
12: bull B, lane 13: bull D, lane 14: bull E, lane 15: bull G. 
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Lanes: 123456789 
Figure 44: Restriction digest patterns of BoLA DQB ex on 2 of four bulls with the lowest 
PTA for sec in 1997 (bulls A, B, D and E) and two bull with the highest PTA for sec 
in 1997 (bulls G and I) obtained by digestion with the enzymes Bsr I (lanes 3-8). Lanes 1 
and 9 are Rae ill control digest of pBR322 (Sigma). Lane 2 is molecular weight markers 
of 20bp and lOObp. Lane 3: bull A, lane 4: bull I, lane 5: bull B, lane 6: bull D, lane 7: 
bull E, lane 8: bull G. 
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Chapter IV 
Discussion 
4.1 Proliferation of Bovine Peripheral Blood Mononuclear Cells 
The method of in vitro antigenic stimulation of PBM employed was established during 
the course of the current study. The method established was a modification of an antigen 
presentation assay, used previously by Fitzpatrick (1992), developed to study the 
proliferative response of separated populations of T cells and APC isolated from 
Holstein-Friesian cows to the mastitis pathogen S. uberis. The previous study required 
withdrawal of large volumes of blood followed by defibrination, to prevent clotting. 
Defibrination was achieved by either mixing the blood with glass beads when dealing 
with large volumes or shaking by hand with smaller volumes. The sample was then 
mechanically defibrinated using a large plastic beaker containing the glass beads and a 
motor-driven rotating paddle. The method of defibrination was initially described by 
Glass and Spooner (1989) and further modified by Fitzpatrick (1992). It was decided to 
refine the initial isolation technique to reduce the volume of blood required, the time 
involved in isolation of PBM, and to minimize the mechanical stress exerted on the PBM 
by the isolation technique. A pure population of peripheral blood T cells isolated by the 
miniMACS method cultured in vitro with S. aureus strain A and fresh irradiated APC 
failed to proliferate. Isolation of T cells by positive miniMACS selection, as mentioned 
previously may have damaged the cells altering their functional capabilities, however, 
when T cells were isolated by negative selection, they also to failed to proliferate when 
cultured in vitro with S. aureus strain A and freshly isolated APe. For the current study, 
peripheral blood was collected by vacutainer directly into lithium heparin coated tubes. 
This eliminated the requirement for defibrination, therefore, reducing the time, the 
volume of blood and the stress exerted on the PBM. The PBM population was isolated 
by centrifugation using media of density 1.077g1l, that used most frequently for isolation 
of these cells in cattle by others (Boyum, 1968; Wilson et ai., 1986; Taylor et ai., 1994; 
Schuberth et ai., 1996; Shafer-Weaver and Sordillo, 1997; McCole et ai., 1998; Asai et 
ai., 1998). 
178 
Cell numbers in healthy lactating mammary glands tend to be relatively low, requiring 
large volumes of milk for isolation of sufficient numbers of cells for in vitro studies 
(Nonnecke and Kehrli, 1985). The use of PBM as the responding cell population to a 
mammary gland pathogen was regarded as logical for during an intramammary infection 
cells are recruited from the peripheral blood of cattle to the mammary gland (Sordillo et 
at., 1997). Previously published results suggest that a large proportion of intramammary 
lymphocytes are derived from the peripheral system (Yamaguchi et at., 1999). This 
migration of cells from the peripheral blood to the mammary gland has also been reported 
in rats (Seelig, 1980). Migration of cells from the peripheral blood of cattle to the 
mammary gland can be measured by the rise in the number of somatic cells recorded in 
milk (Heald, 1979; Gudding et at., 1984; Nickerson, 1985). Migration of cells from the 
peripheral system involves rolling of leucocytes onto the vascular wall followed by tight 
adhesion (Zimmerman et ai., 1992; Lawrence and Springer, 1993). For migration of 
leucocytes across the endothelium to be successful, opening of the tight junctions present 
in the endothelium must be accomplished (Milks et at., 1986). Recruitment of leucocytes 
and the exudation of plasma from peripheral blood through the mammary parenchyma 
(Schlam et at., 1971), across the epithelium to the lactiferous ducts and glandular alveoli 
(Anderson, 1983), was reported due to intramammary infection of cows caused by S. 
aureus (Nickerson and Heald, 1981). In addition to the migration of cells from peripheral 
blood to the mammary gland, IgG, the major immunoglobulin class in milk (Norcross, 
1977), is not produced locally within the mammary gland but undergoes selective transfer 
from serum (Murphy et at., 1964; Pierce and Fienstein, 1965). 
The uptake and distribution of S. uberis in cows was followed from the site of inoculation 
in the mammary gland via the teat to the subepithelial connective tissue of the mammary 
gland. The bacteria were then transported to the lymph vessels and the supramammary 
lymph node, from where they entered into the peripheral circulation (Nashar et at., 1990). 
Cellular responses induced by the intramammary inoculation of S. uberis resulted in an 
accumulation of neutrophils in the secretory acini (Thomas et at., 1994), and up-
regulation of the adhesion molecule, CD 18, a ~2 integrin subunit, which combines with 
CDlla to form LFA-l, on neutrophils in the mammary gland and on neutrophils in the 
peripheral blood of cattle (Persson et at., 1996). Demonstration of the transfer of cells 
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between the mammary gland and peripheral blood was reported when cattle were 
inoculated via the intramammary route with bovine rotavirus. Intramammary inoculation 
of heifers and cows with bovine rotavirus in a water-in-oil emulsion was capable of 
inducing both systemic and local antigen specific transformation of lymphocytes and the 
production of neutralising antibodies (Castrucci et ai., 1984; Archambault et ai., 1988). 
The results of this study suggested that primed lymphocytes migrate to the mammary 
gland, which has been published previously (Seelig, 1980). However, the development of 
local immunity in the mammary gland after intramammary inoculation cannot be ruled 
out (Archambault et ai., 1988). Antigen specific lymphocytes were also detected in the 
peripheral blood of cows inoculated via the intramammary route with killed 
Mycobacterium bovis (Nonnecke et ai., 1986), suggesting migration of these antigen 
specific lymphocytes from the mammary gland to the peripheral circulation. 
In non-ruminant species, a functional link between mammary and gut associated 
lymphoid tissue has been described (Evans, 1980; Kortbeek-lacobs and Van der Donk, 
1981). In ruminant species, a link between mammary and peripheral lymph nodes has 
been reported (Harp and Moon, 1987; Harp et ai., 1988). Gastrointestinal priming with 
antigen has been shown to elicit a mammary immune response in non-ruminants 
(Goldblum et ai., 1975; Parmely and Beer, 1977; Evans, 1980). This common mucosal 
immune system, known as the entero-mammary link, where specific immunity at distant 
mucosal sites following intestinal exposure to antigen has been described in non-
ruminants, but has not been established as fully functional in ruminants (Chang et ai., 
1981; Moon and MacDonald, 1983). It has been reported that localisation of mammary 
gland lymphocytes in intestinal mesenteric lymph nodes is poor and that accumulation 
occurs preferentially in mammary and prescapular nodes as shown previously in sheep 
(Harp and Moon, 1987), and cows (Harp et ai., 1988). 
Development of the in vitro assay for the current study required optimisation of PBM and 
S. aureus concentrations to determine which combination induced an optimal 
proliferative response. The kinetics of the proliferative response were followed over an 
eleven day culture period to determine the day of peak proliferative response, measured 
by 3H-thymidine incorporation in the responding PBM population, as used routinely by 
others (Schore et ai., 1981; Concha et ai., 1996; Shafer-Weaver and Sordillo, 1997). The 
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degree of stimulation was measured as counts per minute of the test well divided by the 
counts per minute of the control well and represented as a SI. Others have reported using 
~ cpm, where the control cpm is simply subtracted from the test well cpm (Lan et ai., 
1995). In the current study the concentration of S. aureus and PBM that induced the 
optimal proliferative response was 0.5x106 bacteria/ml and 2x106 cells/ml, respectively. 
The day of peak proliferation of PBM induced by S. aureus strain A occurred on day 
seven to nine of culture. Others have reported that when T lymphocytes and APC in an in 
vitro antigen presentation assay were mixed at a ratio of 10: 1, S. uberis induced a 
proliferative response which peaked on day six (Fitzpatrick et ai., 1995). In a separate 
study by Miller-Edge and Splitter (1986), PBM challenged with UV -inactivated Bovine 
Herpes Virus-1 (BHV -1) induced a peak proliferative response on day 5-6. The kinetics 
of the response induced by antigen in the current study is, therefore, similar to those 
reported previously. Proliferation assays are widely used to study in vitro immunological 
responses to a variety of antigenic, mitogenic, parasitic and viral stimuli. Mitogens have 
been used to evaluate lymphocyte function (Concha et ai., 1980), and in cattle, to 
elucidate immunological problems that may arise due to defects in regulatory pathways 
(Lan et ai., 1995). Detection of cytokine production by PBM induced by Brucella 
abortus in cattle was measured during vaccine trials through collection of proliferation 
assay culture supernatant (Stevens and Olsen, 1994). The proliferative response of 
bovine PBM induced by UV -inactivated BHV -1 was used as a measure of T cell 
mediated immunological response (Rouse and Babiuk, 1974). In vitro proliferative 
studies permit investigation of responses to parasites such as Theileria annuiata, a 
protozoan parasite of cattle, which often results in death 2-3 weeks post in vivo 
experimental challenge (Samantary et ai., 1980; Preston et ai., 1992; Campbell et ai., 
1997). 
In the current study, the SI measured on the day of peak proliferation was reported to 
range from 0 to 164. The variation in the magnitude of the proliferative response induced 
by antigenic challenge was also reported by others (Fitzpatrick et ai., 1995; Miller-Edge 
and Splitter, 1986; Nonnecke and Harp, 1985; McCole et ai., 1998). The variability 
among animals in the intensity of the immune response triggered, reflects the efficiency 
of antigenic processing, association between antigenic peptides and MHC class II, and 
ultimately presentation to T helper cells (Buus et ai., 1987). Individual variability in the 
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intensity of an immune response induced by a specific antigen has been reported as 
common in an outbred population, such as cattle (Lutje and Black, 1991). Marked 
variation in the inflammatory response among cows was reported after intramammary 
infusion with whole killed staphylococci or staphylococcal cell walls (Targowski and 
Berman, 1975). The use of inbred strains of mice in studying immunological responses to 
various antigens has the advantage over outbred populations, in that variation due to an 
individual is minimized as parental genetic contribution and environmental affects are 
controlled producing animals which are genetically identical or nearly identical (Hooper 
et ai., 1987). 
The number and type of cells present in peripheral blood capable of recognizing and 
responding to the pathogenic stimulus will affect the intensity of the immune response. 
Previous exposure to the pathogenic stimulus may result in the presence of CD4+ T cells 
expressing a memory phenotype (CD45RO). The presence of CD4+ memory T cells 
alters the kinetics of the proliferative response, requiring a much lower does of antigen 
presented by co-stimulatory molecules to induce a proliferative response (Rogers et ai., 
2000). When T cells, expressing memory phenotype, are induced to proliferate by a recall 
antigen, they display rapid kinetics associated with their proliferative response, while 
naive T cells exhibit a lag period prior to induction of a proliferative response (Rogers et 
ai., 2000). The accumulation of CD8+ T cells near the epithelium suggests a potential 
role in maintaining the integrity of the bovine mammary gland through the removal of 
damaged or infected cells (Taylor et ai., 1984). Conversely, CD8+ T cells have also been 
shown to mediate hypo-responsiveness of lymphocytes from bovine mammary glands 
infected with S. aureus to mitogens or bacterial antigen (Park et ai., 1992). Murine CD8+ 
splenic T cells inhibit antigen positive anti-TCR induced proliferation of CD4+ T cells 
(Hisatsune et ai., 1990), and immunoglobulin production (Huston, 1991). 
The results of the current study reported that the within assay repeatability of the in vitro 
proliferative assay was good, indicating that methodology and operator error were 
unlikely to explain the observed variation among animals in the proliferative response 
induced by S. aureus strain A. The between assay repeatability in the current study was, 
however, poorer. Following the kinetics of the response, it was noted that the 
repeatability was reduced during the period when the PBM were undergoing clonal 
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expansion in response to antigenic stimulus compared with the period of initial culture or 
the end phase of the response. Activated T cells have been shown to activate resting T 
cells in vitro, in a non-MHC restricted manner (Mokhtarian et aI, 1997). This activation 
does not require viable cells and occurs when initial stimulation is induced by mitogen or 
antigen (Brod et al., 1990; Bouchonnet, 1994). Non-specific activation of the T cell 
population through the presence of an unknown protein present in the culture media was 
eliminated by the lack of a detectable proliferative response in the absence of S. aureus 
strain A. Far less is known regarding cell proliferation induced by Gram positive whole 
bacteria, for example when compared with the knowledge of cell proliferation induced by 
bacterial lipopolysaccharide, a product of Gram negative bacteria (Cuzzola et al., 2000). 
The variation in proliferative response of PBM induced by S. aureus strain A noted 
among cows, was also noted among strains of S. aureus. These strains of S. aureus, four 
mammary gland isolates and one vaginal isolate, were characterized as genetically 
different by REFP analysis during the current study. Characterisation of strain C and 
strain D, isolated from the mammary gland of the same cow, by REFP, resulted in two 
identical enzymatic digestion patterns. The diversity of S. aureus genotypes within a herd 
has been reported as limited (Lam et al., 1996) due to the contagious nature of 
transmission of S. aureus between cows and between quarters during milking. The 
majority of recurrent cases of S. aureus mastitis within a herd were due to isolates of the 
same genotype, suggesting either intermittent shedding of bacteria from a chronically 
infected quarter or repeated infection with the same pathogen (Lam et al., 1996). 
Restriction Enzyme Fragmentation Pattern analysis identified several different S. aureus 
genotypes within a herd, but also within individual cows, and within individual quarters, 
suggesting that mixed infections do occur within the mammary gland (Young, 1997). 
The other strains of S. aureus, A, Band F used in the current study were identified as 
genetically distinct from each other by REFP analysis. Characterisation of S. aureus 
strain A and strain B by REFP was supported by previously published patterns (Young, 
1997), however, S. aureus strains C, D and F in the current study had not been 
characterized previously. The strongest proliferative response induced by a mammary 
gland isolate was by strain A. The mammary gland isolate, strain B induced a very weak 
proliferative response in some animals and failed to induce a proliferative response in 
others. The mammary gland isolates, strain C and strain D induced a proliferative 
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response that was greater than strain B but less than strain A. The proliferative response 
induced by the vaginal isolate, strain F, was far greater than that to strains isolated from 
the mammary gland. This suggests that this vaginal isolate may represent a common 
strain of S. aureus, possibly causing widespread exposure to cows, which may result in a 
greater number of circulating memory cells primed to respond to this pathogen. Variation 
in the virulence factors produced by individual strains may affect the proliferative 
response mounted against them. Cell-mediated reactions in vivo have been induced by 
living and killed, whole staphylococci, non-fractionated staphylococcal lysates, purified 
cell wall, and defined peptidoglycan sub-units of the cell wall (Derbyshire and Berman, 
1968; Baughn and Bonventre, 1975). Secreted toxins also contribute to the pathogenesis 
of S. aureus and those isolated from cases of bovine mastitis have been shown to express 
a, ~, yand 8 toxins, enterotoxin and coagulase (Bramley et ai., 1989; Matsunga et ai., 
1993). The variation in virulence factors among strains of S. aureus may help to explain 
the variation in proliferative response, not only among cows but also variation within an 
individual cow, to various different strains of the same bacteria. Variation among 
animals in response to immunological stimuli has been reported after vaccination, where 
the antigen to be administered has to be prepared in line with strict protocols (Reinhardt 
et ai., 1999). 
The variation in proliferative response and kinetics associated with new batches of S. 
aureus strain A may have been due to difference in the initial preparation of the bacteria 
between laboratories. To ensure that adequate numbers of bacteria were available, 
subsequent batches of S. aureus strain A were cultured as bigger batches. One 
explanation for the variation among batches is that differences in preparation may have 
resulted in an alteration in the immunological epitopes expressed on the surface of the 
bacteria. Enzymatic digestion of S. aureus strain A and REFP analysis carried out in the 
current study showed that, genotypically, the original strain A, used to optimise the 
proliferative assay and test all of the bulls sampled, was identical to the strain A cultured 
subsequently. Alteration in the kinetics of the proliferative response induced by S. aureus 
strain A with the day of peak proliferation occurring later than with the original batch 
may be due to differences in concentration of bacteria between the original batch and 
subsequent batches. This could limit the number of bacteria available for APC 
processing and presentation to T cells. 
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Rapid induction of an effective immune response is essential in the prevention of 
colonization by invading pathogens (Jensen and Eberhart, 1975; Sordillo et ai., 1997). 
The variation among animals in eliciting a proliferative response in vitro may reflect their 
ability to present an effective defence against invading pathogens in vivo. Failure to 
recognize different strains of S. aureus may be due to an inability to initially process 
antigen and subsequently present antigenic peptides in association with MHC class II 
molecules to CD4+ T cells (Nonnecke and Harp, 1989; Sordillo et ai., 1997). 
In the results of the current study it was noted that when a strong proliferative response 
was induced by S. aureus strain A in a particular animal, in general the proliferative 
response induced by the other S. aureus strains, C, D and F was also strong. Selection for 
improved resistance to one pathogen may potentially result in susceptibility to another. 
Mastitis is a multi-factoral disease with an extremely complex aetiology, therefore, 
improved resistance to one pathogen may not be true for other mastitis causing pathogens 
(Shook, 1993). 
The large variation induced by antigenic stimuli among animals reported in the current 
study has also been reported when PBM were challenged with mitogens (Schore et ai., 
1981). This study reported that the variation in proliferative response among animals was 
far greater in the presence of mitogen when compared to antigen. Marked variation in 
lymphocyte blastogenesis was also noted with day-to-day sampling (Smith and Schultz, 
1977). Many of the previously published studies relating to the immunological responses 
of cattle have been carried out using mitogenic stimuli rather than antigenic stimuli 
(Concha et ai., 1980; Lutje and Black, 1992). 
The kinetics of the proliferative response induced by S. aureus in the current study could 
be suggestive of a primary response to antigen. The kinetics of an immune response may 
be used as an indicator of an animal's previous exposure to antigen. The kinetics 
associated with a primary immune response, where the responding cell population is 
naive, are different to those where the responding cell population has encountered the 
antigen previously (Mackay et ai., 1990). The day of peak proliferation induced by 
antigenic stimuli is earlier in a secondary immune response when compared to that in a 
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primary response. Peripheral blood mononuclear cells isolated from cats when 
challenged with human serum albumin (HSA) produced a proliferative response that 
peaked at day 8-9. When rechallenged with HSA the proliferative response peaked on 
day 2 (Bishop et al., 1992). The kinetics of this study were similar when peripheral blood 
leucocytes from healthy humans were challenged then rechallenged with antigen 
(Plebanski et al., 1992). Expression of the different forms of the cell surface marker 
CD45 can distinguish naIve from memory T cells (Smith et ai., 1986). NaIve T cells 
express CD45RA, and require recognition of high densities of antigen presented by APC 
(Ingulli et ai., 1997; Cella et ai., 1997). The kinetics of CD45RA+ T cells is suggestive of 
a primary proliferative response induced by antigenic stimuli (Mackay et al., 1990). 
Memory T cells express CD45RO and proliferate in response to a recall antigen presented 
by APC at a lower concentration than that presented primarily (Rogers et al., 2000). The 
kinetics of CD45RO+ T cells are suggestive of a secondary proliferative response (Pilling 
et al., 1996), and as would be expected, T cells expressing a memory phenotype have 
been shown to exhibit more rapid effector functions when compared to naIve T cells 
(Swain et al., 1996). 
In the current study, S. aureus strains A, C, D, and F produced enterotoxins, and strains C 
and D also produced TSST -1. Production of SE was detected by RPLA, which has been 
described as sensitive and rapid, and requiring no specialized equipment (Park and Szabo, 
1986; Wieneke and Gilbert, 1987; Matsunaga et al., 1993; Takeuchi et al., 1998). Of the 
four S. aureus strains tested, the two mammary isolates recovered from the same cow but 
different quarters: strain C and strain D, both produced SEC and TSST -1, which was 
expected, as they were genotypically identical as determined by REFP analysis. 
Staphylococcus aureus strain A, the other mammary gland isolate, produced SED only 
and strain F, the vaginal isolate, produced SEA and SEB. Others studies have reported 
SEC and TSST-1 as the most frequently isolated SE from sheep, goats and cattle (Orden 
et ai., 1992; Matsunaga et al., 1993; Kenny et al., 1993). Bovine S. aureus isolates are 
reported to frequently produce more than one toxin, especially SEC, SED and TSST-1 
(Ferens et al., 1998). Staphylococcal enterotoxin A and TSST -1 have been reported as 
more potent inducers of the characteristic mitogenic polyclonal T cell response when 
compared to SEB and SEC (Yokomizo et al., 1995). Staphylococcal enterotoxin B has 
been reported by others to induce an in vivo state of immunosupression that affects 
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humoral and cell mediated immunity when challenged with antigen complexes such as 
sheep red blood cells and allo-MHC molecules in mice (Pinto et at., 1978). The 
induction of an immune response by SEB is characterized by early activation and clonal 
expansion of the responding cell population. 
To ensure that the proliferative response being measured was due to induction by S. 
aureus and not enterotoxin, PBM were cultured in the presence of SEB and the kinetics 
were followed. In the current study PBM incubated with SEB in vitro, induced a 
proliferative response that peaked on day three to four of culture. Others have reported 
similar findings when the prolifer~tive response of PBM induced by SEA, SEB and SED 
was studied in humans (Fleischer and Schrezenmeirer, 1988), and cattle (Yokomizo et aI., 
1994). The difference in the day of peak proliferative response induced by S. aureus 
compared with SEB, highlights the difference in type of immune response generated by 
SE compared to formalin-fixed whole S. aureus. Staphylococcal enterotoxins are bi-
functional molecules capable of recognising and binding to both the MHC molecule and 
the TCR (Fleisher, 1989; White et aI., 1989). The requirement for MHC class II 
molecules is not due to immunological recognition of processed SE, as SE act directly on 
the T cells, but rather due to cross linking of variable parts of their antigen receptors with 
MHC class II molecules on accessory or target cells (Fleischer and Schrezenmeier, 1988). 
Staphylococcal enterotoxin stimulation of T cells according to the composition of the 
TCR ~ chain alone (Choi et aI., 1989), rather than the precise antigenic specificity of their 
TCR (Wood et at., 1991). As a result of SE being able to stimulate a variety of V~ T cell 
types they are regarded as polyclonal stimulants rather than monoclonal stimulants. This 
polyclonal ability to stimulate a range of V~ T cell types has earned SE the name 
superantigens (Choi et aI., 1989). 
T lymphocytes have been shown to be the predominant cell type that proliferates in 
response to SE (Yokomizo et at., 1994), with equal proportions of CD4+ T cells and 
CD8+ T cells induced in human and murine studies (Uchiyama et at., 1990). Further 
studies have reported activation of T cells lacking both the CD4 and CD8 cell surface 
marker by SE, indicating that CD4 and CD8 markers are not essential for induction of a 
SE response (Quarantino, 1991). Staphylococcal enterotoxin B has been shown in 
humans to downregulate the expression of mucosal T cell homing receptor on human 
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activated T cells (Hemandez-Caselles et ai., 1996), as well as exacerbate the 
inflammatory response by the secretion of cytokines. In cattle, the activation of CD8+ T 
cells induced by staphylococcal superantigens has been reported to result in a down-
regulation of the CD4+ T cell immune response (Park et ai., 1993). Elevated levels of 
CD8+ T cells have been reported in S. aureus-contaminated milk (Ferens et ai., 1998). 
The down regulation of CD4+ T cells by activation of CD8+ T cells suggests a potential 
role of SE in the pathogenesis of intramammary infection. T cell unresponsiveness has 
been reported as mediated by peripheral cell apoptosis (Rellahan et ai., 1990) and 
induction of anergy (Migita and Ochi, 1993). It has been suggested that the phenomenon 
of T cell unresponsiveness may not affect the host's antibacterial response but rather 
represent an efficient mechanism by which Gram positive bacteria subvert the hosts 
immune response (Muraille et ai., 1997). 
In the current study, PBM isolated from cows cultured in the presence of 14% normal 
milk and SEB resulted in a reduction in the proliferative response induced by SEB. A 
concentration of 7% normal milk also reduced the proliferative response induced by SEB 
but to a lesser extent than the higher concentration. Soluble components of milk may 
inhibit lymphocyte proliferation by masking cell surface receptors (Brock and Mainou-
Fowler, 1983). Mammary gland secretions have been reported previously to non-
specifically depress the activity of mammary gland lymphocytes (Schore et ai., 1981). 
The presence of colostral skim has also been shown to inhibit the proliferative response 
of PBM isolated from cattle induced by mitogenic stimulus in vitro (Collins and Oldham, 
1986; Torre and Oliver, 1988). Bovine peripheral blood lymphocytes cultured in the 
presence of cell free milk for 30 minutes, which were then washed prior to incubation 
with PHA resulted in a reduction in proliferative response induced by the mitogenic 
stimulus (Parmely et ai., 1976). Human peripheral blood leucocytes cultured in vitro in 
milk demonstrated an inhibition of phagocytosis due to the presence of the milk (Russell 
et ai., 1976), as well as a reduction in proliferative response induced by mitogenic 
stimulus (Diaz-Jouanen and Williams, 1974). Other studies have reported that the 
reduction in proliferative response can be attributed to the fat and casein present in the 
milk, which penetrate the monocytes and macrophages, resulting in a reduction in the 
ability to process pathogens (Lee and Outteridge, 1976). 
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In the current study, the presence of an anti-MHC class IT antibody resulted in a 
significant reduction the proliferative response of PBM induced by S. aureus strain A. 
The expression of MHC class IT molecules on the surface of antigen presenting cells is 
necessary for effective processing of antigen and subsequent presentation to T cells 
(Babbitt et ai., 1985; Sette et ai., 1987). Addition of the anti-MHC class IT MAb blocked 
the site for presentation of the antigenic peptide, which is presented to the responding T 
cell population as an antigenic peptide-MHC class IT complex. Inhibition of the 
proliferative response of PBM induced by an antigenic stimulus was reported after 
depletion of MHC class IT expressing cells. Reduction in proliferative response induced 
by ovalbumin was reported in the presence of an anti-MHC class IT MAb (Hooper et ai., 
1987; Glass and Spooner, 1989; Fitzpatrick et ai., 1995). The proliferative response in 
the current study, although reduced, was not abrogated as reported by others in mice 
(Hooper and Taylor, 1987) and cattle (Fitzpatrick, 1992). Incomplete blocking of the 
available MHC class IT binding sites may have arisen due to insufficient anti-MHC class 
IT MAb being present. The addition of PBM, S. a.ureus strain A and anti-MHC class IT 
MAb simultaneously may have permitted a degree of antigenic processing to occur before 
the anti-MHC class IT MAb could block all the MHC class IT sites on present on the APC 
present. The culture of PBM and anti-MHC class IT MAb prior to the addition of S. 
aureus strain A, may have resulted in complete inhibition of the proliferative response as 
reported previously by others. 
Variation in proliferative response among individuals can be influenced by age, sex, 
breed, stress, health status and genetic background (Schalm et at., 1976; Kristensen et at., 
1982). The variation in the proliferative response observed among progeny groups in the 
current study suggested that genetic control plays an important role in the proliferative 
response induced by S. aureus. The proliferative response of PBM isolated from 
Holstein-Friesian cows sired by two different bulls, induced by S. aureus strain A showed 
statistically significant differences (p=O.03) in proliferative responses when measured on 
the day of peak proliferation, day nine. The significant difference in proliferative 
response induced by S. aureus strain A between the two progeny groups suggests that 
genetics associated with immune function can influence the magnitude of the proliferative 
response induced. The immune system is the most important factor affecting disease 
resistance and susceptibility (Nonnecke and Harp, 1989). Expression of MHC molecules 
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on cells which form part of the adaptive immune system have been shown to have a 
pronounced effect on resistance to infectious agents. This has been reported in mice in 
relation to antibody production (Biozzi et ai., 1974). Five, bi-directional, selective 
breedings were carried out to characterise antibody production (Biozzi et al., 1979). 
After several generations of selection, high and low responder lines, which differed in 
antibody production by 80-200 fold, were obtained. The genetic control demonstrated in 
these lines of selected mice was shown to span unrelated antigens, not just those used in 
the experimental design (Biozzi et al., 1974; Siqueira et al., 1977; Heumann and Stiffel, 
1978). The variation in antibody production between the two lines of mice was estimated 
to be a result of ten independently segregated loci with additional additive effects 
(Feingold et al., 1976). A genome-wide mapping search (Puel et al., 1995), confirmed 
the involvement of /gh and MHC linked genes (Lieberman et al., 1972; Vidard et al., 
1990) located on chromosomes 12 and 17 respectively. The results also highlighted the 
presence of immunomodulatory genes. These immunomodulatory genes were located on 
five distinct chromosomes (2, 4, 6, 8 and 10), (Puel et ai., 1995). Biozzi mice with high 
antibody production after H-2 typing were suggested to express Kd, Dq with the class II 
MHC derived from an unknown haplotype (Colombani et al., 1979). This has also been 
reported in chickens in relation to Marek's disease, where a specific haplotype, B2t, 
seems to convey resistance to Marek's disease in chickens of many different genetic 
backgrounds (Lamont, 1998). As described in Biozzi mice, the contribution of non-MHC 
alleles, linked to antibody responses, with MHC alleles, linked to resistance to Marek's 
disease may affect susceptibility/resistance of lines of chickens to Marek's disease 
(Pinard and Vanderzijpp, 1993). An association between the MHC and 
resistance/susceptibility to mastitis has also been reported in cattle (Solbu, 1983; Larsen 
et al., 1985). Susceptibility to clinical mastitis has been reported previously in cattle with 
respect to BoLA class II DQIA haplotype (Lunden et al., 1990). This DQ haplotype was 
measured in sires and susceptibility to clinical mastitis was recorded in their daughters. 
Previously published studies in heifers have shown that those animals carrying the class I 
combination W8IW20 had lower SCC than those animals without this combination 
(Meyer et al., 1989). Aarestrup et al. (1995) reported that allele A19 (A6) was associated 
with a decreased likelihood of isolation of S. aureus. Conversely allele A31 (A30) was 
associated with an increased likelihood of isolation of S. aureus. 
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The initial results from the progeny groups led to the hypothesis that the proliferative 
response induced by S. aureus in cows may also be measurable in bulls. Initially, ten 
bulls were selected on the basis of extreme PTA for see, five bulls with the highest PTA 
for see (mean 13.71+/-3.45) and five bulls with the lowest PTA for see (-9.33+/-3.06). 
It was anticipated that selection of extreme bulls would provide the greatest chance of 
detecting a difference in proliferative response induced by S. aureus. The kinetics of the 
response induced by S. aureus in bulls was similar to that previously reported in cows. 
The proliferative response of PBM isolated from bulls induced by S. aureus strain A, 
could suggest the kinetics of a primary response. Kinetics of a primary response would 
be reasonable as recognition of S. aureus via the same route as the cows i.e., the 
mammary gland, would not be possible in bulls. Bulls may have had previous exposure 
to S. aureus via a number of anatomical sites, such as the skin and, therefore, secondary 
immune responses would also be possible. The restriction digest patterns of S. aureus 
strains isolated from different sites in cows has not been investigated to date and no work 
has been performed in bulls. It is, therefore, not possible to state if the S. aureus strain A 
used in the current study is solely an intramammary gland isolate, or whether it is 
widespread on other sites on cattle and throughout the country. Variation in the 
magnitude of the proliferative response induced by S. aureus was noted in bulls, with 
some animals generating a stronger proliferative response of PBM induced by S. aureus 
than others. Bulls with a low PTA for see generally had a stronger proliferative 
response induced by S. aureus than bulls with a high PTA for Sec. The results showed 
that the responses of the two bull groups were not dichotomous but bimodal and 
overlapping, in that one of the five bulls with low PTA for see had a weak proliferative 
response induced by S. aureus strain A, while one of the five bulls with high PTA for 
see had a strong proliferative response induced by S. aureus strain A. The results also 
indicated that there was a highly significant negative correlation between the log SI and 
PTA for Sec. A negative correlation means that as the PTA for see reduces, the 
proliferative response induced by S. aureus strain A increases. These results suggest that 
the measurement of the proliferative response of PBM may be used as a possible marker 
for identifying bulls that have an improved response to mastitis pathogens, in the case of 
the current study, S. aureus. This may allow identification of bulls that could be selected 
for breeding programs based on the potential to improve their progeny's ability to respond 
to mastitis pathogens. The rationale for this method of selection is that it has been shown 
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that the incidence of clinical mastitis was higher during the first and second lactations 
among daughters of sires that transmitted higher somatic cell score (SeS), (Nash et ai., 
2000). While daughters of sires that transmitted lower ses had fewer incidences of 
mastitis (Nash et ai., 2000). The increased incidence of mastitis in first lactation cows 
was reflected throughout the herd life of those cows (Grootenhuis, 1981). It has been 
suggested that selection of cows with very low ses may result in cows that were unable 
to respond to infection (Schukken et ai., 1988; Kremer et ai., 1993). Very low see 
translate to very low levels of leucocytes present in the mammary gland. These cells are 
present in the mammary gland to combat bacterial pathogens, which have managed to 
evaded the innate immune system, therefore, removal of these cell types may predispose 
cows to a higher risk of clinical mastitis (Suriyasathapom et ai., 2000). Others have 
reported a linear association between clinical mastitis and ses which does not support 
the theory that selection of cows for very low ses will produce cows that are unable to 
respond to infection (Philips son et ai., 1995; Rogers et ai., 1998; Nash et ai., 2000). 
The association shown between the PTA for see and the immune response induced by S. 
aureus in the extreme bulls led to a more extensive study to examine if this association 
was maintained among bulls across the range of PTA for Sec. A total of 103 bulls were 
chosen at random for the current study. The mean PTA for see in 1998 was 4.8+/-6.0, 
and the mean proliferative response (+/-SD) induced by S. aureus strain A was 9.1+/-16.0 
when tested on the day of peak proliferation. Results from the current study showed no 
correlation between PTA for see and immune response in the 103 bulls chosen from the 
population at random. During the course of the current study, the PTA for see changed 
considerably for the 103 Holstein-Friesian bulls. As young bulls generated more 
daughters through progeny testing, the reliability of the estimate of PTA for see 
increased, as more lactational records were included. For daughter's lactational records 
to be included, a minimum of six individual monthly see for a single lactation must be 
available (Mrode and Swanson, 1996). The estimate of PTA for see does not, however, 
take into account daughters that have been culled or excluded from monthly see 
measurements possibly due to chronic infection or persistently high see. Exclusion of 
those daughters culled as a result of persistently high see or chronic infection will effect 
the estimate of PTA for see for an individual bull resulting in an underestimation of 
PTA for Sec. As the estimate for PTA for see is based on monthly lactational see, 
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elevated recordings are more likely to represent infection due to contagious pathogens 
rather than environmental pathogens, as the latter usually result in transient increases in 
sec rather than chronic elevation. The data in the current study was re-analysed on a 
number of occasions to account for the PTA for sec being updated twice yearly by the 
Animal Data eentre. With the implementation of Ee legislation regarding the levels of 
somatic cells in milk and the heavy financial penalties imposed by milk purchasers, 
farmers are eager to remove cows that have persistently elevated see and those with 
chronic IMI as a result of contagious pathogens from their herds. Bull breeding 
companies will also be eager to remove bulls that are likely to pass on an increase in sec 
to their daughters from their breeding programs. The removal of bulls with the highest 
PTA for sec should narrow and reduce the range of PTA for sec in bulls. Even when 
the changing PTA for see data was taken into account, there was still no correlation 
between PTA for see and log SI. It is possible, therefore, that the in vitro proliferative 
assay developed in the current study might be useful in potentially detecting the very good 
or very poor bulls, rather than being able to rank all potential breeding bulls in terms of 
PTA for Sec. Another possibility for the failure to correlate immune response and PTA 
for sec in the randomly selected bulls is that PTA for see will reflect infection with 
organisms other than S. aureus. Alternatively, the trait being measured may be so 
complex and reflect infection with such a wide range of organisms that the power and 
design of the current study is insufficient to detect any association, even if one is present. 
The ability to eliminate extremely poor bulls from progeny testing programs at an early 
stage would be of considerable benefit to the breeding industry. Early culling of bulls, 
which are undesirable due to increased prevalence of disease in their progeny would 
create considerable economic saving on progeny testing in addition to improving the 
overall health of the future dairy herd in the UK. 
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4.2 Phenotyping of Peripheral Blood Mononuclear Cells 
Peripheral blood mononuclear cells were isolated from healthy lactating Holstein-Friesian 
dairy cows by centrifugation using a medium of density 1.077 gil, that used most 
frequently for isolation of these cells in cattle by others (Boyum, 1968; Wilson et ai., 
1986; Schuberth et ai., 1996; Shafer-Weaver and Sordillo, 1997; McCole et ai., 1998; 
Asai et ai., 1998). Although many studies have utilised flow cytometry to analyse 
differences in cell subpopulations by identification of cell surface markers, there is little 
information available in the available literature that defines a time period for fixation and 
sample analysis. The time period should provide a result where the cells identified 
represent accurately the cells present in vivo. For the purpose of the current study, initial 
fixation of the PBM was carried out as soon as possible, and no later than ten hours after 
the blood sample was collected. Results from the current study (not reported) showed 
that storage of blood for a 24 hour period prior to cell labelling reduced the level of 
expression of cell surface markers and reflects those findings previously reported in 
humans (Weiblen et ai., 1983; Ashmore et ai., 1989). There are, however, published 
studies that have found differently, reporting that overnight storage of human whole blood 
did not affect lymphocyte surface marker expression (Shield et ai., 1983; Nicholson et ai., 
1984; Prince and Arens, 1986). Lloyd et al. (1995) reported that sheep whole blood could 
be stored for up to 48 hours without significantly affecting the cell surface expression of 
CD4, CD5, CD8 or the B cell marker. For the purpose of the current study, flow 
cytometry was carried out on stained, fixed, PBM as soon as possible, and no later than 
two days post fixation. Previously published work in sheep reported that stained, fixed 
cells stored at 4°C, showed no significant reduction in cell surface marker expression after 
24 hours. However, the same study reported a significant reduction in cell surface marker 
expression of CD5, CD8, B cell marker, and 'Y8 T cell markers after a period of seven 
days (Lloyd et ai., 1995). 
From the phenotyping studies carried out on PBM of cows, the mean percentage (+/-SD) 
of cells expressing CD4 was 26+1-8%, CD8 was 16+/-10%, 'Y8 was 7+/-4%, the B cell 
marker was 17+/-8%, the monocyte marker was 38+/-17% and the MHC class IT marker 
was 34+/-9% of the PBM population, which are similar to those reported previously in 
cattle (Taylor et ai., 1994). 
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The mean percentage (+/-SD) of CD4+ T cells in peripheral blood was found to be 26+/-
8% of the PBM population in the current study. The percentage of CD4+ T cells has been 
reported previously to range from 15-35% of the PBM population depending on the age 
of the animal (Bensaid and Hadam, 1991). Others have reported the percentage of CD4+ 
T cells to range from 23-42% of the PBM population (Harp et al., 1991; Shafer-Weaver 
et aI., 1999; Soder and Holden, 1999). 
The mean percentage (+/-SD) of CD8+ T cells in peripheral blood was found to be 17+/-
8% of the PBM population in the current study. The percentage of CD8+ T cells in adult 
cattle has been reported previously as ranging from 11-22% of the PBM population (Harp 
et al., 1991; Taylor et al., 1994; Shafer-Weaver et al., 1999). The percentage of CD8+ T 
cells in the current study varied considerably among cows with one cow expressing CD8 
on 41 % of the stained PBM population. The elevated levels of CD8+ T cells may have 
simply reflected an extreme variation in this cow. None of the cows at the time of 
sampling showed any visible signs of illness or were suffering from an intramammary 
infection, however, the elevated levels of CD8+ T cells may have been due to infection 
that was not detectable clinically in this individual animal. 
The mean percentage (+/-SD) of T cells expressing the 'Yo marker in peripheral blood was 
found to be 7+/-4% of the PBM population in the current study. The percentage of T 
cells expressing the 'Yo marker has been reported previously to range from 5-15% of PBM 
(Davis et al., 1996). Other authors reported that 10+/-2% (Soder and Holden, 1999), or 
8+/-1 % (Taylor et al., 1994) of PBM expressed the 'Yo T cell marker, supporting the 
results of the current study. All of the cows used in the current study were in at least their 
second lactation. In calves aged 1-2 weeks of age, 'Yo T cells have been reported to 
comprise 40-80% of PBM (Hein and Mackay, 1991; Wyatt et al., 1994). The percentage 
of 'Y0+ T cells in cattle has been reported previously to decline with age, with 'Y0+ T cells 
accounting for 5-10% of PBM in adult animals of 5-8 years of age (Clevers et al., 1990). 
The mean percentage (+/-SD) of lymphocytes expressing the B cell marker was found to 
be 17+/-8% of the PBM population in the current study. The percentage of cells 
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expressing the B cell marker has been reported previously in cattle as 21 % (Frunchtmann 
et ai., 1977),31+/-4% (Shafer-Weaver et ai., 1999) and 35+/-2% (Taylor et ai., 1994), or 
ranging from 10-30% (Reeves and Renshaw, 1978; Yang, 1981) of the PBM population. 
The mean percentage of peripheral blood cells expressing the monocyte marker was 
found to be 38+/-17% of the PBM population in the current study. The percentage of 
cells expressing the monocyte marker has been reported by others as 16+/-1 % (Fitzpatrick 
et ai., 1995) or 20+/-2% (Shafer-Weaver et ai., 1999) of the PBM population. These 
published results are significantly different from those found in the current study. The 
primary MAb used in the current study was JL-A24, which has been reported to stain 94% 
of cells identified by morphology as peripheral blood monocytes (Ellis et ai., 1987). Of 
the ten cows in the current study, six of the animals were less than four years of age, 
while four animals were older than four years of age. In the older cows, the mean 
percentage (+/-SD) of cells expressing the monocyte marker was 19+/-8%, and in 
younger cows the mean percentage (+/-SD) of cells expressing the monocyte marker was 
50+/-7%. These results suggest that the age of the cow may have an effect on the 
percentage of PBM. expressing the monocyte marker. 
The mean percentage of cells expressing the MHC class II marker was found to. be 34+/-
9% of the PBM population in the current study. The percentage cells expressing MHC 
class II has been reported previously in cattle as 22+/-2% (Soder and Holden, 1999), 
43+/-3% (Fitzpatrick et ai., 1995) and 32+/-3% (Taylor et ai., 1994) of the PBM 
population, supporting the current work. Expression of MHC class II molecules on 
unstimulated PBM is present on monocytes, dendritic cells and B cells (Wiman et ai., 
1976). 
The stage of lactation has been reported previously to effect cell subpopulations 
expressing certain surface markers in the peripheral blood and mammary gland of cattle 
(Taylor et ai., 1994; Asai et ai., 1998). All of the cows sampled during the current study 
were lactating. The stage of lactation did vary among cows, ranging from just after 
parturition to a few days prior to drying off. None of the cows were sampled during the 
dry period. Variation in the percentage of peripheral blood lymphocytes during lactation 
has been reported as minimal (Taylor et ai., 1994). The percentages of CD4+ and CD8+ T 
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cells in peripheral blood however has been reported previously to be higher prior to 
calving compared to the period prior to drying off (Park et al., 1992; Taylor et al., 1994; 
Asai et al., 1998). A reduction in the percentage of peripheral blood cells expressing 
CD3, CD4, CD8, and the "() T cell marker has also been reported prior to calving with 
levels returning to normal after calving (Kimura et al., 1999). The reduction in the 
percentage of cells expressing the "() T cell marker in peripheral blood prior to calving 
was supported by Shafer-Weaver and Sordillo (1996), who reported levels of cells 
expressing the "() T cell marker to be higher during lactation compared to at calving. 
Expression of MHC class II molecules on PBM was shown to be similar during lactation 
and prior to parturition (Shafer-Weaver and Sordillo, 1996). No obvious differences in 
the proportions of cell subpopulations identified in cows were seen in the current study, 
although the numbers of cows at various stages of lactation was too small for statistical 
analysis. 
It was not possible, due to time constraints and low cell numbers, to examine all cell 
subpopulations in milk isolated from the cows in the current study. Cell isolation from 
milk requires large volumes of milk due to low cell concentrations, especially in normal, 
uninfected, milk. Cell isolation from infected milk can also be extremely difficult due to 
the presence of clots or pus, which trap the cells. During the current study, expression of 
CD4 on milk leucocytes was shown to be similar between cows with high SCC (>400,000 
cells/rnl of milk over a period of three consecutive months) and cows with low SCC 
«150,000 cells/rnl of milk at the time of sampling). Expression of CD8 on milk 
leucocytes was shown to be higher in cows with persistently high SCC compared to cows 
with low SCc. Variation in the percentage of cells expressing certain cell surface 
markers has been reported with stage of lactation in the bovine mammary gland (Asai et 
al., 1998). The ratio of CD4+ T cells to CD8+ T cells has been shown to vary with the 
stage of lactation (Yamaguchi et al., 1999). There are greater numbers of CD8+ T cells 
than CD4+ T cells during lactation (Park et al., 1992), a situation which is reversed late on 
during the dry period when CD4+ T cells predominate (Asai et al., 1998). The overall 
percentage of CD8+ T cells has been reported to remain constant throughout lactation, 
unlike the CD4+ T cell population (Taylor et al., 1994). Milk mononuclear cells from 
cows with persistently high SCC expressing MHC class II was reported in the current 
study as 39+/-21 % and from cows with low SCC as 32+/-10%. Cows with consecutively 
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high monthly SCC records were chosen as persistently elevated SCC are characteristic of 
chronic intramammary infection, often due to infection with S. aureus. The proportion of 
cells expressing the MHC class II marker was lower in milk leucocytes compared to milk 
mononuclear cells in both groups of cows. The lower proportion of cells expressing 
MHC class II in the leucocyte population is not unexpected as this population contains 
neutrophils, which do not express MHC class II. The results of the current study do not 
show up-regulation of MHC class II expression in cows with high SCC compared to cows 
with low SCC. The increased percentage of CD8+ T cells in cows with persistently high 
SCC may be one possible explanation for the apparent lack of up-regulation, with the 
increase in CD8+ T cells suppressing the MHC class II1CD4+ T cell response. Differences 
between the percentages of MHC class II expressing cells isolated from peripheral blood 
and the mammary gland has also been reported. The mean percentage of cells expressing 
the MHC class II marker in peripheral blood has been reported as 22+/-2% of PBM 
compared to 13+/-4% in the mammary gland (Soder and Holden, 1999). This value has 
also been reported as 32+/-3% of PBM and 2+/-0.17% in the mammary gland (Taylor et 
ai., 1994). The expression of MHC class II on milk leucocytes reported in the current 
study is higher than those published previously. The secretion of IFN-y by activated T 
cells has been reported to up-regulate the expression of MHC class II on the surface of 
macrophages (Steeg et ai., 1982). Up-regulation of MHC class II was also reported on 
mammary epithelial cells after inoculation of formalin-fixed S. uberis into the gland 
(Fitzpatrick et ai., 1992). The expression of MHC class II described in the previously 
published studies was in non-infected glands, while in the current study, the cows were 
known to be suffering from an intramammary infection. The high level of expression of 
MHC class II reported in the cows with low SCC was shown to be due to one animal. 
This group was chosen based on the month prior to sampling lactational record and one 
possibility is that the cow with a high proportion of cells expressing MHC class II was 
suffering from a subclinical intramammary infection, which had not been detected 
clinically at the time of sampling. Immunological indicators, such as expression of 
surface markers on cell subpopulations, have been reported in a recent study to reflect 
intramammary infection and health status to the same degree or better than bacteriology 
or somatic cell counting (Rivas et ai., 2000). Although not investigated in the current 
study, cells expressing the yo T cell marker in cattle have been reported as higher in PBM 
(8+/-1 %) when compared to the mammary gland (2+/-0.3%), (Taylor et ai., 1994). The 
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situation in cattle is in contrast to that of humans where human breast milk is relatively 
rich in cells expressing the 18 T cell marker compared to peripheral blood (Bertotto et al., 
1990). 
The proportion of the various cell subpopulations identified in peripheral blood of cows 
during the current study suggested that these animals were capable potentially of 
generating an immune response if challenged. During the current study, only the 
proliferative response of PBM induced by antigenic stimuli was investigated rather than 
the effector functions that are responsible for removal of the pathogen, such as 
opsonisation, phagocytosis, or cell cytotoxicity. The proliferating PBM population 
induced by S. aureus strain A in cows in the current study was shown to comprise T cells 
expressing CD4 (53+/-8%), CD8 (21.3+/-5%) and 18 (13.3+/-4%) molecules. T cells 
expressing the CD4 cell surface marker are required for the development of humoral and 
cell mediated immunity, as well as the recruitment of neutrophils and non-specific 
phagocytic cells to the site of inflammation (Kimura et al., 1999). T cells expressing the 
CD8 marker protect and elicit recovery from viral, certain bacterial and parasitic 
infections (Kimura et aI., 1999). Previously published studies on the functional 
properties of ruminant 18 T cells have been limited and inconclusive. 18 T cells have 
been identified as a predominant cell type that proliferates during autologous mixed 
leucocyte reactions (Goddeeris et al., 1997), suggesting that they may recognise self-
determinants expressed on the surface of damaged or stressed cells. 18 T cells may be 
involved in the defence against intracellular microbial infections, as well as the 
production of cytokines in response to antigenic challenge (Haas, 1993; Bluestone et al., 
1988). The protective role of 18 T cells in cattle associated with cytokine production has 
been supported by the positive correlation between the percentage of 18 T cells present 
and the secretion of IgM and IFN-1 (Ferrick et al., 1995; Nonnecke et al., 1997). These 
findings suggest that 18 T cells contribute to cellular and humoral immune responses of 
cattle. 18+ T cells in cattle that lack expression of WCl represent a small proportion of 
PBM, but are more abundant in the spleen, mammary gland and mammary gland 
secretions (Wyatt et al., 1994 & 1995; MacHugh, 1997). 18 T cells that express and lack 
the WCl marker have been shown to be able to modulate an immune response directed 
against S. aureus and Mycobacterium paratuberculosis (Chiodini and Davis, 1992; 
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Brown et ai., 1994). yo T cells are also found in large numbers in the skin, suggesting a 
role in the protection of epithelial surfaces (Mackay and Hein, 1989; Clevers et ai., 1990). 
B cells are one cell type capable of acting as APCs. On receiving a second signal from 
the T cell, after effective presentation of antigen, B cells proliferate and differentiate into 
plasma cells (Butler, 1998). The maturation of B cells into antibody producing cells leads 
to the development of the humoral immune response (Morafo et ai., 1999). The 
percentage of B cells present in the peripheral blood of cattle has been reported as 20% of 
the lymphocyte population and similar to the numbers reported in mammary gland 
(Hellstrom et ai., 1976; Concha et ai., 1978). Reduced numbers of B cells in the 
mammary gland was reported in cows suffering from an intramammary infection (Yang et 
ai., 1987), suggesting that during an intramammary infection the development of an 
antibody mediated response may be impaired. 
Monocytes present in peripheral blood are the precursors for tissue macrophages and 
participate in the development of a secondary immune response (Filion et ai., 1984; Glass 
and Spooner, 1989). T cell recognition of antigen requires interaction between the TCR, 
MHC and peptide fragments of antigen, which has been processed by the APC (Ashwell 
and Schwartz, 1986; Glass and Spooner, 1989). For development of specific immune 
responses, the expression of MHC class IT cell surface markers on antigen presenting cells 
is of key importance (Petroff et ai., 1997). Expression of MHC class IT is a requirement 
for T cells to recognise antigenic peptide presented on the surface of the APe. 
The presence of a cell population, lacking all identifiable cell surface markers, has been 
reported in the peripheral blood of different species. These cells, termed null cells, have 
been reported to range from 20-40% of the PBM population of cattle (Wilson et ai., 
1986). They have also been reported to represent 5-10% of mouse spleen cells and 
human peripheral blood lymphocytes and up to 50% of peripheral blood lymphocytes of 
sheep (Kristensen et ai., 1982). Functionally, these null cells have been ascribed the same 
activity as NK cells (Kiessling and Haller, 1978; Roder et ai., 1980). Natural killer cells 
are known to produce cytokines that regulate the immune response, and are themselves 
regulated by the cytokines produced during an immune response (Fearon and Locksley, 
1996). Natural killer cells contribute to early regulatory signals as well as effector 
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functions during an immune response (Raymond and Wilkie, 1998). The NK population 
isolated from Yorkshire pigs have been described as non-granular, non-adherent cells 
(Pinto and Ferguson, 1988) expressing CD2 as well as in some cases CD8 (Pescovitz et 
at., 1988; Saalmuller and Reddenase, 1988). It has been suggested that null cells may 
participate in a cytotoxic mechanism, Spontaneous Cell Mediated Cytotoxicity (SCMC), 
(Leibold et at., 1979), which has been reported previously in pigs, cattle and horses 
(Leibold et at., 1980). 
Migration of cells from peripheral blood to the mammary gland can be measured by the 
rise in the number of somatic cells recorded in milk (Nickerson, 1985). The link between 
peripheral blood and the mammary gland can also be demonstrated by the presence of 
IgG in milk. Immunoglobulin G, the major Ig class in milk (Norcross, 1977), is not 
produced locally within the mammary gland but undergoes selective transfer from serum 
(Murphy et at., 1964; Pierce and Feinstein, 1965). Further demonstration of the transfer 
of cells between the mammary gland and peripheral blood was reported when cattle 
inoculated via the intramammary route with bovine rotavirus showed detectable levels of 
neutralising antibodies and antigen specific lymphocytes in the peripheral blood 
(Castrucci et at., 1984; Archambault et at., 1988). Migration of antigen-specific 
lymphocytes from peripheral blood to the mammary gland has also been reported in rats 
(Seelig, 1980). In non-ruminant species a functional link between mammary and gut 
associated lymphoid tissue has been described (Evans, 1980; Kortbeek-lacobs and Van 
der Donk, 1981). In cattle species mammary gland lymph node lymphocytes were shown 
to localise to the mammary gland lymph node, the node of origin, and to the prescapular 
node, the peripheral node. However, only a very small proportion of mammary gland 
lymph node lymphocytes that were radiolabelled were detected in the intestinal 
mesenteric node (Harp et at., 1988). The localisation of mammary gland lymph node 
lymphocytes to the node of origin and the prescapular node but not to the intestinal 
mesenteric node has also been reported in sheep (Harp and Moon, 1987). These results 
indicate that the entero-mammary link described in non-ruminants is not as functional in 
ruminants (Chang et at., 1981; Moon and McDonald, 1983). 
The isolation of PBM by density centrifugation was used again in the current study to 
identify cells expressing CD4, CD8, the 'Y'O T cell marker, the B cell marker, the monocyte 
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marker and the MHC class II marker in Holstein-Friesian bulls. The results from the 
phenotyping studies showed the mean percentage (+/-SD) of peripheral blood cells 
expressing CD4 was 17+/-3%, CDS was 7+/-3%, the y8 T cell marker was 1+/-0.5%, the 
B cell marker was 10+/-3%, the monocyte marker was 0.5+/-0.5%, and the MHC class II 
was 32+/-12% of the PBM population of bulls. Results from the current study showed 
that the percentage of peripheral blood cells expressing the various cell surface markers 
was not significantly lower in the PBM population of bulls than those previously reported 
in cows, with the exception of expression of the monocyte marker. However, the 
difference in the proportion of cells expressing CD4 and the y8 marker approached 
significance. Unfortunately there have been very few published studies on the expression 
of cell surface markers of PBM of Holstein-Friesian bulls with which to compare the 
results obtained in the present study. A study by Nonnecke et al. (1997) was carried out 
on PBM of young Holstein bulls that had reached sexual maturity. The MAbs used in 
this study to identify PBM for various cell surface markers were different from those used 
in the current study. In the study by Nonnecke et al. (1997) the mean percentage (+/-SD) 
of PBM expressing the B cell marker was 22+/-3%; expressing the MHC class II marker 
was 4S+/-3% and expressing the y8 T cell marker was 16+/-3%, which were all higher 
than those of the current study. A possible explanation for the difference in the level of 
y8 T cells may be due to the age of the bulls studied. The age of the bulls is of relevance 
as y8 T cells have been shown to diminish in number in the peripheral blood of cattle as 
they mature (Wyatt et al., 1994; Davis et al., 1996; Soder and Holden, 1999). The bulls 
sampled during the current study were mature bulls all over the age of four years. The 
bulls sampled by Nonnecke et al. (1997) were described as sexually mature. Bulls are 
reported to be physiologically mature in terms of reproduction as early as nine months of 
age. The MAb used in the current study to stain PBM expressing the y8 T cell marker in 
cattle has been used previously by others, although not in bulls (Clevers et al., 1990; 
Morrison and Davis 1991; MacHugh et al., 1997). No comparison of the percentage of 
PBM expressing the monocyte marker can be made, as expression of this cell surface 
marker was not examined by Nonnecke et al. (1997). The results of the percentage of 
PBM expressing CD4 and CDS were not published by Nonnecke et al. (1997). The 
expression of CD3, a cell surface marker present on all T cells, was shown to be 4S+/-5% 
of PBM. The CD3 molecule is required for T cell development as well as the assembly 
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and efficient expression of the TCR (Exley et al., 1991; Tanaka et al., 1995). Cells 
expressing CD3 would include CD4+ T cells and CD8+ T cells. The combined percentage 
of CD4+ and CD8+ T cells in the current study accounted for 24+/-6% of PBM, which is 
below that reported previously by Nonnecke et al. (1997). As no MAb was used to detect 
the expression of the cell surface marker CD3 in the current study, differences between 
CD3 and CD4/CD8 expression on PBM cannot be compared. CD4+ and CD8+ T cells 
both express an a~ TCR, while CD3 expression has been associated with both a~ and y8 
TCR (Bank et al., 1986; Van Neerven et al., 1990). 
On comparison of the percentage of cell subpopulations present in PBM of cows and 
bulls, the mean percentage (+/-SD) of PBM expressing CD4 was noted to be lower in 
bulls (17+/-3%) than in cows (26+/-8%), as mentioned previously this result was not 
statistically significant. A reduction in the mean percentage (+/-SD) of PBM expressing 
CD8 was also noted in bulls (7+/-3%) compared to cows (16+/-10%). Furthermore, a 
significant reduction in the mean percentage (+/-SD) of PBM expressing the monocyte 
marker was noted in the current study in bulls (0.5+/-0.5%) compared to cows (38+/-
17%). Differences in MAb used to identify cell surface markers are apparent among the 
previously published studies. The MAb IL-A24, used in the present study, has been 
shown to stain 94% of cells identified by morphology as peripheral blood monocytes 
(Ellis et al., 1987). For consistency, all the MAb used to study the different cell 
subpopulations of PBM of cows were the same as those used to study the different cell 
subpopulations of PBM of bulls. The differences in the percentage of cell expressing the 
various cell surface markers reported by the current study may represent differences in 
biological factors including, age, sex or genetics rather than the methodology used to 
isolate and stain the cells. One possible explanation for the lower proportion of cells 
expressing the various cell surface markers in bulls compared to cows is the presence of 
null cells, which lack cell surface markers to identify cell subpopulations by flow 
cytometry. These null cells may form a greater proportion of PBM in bulls than in cows. 
To try and explain the differences in the percentage of stained cells reported in the current 
study for PBM of bulls, media of different densities were used to isolate PBM, to 
investigate if cells were being lost during density centrifugation. Other studies have 
reported using ficoll-isopaque of density 1.083g1l (Naessens et al., 1990; Asai et al., 
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1995). The use of whole blood (Naverro et ai., 1996), or whole blood with erythrocyte 
lysis (Davis et al., 1996; Sopp and Howard, 1996) or centrifuged whole blood with the 
layer of mononuclear cells removed without the use of a density medium (Kimura et al., 
1999) have all been reported in flow cytometry studies. 
Results from this study indicated that the mean percentage (+I-SD) of all cell 
subpopulations studied were lower in the PBM isolated by the media of greater density 
when compared to the density media routinely used, indicating that mononuclear cells 
were not being lost into the pellet on centrifugation. 
To investigate the possible benefits of the whole blood isolation technique, as described 
by others (Naverro et al., 1996; Davis et al., 1996; Sopp and Howard, 1996), a 
comparison was made between the percentage of stained cells isolated from bulls by 
centrifugation with media density 1.077g/l, as used routinely, and the percentage of 
stained cells isolated from whole blood treated to remove the erythrocyte population. The 
results of the current study showed that cells isolated by density centrifugation had a 
higher percentage of cells expressing CD4, CDS, the B cell marker and the MHC class IT 
marker when compared to those isolated using the whole blood with erythrocyte lysis 
technique. The population of cells isolated from whole blood following erythrocyte lysis 
still contains neutrophils, which would proportionally reduce the percentage of cells 
expressing the various cell surface markers when compared to PBM. Interestingly the 
percentage of cells expressing the yo T cell marker was unaffected by the centrifugation 
media used. A possible explanation for this may be that some cells expressing yo are lost 
due to density centrifugation with media 1.077 gil and, therefore, can only be identified 
when whole blood analysis is carried out. 
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4.3 Restriction Fragment Length Polymorphism enzymatic digestion of MHC class 
II DOB and DRB exon 2 Polymerase Chain Reaction products 
Development of an immune response induced by pathogens is a complex mechanism. 
One essential step in this pathway involves recognition of processed peptides by T cells. 
Recognition of antigenic peptides expressed on the surface of APC by T cells must be in 
association with an appropriate MHC molecule (Klein, 1986). 
The MHC of vertebrates comprises class I and class II genes, which encode cell surface 
proteins with a central function in the immune system (Klein, 1975; Zinkemagal and 
Doherty, 1979; Nagy et al., 1981). Experiments performed in mice, which were designed 
to study antibody production induced by natural immunogens, demonstrated that after 
several generations, mice could be segregated based on high or low antibody production 
(Biozzi et ai., 1979). The trait of antibody production was shown to be under polygenic 
control, and that the genetic control exhibited in differing levels of antibody production 
was shown not to be restricted to the original immunogens tested. The difference 
between high and low antibody production in these selectively bred mice was shown to 
involve MHC linked genes (Stiffel et al., 1977; Vidard et al., 1990). 
Definition of the MHC class II region is important for studying T cell responses induced 
by antigen. In vaccine development, knowledge of the candidate species MHC genes is 
needed for successful vaccine development (Glass et al., 1991; van Lierop et al., 1995). 
The recognition of foreign antigen or a subunit of a vaccine in association with self MHC 
class II molecules on the surface of APC is a known requirement for T helper cell 
activation (Schwartz et al., 1986). The effect of MHC class II polymorphisms can be 
used to study the T-cell response to peptides after vaccination in an outbred population 
(van Lierop et al., 1995). Definition of the MHC class II region has also been reported as 
important in the progression of MHC disease association studies, where resistance and 
susceptibility to persistent lymphocytosis has been reported previously to be associated 
with BoLA MHC class II genes (Xu et al., 1993). In particular the association with DRB-
linked resistance has been shown to be dominant, whereas susceptibility is inherited as a 
complex recessive trait (Wu et ai., 1989). The ability of an MHC class II molecule to 
bind peptide and subsequently form a complex with an appropriate T cell is determined 
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by the structural variation of the MHC molecule (Buus et ai., 1987). These structural 
variations, termed polymorphisms, are characterised by a large number of alleles at each 
locus and a large number of amino acid substitutions between alleles (Ellegren et ai., 
1993). The antigen-binding site is encoded within ex on 2 of the respective MHC class IT 
a. and ~ genes (Brown et ai., 1993). Polymorphisms in ex on 2 have been reported to 
affect the range of antigenic peptides that can be bound and presented, making exon 2 
particularly appropriate to study the presence and function of immune response genes. 
Major Histocompatibility Complex mediated susceptibility to infectious disease has been 
associated with a low responder status to immunodominant pathogen derived peptides 
(Braciale et ai., 1989). The low responder status may correlate to holes in the T cell 
repertoire created during T cell education within the thymus (Lewin et ai., 1999). Major 
Histocompatibility Complex associations in outbred species, while although well 
documented, few are understood clearly at the physiological level (Lewin et ai., 1999). 
Inter-haplotype interactions may contribute to sources of functional polymorphism in 
MHC molecules, especially in the DQ isotype. The a. and ~ regions of the DQ isotype are 
extremely polymorphic. This may complicate the analysis of MHC function or disease 
association and explain the complex patterns of reactivity observed for some T cell clones 
(Glass and Millar, 1994). The genomic arrangement of the MHC class IT a. and ~ chains 
encoding genes consists of five and six exons respectively. Exon 2 of DRB3 and DQB 
represents the extracellular domain of the MHC class IT genes (Lewin et ai., 1999). The 
a.l and ~ 1 domains comprise the antigen-binding site and are encoded within the 
extracellular region. In contrast to MHC class I antigen binding sites, the MHC class IT 
sites have conserved residues distributed throughout the antigen binding site (Rudensky et 
ai., 1991; Hunt et ai., 1992). Amino acid substitution, which results in sequence 
variability, occurs almost exclusively within ex on 2 of the MHC class IT genes (Rask et 
ai., 1991). Amino acids possess an electrical charge, which is either positive or negative; 
thus, an amino acid substitution may alter the polarity of the antigen-binding site. 
Alteration in polarity may result in peptides with like charges to the antigen-binding site 
being repelled. Changes in amino acid sequence in the region of the antigen-binding site 
have been linked to resistance and susceptibility towards Bovine Leukaemia Virus (BL V), 
(Stern et ai., 1994). 
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At present, a bull's potential as a sire is measured by his daughters' phenotype. This 
method of progeny testing which is routinely carried out by breeding companies is both 
time consuming and expensive, as well as potentially producing many daughters that may 
express undesirable traits including susceptibility to disease. In comparison to progeny 
testing, MHC alleles expressed in cattle can be measured accurately and relatively 
cheaply by a variety of established laboratory techniques early in life (Bemoco et al., 
1991; Davies et aI., 1993). A genetic marker, which may predict animals that are 
resistant/susceptible to disease, would be of benefit in the control of IMI in dairy cattle 
(Aarestrup et al., 1995). As the husbandry and management control measures currently 
available on farms are insufficient to reduce adequately the incidence of IMI, the effects 
of selection of superior sires has been suggested as a desirable control method (Nonnecke 
and Harp, 1989; Schukken et al., 1994). To date, genetic selection for improved 
resistance to disease has concentrated on those diseases for which vaccine development 
has been unsuccessful or where the development of a vaccine is not economically viable, 
rather than in the direction of improved udder health (Lewin, 1996). Further development 
of the current study involved investigation of the locus encoding the MHC class II DRB 
and DQB genes. 
Typing of BoLA class II has been successfully performed using various techniques 
(Bemoco et al., 1991) including mixed lymphocyte cultures (Davis and Splitter, 1991), 
serology (Emery et al., 1987), immunoprecipitation with isoelectric focusing (Watkins et 
al., 1989; Glass et al., 1992), DNA probes (MuggliCockett and Stone, 1988), PCR-RFLP 
(Van Eijk et al., 1992) and ultimately DNA sequencing (MuggliCockett and Stone, 1989; 
Sigurdardottir, 1991). DNA sequencing is the gold standard in defining genomic alleles 
(Aldridge et aI., 1998), however the technique is laborious and not practical for studying 
whole populations (Groenen et al., 1989; Sigurdardottir, 1991). Even with the 
development of new techniques for the typing of BoLA-DRB3 ex on 2, the technique of 
PCR-RFLP is still used routinely (Dietz et al., 1997a; Sharif et al., 1998a; Gilliespie et 
al., 1999; Aravindakshan et al., 2000). Polymerase Chain Reaction-RFLP is a powerful 
and sensitive technique, permitting a high level of allele identification with the additional 
benefits of being non-radioactive and having high throughput efficiency (Van Eijk et al., 
1992). 
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In the current study, PCR amplification of BoLA DQB ex on 2, and blunt end cloning of 
three bulls with low PTA for SCC and one bull with a high PTA for SCC, generated a 
total of four allelic sequences, three of which had been reported previously (Nasir et al., 
1997), and one novel allelic sequence. Blunt end cloning of DQB ex on 2 demonstrated 
frequent isolation of allele DQB2*1-3. The frequent isolation of this allele may have 
been due to a low degree of polymorphism within one locus of the BoLA DQB region 
(Nasir et al., 1997), as DQB polymorphisms have been reported to be restricted to the 
second DQB locus in humans (Berdoz et ai., 1989). Polymerase Chain Reaction-RFLP 
was used subsequently as a rapid typing method to improve detection of DQB alleles. 
The results of the current study demonstrated that following enzymatic digestion of DQB 
exon 2 by PCR-RFLP, the patterns although relatively clean, were generally too complex 
to be resolved unambiguously as previously recognised allelic patterns. The lack of 
definition of polymorphisms at the DQB loci has been reported previously (Davies et al., 
1994). The number of bands generated by enzymatic degradation of DQB ex on 2 
suggested the presence of multiple alleles in most animals studied, characteristic of gene 
duplication (Russell, 2000, personal communication). The suggestion of gene duplication 
in the current study was supported by further cloning and sequencing, which showed the 
presence of three distinct alleles in one individual bull. Gene duplication has been 
reported previously to effect approximately half of the common class II haplotypes in 
European cattle (Andersson and Rask, 1988; Sigurdardottir et al., 1992). It is believed 
that the DQB 1 gene is present in all haplotypes, whereas DQB2, DQB3 and DQB4 are 
present only in duplicated haplotypes (Sigurdardottir et ai., 1992). The DQB3 and DQB4 
genes are the most divergent, with DQB3 exhibiting multiple substitutions at the 
conserved positions in the ~-chain genes (Lewin et al., 1999). It has been reported 
previously that a high level of linkage disequilibrium exists between DQ and DR 
polymorphisms, which is a non-random association often linked with selection 
(Sigurdardottir et ai., 1991). 
Development of the current study resulted in the DRB locus ex on 2 being investigated. 
Of the three DRB genes only DRB3 is expressed at high levels on cells in peripheral 
blood (Burke et ai., 1991). The DRB3 locus in cattle, unlike humans, is well-conserved 
(Sigurdardottir et ai., 1991). The level of conservation exhibited makes the DRB3 locus 
in cattle possibly the most important in terms of function (Ellegren et ai., 1993). The 
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rationale behind the investigation of DRB3 alleles in the current study was that this locus 
may potentially affect many traits that are linked to immunity, including SCC and mastitis 
incidence (Dietz et al., 1997b). The alleles present in DRB3 exon 2, which contains the 
antigen binding site, may therefore be of importance when selecting for improved udder 
health (Starkenburg et al., 1997). 
A recent study reported a total of 63 alleles identified by PCR-RFLP in the DRB3 locus 
(Davies et al., 1997). Results from the current study based on PCR-RFLP of DRB3 exon 
2 of ten Holstein-Friesian dairy bulls identified 12 DRB3.2*types, namely DRB3.2*16, 
23, 24, 8, 22, 3, 11, 27, 10, 32, 13 and 51. The results of the current study showed that 
DRB3.2*16 was present in five of the ten bulls, DRB3.2*23 was present in four of the ten 
bulls, DRB3.2*24 was present in three of the ten bulls, DRB3.2*8 was present in two of 
the ten bulls, DRB3.2*22 was present in two of the ten bulls, and DRB3.2*3, 11, 27, 10, 
32, 13, and 51 were each only present in one of the ten bulls. On further consideration of 
the four DRB3.2*types that were present in more than one of the bulls, DRB3.2*16 was 
present in four of the five bulls with the lowest PTA for SCC and one of the five bulls 
with the highest PTA for SCC. DRB3.2*23 was present in one of the five bulls with the 
lowest PTA for SCC and was present in three of the five bulls with the highest PTA for 
SCC. DRB3.2*24 was present in two the five bulls with the lowest PTA for SCC and 
was present in one of the five bulls with the highest PTA for SCC. DRB3.2*8 was 
present in one of the five bulls with the lowest PTA for SCC and was present in one of 
the five bulls with the highest PTA for SCC. DRB3.2*22 was present in two of the five 
bulls with the highest PTA for SCC only. These five alleles were, therefore, the most 
frequent alleles recognised in the current study (Table 11). 
The frequency of DRB3.2*16 has been reported in 835 Holstein cows as 0.09, 
DRB3.2*23 as 0.06, DRB3.2*24 as 0.19, DRB3.2*8 as 0.20 and DRB3.2*22 as 0.13 
(Sharif et al., 1998b). Others have reported the frequencies of DRB3.2*16 as 0.10, 
DRB3.2*23 as 0.09, DRB3.2*24 as 0.14, DRB3.2*8 as 0.14 and DRB3.2*22 as 0.14 
(Dietz et al., 1997a), or DRB3.2*16 as 0.06, DRB3.2*23 as 0.08, DRB3.2*24 as 0.08, 
DRB3.2*8 as 0.21 and DRB3.2*22 as 0.08 ofDRB alleles identified (KeIrn et al., 1997). 
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A study of Holstein-Friesian cows in at least their second lactation, reported that 
DRB3.2*16 was associated with a significant reduction in ses (Sharif et al., 1998b). 
The data analysed in this study was collected from cows in herds across Ontario, where 
cases of mastitis were graded as either mild or severe. Mild cases were characterised by 
abnormal milk with no clinical signs. Severe cases were characterised by abnormal milk 
and systemic illness such as fever or anorexia. Bacteriological analysis of the isolates 
from mild and severe cases showed that the two groups presented different pathogen 
profiles. The causative agents of mild cases were identified as coagulase negative 
Staphylococcus species (24.1%), Streptococcus species (16.8%), S. aureus (9.5%) and 
coliforms (9.5%). In the severe cases the causative agents were identified as 
predominately coli forms (25.8%), S. aureus (17.2%) and coagulase negative 
Staphylococcus species (Scottet al., 1996). Identification of the bacterial isolates from 
cases of mastitis is important as the influence of the BoLA alleles on the immune 
response may differ significantly among pathogens (Dietz et al., 1997a). For example 
when analysing the affect of BoLA alleles on see, the differences between pathogens 
such as S. aureus, that results in chronically elevated see, and E. coli that results in 
transiently elevated see (Dietz et al., 1997a) are important factors which must be 
considered. The results of the previously published study indicated that BoLA alleles had 
no statistically significant association with the incidence of mild cases of mastitis, 
however, a certain DRB3 allele (DRB3.2*23) was shown to significantly increase the 
incidence of severe cases of mastitis, as defined previously (Sharif et ai., 1998b). 
There have been conflicting reports as to the effect of DRB3.2*16 on see used as an 
indicator of udder health. Dietz et al (1997a) reported that DRB3.2*16 was associated 
with an increase in the risk of elevated see in the second lactation, in addition to an 
increase in the susceptibility to intramammary infection by major pathogens in those 
animals suffering from acutely elevated sec. The results of this study classified see as 
chronically elevated when see for three consecutive months was >300,000 cells/mI or if 
see for two consecutive months was >500,000 cells/mi. Staphylococcus aureus and S. 
agalactiae were named as causative agents for chronically elevated see, and E. coli as 
the causative agent of acutely elevated Sec. Dietz et al. (1997a) did, however, state that 
pathogens that induce a chronic elevation of see in some cows may result in acute 
elevation of see in others. eases and controls in this study by Dietz et al. (1997a) were 
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matched to eliminate the effects of breed, herd, lactation number and days in lactation, all 
factors that affect Sec. In a study designed to measure the genetic association between 
measures of mastitis prevalence and genotypes for the MHe class II DRB3 locus, 
DRB3.2*16 was reported to increase the Estimated Breeding Value (EBV) associated 
with mastitis in cows in the first lactation (KeIrn et al., 1997). The increase in the EBV 
associated with DRB3.2*16 was undesirable as it resulted in an increase in the incidence 
of mastitis. An association between DRB3.2*16 and reduced numbers of circulating 
mononuclear cells has been reported previously (Dietz et al., 1997b). Interestingly during 
the same study, DRB3.2*16 was reported to be associated with an increase in the levels 
of IgM and serum complement (Dietz et al., 1997b). Interpretation of the results from 
this study suggests that expression of allele DRB3.2*16 lowers the number of 
mononuclear cells, which may be important for the development an effective immune 
response. 
Thus, the findings of KeIrn et al. (1997) and Dietz et al. (1997a) suggested that 
DRB3.2*16 was associated with an increase in ses and see respectively, in 
contradiction to those of the current study, where it was found that four of the five bulls 
with low PTA for see generated a RFLP pattern associated with DRB3.2*16. However 
the findings of Starkenburg et al. (1998), and Sharif et al. (1998a, 1998b) support the 
results of the current study. 
DRB3.2*23, present in one of the five bulls with low PTA for see and three of the five 
bulls with high PTA for see, was the second most frequent allele identified in the ten 
bulls investigated in the current study. DRB3.2*23 has been reported previously to be 
expressed at a relatively high frequency in Holstein cattle (Dietz et al., 1997a). These 
researchers also reported within this study an association between DRB3.2*23 and an 
increase in see in cows in their second or greater lactation, this supports the results of 
the current study where three of the five bulls with the highest PTA for see expressed 
DRB3.2*23. Another published study in Holstein cows supported the results of Dietz et 
al. (1997b) in that DRB3.2*23 was associated with an increase in ses and with an 
increase in the number of cases of mastitis (Sharif et al., 1998b). Again, the results of 
this published study support those reported in the current study. The increase in the 
number of cases of mastitis was based on pooled samples that were not differentiated by 
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severity. With respect to DRB3.2*23, Dietz et al. (1997b) and Sharif et al. (1998b) agree 
that when DRB3.2*23 was detected, those cows had higher see during the second 
lactation. A possible association between DRB3.2*23 and an increase in placenta 
retention post calving has also been reported (Dietz et al., 1997a), supporting the 
hypothesis that MHe alleles may be important in a number of diseases or disorders in 
cattle. 
DRB3.2*24, present in two of the five bulls with the low PTA for see and one of the 
five bulls with the high PTA for see, was reported previously to be associated with 
susceptibility to clinical mastitis (Lunden et ai., 1990). It has been published previously 
that DRB3.2*24 was associated with a reduction in the EBV for ses. It was also noted 
within the same study that DRB3.2*24 was associated with a significant increase in the 
EBV for IMI caused by major mastitis pathogens. It was suggested that DRB3.2*24 may 
result in susceptibility of the mammary gland to initial establishment of an IMI but 
conversely may result in resistance to the bacteria and its virulence factors once 
established within the mammary gland (Keirn et al., 1997). As well as the effect on see 
and the incidence of clinical mastitis, DRB3.2*24 has also been reported to increase fat 
yield in cows during the first lactation (Starkenburg et al., 1997). The effect on fat yield 
was not reproduced in any of the other yield traits examined, nor was any adverse effect 
on a yield trait reported. The association between DRB3.2*24 and clinical mastitis 
reported by KeIrn et ai. (1997) was not supported by other published studies (Starkenburg 
et al., 1997; Sharif et al., 1998b). 
DRB3.2*8 was present in one bull with a low PTA for see and one bull with a high PTA 
for see. Within the Holstein cattle population DRB3.2*8 has been reported previously 
as the most frequently isolated allele (Sharif et al., 1998b). DRB3.2*8 has been reported 
to be associated with an increase in see in first lactation Holstein cows (Dietz et al., 
1997a). DRB3.2*8 has also been associated with susceptibility to mastitis in Holsteins as 
a result of infection with the contagious pathogen S. aureus (Berryere et al., 1994). KeIrn 
et al. (1997) reported an association between DRB3.2*8 and an increase in the number or 
cases of clinical mastitis, a reduction in milk production and a reduction in protein yield. 
The results of KeIrn et al. (1997) identifying traits associated with DRB3.2*8 were also 
supported by Starkenburg et al. (1997). DRB3.2*8 has been positively correlated with 
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serum IgM and in vitro IgM production, as well as serum complement (Dietz et al., 
1997b). DRB3.2*8 has also been reported to be negatively associated with circulating 
levels of mononuclear cells and antibody dependant neutrophil cytotoxicity but positively 
associated with blastogenesis induced by eoncavalin A in vitro (Dietz et aI., 1997b). The 
positive association with blastogenesis was not reported with any of the other alleles 
examined in this study. As DRB3.2*8 was present in only one bull from each of the 
groups based on PTA for see in the current study further conclusions on its potential 
role in intramammary immunity can not be made. No alleles studied by KeIrn et al. 
(1997) demonstrated a consistent directional effect on all measures of mastitis. The lack 
of consistency is indicative of the complexity of both the immune system and 
intramammary infections. 
DRB3.2*22, present in one of the five bulls with the low PTA for see and one of the 
five bulls with the high PTA for see has been suggested previously to reduce the risk of 
elevated see during the second lactation (Dietz ei al., 1997a). As with other alleles 
mentioned conflicting results have been reported. DRB3.2*22 has also been associated 
with an increase in the number of cases of cows suffering from chronically elevated ses 
during the first lactation (Starkenburg et al., 1997). As DRB3.2*22 was present in only 
one bull from each of the groups based on PTA for see in the current study further 
conclusions on its potential role in intramammary immunity cannot be made. 
Reasons for the reported differences in published studies have been linked to differences 
in experimental design i.e. selective breeding of cows to known sires compared to a 
natural selection based within commercial dairy herds (Sharif et al., 1998b). Differences 
in the pathogens isolated from the cows sampled during the individual studies and the 
linkage of DRB3.2 to other BoLA loci may contribute to the differences between the 
published studies. The DQ and DR regions appear to be in strong linkage disequilibrium, 
with greater than 30 DQ-DR haplotypes identified (Sigurdardottir et al., 1988). 
Genotyping of the BoLA DRB3 locus represents the influence of other closely linked loci. 
An association between component four of complement and BoLA has been suggested 
(Skow et al., 1988). A polymorphism in component four may result in linkage 
disequilibrium with the DRB3 allelic state, which may alter serum complement levels. In 
mice, the genes controlling TNF-a and heat shock protein residing within other loci have 
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been linked to the MHC class II DRB locus (Grosz et ai., 1992). Further studies with 
large populations of cattle are required to determine the links between BoLA and the 
traits of innate and adaptive immunity (Dietz et ai., 1997b). The strong effects of the 
environment may influence the moderate to low heritability of the traits studied whereby 
temporal effects such as changes in the environment and pathogens within the mammary 
gland may have a substantial contribution to variation measured (Starkenburg et ai., 
1997). Another possibility for the reported differences between published studies may be 
due to incomplete lactation records, which were used to calculate the EBV (KeIrn et ai., 
1997). One possibility for incomplete lactation records would be that cows had been 
selectively culled from the herd. Although selective culling of persistently infected or 
sick cows is regular practice within a commercial herd, it may bias the results presented 
in the current study. Selective culling would normally result in elimination of those cows 
suffering from chronic IMI usually as a result of contagious pathogens such as S. aureus 
and would thus means that PTA for SCC would be underestimated by the methods 
currently for calculation. 
The complex aetiology of a multi-factorial disease such as mastitis may explain the 
reported inconsistency between published studies and the effects of certain BoLA alleles. 
Variation in the causative agent, genetic background and the criteria used for defining 
mastitis have been suggested as other possible reasons for inconsistencies in published 
studies (Sharif et ai., 1998b). Linkage between regions of the MHC may also be a 
possible explanation for inconsistencies in published studies, where the affect of alleles in 
a different region of the MHC will contribute to the effect of the allele being examined. 
Alleles within the DR and DQ region of the MHC class II are known to be linked and this 
association has been reported between DRB3.2*24 and the DQIA haplotype in cattle 
(Davies et ai., 1994). 
Variation in allelic frequency has been shown to differ between breeds (Sharif et ai., 
1998a). For example, DRB3.2*8, 3, 11, 16,22 and 23 have been reported as representing 
89% of the DRB3 allelic frequency in Holsteins (Dietz et ai., 1997a; Sharif et ai., 1998b). 
However in Jerseys, with the exception of DRB3.2*23, DRB3.2*3, 8, 11, 16 and 22 have 
not been identified (Sharif et ai., 1998b; Gillespie et ai., 1999). The difference in 
expression of DRB3.2*16 in Holstein-Friesian bulls with a strong proliferative response, 
214 
and the absence of DRB3.2*16 in bulls with a weak proliferative response induced by S. 
aureus strain A in the current study was shown to be statistically significant (p=O.00025.). 
The association with allele DRB3.2* 16 and the proliferative response induced by S. 
aureus strain A cannot be classified as random, as a result of the paternal and maternal 
grandsire data reported in Table 12. From this information it can be seen that there is a 
crossover of gransires with a total of seven different grandsires reSUlting in the ten bulls 
chosen for this study based on their PTA for see. 
Genetic selection of dairy cows rests heavily on improvement of production traits, for 
example milk yield, which is positively correlated with mastitis (Emanuelson et at., 1988; 
Shook, 1989; Rogers et at., 1998). Investigation into the possible association between 
DRB3 alleles and production traits (Sharif et at., 1998b), suggested that in this particular 
study there was no association between DRB3.2*16 and production traits. The previously 
published studies where DRB3.2*16 has been reported to lower ses indicates that the 
lack of association between DRB3.2*16 and production traits is beneficial. The lack of 
association in these previously published studies between DRB3 alleles and production 
traits means that selecting animals for improved udder health through identification of 
MHe alleles should not compromise milk production. During the current study the PTA 
for the production traits, milk yield, fat and protein percentage for the ten extreme bulls 
were also available for 1997. The results of the current study showed no statistically 
significant association between PTA for see and the production traits, milk yield, fat and 
protein percentage. The results of the current study also indicated that there was no 
association found between the proliferative response induced by S. aureus strain A or the 
presence of DRB3.2*16 and the PTA for production traits. Interestingly bull D, recorded 
as having a low PTA for see but a weak proliferative response induced by S. aureus 
strain A had the daughters with the lowest PTA for milk yield, fat and protein percentage. 
Unlike PTA for see, low PTA for production traits is undesirable, indicating the 
daughters have lower milk yields, fat and protein percentages. By comparison, only bull 
J, recorded as having the highest PTA for see of the ten bulls and a weak proliferative 
response induced by S. aureus strain A had daughters with PTA for production traits as 
low as bull D. 
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One bull with a high PTA for SCC, bull J, generated three pairs of restriction digest DRB 
pattern combinations. It was considered that double restriction digestion of the product 
created by PCR might help to clarify the RFLP patterns of this bull. The initial digest 
was carried out with Bst YI, which can on some occasions leave the PCR product 
undigested. The undigested product was cut from the gel and digested further with Rsa I. 
This potentially reduced the possible pattern combinations by half, creating a unique Rsa I 
pattern (Russell, 2000, personal communication). Of the possible combinations generated 
by bull J, DRB3.2*8 and DRB3.2*22 are the most likely candidates for these two alleles 
are the most frequently identified in American and Canadian Holstein-Friesian 
populations (Sharif et at., 1998b; Dietz et at., 1997a). 
Improving disease resistance based on genetic selection does have potential pitfalls. The 
complex aetiology of diseases such as mastitis as well as the polygenic nature of the 
host's immune response, makes absolute resistance to all pathogens impossible to achieve 
(Lewin et at., 1999). The combination of MHC alleles of an individual on a chromosome 
results in a haplotype. Haplotypes are derived from both parents, one paternal and one 
maternal, the combination of these two haplotypes creates a heterozygous genotype. 
During selection of genetically controlled traits it is important to maintain heterozygosity 
to promote long-term herd health (Lewin et at., 1999). Breeding animals that are 
homozygous at the MHC loci would compromise the peptide binding repertoire of the 
immune system (Lewin, 1989). Genes out with the MHC region have also been reported 
to contribute to mastitis resistance and susceptibility (Teale, 1999), for example, genes 
controlling morphological features such as udder and teat conformation (Seykora and 
Daniels, 1991). What still remains unclear, however, is the precise nature of the 
important genes within, or linked, to the MHC region. This type of detailed research 
requires the entire haplotype associated with the resistance/susceptibility to be identified. 
A reduction in the ability of the host's immune system to recognise antigenic peptides 
may result in resistance to one particular disease but susceptibility to another 
(Starkenburg et at., 1997). While in some studies alleles DRB3.2*16 and 22 have been 
associated with undesirable udder health they have also been associated with a 
statistically significant reduction in the risk of cystic ovarian disease (Sharif et at., 
1998b). No other alleles identified in this previously published study were reported to 
have a significant effect on the occurrence of cystic ovarian disease. 
216 
The effect of MHC genes on disease resistance and susceptibility has not only been 
associated with infectious bacterial pathogens. The association of BL V with BoLA genes 
was initially detected by the use of serology (Lewin and Bemoco, 1986; Palmer et ai., 
1987). Persistent lymphocytosis (PL) as a result of BLV is characterised by a chronic 
increase in the absolute number of CD5+ B cells in peripheral blood (Mirsky et ai., 1996). 
Persistent lymphocytosis develops in 15-30% of cases of BLV over a period of 1-3 years. 
The development of PL has been reported to be controlled by BoLA in different herds and 
breeds throughout the world (Lewin and Bemoco, 1986; Palmer et ai., 1987; Bernoco and 
Lewin, 1989; Xu et ai., 1993). Alleles of the DRB3 are most closely associated with 
resistance and susceptibility to PL in BLV infected cattle, with the haplotype A14-
DRB3* 11 strongly associated with resistance (Xu et ai., 1993). The position of glutamic 
acid and arginine at position 70-71 is one common feature that all the resistant 
phenotypes share whereas those phenotypes associated with susceptibility share a valine-
aspartic acid-threonine-tyrosine repeat at position 75-78. These regions detailed above 
are part of the peptide-binding groove and crucial in the recognition of antigenic peptides 
by cells of the immune system (Stem et ai., 1994). As well as amino acid sequence the 
DRB3.2*16, 8, 22 and 24 have been reported previously to be associated with 
susceptibility to PL in BLV infected cattle (Lewin et ai., 1994). In contrast to those 
alleles listed above, DRB3.2*23 has been associated with resistance to PL as manifested 
by BLV (Xu et ai., 1993). The association of these alleles with BLV has been confirmed 
by others (Lewin et ai., 1988; Sulimova et ai., 1995; Zanotti et ai., 1996). 
During the current study the antigen presentation assay described previously by 
Fitzpatrick (1992) was further developed to measure the proliferative response of PBM 
isolated from Holstein-Friesian cattle to the contagious mastitis pathogen S. aureus. 
Staphyiococcus aureus is a predominant cause of subclinical mastitis in dairy herds 
(Wilson and Richards, 1980), and often results in chronic 1M1. Dairy cows suffering from 
chronic 1MI are usually removed from the herd, improving the herd's health status but 
reducing longevity and increasing the cost to the dairy farmer. 
Breeding of dairy cattle worldwide is based mainly on profitability. Since 1998 the 
Animal Data Centre has published Predicted Transmitting Abilities for SCC, which are 
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estimates of sires' potential to transmit a reduction or increase in see measured in their 
daughters. The PTA for see were chosen to investigate a possible association with the 
proliferative response induced by S. aureus, as see in milk are used as an indicator of 
infection that can often be attributed to S. aureus (Holdaway et al., 1996). Progeny 
testing carried out by commercial breeding companies to generate PTA for see and 
production traits is both labour and cost intensive, therefore, the rationale of the current 
study was to investigate a possible association between PTA for see and the 
proliferative response induced by S. aureus in vitro of PBM isolated from Holstein-
Friesian bulls. An association between PTA for see and the proliferative response of 
PBM induced by S. aureus would indicate the potential to use the in vitro immunological 
assay to select bulls for breeding whose progeny may be relatively resistant to S. aureus 
mastitis. This would reduce the time and cost involved in the selection of superior bulls. 
The hypothesis was tested first in cows sired by two different bulls. A statistically 
significant difference between two progeny groups was reported during the current study, 
indicated the potential sire's genes to contribute to immunological responses measured in 
his progeny. The significant result reported between the two progeny groups led to the 
ten bulls, held at Genus Ltd. breeding establishments, being selected for measurement of 
the proliferative response induced by S. aureus strain A. The bulls chosen represented the 
two extremes of the spectrum for PTA for see. 
The results of the proliferation assay in the ten bulls showed a statistically significant 
difference between the two groups of bulls (p=0.05). As discussed previously the results 
were bimodal and overlapping, in that one bull with a low PTA for see showed a weak 
proliferative response and one bull with a high PTA for see showed a strong 
proliferative response. The results showed a strong negative correlation (r=-0.7) between 
10gSI and PTA for see, indicating that as the PTA for see increased, the proliferative 
response induced by S. aureus strain A decreased. The study was extended to study bulls 
selected at random from the breeding population. The negative correlation, however, was 
not reported between the proliferative response of the randomly selected bulls and PTA 
for Sec. The difference in the correlation results between the two groups of bulls 
suggests that the in vitro immunological assay developed during the current study requires 
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further work to determine the assays potential for testing bulls reliably for their 
immunological response to S. aureus prior to the established progeny testing schemes. 
The BoLA DRB locus has been reported previously to affect many traits related to 
immunity including see and mastitis incidence (Dietz et ai., 1997b). Results from the 
current study identified 12 different DRB3.2* types that had been previously published 
(Davies et ai., 1997). Frequency of these DRB3.2* types varied between those bulls 
selected for low PTA for see and those selected for high PTA for Sec. Allele 
DRB3.2* 16 was identified in four of the bulls with low PTA for see and one of the bulls 
with high PTA for see in the current study. When the proliferative response induced by 
S. aureus strain A was measured, the five bulls with the strongest proliferation, i.e. the 
four bulls with the low PTA for see and one bull with high PTA for see, were all 
shown to express allele DRB3.2*16, suggesting a possible association between ability to 
respond to S. aureus antigen and expression of this allele. In contrast, none of the five 
bulls with the weakest proliferative response induced by S. aureus strain A expressed 
allele DRB3.2*16. The association of DRB3.2*16 and a strong proliferative response 
induced by S. aureus suggest that this allele may be used as a potential marker for 
improved induced immunological response to S. aureus. 
eomplex traits are associated with continuous underlying distribution of measurement 
and the genes responsible for the genetic variation are known as Quantitative trait loci 
(QTL) (Geldermann, 1975). Disease resistance is a complex trait, which is under the 
control of many genes each with different phenotypic contributions (Heyen et ai., 1999). 
At present the genetic linkage map of cattle is made up of more than 1500 genetic 
markers, known as microsatellites. These microsatellites have been used to identify 
possible QTL affecting milk production, health traits (Ashwell et ai., 1997; Zhang et ai., 
1998) and body conformation traits (Ashwell et ai., 1998). Further studies with larger 
populations of cattle are necessary to determine QTL that may be linked with disease 
resistance and enhance genetic improvement using marker-assisted selection in cattle 
worldwide. 
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Chapter V 
5.1 Future Work 
While the current project focused on measuring immune response to the important 
contagious mastitis pathogen, S. aureus, it is recognised that other mastitis pathogens are 
increasing in prevalence, especially E. coli and S. uberis. It is known that the 
pathogenesis and clinical signs associated with an IMI due to contagious and 
environmental pathogens are often very different. The clinical signs as a result of 
infection with a contagious pathogen are often mild and of long duration. In contrast, the 
signs often associated with an IMI caused by environmental pathogens tend to be more 
clinically obvious but transient in nature. Differences in cellular immune responses to 
various pathogens might be expected in a similar way to those shown in the current study 
using different strains of S. aureus. Investigation of the differences in proliferative 
response induced by different pathogens is important as it is possible that by selecting 
animals for resistance to a particular pathogen that this may result in susceptibility to 
another. 
T cell epitopes to foot and mouth disease virus (FMDV) have been identified previously 
by peptide scanning of cattle immunised with whole-virus vaccine (Collen et ai., 1991; 
van Lierop et ai., 1994). Further studies have shown that MHC class I and class IT 
haplotypes defined the selection of T cell epitopes (Glass et ai., 1991). Using similar 
approaches to those used for FMDV, the interactions among MHC, T cells and epitopes 
could be explored for mastitis. The current study used whole bacterial antigen to induce a 
proliferative response of PBM in vitro. Identification of T cell epitopes would refine the 
current in vitro proliferation assay and allow investigation of the important epitopes 
involved in induction of cellular proliferative response and possibly contributing to 
defence of the mammary gland against infection. 
Future development of the in vitro proliferation assay could involve measurement of 
cytokine production induced by antigenic stimuli as an alternative to, or in conjunction 
with, measurement of cell proliferation. The use of a well-established method such as 
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ELISA could be used to identify a range of cytokines. Possible candidates for 
investigation would include ll.,-2 and IFN-)" which are cytokines that are characteristic of 
a Th I-type response, and ll.,-4 and ll.,-10, which are cytokines that are characteristic of a 
Th2-type response. In addition to detection of secreted cytokines, identification of 
cytokine messenger RNA using reverse transcription-PCR could be undertaken. This 
requires extraction of total cellular RNA, which is then reverse transcribed. The cytokine 
specific cDNAs corresponding to each cytokine sequence created can then be amplified 
by PCR (Ito and Kodama, 1996). Cytokine detection could permit characterisation of the 
type of Th response, as well as reducing the time for in vitro culture, removing the 
requirement for use of radioisotopes and allowing quantification of the immune response. 
During the current study, phenotyping of PBM isolated from cows and bulls showed that· 
bulls had a significantly lower proportion of cells expressing the various cell surface 
markers than cows, and cattle, in previously published studies. In the case of )'0 T cells, 
their function of is still being investigated, however, they are thought to be of importance 
in the ruminant immune system (Rein and Mackay, 1991). Further investigation of the 
reported lower levels of all cell subpopulations in bulls is required. 
The proportion of cells expressing the surface markers associated with neutrophils and 
dendritic cells should be studied. Identification of the proportion of cells expressing 
neutrophil markers would allow the use of whole blood techniques thus eliminating the 
requirement for density centrifugation and the possible differential loss of cell types. 
Dendritic cells are known to be the most potent of the APC and are essential for the 
initiation of immune responses in naIve animals (Steinman, 1991; Banchereau and 
Steinman, 1998). Although dendritic cells usually form a very small proportion of cells 
within the immune system, their presence and function in the bovine immune system is 
essential in the modulation of an effective immune response. Future studies of antigen 
presentation in the local mammary gland environment would benefit from studies on the 
dendritic cell population. 
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Future studies should investigate the expression of CD45RO on the surface of cells 
isolated from peripheral blood and tissue and local mucosal sites in cattle. Expression of 
CD45RO is indicative of a memory phenotype and T cells deficient in surface expression 
of CD45RO have been reported previously to fail to proliferate in response to antigen or 
TCR stimuli (Pingel and Thomas, 1989; Weaver et ai., 1991). It is likely that previous 
exposure to various antigenic stimuli would result in expression of a memory phenotype 
on cells isolated from cattle. It would be of interest to investigate the naIve/memory 
phenotype of the cells involved in peripheral and mammary gland immunity as lack of 
expression of CD45RO on cells isolated from cattle after in vitro stimulation with antigen 
could indicate inadequate T cell development and function (Kong et ai., 1995). 
Clarification of the DRB3 types identified by PCR-RFLP is required to establish the 
expressed alleles in the individual bulls used during the current study. This would require 
improvement in cloning and sequencing techniques through the creation of new primer 
sets to eliminate the recurrent isolation of an individual sequence. Further work would be 
required to identify the ambiguous PCR-RFLP patterns generated by DQB exon 2. 
Improvements in the methods used routinely for rapid identification of BoLA genes are 
continuing. The use of single strand conformational polymorphisms (SSCP) or density 
gradient gel electrophoresis improves the reliability and discriminatory powers of PCR-
RFLP (Mikko and Andersson, 1995; Aldridge et ai., 1998). In a recent study with HLA 
class I alleles, reference strand conformation analysis (RSCA), an electrophoretic typing 
method, has been suggested to supersede current non-sequenced based analytical 
approaches (Arguello et ai., 1998). 
A comparison between the immune responses and phenotype of peripheral blood and 
milk cells could be part of a future study. While the proportion of cells present in 
peripheral blood and in the mammary gland of cows has been well documented (Concha 
et ai., 1977; Hageltorn and Saad, 1986; Park et ai., 1993), the use of the in vitro 
proliferation assay developed during the current study and ELlS As for the detection of 
cytokines could be employed to investigate the previously reported hyporesponsiveness to 
antigen by cells present in the mammary gland. It has been described previously that 
local immunity in the normal, healthy mammary glands is inactive or suppressed (Newby 
and Bourne, 1977). Investigation of the migration, location, presence and function of 
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various cell populations involved in local mucosal mammary gland immunity induced by 
S. aureus and other antigenic stimuli may elucidate possible mechanisms resulting in 
hyporesponsiveness within the mammary gland and provide methods whereby mammary 
gland immunity may be enhanced. 
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Appendix A 
Data from 104 bulls 
Columns are left to right are as follows: 
1. bull name 
2. stimulation index 1 
3. stimulation index 2 
4. stimulation index 3 
5. stimulation index 4 
6. counts per minute in the presence of S. aureus strain A 
7. counts per minute in the absence of S. aureus stain A 
8. PTA for SCC in 1998 
9. PTA for SCC in November 1999 
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data one; 
input @30 S11 @38 S12 @45 SI3 @53 SI4 @60 CPMT1 @69 CPMC1 @76 SCC1 @86 SCC2j 
simean mean(si1,si2,si3,si4); 
logsim log10(simean+1); 
cards; 
amsweer captain 33 0 7262 214 8 
amsweer skip leader 0 477 301 9.5 9 
beechpike genesis 12 738 57 
bromham norton 0 7 500 303 0.4 -2 
catlane corsair 0 0 206 247 -9 
cradenhill j marauder 0 66 89 
cradenhill prelude free 4 388 88 -1 7 
cradenhill superson 8 8 6267 775 
ernespie mascot 17 3021 177 7.1 5 
fielders exchequer 27 45 33 5 9016 335 -8 
frankenhof bodygaurd 5 3 1977 385 5 
frankenhof capsule 19 5681 291 6 
frankenhof dacey 16 6 6059 369 5 
N g.aeromon 0 71 61 -2.3 2 N 
VI g.ashton 5 1519 303 -1.7 
-3 
g.barometer 0 0 193 136 -2 -4 
g.bonanza 14 5209 373 -0.8 -9 
g.brandon 4 10 4 14 1776 367 
g.canby 0 0 154 221 4.8 14 
g.carolina 13 0 2273 171 3.9 4 
g. carter 17 10 5311 301 0 
g.derry 6 2 2535 384 10 13 
g.diamond 7 520 73 -6 
g.dieppe 0 75 63 7.8 26 
g.domaine 4 1875 405 7.3 -1 
g.dordogne 2 638 232 14 
g.emperor 39 0 19241 486 -7.5 -2 
g.flame 0 293 224 11.7 18 
g.fortune 3 1227 409 5 
g.frontier 14 4 6976 496 15 
g.garcon 0 5 318 248 9 
g.goodwin 0 2 215 307 
g.hollywood 0 243 206 -3 
g.kennedy 17 16 7850 441 -6 -8 
g.lakewood 3 21 4195 . 1399 10.2 3 
g.lincroft 3 
1382 428 -5 -12 
g.lomas 21 
1722 82 
g.longview 0 0 
153 176 0.9 -1 
g.melbourne 49 
3585 73 9 
g.pendleton 17 
9117 511 1.9 -2 
g.penland 5 0 
1192· 206 4.5 -4 
g.perkins 12 
647 52 4 
g.roscoe 9 10 
3656 378 7 
g.townley 0 4 
455 317 3 
g.trenton 6 
4749 696 0.3 -3 
holywell maine 25 0 
·19144 741 -0.2 
holywell milwaukee 0 6 
278 332 - 0.1 -1 
hunday lightning 3 0 0 
960 263 -0.1 -12 
kolhorner comet 2 2 
1185 441 9.7 10 
kolhorner crusader 0 
236 305 11 
kynarton fruiton 3 48 
734 192 27 
llandanglws mascot rebel 27 
14164 522 3.7 2 
tv 
tv 
m.alicia edderton 15 
7566 479 2.7 4 
a- m.alicia frontier 131 
9894 75 10.4 1 
m.cadet fortran 2 0 4 
386 159 6.6 5 
m.cadet foxton 12 0 
5373 424 18 
m.deb farnley 0 
248 191 1 .1 -9 
m.deb fountain 3 9 
1897 643 0.3 -3 
m.deirdre dependable 0 0 
92 226 -1.6 0 
m.diamond felton 3 29 
1221 349 9.4 16 
m.diamond finson 0 
273 206 8.9 -4 
m.dream gallery 0 14 
537 476 1 
m.elsa fountain 8 3 30 2 
2321 285 9 
m.elsas contest 0 0 
216 155 -0.7 8 
m.exalt 0 11 
813 430 9.3 8 
m.extol 2 
490 239 13.8 16 
m.federal 4 
2791 621 6 4 
m.flirt eastheath 12 
5587 456 22.6 23 
m.flirt francis 5 3 
1040 204 7.9 8 
m.flirt freeman 9 0 
1564 163 9.5 13 
m.flirt fusion 20 12 
4523 220 5 5 
m.flirt guesswork et 21 
2261 107 12 
m.genie finstock 0 
474 322 15.6 18 
m. genie fitment 0 
331 184 13 
m.genie florin 0 
159 192 11.9 
m.genies double 0 0 
210 164 3.7 7 
m.holly endive 0 
133 82 19.6 23 
m.jenny ensignet 2 295 119 
8 7 
m. joy easming 0 531 297 
-3.4 -9 
m.leilani fixation 0 0 0 
341 193 10 
m.lemon folio 7 0 
22929 3133 -4 
m .lill formula 7 13 15 5 
2883 388 6 
m.mandy favour 15 32 2 10 
8758 565 -6 
m.mandy fern 38 
20472 538 2 11 
m.mandy functional 4 9.77 
233 -0.7 5 
m.marissa glamour 5. 
357 71 
m.martha felton 0 0 0 
311 401 -3 
m.martha franchise 0 
281 185 5 
m.rozana firth 3 5 0 0 
1307 436 -6 
m.rozana fullerton 5 
374 67 8.4 2 
2 
m.secure gunner 8 
m.vale eastwell 7 
2432 245 7 8 
tv mars chieftain 2 0 
tv 
485 229 14 
-.l olympian muscat 8 0 
2557 304 6.4 8 
olympian musketeer 11 
5215 448 1 0 
skalsumer lucky boy 2 7 
697 325 17 
star ebony 2 
415 197 11.4 12 
tallent vivaldi 22 1990 
90 3.5 3 
vero elton boy 25 45 
11299 446 12 
weetondale hotshot 2 597 
247 8.4 21 
woeudhoeve criteriun 48 17346 
355 9 
woudhoeve commander 0 0 289 
264 3.3 7 
woudhoeve criteriun 5 906 
169 9 
zandenburg wayne 0 544 
386 -2 
proc print; 
run; 
proc corr; 
run; 
proc gplot; 
plot SCC2*logsim; 
run; 
AppendixB 
Data from 104 bulls 
Columns from left to right are as follows: 
1 bull code number 
2 stimulation index 1 
3 stimulation index 2 
4 stimulation index 3 
5 stimulation index 4 
6 counts per minute in the presence of S. aureus stain A 
7 counts per minute in the absence of S. aureus strain A 
8 PTA for SCC in 1998 
9 PTA for SCC in November 1999 
10 Mean of the stumulation indices 
11 Logged stimulation indices 
228 
OBS SI1 SI2 SI3 SI4 CPMT1 CPMC1 SCC1 SCC2 SIMEAN LOGSIM 
1 33 a 7262 214 8 16.5 1.24304 
2 0 477 301 9.5 9 0.0 0.00000 
3 12 738 57 12.0 1.11394 
4 a 7 500 303 0.4 -2 3.5 0.65321 
5 0 a 206 247 -9 0.0 0.00000 
6 0 66 89 0.0 0.00000 
7 4 388 88 -1.0 7 4.0 0.69897 
8 8 8 6267 775 8.0 0.95424 
9 17 3021 177 7.1 5 17.0 1.25527 
10 27 45 33 5 9016 335 -8 27.5 1.45484 
11 5 3 1977 385 5 4.0 0.69897 
12 19 5681 291 6 19.0 1.30103 
13 16 6 6059 369 5 11.0 1.07918 
tv 14 0 71 61 -2.3 2 0.0 0.00000 
tv 
\0 15 5 1519 303 -1.7 -3 5.0 0.77815 
16 0 0 193 136 -2.0 -4 0.0 0.00000 
17 14 5209 373 -0.8 -9 14.0 1.17609 
18 4 10 4 14 1776 367 1 8.0 0.95424 
19 0 a 154 221 4.8 14 0.0 0.00000 
20 13 0 2273 171 3.9 4 6.5 0.87506 
21 17 10 5311 301 0 13.5 1.16137 
22 6 2 2535 384 10.0 13 4.0 0.69897 
23 7 520 73 -6 7.0 0.90309 
24 a 75 63 7.8 26 0.0 0.00000 
25 4 1875 405 7.3 -1 4.0 0.69897 
26 2 638 232 14 2.0 0.47712 
27 39 0 19241 486 ·-7.5 -2 19.5 1.31175 
28 0 293 224 11 .7 18 0.0 0.00000 
29 3 1227 409 5 3.0 0.60206 
30 14 4 6976 496 15 9.0 1.00000 
31 0 5 318 248 9 2.5 0.54407 
32 0 2 215 307 1.0 0.30103 
33 a 243 206 . -3 0.0 0.00000 
34 17 16 7850 441 -6.0 -8 16.5 1.24304 
35 3 21 4195 1399 10.2 3 12.0 1.11394 
36 3 1382 428 -5.0 -12 3.0 0.60206 
OBS S11 S12 S13 S14 CPMT1 CPMC1 SCC1 SCC2 SIMEAN LOGS 1M 
37 21 1722 82 21.00 1.34242 
38 0 0 153 176 0.9 -1 0.00 0.00000 
39 49 3585 73 9 49.00 1.69897 
40 17 9117 511 . 1.9 -2 17.00 1.25527 
41 5 0 1192 206 . 4.5 -4 2.50 0.54407 
42 12 647 52 4 12.00 1.11394 
43 9 10 3656 378 7 9.50 1.02119 
44 0 4 455 317 3 2.00 0.47712 
45 6 4749 696 0.3 -3 6.00 0.84510 
46 25 0 19144 741 -0.2 12.50 1.13033 
47 0 6 278 332 - 0.1 -1 3.00 0.60206 
48 3 0 0 960 263 -0.1 -12 1.00 0.30103 
49 2 2 1185 441 9.7 10 2.00 0.47712 
50 0 236 305 11 0.00 0.00000 
tv 51 3 48 734 192 27 25.50 1.42325 \;.l 0 52 27 14164 522 3.7 2 27.00 1.44716 
53 15 7566 479 2.7 4 15.00 1.20412 
54 131 9894 75 10.4 131.00 2.12057 
55 2 0 4 386 159 6.6 5 2.00 0.47712 
56 12 0 5373 424 18 6.00 0.84510 
57 0 248 191 1 .1 -9 0.00 0.00000 
58 3 9 1897 643 0.3 -3 6.00 0.84510 
59 0 0 92 226 -1 .6 0 0.00 0.00000 
60 3 29 1221 349 9.4 16 16.00 1.23045 
61 0 273 206 8.9 
-4 0.00 0.00000 
62 0 14 537 476 1 7.00 0.90309 
63 8 3 30 2 2321 285 9 10.75 1.07004 
64 0 0 216 . 155 -0.7 8 0.00 0.00000 
65 0 11 813 430 9.3 8 5.50 0.81291 
66 2 490 239 13.8 16 2.00 0.47712 
67 4 2791 621 6.0 4 4.00 0.69897 
68 12 5587 456 22.6 23 12.00 1.11394 
69 5 3 1040 204 7.9 8 4.00 0.69897 
70 9 0 1564 163 9.5 13 4.50 0.74036 
71 20 12 4523 220 5~0 5 16.00 1.23045 
72 21 2261 107 12 21.00 1.34242 
OBS SIl SI2 SI3 SI4 CPMTl CPMCl SCCl SCC2 SIMEAN LOGSIM 
73 a 474 . 322 15.6 18 0.00 0.00000 
74 a 331 184 13 0.00 0.00000 
75 a 159 192 11.9 0.00 0.00000 
76 a a 210 164 3;7 7 0.00 0.00000 
77 a 133 82 19.6 23 0.00 0.00000 
7B 2 295 119 8.0 7 2.00 0.47712 
79 a 531 297 -3.4 -9 0.00 0.00000 
BO a a a 341 193 . 10 0.00 0.00000 
81 7 a 22929 3133 -4 3.50 0.65321 
82 7 13 15 5 2883 388 6 10.00 1.04139 
83 15 32 2 10 8758 565 -6 14.75 1.19728 
84 38 20472 538 2.0 11 38.00 1.59106 
85 4 977 233 -0.7 5 4.00 0.69897 
86 5 357 71 5.00 0.77815 
N 87 a a a 311 401 -3 0.00 0.00000 ..., 
88 .0 281 185 5 0.00 0.00000 
89 3 5 0 0 1307 436 -6 2.00 0.47712 
90 5 374 67 8.4 2 5.00 0.77815 
91 8 2 8.00 0.95424 
92 7 2432 245 7.0 8 7.00 0.90309 
93 2 0 485 229 14 1.00 0.30103 
94 8 a 2557 304 6.4 8 4.00 0.69897 
95 11 5215 448 1.0 a 11. 00 1.0791B 
96 2 7 697 325. 17 4.50 0.74036 
97 2 415 197 11.4 12 2.00 0.47712 
9B 22 1990 90 3.5 3 22.00 1.36173 
99 25 45 11299 446 12 35.00 1.55630 
100 2 597 247 8.4 21 2.00 0.47712 
101 48 17346 355 9 48.00 1.69020 
102 a a 289 264 3.3 7 0.00 0.00000 
103 5 906 169 9 5.00 0.77815 
104 a 544 386 
-2 0.00 0.00000 
Appendix C 
Data from 104 bulls 
Correlation analysis 
232 
Correlation Analysis 
10 'VAR' Variables: SI1 SI2 SI3 SI4 CPMT1 CPMC1 SCC1 SCC2 SIMEAN LOGSIM 
Simple Statistics 
Variable N Mean Std Dev Sum Minimum Maximum 
tv SI1 104 9,096154 15,985138 946.000000 0 131.000000 
w SI2 52 7.538462 11.986040 392.000000 0 48.000000 w 
SI3 10 8.800000 12.804513 88.000000 0 33.000000 
SI4 6 6.000000 5.176872 36.000000 0 14.000000 
CPMT1 103 3133.126214 4752.231160 322712 66.000000 22929 
CPMC1 103 330.436893 338.752749 34035 52.000000 3133.000000 
SCC1 59 4.818644 6.028938 284.300000 -7.500000 22.600000 
SCC2 98 4.979592 8.443847 488.000000 -12.000000 27.000000 
SIMEAN 104 9.033654 15.578803 939.500000 0 131.000000 
_OGSIM 104 0.702822 0.518455 73.093460 0 2.120574 
Correlation Analysis 
Pearson Correlation Coefficients / Prob > IAI under Ho: Aho=O Number of Observations 
S1l S12 S13 S14 CPMTl CPMCl SCCl SCC2 S1MEAN LOGS1M 
1.00000 0.26233 0.70879 0.03416 0.58080 -0.01360 -0.01702 -0.05338 0.96041 0.70265 
0.0 0.0603 0.0217 0.9488 0.0001 0.8915 0.8982 0.6016 0.0001 0.0001 
104 52 10 6 103 103 59 98 104 104 
0.26233 1.00000 0.51430 0.24864 0.16009 0.04035 0.23505 0.12224 0.81158 0.64967 
0.0603 0.0 0.1283 0.6347 0.2569 0.7764 0.2477 0.3928 0.0001 0.0001 
52 52 10 6 52 52 26 51 52 52 
0.70879 0.51430 1.00000 -0.33995 0.49593 -0~08598 1.00000 0.16187 0.77665 0.71793 
0.0217 0.1283 0.0 0.5097 0.1449 0.8133 0.6550 0.0082 0.0194 
N 10 10 10 6 10 10 2 10 10 10 VJ 
~ 
0.03416 0.24864 -0.33995 1.00000 0.21940 0.28538 -0.07629 0.13712 0.33300 
0.9488 0.6347 0.5097 0.0 0.6762 0.5836 0.8858 0.7956 0.5190 
6 6 6 6 6 6 0 6 6 6 
0.58080 0.16009 0.49593 0.21940 1.00000 0.57401 -0.23913 -0.12798 0.49718 0.59487 
0.0001 0.2569 0.1449 0.6762 0.0 0.0001 0.0681 0.2116 0.0001 0.0001 
103 52 10 6 103 103 59 97 103 103 
-0.01360 0.04035 -0.08598 0.28538 0.57401 1.00000 -0.07917 -0.19141 -0.02253 0.13694 
0.8915 0.7764 0.8133 0.5836 0.0001 0.0 0.5512 0.0604 0.8213 0.1678 
103 52 10 6 103 103 59 97 103 103 
-0.01702 0.23505 1.00000 -0.23913 -0.07917 1.00000 0.74675 0.04152 -0.07434 
0.8982 0.2477 0.0681 0;5512 0.0 0.0001 0.7549 0.5758 
59 26 2 0 59 59 59 58 59 59 
-0.05338 0.12224 0.16187 -0.07629 -0.12798 -0.19141 0.74675 1.00000 -0.00068 -0.01137 
0.6016 0.3928 0.6550 0.8858 0.2116 0.0604 0.0001 0.0 0.9947 0.9115 
98 51 10 6 97 97 58 98 98 98 
Correlation Anal~sis 
&ear'son Corr;E!lanon CoefficJ~'j)it$ I Prob > IRI under Ho: Rho=O Number of Observations 
SIl S12 S13 SI4 CPMT1 CPMCl SCC;li SC'C2 SIMEAN LOGS 1M 
0.96041 0.81158 0.77665 0.13712 0.49718 -0.02253 0.04152 -0.00068 1.00000 0.72813 
0.0001 0.0001 0.0082 0.7956 0.0001 0.8213 0.7549 0.9947 0.0 0.0001 
tv 104 52 10 6 103 103 59 98 104 104 
VJ 
Ul 
0.70265 0.64967 0.71793 0.33300 0.59487 0.13694 I;rOmOii~3:.41 n.'o:',CMr,;ifS7i 0.72813 1.00000 
0.0001 0.0001 0.0194 0.5.190 0.0001 0.1678 0.5758 u.9115 0.0001 0.0 
104 52 10 6 103 Hi3 59 98 104 104 
Appendix D 
Restriction Fragment Length Polymorphism Patterns of BoLA DRB3 created by 
enzymatic digestion with Rsa I. Patterns A to S, van Eijk et ai., 1992; patterns T and U, 
Gelhaus et ai., 1995; patterns V to Y, based on new allele sequences. 
78 33 30 39 54 SO 
a, ______________ , _________ I_ 
111 30 39 54 SO 
h ___________ " _____________ I __ 
111 30 93 so 
c _______________________ _ 
111 30 143 
d ________________________ _ 
141 39 51 SO 
e, _______________ ,, _____ I_V ____ I_ 
141 39 54 so 
f _______________ , _____ , ____ _ 
141 39 104 
g 
111 69 54 SO 
h, ___________ , _______ ,, _____ I_ 
236 
180 54 50 
i 1 
--------------------------------------------
78 63 93 50 
j------------------------------------------
78 156 50 
k. ______________ , _________________________ I __ 
234 50 
1, _________________________________________ 1 __ 
111 69 104 
m, ____________________ , _____________ , _________ _ 
180 104 
n, __________________________________ , _________ _ 
284 
0 __________________________________________ ___ 
111 30 39 51 50 
p ___________________ , ____________ '-V ____ , 
141 90 50 
ql _________________________ , _______ V ____ I __ 
111 30 90 50 
__________________ , ____________ V _____ I_ 
237 
141 93 50 
s ___________________________________________ I ___ 
141 143 
t, ___________________________ , ________________ __ 
111 123 50 
u, ____________________ , _____________________ 1 
78 102 54 50 
v ________________________________ , ______ 1 __ 
78 33 69 54 50 
w __________________ , ____________________ 1 __ _ 
78 33 69 104 
x, __________________ , _____________ , __________ _ 
78 63 39 54 50 
y--------------------------------------I_-
238 
Restriction Fragment Length Polymorphism Patterns of BoLA DRB3 created by 
enzymatic digestion with Bst YI. Patterns A to E, van Eijk et al., 1992 
199 85 
a ____________________________________________ , _____ __ 
284 
b __________________________________________________ __ 
196 85 
c. _________________________________________ V_I. ________ _ 
87 197 
d, _________________ , _________________________________ _ 
87 112 85 
e. _________________ , _________________________________ _ 
239 
Restriction Fragment Length Polymorphism Patterns of BoLA DRB3 created by 
enzymatic digestion with Hae III. Patterns A to F, van Eijk et ai., 1992; patterns G and 
H, Gelhaus et aI., 1995; pattern I, based on allele DRB3*25011. 
167 52 65 
a _________________ , _______  __ 
219 65 
b ______________________________________________ I __ 
167 49 65 
c. _____________________ V ___ I __ 
190 29 65 
d. _____________________ I __ I __ 
167 117 
e. __________________________ _ 
167 4 48 65 
f _________________ ,1 1, __________ , 
164 55 65 
~g------------------------------_I_-
167 46 6 65 
h. _______________________ I_I __ 
167 4 113 
i _________________ U _______ _ 
240 
Allele DRB3 PCR-RFLP Rsa I, Bst YI, Hae III 
patterns 
DRB3*0501 01 aaa 
DRB3*0503 01 aaa 
DRB3*1301 02 bba 
DRB3*1001 03 bbb 
DRB3*1002 03 bbb 
No sequence 04 caa 
DRB3*3301 05 fCC 
DRB3*2201 06 daa 
DRB3*2202 06 daa 
DRB3*0201 07 ecc 
DRB3*1201 08 faa 
DRB3*0301 09 fda 
DRB3*0302 09 fda 
DRB3*1601 10 fba 
DRB3*1602 10 fba 
DRB3*0901 11 gea 
DRB3*0902 11 gea 
DRB3*1202 11 gea 
DRB3*1701 12 haa 
DRB3*1702 12 haa 
DRB3*3201 12 haa 
DRB3*3202 12 haa 
DRB3*3203 12 haa 
DRB3*0401 13 hba 
No sequence 14 hbb 
DRB3*20011 15 iba 
DRB3*20012 15 iba 
DRB3*2002 15 iba 
DRB3*2003 15 iba 
DRB3*1501 16 ibd 
DRB3*1502 16 ibd 
DRB3*4301 16 kbb 
No sequence 17 Ibf 
DRB3*1801 18 Ibf 
DRB3*1802 18 sbb 
DRB3*2601 19 Ibb 
DRB3*2301 20 Ibb 
DRB3*2901 20 Ibb 
DRB3*3601 20 Ibe 
DRB3*0801 21 mba 
DRB3*1101 22 nba 
DRB3*2701 23 nba 
DRB3*2702 23 nba 
241 
Allele DRB3 PCR-RFLP Rsa I, Bst VI, Hae III 
patterns 
DRB3*2703 23 nba 
DRB3*2705 23 nba 
DRB3*2706 23 nba 
DRB3*2707 23 nba 
DRB3*0101 24 nbb 
DRB3*0102 24 nbb 
No sequence 25 oaa 
DRB3*0601 26 oab 
DRB3*14011 27 obf 
DRB3*14012 27 obf 
DRB3*3101 27 obf 
DRB3*0701 28 obb 
DRB3*4101 29 pcc 
Genotyping error 30 qcc 
DRB3*2801 31 ibf 
DRB3*2401 32 maa 
DRB3*2704 33 nbf 
DRB3*3001 34 lab 
DRB3*3002 34 lab 
DRB3*2101 35 cbb 
DRB05 36 lba 
DRB07 37 oba 
DRB18 38 bda 
No sequence 39 tba 
No sequence 40 uba 
DRB3*0502 41 aba 
DRB3*1901 41 aba 
DRB3*3801 41 aba 
DRB3*2802 42 hbf 
DRB3*25012 43 kbf 
DRB3*25011 44 kbi 
DRB3*3401 45 sdb 
DRB3*3402 45 sdb 
DRB3*3501 46 vba 
DRB3*1703 47 waa 
DRB3*3901 48 wba 
DRB3*3701 49 wbe 
DRB3*4001 50 xba 
DRB3*4201 51 gaa 
DRB3*0303 52 sda 
DRB3*1902 53 yba 
242 
References 
Anon. 1996. The Veterinary Formulary: handbook of medicines used in veterinary 
practice. Royal Pharmaceutical Society of Great Britain: British Veterinary Association. 
Aarestrup,F.M., N.E.Jensen, and H.Ostergard. 1995. Analysis of associations between 
Major Histocompatibility Complex (BoLA) Class-I haplotypes and subclinical mastitis of 
dairy cows. Journal of Dairy Science 78:1684-1692. 
Aarestrup,F.M. and N.E.Jensen. 1996. Genotypic and phenotypic diversity of 
Streptococcus dysgalactiae strains isolated from clinical and subclinical cases of bovine 
mastitis. Veterinary Microbiology 53:315-323. 
Aarestrup,F.M. and N.E.Jensen. 1998. Development of penicillin resistance among 
Staphylococcus aureus isolated from bovine mastitis in Denmark and other countries. 
Microbial Drug Resistance-Mechanisms Epidemiology and Disease 4:247-256. 
Abbar,F.M., M.T.Mohammed, and S.H.Arslain. 1986. Selected biological properties of 
enterotoxigenic staphylococci isolated from milk. Journal of Food Protection 49:871-
873. 
Abbas,A.K, KM.Murphy, and A.Sher. 1996. Functional diversity of helper T 
lymphocytes. Nature 383:787-793. 
Abramson,J.S. and E.L.Mills. 1988. Depression of neutrophil function induced by viruses 
and its role in secondary microbial infections. Reviews of Infectious Diseases 10:326-
341. 
Adema,G.J., F.Hartgers, R.Verstraten, E.deVries, G.Marland, S.Menon, J.Foster, 
Y.M.xu, P.Nooyen, T.McClanahan, KB.Bacon, and C.G.Figdor. 1997. A dendritic cell 
derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713-717. 
Aida,Y., M.Niimi, M.Asahina, KOkada, Y.Nakai, and KOgimoto. 1995. Identification 
of a new bovine MHC class-II DRB allele by nucleotide sequencing and an analysis of 
243 
phylogenetic relationships. Biochemical and Biophysical Research Communications 
209:981-988. 
Akbar,AN., N.Borthwick, M.Salmon, W.Gombert, M.Bofill, N.Shamsadeen, D.Pilling, 
S.Pett, J.E.Grundy, and G.Janossy. 1993. The significance of low bcl-2 expression by 
CD45RO T -cells in normal individuals and patients with acute viral infections - the role 
of apoptosis in T-cell memory. Journal of Experimental Medicine 178:427-438. 
AI-Daccak,R, K.Mehindate, F.Damdoumi, P.Etongue-Mayer, H.Nilsson, P.Antonsson, 
M.Sundstrom, M.Dohlsten, RP.Sekaly, and W.Mourad. 1998. Staphylococcal 
enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with 
the MHC class II receptors. Journal of Immunology 160:225-232. 
Alderson,M.R, T.W.Tough, S.F.Ziegler, and K.H.Grabstein. 1991. Inte.r1eukin-7 induces 
cytokine secretion and tumoricidal activity by human peripheral blood monocytes. 
Journal of Experimental Medicine 173:923-930. 
Aldridge,B.M., S.M.McGuirk, RJ.LClark, W.AKnapp, D.I.Watkins, and D.P.Lunn. 
1998. Denaturing gradient gel electrophoresis: a rapid method for differentiating BoLA-
DRB3 alleles. Animal Genetics 29:389-394. 
Alexander,M., H.Newmark, and RG.Miller. 1985. Oral beta-carotene can increase the 
number of okt4+ cells in human blood. Immunology Letters 9:221-224. 
Allaire,F.R, H.E.Sterwerf, and T.M.Ludwick. 1977. Variations in removal reasons and 
culling rates with age for dairy females. Journal of Dairy Science 60:254-267. 
Allaire,F.R and J.P.Gibson. 1992. Genetic value of herd life adjusted for milk 
production. Journal of Dairy Science 75: 1349-1356. 
Allen,P.D., M.G.Macey, D.H.Johnson, N.S.Williams, and AC.Newland. 1990. 
Intraperitoneal activation of lymphocytes by IL-2 - initial hematological and 
immunological observations. British Journal of Cancer 61: 169. 
244 
Allison,J.P. 1994. CD28-B7 interactions in T-cell activation. Current Opinion in 
Immunology 6:414-419. 
Amorena,B. and W.H.Stone. 1978. Serologically defined (SD) locus in cattle. Science 
201:159-160. 
Anderson,J.c. 1983. Staphylococci and staphylococcal infections. C.S.F.Easmon and 
C.Adlam, editors. Academic Press, London. 
Anderson,J.C. 1986. Staphylcoccus. In Pathogenesis of bacterial infections in animals. 
C.L.Gyles and T.O.Charles, editors. Iowa State University Press, 14-20. 
Andersson,L. 1988. Organization of the bovine MHC class II region as revealed by 
genomic hybridizations. Animal Genetics 19:32-34. 
Andersson,L. and L.Rask. 1988. Characterization of the MHC class-II region in cattle -
the number of DQ genes varies between haplotypes. Immunogenetics 27: 110-120. 
Andrews,A.H., R.W. Blowey, H.Boyd, and R.G.Eddy. 1992. Bovine Medicine - Diseases 
and Husbandry of Cattle. Blackwell Scientific, Oxford. 
Animal Data Centre. 1996. UK statistics for genetic evaluation. Dairy July. 
Aravindakshan,T.V., A.M.Nainar, and S.N.Sivaselvam. 2000. Polymorphism in exon 2 
of the BuLA-DRB3 gene in Indian buffalo (Bubalus bubalis var. indicus) detected by 
PCR-RFLP. Animal Science 70:221-226. 
Arbones,M.L., D.C.Ord, K.Ley, H.Ratech, C.Maynardcurry, G.Otten, D.J.Capon, and 
T.F.Tedder. 1994. Lymphocyte homing and leukocyte rolling and migration are impaired 
in L-selectin deficient mice. Immunity 1:247-260. 
Archambault,D., G.Morin, and Y.Elazhary. 1988. Influence of immunomodulatory 
agents on bovine humoral and cellular immune-responses to parenteral inoculation with 
bovine rotavirus vaccines. Veterinary Microbiology 17:323-334. 
245 
Arriens,M.A., G.Ruff, M.Schallibaum, and S.Lazary. 1994. Possible association between 
a serologically detected haplotype of the bovine Major Histocompatibility Complex and 
subclinical mastitis. Journal of Animal Breeding and Genetics 111: 152-161. 
Asai,K., K.Kai, H.Rikiishi, S.Sugawara, Y.Maruyama, T.Yamaguchi, M.Ohta, and 
K.Kumagai. 1998. Variation in CD4(+) T and CD8(+) T lymphocyte subpopulations in 
bovine mammary gland secretions during lactating and non-lactating periods. Veterinary 
Immunology and Immunopathology 65:51-61. 
Ashmore,L.M., G.M.Shopp, and B.S.Edwards. 1989. Lymphocyte subset analysis by 
flow cytometry. Comparison of three staining techniques and effects of blood storage. 
Journal of Immunological Methods 118:209-215. 
Ashwell,J.D. and RH.Schwartz. 1986. T-cell recognition of antigen and the Ia molecule 
as a ternary complex. Nature 320:176-179. 
Ashwell,M.S., C.E.Rexroad, RH.Miller, P.M.VanRaden, and Y.Da. 1997. Detection of 
loci affecting milk production and health traits in an elite US Holstein population using 
microsatellite markers. Animal Genetics 28:216-222. 
Ashwell,M.S., Y.Da, P.M.VanRaden, C.E.Rexroad, and RH.Miller. 1998. Detection of 
putative loci affecting conformational type traits in an elite population of United States 
Holsteins using microsatellite markers. Journal of Dairy Science 81: 1120-1125. 
Ashwell,M.S., C.E.Rexroad, RH.Miller, and P.M.VanRaden. 1996. Mapping economic 
trait loci for somatic cell score in Holstein cattle. Animal Genetics 27:235-242. 
Ashwell,M.S., C.E.Rexroad, RH.Miller, P.M.VanRaden, and Y.Da. 1997. Detection of 
loci affecting milk production and health traits in an elite US Holstein population using 
microsatellite markers. Animal Genetics 28:216-222. 
Ayoub,I.A. and TJ.Yang. 1996. Age dependent changes in peripheral blood lymphocyte 
subpopulations in cattle: A longitudinal study. Developmental and Comparative 
Immunology 20:353-363. 
246 
Aziz,E. and P.H.Klesius. 1986. Effect of selenium deficiency on caprine 
polymorphonuclear leukocyte production of leukotriene-B4 and its neutrophil 
chemotactic activity. American Journal of Veterinary Research 47:426-428. 
Azuma,M., D.lto, H.Yagita, K.Okumura, J.H.Phillips, L.L.Lanier, and C.Somoza. 1993. 
B70 antigen is a 2nd ligand for CTLA-4 and CD28. Nature 366:76-79. 
Babbitt,B.P., P.M.Allen, G.Matsueda, E.Haber, and E.RUnanue. 1985. Binding of 
immunogenic peptides to Ia histocompatibility molecules. Nature 317:359-361. 
Babu,U. and M.L.Failla. 1990. Copper status and function of neutrophils are reversibly 
depressed in marginally and severely copper deficient rats. Journal of Nutrition 
120: 1700-1709. 
Babuik,L.A., M.J.P.Lawman, and G.A.Gifford. 1987. Use of recombinant bovine alpha 
interferon in reducing respiratory disease induced by Bovine Herpes Virus Type 1. 
Antimicrobial Agents and Chemotherapy 31:752-757. 
Badley,A.D., J.A.McElhinny, P.J.Leibson, D.H.Lynch, M.RAlderson, and C.V.Paya. 
1996. Upregulation of FAS ligand expression by human immunodeficiency virus in 
human macrophages mediates apoptosis of un infected T lymphocytes. Journal of 
Virology 70: 199-206. 
Bahram,S., M.Bresnahan, D.E.Geraghty, and T.Spies. 1994. A 2nd lineage of 
mammalian Major Histocompatibility Complex class-I genes. Proceedings of The 
National Academy of Sciences of The United States of America 91 :6259-6263. 
Baines, J. R EC Hygeine Directive, A MAFF sponsored campaign to reduce somatic cell 
counts. Proceedings of British Mastitis Conference, Stoneleigh. 1996. 
Baker,D.A., C.A.Phillips, K.Roessner, RJ.Albertini, and L.I.Mann. 1980. Suppression 
by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism 
for the enhancement of herpes simplex virus type 2 vaginal infection. American Journal 
of Obstetrics and Gynecology 136:440-445. 
247 
Baldwin,C.L., AJ.Teale, J.G.Naessens, B.M.Goddeeris, N.D.Machugh, and 
W.I.Morrison. 1986. Characterization of a subset of bovine T-Iymphocytes that express 
BoT4 by monoclonal antibodies and function - similarity to lymphocytes defined by 
human T4 and murine L3T4. Journal of Immunology 136:4385-4391. 
Baldwin,C.L., N.D.Machugh, J.AEllis, J.Naessens, J.Newson, and W.I.Morrison. 1988. 
Monoclonal antibodies which react with bovine T -lymphocyte antigens and induce 
blastogenesis - tissue distribution and functional characteristics of the target antigens. 
Immunology 63:439-446. 
Ballingall,K.T., ALuyai, and D.J.Mckeever. 1997. Analysis of genetic diversity at the 
DQA loci in African cattle: Evidence for a BoLA-DQA3 locus. Immunogenetics 46:237-
244. 
Banchereau,J., D.Blanchard, F.Briere, and Y.J.Liu. 1994. Molecular control of B-cell 
immunopoiesis. Cells and Cytokines in Lung Inflammation 725:22-33. 
Banchereau,J., F.Bazan, D.Blanchard, F.Briere, J.P.Galizzi, C.Vankooten, Y.J.Liu, 
F.Rousset, and S.Sealand. 1994. The CD40 antigen and its ligand. Annual Review of 
Immunology 12:881-922. 
Banchereau,J. and R.M.Steinman. 1998. Dendritic cells and the control of immunity. 
Nature 392:245-252. 
Bank,I., R.ADepinho, M.B.Brenner, J.Cassimeris, F.W.Alt, and L.Chess. 1986. A 
functional T3 molecule associated with a novel heterodimer on the surface of immature 
human thymocytes. Nature 322:179-181. 
Banos,G. and G.E.Shook. 1990. Genotype by environment interaction and genetic 
correlations among. Journal of Dairy Science 73:2563-2573. 
Bargatze,R.F., M.AJutila, and E.C.Butcher. 1995. Distinct roles of L-selectin and 
integrins alpha-4-beta-7 and LFA-l in lymphocyte homing to Peyers Patches HEV in situ 
the multistep model confirmed and refined. Immunity 3:99-108. 
248 
I 
Barrios,e., e.Brandt, M.Berney, P.H.Lambert, and e.A.Siegrist. 1996. Partial correction 
of the Th2trh 1 imbalance in neonatal murine responses to vaccine antigens through 
selective adjuvant effects. European Journal of Immunology 26:2666-2670. 
Bartlett,P.e., G.Y.Miller, S.E.Lance, L.E.Heider, and e.R.Anderson. 1992. 
Environmental and managerial risk-factors of intramammary infection with coagulase 
negative staphylococci in Ohio dairy herds. Preventive Veterinary Medicine 14:129-142. 
Bartlett,P.C., G.Y.Miller, S.E.Lance, and L.E.Heider. 1992. Managerial determinants of 
intramammary coliform and environmental streptococci infections in Ohio dairy herds. 
Journal of Dairy Science 75:1241-1252. 
Batish,V.K., B.Nataraj, and S.Grover. 1990. Variations in growth of Staphylococcus 
aureus 234 after heat- stress in milk. Lait 70:453-457. 
Batish,V.K., B.Nataraj, and S.Grover. 1991. Heat resistance of enterotoxigenic 
Staphylococcus aureus in milk, reconstituted infant food and cream. Journal of Food 
Science and Technology-Mysore 28:391-393. 
Batra,T.R., A.J.Lee, and J.S.Gavora. 1989. Class I alleles of the bovine Major 
Histocompatibility System and their association with economic traits. Journal of Dairy 
Science 72:2115-2124. 
Baughn,R. and P.F.Bonventre. 1975. Phagocytosis and intracellular killing of 
Staphylococcus aureus by normal mouse peritoneal macrophages. Infection and 
Immunity 12:346-352. 
Beckmann,E. and D.Levitt. 1984. Phosphorylcholine on Streptococcus pneumoniae r36a 
is responsible for in vitro polyclonal antibody secretion by human peripheral blood 
lymphocytes. Journal of Immunology 132:2174-2176. 
Bell,E.B. and S.M.Sparshott. 1990. Interconversion of CD45R subsets of CD4 T-cells in 
vivo. Nature 348: 163-166. 
249 
Bembridge,G.P., N.D.Machugh, D.McKeever, E.Awino, P.Sopp, RA.Collins, 
K.I.Gelder, and C.J.Howard. 1995. CD45RO expression on bovine T cells: Relation to 
biological function. Immunology 86:537-544. 
Benacerraf,B. and RN.Germain. 1978. The Immune response genes of the Major 
Histocompatibility Complex. Immunological Reviews 38:70-118. 
Benjamini,E., G.Sunshine, and S.Leskowitz. 1996. Immunology: A short course 3rd 
edition. Wiley-Liss, New York. 
Bensaid,A. and M.Hadam. 1991. Bovine CD4 (BoCD4). Veterinary Immunology and 
Immunopathology 27:51-54. 
Bensaid,A., A.Kaushal, C.L.Baldwin, H.Clevers, J.RYoung, S.J.Kemp, N.D.Machugh, 
P.G.Toye, and A.J.Teale. 1991. Identification of expressed bovine class-I MHC genes at 
2 loci and demonstration of physical linkage. Immunogenetics 33:247-254. 
Berdoz,J., J.M.Tiercy, P.Rollini, B.Mach, and J.Gorski. 1989. Remarkable sequence 
conservation of the HLA-DQB2 locus (Dx- beta) within the highly polymorphic DQ 
subregion of the human MHC. Immunogenetics 29:241-248. 
Bergholtz,B.O. and E.Thorsby. 1978. HLA-D restriction of the macrophage dependent 
response of immune human T lymphocytes to PPD in vitro: inhibition by anti HLA-DR 
antisera. Scandinavian Journal of Immunology 8:63-73. 
Bernoco,D. and H.A.Lewin. 1989. The bovine lymphocyte antigen (BoLa) System -
importance and relationship to disease in cattle. Revista Brasileira de Genetica 12: 107-
122. 
Bernoco,D., H.A.Lewin, L.Andersson, M.A.Arriens, G.Byrns, S.Cwik, C.J.Davies, 
H.C.Hines, W.Leibold, and O.Lie. 1991. Joint report of the fourth bovine lymphocyte 
antigen (BoLA) workshop. Animal Genetics 22:477-496. 
Berry,E.A. 1998. Mastitis incidence in straw yards and cubicles. Veterinary Record 
142:517-518. 
250 
Berryere, T. G., Muggli-Cockett, N. E., and Robbins, J. W. 1994. Molecular studies of 
DRB relative to Staphylococcus aureus mastitis. Proceedings of the 5th World Congress 
on Genetics Applied to Livestock Production. 21, 187-190. 
Bertho,J.M., C.Demarquay, N.Moulian, AVanderMeeren, S.BerrihAknin, and 
P.Gourmelon. 1997. Phenotypic and immunohistological analyses of the human adult 
thymus: Evidence for an active thymus during adult life. Cellular Immunology 179:30-
40. 
Bertotto,A, G.Castellucci, G.Fabietti, F.Scalise, and R.Vaccaro. 1990. Lymphocytes 
bearing the gamma delta T-cell receptor in human breast milk. Archives of Disease in 
Childhood 65:1274-1275. 
Beutler,B. and ACerami. 1989. The biology of cachectinlTNF - a primary mediator of 
the host response. Annual Review of Immunology 7:625-655. 
Beverley,P.L. 1990. Is T-cell memory maintained by cross reactive stimulation. 
Immunology Today 11 :203-205. 
Bhakdi,S. and J.Tranumjensen. 1991. Alpha-toxin of Staphylococcus aureus. 
Microbiological Reviews 55:733-751. 
Bhat,N.M., AB.Kantor, M.M.Bieber, AM.Stall, L.AHerzenberg, and N.H.Teng. 1992. 
The ontogeny and functional characteristics of human B-1 (CD5+B) cells. International 
Immunology 4:243-252. 
Bielefeldt Ohmann,H., W.C.Davis, and L.ABabiuk. 1986. Surface antigen expression by 
bovine alveolar macrophages: functional correlation and influence of interferons in vivo 
and in vitro. Immunobiology 171:125-142. 
Bielefeldt Ohmann,H., M.Sabara, MJ.P.Lawman, P.Griebel, and L.ABabiuk. 1988. A 
monoclonal antibody detects macrophage maturation antigen which appears 
independently of class-II antigen expression - reactivity of monoclonal EBMll with 
bovine macrophages. Journal of Immunology 140:2201-2209. 
251 
Bigby,M., J.S.Markowitz, P.A.Bleicher, M.J.Grusby, S.Simha, M.Siebrecht, M.Wagner, 
C.Nagleranderson, and L.H.Glimcher. 1993. Most gamma delta T-cells develop normally 
in the absence of MHC class-II molecules. Journal of Immunology 151 :4465-4475. 
Bill,J. and E.Palmer. 1989. Positive selection of CD4+ T-cells mediated by MHC class-II 
bearing stromal cell in the thymic cortex. Nature 341 :649-651. 
Binns,RM., RPabst, and S.T.Licence. 1988. Subpopulations of T-Iymphocytes 
emigrating in venous-blood draining pig thymus labelled in vivo with fluorochrome. 
Immunology 63:261-267. 
Binns,RM. 1994. The nUll/gamma delta TCR(+) T-cell family in the pig. Veterinary 
Immunology and Immunopathology 43:69-77. 
Biochard,P.J. and RRupp. 1997. Genetic analysis and genetic evaluation for somatic cell 
score in French dairy cattle. Proceedings International workshop on genetic improvement 
offunctional traits in cattle health 15:54-60. 
Biozzi,G., C.Stiffel, D.Mouton, and Y.Bouthiller. 1974. Selection of mice with high and 
low antibody response to complex immunogens. In Immunogenetics and 
Immunodeficiency. B.Benacerraf, editor. University Park Press, Baltimore, 180-225. 
Biozzi,G., C.Stiffel, D.Mouton, and Y.Bouthiller. 1975. Selection of lines of mice with 
high and low antibody responses to complex immunogens. In Immunogenetics and 
Immunodeficiency. B.Benacerraf, editor. MTP, Lancaster, 179-195. 
Bishop,J.G., F.L.Schanbacher, L.C.Ferguson, and K.L.Smith. 1976. In vitro growth 
inbibition of mastitis causing coliform bacteria by bovine apo-Iactoferrin and reversal of 
inhibition by cirate and increase of apo-Iactoferrin. Infection and Immunity 14:911-918. 
Bishop,S.A., N.A.Williams, TJ.Gruffydd-Jones, D.A.Harbour, and C.RStokes. 1992. 
An early defect in primary and secondary T-cell responses in asymptomatic cats during 
acute feline immunodeficiency virus (FlY) Infection. Clinical and Experimental 
Immunology 90:491-496. 
252 
Bisping,W. and G.Amtsberg. 1988. Colour atlas for the diagnosis of bacterial pathogens 
in animals. W.Siller, J.Phillips editors. P. Parey Scientific Publishers, Berlin. 
Bitman,J., D.L.Wood, S.A.Bright, and RH.Miller. Lipid composition of bovine teat 
canal keratin. Journal of Dairy Science 71: 1389-1395. 
Bjorkman,P.J., M.A.Saper, B.Samraoui, W.S.Bennett, J.L.Strominger, and D.C.Wiley. 
1987. Structure of the human class-I Histocompatibility antigen, HLA-A2. Nature 
329:506-512. 
Blalock,J.E. 1994. The syntax of immune-neuroendocrine communication. Immunology 
Today 15:504-511. 
Blowey,RW., Roger,W. 1999. A veterinary book for dairy farmers 3rd edition. Farming 
Press Limited, Oxford. 
Bluestone,J.A., RQ.Cron, M.Cotterman, B.A.Houlden, and L.A.Matis. 1988. Structure 
and specificity of T cell receptor gamma/delta on Major Histocompatibility Complex 
antigen-specific CD3+, CD4-, CDS- T lymphocytes. Journal of Experimental Medicine 
168: 1899-1916. 
Boettcher,PJ., J.C.M.Dekkers, and B.W.Kolstad. 1998. Development of an udder health 
index for sire selection based on somatic cell score, udder conformation, and milking 
speed. Journal of Dairy Science 81:1157-1168. 
Boettcher,P.J., L.K.Jairath, and J.C.W.Dekkers. 1999. Comparison of methods for 
genetic evaluation of sires for survival of their daughters in the first three lactations. 
Journal of Dairy Science 82: 1034-1044. 
Boichard,D. and RRupp. 1997. Genetic analysis and genetic evaluation for somatic cell 
score in French dairy cattle. InterbullI5:54-60. 
Booth,J.M. 1986. Possible antibiotic contamination of milk. Veterinary Record 119:634. 
253 
Booth,J.M. 1988. Update on mastitis .1. Control measures in England and Wales - how 
have they influenced incidence and etiology. British Veterinary Journal 144:316-322. 
Booth,J.M. and F.Harding. 1986. Testing for antibiotic residues in milk. Veterinary 
Record 119:565-569. 
Booth, J. M. 1997. Progress in mastitis control - an evolving problem. British Mastitis 
Conference , 3-9. 
Borst,J., R.J.Vandegriend, J.W.Vanoostveen, S.L.Ang, C.J.Melief, J.G.Seidman, and 
R.l.H.Bolhuis. 1987. AT-cell receptor gamma-CD3 complex found on cloned functional 
lymphocytes. Nature 325:683-688. 
Bouchonnet,F., D.Lecossier, ABellocq, I.Hamy, and AJ.Hance. 1994. Activation of T-
cells by previously activated T -cells - HLA unrestricted alternative pathway that modifies 
their proliferative potential. Journal of Immunology 153: 1921-1935. 
Boumann,M. and J .M.Booth. 1992. Update on the incidence of summer mastitis In 
England and Wales. Veterinary Record 131:417-418. 
Boussiotis,V.A, G.J.Freeman, J.G.Gribben, and L.M.Nadler. 1996. The role of B7-11B7-
2; CD28/CLTA-4 pathways in the prevention of anergy, induction of productive 
immunity and down-regulation of the immune response. Immunological Reviews 153:5-
26. 
Boyum,A 1968. A one-stage procedure for isolation of granulocytes and lymphocytes 
from human blood. Scandinavian Journal of Immunology 21:77-100. 
Braakman,E., F.T.M.Rotteveel, G.Vanbleek, G.AVanseventer, and C.J.Lucas. 1987. Are 
MHC class II restricted cytotoxic T-Iymphocytes important? Immunology Today 8:265-
267. 
Braciale,T.J., M.T.Sweetser, L.AMorrison, DJ.Kittlesen, and V.L.Braciale. 1989. Class-
I Major Histocompatibility Complex restricted cytolytic T -lymphocytes recognize a 
254 
limited number of sites on the influenza hemagglutinin. Proceedings of The National 
Academy of Sciences of The United States of America 86:277-281. 
Brambell,F.W.R 1970. The transmission of passive immunity from mother to young. 
Frontiers of Biology. 18. North-Holland Publishing Company, Amsterdam. 
Bramley ,A.J. and F.H.Dodd. 1984. Reviews of the progress of dairy science - mastitis 
control - progress and prospects. Journal of Dairy Research 51 :481-512. 
Bramley,A.J., A.H.Patel, M.OReilly, RFoster, and T.J.Foster. 1989. Roles of alpha-toxin 
and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. 
Infection and Immunity 57:2489-2494. 
Brandon,M.R, D.L.Watson, and A.K.Lascelles. 1971. The mechanism of transfer of 
immunoglobulins into mammary secretions of cows. Journal of Experimental Biological 
Medical Science 49:613-623. 
Bretscher,P. and M.Cohn. 1970. A theory of self nonself discrimination. Science 
169:1042-1044. 
Briles,RW., W.H.McGibbon, and M.RIrwin. 1950. On multiple alleles affecting cellular 
antigens in the chicken. Genetics 35:633-652. 
Briles,W.E., H.A.Stone, and RK.Cole. 1977. Mareks disease: effects of B 
histocompatibility alloalles in resistant and susceptible chicken lines. Science 195: 193-
195. 
Briles,W.E., RW.Briles, W.H.McGibbon, and H.A.Stone. 1980. Identification of B 
alloalleles associated with resistance to Mareks disease. In Resistance and Immunity to 
Mareks Disease. CEC Publication, 395-416. 
Brock,J.H. and T.Mainoufowler. 1983. The role of iron and transferrin in lymphocyte 
transformation. Immunology Today 4:347-351. 
255 
Brod,S.A, M.Purvee, D.Benjamin, and D.AHafler. 1990. T-T-cell interactions are 
mediated by adhesion molecules. European Journal of Immunology 20:2259-2268. 
Brotherstone,S. and W.G.Hill. 1991. Dairy herd life in relation to linear type traits and 
production 2. Genetic analysis for pedigree and non pedigree cows. Animal Production 
53:289-297. 
Brotherstone,S., R.F.Veerkamp, and W.G.Hill. 1997. Genetic parameters for a simple 
predictor of the lifespan of Holstein-Friesian dairy cattle and it's relationship to 
production. Animal Science 65:31-37. 
Brown,AM., K.L.Wright, and J.P.y'Ting. 1993. Human Major Histocompatibility 
Complex class-IT associated invariant chain gene promoter - functional analysis and in-
vivo protein-DNA interactions of constitutive and IFN-gamma-induced expression. 
Journal of Biological Chemistry 268:26328-26333. 
Brown,W.e., W.e.Davis, S.H.Choi, D.AE.Dobbelaere, and G.ASplitter. 1994. 
Functional and phenotypic characterization of WC 1 + yo T cells isolated from Babesia 
bovis stimulated T cell lines. Cellular Immunology 153:9-27. 
Brown,J.H., TJardetzky, J.e.Gorga, L.J.Stern, J.e.Gorga, J.L.Strominger, and 
D.e.Wiley. 1993. Three dimensional structure of the human class IT histocompatibility 
antigen HLA-DRI. Nature. 364:33-39 
Bryan,L.A, P.J.Griebel, D.M.Haines, W.e.Davis, and J.R.Allen. 1988. 
Immunocytochemical identification of bovine Langerhans cells by use of a monoclonal 
antibody directed against class-IT MHC antigens. Journal of Histochemistry & 
Cytochemistry 36:991-995. 
Buelens,e., F.Willems, ADelvaux, G.Pierard, J.P.Delville, T.Velu, and M.Goldman. 
1995. Interleukin-IO differentially regulates B7-1 (CD80) and B7-2 (CD86) Expression 
on human peripheral blood dendritic cells. European Journal of Immunology 25:2668-
2672. 
256 
Burke,M.G., R.T.Stone, and N.E.Muggli-Cockett. 1991. Nucleotide sequence and 
Northern analysis of a bovine major histocompatibiility class II DRB-like cDNA Animal 
Genetics 22:343-352. 
Butcher,E.C. and LJ.Picker. 1996. Lymphocyte homing and homeostasis. Science 
272:60-66. 
Butler,J.E. 1974. Lactation: a comprehensive treatise. B.L.Larson and V.R.Smith, 
editors. Academic Press, New York. 
Butler,J.E. 1998. Immunoglobulin diversity, B-cell and antibody repertoire development 
in large farm animals. Review of Scientific Technology 17:43-70. 
Buus,S., ASette, S.M.Colon, C.Miles, and H.M.Grey. 1987. The relation between Major 
Histocompatibility Complex (MHC) Restriction and the capacity of Ia to bind 
immunogenic peptides. Science 235: 1353-1358. 
Cabrera,W.H., O.M.lbanez, S.L.Oliveira, O.ASant'Anna, M.Siqueira, D.Mouton, and 
G.Biozzi. 1982. Evidence for distinct polygenic regulation of antibody responses to some 
unrelated antigens in lines of mice selected for high or low antibody responses to somatic 
antigen of Salmonella. Immunogenetics 16:583-592. 
Cahill,R.P., H.Frost, and Z.Trnka. 1976. The effects of antigen on the migration of 
recirculating lymphocytes through single lymph nodes. Journal of Experimental 
Medicine 143:870-888. 
Cahill,R.P. and Z.Tmka. 1980. Growth and development of recirculating lymphocytes in 
the sheep foetus. Essays on the Anatomy and Physiology of lymphoid tissue. 16:38-49 
Cai,Z.L., ABrunmark, M.R.Jackson, D.Loh, P.APeterson, and J.Sprent. 1996. 
Transfected Drosophila cells as a probe for defining the minimal requirements for 
stimulating unprimed CD8( +) T cells. Proceedings of The National Academy of Sciences 
of The United States of America 93: 14736-14741. 
257 
Caligiuri,M.A, AZmuidzinas, T.J.Manley, H.Levine, K.ASmith, and J.Ritz. 1990. 
Functional consequences of interleukin-2 receptor expression on resting human 
lymphocytes - identification of a novel natural killer cell subset with high affinity 
receptors. Journal of Experimental Medicine 171: 1509-1526. 
Callard,RE., C.M.Smith, and P.L.Beverley. 1982. Phenotype of human T-helper and 
suppressor cells in an in vitro specific antibody response. European Journal of 
Immunology 12:232-236. 
Calvinho,L.F. and S.P.Oliver. 1998. Characterization of mechanisms involved in uptake 
of Streptococcus dysgalactiae by bovine mammary epithelial cells. Veterinary 
Microbiology 63:261-274. 
Calvinho,L.F., RAAlmeida, and S.P.Oliver. 1996. Influence of Streptococcus 
dysgalactiae surface hydrophobicity on adherence to mammary epithelial cells and 
phagocytosis by mammary macrophages. Journal of Veterinary Medicine Series B-
Zentralblatt Fur Veterinarmedizin Reihe B-Infectious Diseases and Veterinary Public 
Health 43:257-266. 
Cameron,P.U., H.ATabarias, B.Pulendran, W.Robinson, and RL.Dawkins. 1990. 
Conservation of the central MHC genome - PFGE mapping and RFLP analysis of 
complement, HSP70, and TNF genes in the goat. Immunogenetics 31 :253-264. 
Campbell,D.E., G.M.Georgiou, and AS.Kemp. 1999. Pooled human immunoglobulin 
inhibits IL-4 but not IFN-gamma or TNF- alpha secretion following in vitro stimulation 
of mononuclear cells with staphylococcal superantigen. Cytokine 11 :359-365. 
Campbell,J.M., DJ.Brown, AK.Nichani, S.E.M.Howie, RL.Spooner, and E.J.Glass. 
1997. A non-protective T helper 1 response against the intra macrophage protozoan 
Theileria annulata. Clinical and Experimental Immunology 108:463-470. 
Capone,M., RD.Hockett, and AZlotnik. 1998. Kinetics of T cell receptor beta, gamma, 
and delta rearrangements during adult thymic development: T cell receptor 
258 
rearrangements are present in CD44( + )CD25( +) Pro-T thymocytes. Proceedings of The 
National Academy of Sciences of The United States of America 95: 12522-12527. 
Carroll,E.J., O.W.Schalm, and J.Lasmanis. 1964. Experimental coliform (Aerobacter 
aerogenes) mastitis: characteristics of the endotoxin and its role in pathogenesis. 
American Journal Veterinary Research 25:720-726. 
Carter,L.L. and R.W.Dutton. 1996. Type 1 and Type 2: A fundamental dichotomy for all 
T -cell subsets. Current Opinion in Immunology 8:336-342. 
Castrucci,G., F.Frigeri, M.Ferrari, V.Cilli, F.Caleffi, V.Aldrouandi, and ANigrelli. 1984. 
The efficacy of colostrum from cows vaccinated with rotavirus in protecting calves to 
experimentally induced rotavirus infection. Comparative Immunology Microbiology and 
Infectious Diseases 7: 11-18. 
Cella,M., M.Salio, Y.Sakakibara, H.Langen, I.Julkunen, and A.Lanzavecchia. 1999. 
Maturation, activation, and protection of dendritic cells induced by double stranded 
RNA Journal of Experimental Medicine 189:821-829. 
Cella,M., AEngering, V.Pinet, J.Pieters, and ALanzavecchia. 1997. Inflammatory 
stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 
388:782-787. 
Cerretti,D.P., K.McKeregan, ALarsen, M.ACantrell, D.Anderson, S.Gillis, D.Cosman, 
and P.E.Baker. 1986. Cloning, sequencing and expression of bovine interleukin-2. 
Proceedings of The National Academy of Sciences of The United States of America 
83:3223-3227. 
Chambers,C.A, M.F.Krnmmel, B.Boitel, AHurwitz, T.J.Sullivan, S.Foumier, D.Cassell, 
M.Brunner, and J.P.Allison. 1996. The role of CTLA-4 in the regulation and initiation of 
T-cell responses. Immunological Reviews 153:27-46. 
Chan,AC., D.M.Desai, and AWeiss. 1994. The role of protein-tyrosine kinases and 
protein-tyrosine phosphatases in T-cell antigen receptor signal transduction. Annual 
Review of Immunology 12:555-592. 
259 
Chan,S., M.CorreiaNeves, C.Benoist, and D.Mathis. 1998. CD4/CD8 lineage 
commitment: matching fate with competence. Immunological Reviews 165:195-207. 
Chandran,RC., K.M.Shahani, and K.G.Holly. 1964. Lysozyme content of human milk. 
Nature 204:76-77. 
Chang,C.c., A.J.Winter, and N.L.Norcross. 1981. Immune response in the bovine 
mammary gland after intestinal, local, and systemic immunization. Infection and 
Immunity 31 :650-659. 
Cher,D.J. and T.RMosmann. 1987. 2 Types of murine helper T-cell clone .2. Delayed 
type hypersensitivity is mediated by Thl clones. Journal of Immunology 138:3688-3694. 
Cherwinski,H.M., J.H.Schumacher, K.D.Brown, and T.RMosmann. 1987. 2 Types of 
mouse helper T-cell clone .3. Further differences in lymphokine synthesis between Thl 
and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, 
and monoclonal antibodies. Journal of Experimental Medicine 166:1229-1244. 
Cheung,A.L., J.M.Koomey, S.N.Lee, E.A.Jaffe, and V.A.Fischetti. 1991. Recombinant 
human tumor necrosis factor-alpha promotes adherence of Staphylococcus aureus to 
cultured human endothelial cells. Infection and Immunity 59:3827-3831. 
Chew,B.P. 1993. Role of carotenoids in the immune response. Journal of Dairy Science 
76:28042811. 
Chicz,RM., RG.Urban, J.C.Gorga, D.A.A.Vignali, W.S.Lane, and J.L.Strominger. 
1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR 
alleles. Journal of Experimental Medicine 178:27-47. 
Chin,W. and J.B.Hay. 1980. A comparison of lymphocyte migration through intestinal 
lymph nodes, subcutaneous lymph nodes, and chronic inflammatory sites of sheep. 
Gastroenterology 79: 1231-1242. 
260 
Chiodini,R.J. and W.C.Davis. 1992. The cellular immunology of bovine 
paratuberculosis: the predominant response is mediated by cytotoxic y'O T lymphocytes 
which prevent CD4+ activity. Microbial Pathogenesis 13:447-463. 
Choi,Y.W., B.Kotzin, L.Herron, J.Callahan, P.Marrack, and J.Kappler. 1989. Interaction 
of Staphylococcus aureus toxin superantigens with human T -cells. Proceedings of The 
National Academy of Sciences of The United States of America 86:8941-8945. 
Chow,Y.H., B.L.Chiang, Y.L.Lee, W.K.Chi, W.C.Lin, Y.T.Chen, and M.H.ao. 1998. 
Development of Thl and Th2 populations and the nature of immune responses to 
hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine 
genes. Journal of Immunology 160:1320-1329. 
Cipriano,J.E., J.L.Morrill, and N.V.Anderson. 1982. Effect of dietary vitamin-E on 
immune responses of calves. Journal of Dairy Science 65:2357-2365. 
Clarke,C.J.P., A.Hales, AHunt, and B.M.J.Foxwell. 1998. IL-lO mediated suppression of 
TNF-alpha production is independent of its ability to inhibit NF chi B activity. European 
Journal of Immunology 28:1719-1726. 
Clegg,F.G., G.J.Halliday, and H.Hardie. 1975. Dry cow therapy: a comparative field trial 
using benzathine cloxacillin and erythromycin. British Veterinary Journal 131 :639-642. 
Clerici,M. and G.M.Shearer. 1994. The Thl-Th2 hypothesis of HIV infection - new 
insights. Immunology Today 15:575-581. 
Clevers,H., N.D.Machugh, ABensaid, S.Dunlap, C.L.Baldwin, AKaushal, K.lams, 
C.J.Howard, and W.I.Morrison. 1990. Identification of a bovine surface antigen uniquely 
expressed on CD4· CD8- T-cell receptor gamma-delta+ T -lymphocytes. European 
Journal of Immunology 20:809-817. 
Coffey,E.M., W.E.Vinson, and R.E.Pearson. 1986. Potential of somatic cell 
concentration in milk as a sire selection. Journal of Dairy Science 69:2163-2172. 
261 
Coffey,E.M., W.E.Vinson, and RE.Pearson. 1986. Somatic cell counts and infection 
rates for cows of varying somatic. Journal of Dairy Science 69:552-555. 
Coffey,E.M., W.E.Vinson, RE.Pearson, L.Jairath, J.C.M.Dekkers, L.RSchaeffer, Z.Liu, 
E.B.Burnside, and B.Kolstad. 1986. Potential of somatic cell concentration in milk as a 
sire selection criterion to reduce mastitis in dairy cattle. Genetic evaluation for herd life 
in Canada. Journal of Dairy Science 69:2163-2172. 
Coffman,RL. and J.Carty. 1986. A T-cell activity that enhances polyclonal IgE 
production and its inhibition by interferon-gamma. Journal of Immunology 136:949-954. 
Cole,G.J. and B.Morris. 1973. The lymphoid apparatus of the sheep: its growth, 
development and significance in immunologic reactions. Advances in Veterirnary 
Science and Comparative Medicine 17:225-263. 
Collen,T., RDimarchi, and T.RDoe!. 1991. A T-cell epitope in vpl of foot and mouth 
disease virus is immunodominant for vaccinated cattle. Journal of Immunology 146:749-
755. 
Collins,RA. and G.Oldham. 1986. Proliferative responses and IL-2 production by 
mononuclear cells from bovine mammary secretions, and the effect of mammary 
secretions on peripheral blood lymphocytes. Immunology 58:647-651. 
Colombani,KJ., M.Pla, D.Mouton, and L.Degos. 1979. H-2 typing of mice genetically 
selected for high or low antibody production. Immunogenetics 8:237-243. 
Colotta,F., N.Polentarutti, S.Sozzani, and AMantovani. 1992. Modulation of granulocyte 
survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-
2020. 
Concha,C., S.Hu, and O.Holmberg. 1996. The proliferative responses of cow stripping 
milk and blood lymphocytes to pokeweed mitogen and ginseng in vitro. Veterinary 
Research 27: 107-115. 
262 
Concha,C., O.Holmberg, and B.Morein. 1978. Proportion of Band T lymphocytes in 
normal bovine milk. Journal of Dairy Research 45:287-290. 
Concha,C., O.Holmberg, and B.Morein. 1980. Characterisation and response to mitogens 
of mammary lymphocytes from the bovine dry period. Journal of Dairy Research 
47:305-311. 
Concha,C. and O.Holmberg. 1990. Ability of bovine mammary macrophages to enhance 
proliferation of autologous blood and mammary secretion lymphocytes. Journal of Dairy 
Research 57:7-16. 
Concha,C., S.Hu, and O.Holmberg. 1996. The proliferative responses of cow stripping 
milk and blood lymphocytes to pokeweed mitogen and ginseng in vitro. Veterinary 
Research 27:107-115. 
Cooper,M.D. 1987. Current concepts of B-Iymphocytes - normal development and 
function. New England Journal of Medicine 317: 1452-1456. 
Cormican,M.G. and R.N.Jones. 1996. Emerging resistance to antimicrobial agents in 
gram positive bacteria - enterococci, staphylococci and nonpneumococcal streptococci. 
Drugs 51:6-12. 
Correa,I., M.Bix, N.S.Liao, M.Zijlstra, R.Jaenisch, and D.Raulet. 1992. Most gamma-
delta T -cells develop normally in beta-2-microglobulin deficient mice. Proceedings of 
The National Academy of Sciences of The United States of America 89:653-657. 
Craven,N. and M.R.Williams. 1985. Defenses of the bovine mammary gland against 
infection and prospects for their enhancement. Veterinary Immunology and 
Immunopathology 10:71-127. 
Craven,N. 1987. Efficacy and financial value of antibiotic teatment of bovine clinical 
mastitis during lactation - a review. British Veterinary Journal 143:410-421. 
Creery,W.D., F.DiazMitoma, L.Filion, and A.Kumar. 1996. Differential modulation of 
B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence 
263 
the development of T helper cell phenotype. European Journal of Immunology 26: 1273-
1277. 
Croft,M., L.M.Bradley, and S.L.Swain. 1994. Naive versus memory CD4 T-cell response 
to antigen - memory cells are less dependent on accessory cell costimulation and can 
respond to many antigen-presenting cell types including resting B-cells. Journal of 
Immunology 152:2675-2685. 
Cummins,K.A. and T.A.McCaskey. 1987. Multiple infusions of cloxacillin for treatment 
of mastitis during the dry period. Journal of Dairy Science 70:2658-2665. 
Cuzzola,M., G.Mancuso, C.Beninati, C.Biondo, F.Genovese, F.Tomasello, T.H.F1o, 
T.Espevik, and G.Teti. 2000. Beta(2) integrins are involved in cytokine responses to 
whole Gram positive bacteria. Journal of Immunology 164:5871-5876. 
Czop,J.K. and M.S.Bergdoll. 1974. Staphylococcal enterotoxin synthesis during the 
exponential, tansitional and stationary growth phase. Infection and Immunity 9:229-235. 
Da,Y., M.Grossman, I.Misztal, and G.R.Wiggans. 1992. Estimation of genetic 
parameters for somatic cell score in Holsteins. Journal of Dairy Science 75:2265-2271. 
Daley,M., T.Williams, P.Coyle, G.Furda, R.Dougherty, and P.Hayes. 1993. Prevention 
and treatment of Staphylococcus aureus infections with recombinant cytokines. Cytokine 
5:276-284. 
Daley,M.J., E.R.Oldham, T.J.Williams, and P.A.Coyle. 1991. Quantitative and 
qualitative properties of host polymorphonuclear cells during experimentally induced 
Staphylococcus aureus mastitis in cows. American Journal of Veterinary Research 
52:474-479. 
Daniel,L.S., B.P.Chew, T.S.Tanaka, and L.W.Tjoelker. 1991. In vitro effects of beta-
carotene and vitamin A on peripartum bovine peripheral blood mononulcear cell 
proliferation. Journal of Dairy Science 74:911-915. 
264 
Darzynkiewicz,Z., F.Traganos, T.Sharpless, and M.RMelamed. 1976. Lymphocyte 
stimulation: A rapid multiparameter analysis. Proceedings of The National Academy of 
Sciences of The United States of America 73:2881-2884. 
Davies,C.J., IJoosten, L.Andersson, M.A.Arriens, D.Bernoco, B.Bissumbhar, a.Byrns, 
M.J.T.van Eijk, B.Kristensen, H.A.Lewin, S.Mikko, A.G.Morgan, N.E.Mugglicockett, 
P.RNilsson, RA.Oliver, C. A. Park, JJ.Vanderpoel, M.Polli, RL.Spooner, and 
J.A.Stewart. 1994. Polymorphism of bovine MHC class-II genes. European Journal of 
Immunogenetics 21:259-289. 
Davies,C.J., L.Andersson, and S.A.Ellis. 1997. Nomenclature for factors of the BoLA 
system. Animal Genetics 28:159-168. 
Davis,W.C., J.A.Ellis, N.D.Machugh, and C.L.Baldwin. 1988. Bovine pan T-cell 
monoclonal antibodies reactive with a molecule similar to CD2. Immunology 63:165-
167. 
Davis,W.C. and G.S.Splitter. 1991. Individual antigens of cattle. Bovine CD2 (BoCD2). 
Veterinary Immunology and Immunopathology 27:43-50. 
Davis,W.C., W.C.Brown, M.J.Hamilton, C.RWyatt, J.A.Orden, A.M.Khalid, and 
J.Naessens. 1996. Analysis of monoclonal antibodies specific for the y8 TCR Veterinary 
Immunology and Immunopathology 52:275-283. 
DeBenedette,M.A., A.Shahinian, T.W.Mak, and T.H.Watts. 1997. Costimulation of 
CD28- T lymphocytes by 4-1BB ligand. Journal of Immunology 158:551-559. 
Deeths,M.J. and M.F.Mescher. 1997. B7-1 dependent co-stimulation results in 
qualitatively and quantitatively different responses by CD4(+) and CD8(+) T cells. 
European Journal of Immunology 27:598-608. 
Dekker,J.W. and S.Easteal. 1990. HLA-DQ typing by amplified fragment length 
polymorphisms (AFLPS). Immunogenetics 32:56-59. 
265 
Derbyshire,J.B. and D.T.Berman. 1968. Leukocytic responses of the bovine udder to 
infusion of certain irritants. American Journal of Veterinary Research 29: 1971-1977. 
Detilleux,J.c., K.J.Koehler, AS.Freedman, M.E.Kehrli, and D.H.Kelley. 1994. 
Immunological parameters of periparturient Holstein cattle: genetic variation. Journal of 
Dairy Science 77:2640-2650. 
Detilleux,J.c., M.E.Kehrli, J.RStabel, AE.Freeman, and D.H.Kelley. 1995. Study of 
immunological dysfunction in peri parturient Holstein cattle selected for high and average 
milk production. Veterinary Immunology and Immunopathology 44:251-267. 
Deutsch,H.F. and V.RSmith. 1957. Intestinal permeability to proteins in the newborn 
herbivore. American Journal of Physiology 191:271-276. 
Diaz-Jouanen,E. and RC.Williams. 1974. T and B lymphocytes in human colostrum. 
Clinical Immunology and Immunopathology 3:248-255. 
Dietz,AB., N.D. Cohen, L.Timms, and M.E.Kehrli. 1997. Bovine lymphocyte antigen 
class II alleles as risk factors for high somatic cell counts in milk of lactating dairy cows 
(a). Journal of Dairy Science 80:406-412. 
Dietz,AB., J.C.Detilleux, AE.Freeman, D.H.Kelley, J.RStabel, and M.E.Kehrli. 1997. 
Genetic association of bovine lymphocyte antigen DRB3 alleles with immunological 
traits of Holstein cattle (b). Journal of Dairy Science 80:400-405. 
Dikiniene,N. and Y.Aida. 1995. Cattle cDNA clones encoding MHC class-II DQBl and 
DQB2 genes. Immunogenetics 42:75. 
Dinarello,C.A 1989. Interleukin-l and its biologically related cytokines. Advances in 
Immunology 44: 153-205. 
Ding,L. and E.M.Shevach. 1996. Activated B cells express CD281B7 independent 
costimulatory activity. Journal of Immunology 157: 1389-1396. 
266 
Dixon,F.J., W.O.Weigle, and J.J.Vazquez. 1961. Metabolism and mammary secretion of 
serum proteins in the cow. Laboratory Investigation 10:216-237. 
Dodd,F.H., D.RWestgarth, F.K.Neave, and RG.Kingwill. 1969. Mastitis - the control 
strategy. Journal of Dairy Science 52:689-696. 
Dubey,C., M.Croft, and S.L.Swain. 1995. Costimulatory requirements of naive CD4(+) 
T-cells - ICAM-l or B7-1 can costimulate naive CD4 T-cell activation but both are 
required for optimum response. Journal of Immunology 155:45-57. 
Dubey,C. and M.Croft. 1996. Accessory molecule regulation of naive CD4 T cell 
activation. Immunologic Research 15: 114-125. 
Durandy,A., G.Desaintbasile, B.Lisowskagrospierre, J.F.Gauchat, M.Forveille, 
RA.Kroczek, J.Y.Bonnefoy, and A.Fischer. 1995. Undetectable CD40 ligand expression 
on T -cells and low B-cell responses to CD40 binding agonists in human newborns. 
Journal of Immunology 154: 1560-1568. 
Durie,F.H., T.M.Foy, S.RMasters, J.D.Laman, and RJ.Noelle. 1994. The role of CD40 
in the regulation of humoral and cell mediated immunity. Immunology Today 15:406-
411. 
Durum,S.K., C.Higuchi, and Y.Ron. 1984. Accessory cells and T-cell activation the 
relationship between 2 components of macrophage accessory cell function - Ia and IL-l. 
Immunobiology 168:213-231. 
Dustin,M.L., RRothlein, A.K.Bhan, C.A.Dinarello, and T.A.Springer. 1986. Induction 
by IL-l and interferon-gamma - tissue distribution, biochemistry, and function of a 
natural adherence molecule (ICAM-l). Journal of Immunology 137:245-254. 
Dustin,M.L., M.E.Sanders, S.Shaw, and T.A.Springer. 1987. Purified lymphocyte 
function associated antigen-3 binds to CD2 and mediates T -lymphocyte adhesion. 
Journal of Experimental Medicine 165:677-692. 
267 
Dustin,M.L. and T.ASpringer. 1991. Role oflymphocyte adhesion receptors in transient 
interactions and cell locomotion. Annual Review of Immunology 9:27-66. 
Du Preez,J .H., 1987. Comparison of various criteria for determining the health status of 
the bovine udder. Journal of the South African Veterinary Association 58:9-14. 
Eberhart,R.J., R.P.Natzke, and F.H.S.Newbould. 1979. Coliform mastitis - a review. 
Journal of Dairy Science 62:1-22. 
Egan,J. 1986. Summer mastitis prevalence in selected herds in the Irish Republic. 
Veterinary Record 119:577-578. 
Egan,J. 1990. Prevalence of summer mastitis in selected herds in the province of 
Leinster. Irish Veterinary Journal 43:74-75. 
Ellegren,H., C.J.Davies, and L.Andersson. 1993. Strong association between 
polymorphisms in an intronic microsatellite and in the coding sequence of the BoLA-
DRB3 gene - implications for microsatellite stability and PCR-based DRB3 typing. 
Animal Genetics 24:269-275. 
Elliott,T., V.Cerundolo, J.Elvin, and ATownsend. 1991. Peptide induced conformational 
change of the class-I heavy chain. Nature 351:402-406. 
Ellis,J.A, C.L.Baldwin, N.D.Machugh, ABensaid, AJ.Teale, B.M.Goddeeris, and 
W.I.Morrison. 1986. Characterisation by a monoclonal antibody and functional analysis 
of a subset bovine T lymphocytes that express BoT8, a molecule analogous to human 
CD8. Immunology 58:351-358. 
Ellis,J.A, W.I.Morrison, B.M.Goddeeris, and D.L.Emery. 1987. Bovine mononuclear 
phagocytic cells - identification by monoclonal antibodies and analysis of functional 
properties. Veterinary Immunology and Immunopathology 17: 125-134. 
268 
Emanuelson,U. 1988. Recording of production diseases in cattle and possibilities for 
genetic improvements - a review. Livestock Production Science 20:89-106. 
Emanuelson,U., B.Danell, and J.Philipsson. 1988. Genetic parameters for clinical 
mastitis, somatic cell counts, and milk production estimated by multiple trait restricted 
maximum likelihood. Journal of Dairy Science 71:467-476. 
Emery,D.L., N.K.Puri, Dufty.J.H., M.D.Gorrell, and M.RBrandon. 1987. A functional 
and biochemical analysis of bovine class II MHC antigens using monoclonal antibodies. 
Veterinary Immunology and Immunopathology 16:215-234. 
Engelhard,V.H. 1994. How cells process antigens. Scientific American 271:54-61. 
Engering,A.J., C.D.Richters, D.M.F1uitsma, A.M.van Pelt, E.W.A.Kamperdijk, 
E.C.M.Hoefsmit, and J.Pieters. 1998. MHC class II and invariant chain biosynthesis and 
transport during maturation of human precursor dendritic cells. International 
Immunology 10: 1713-1723. 
Erskine,RJ., RJ.Eberhart, L.J.Hutchison, S.B.Spencer, and M.A.Campbell. 1988. 
Incidence and types of clinical mastitis in dairy herds with high and low somatic cell 
counts. Journal of The American Veterinary Medical Association 192:761-765. 
Evans,C.W., J.E.Taylor, J.D.Walker, and N.L.Simmons. 1983. Transepithelial 
chemotaxis of the rat peritoneal exudate cells. British Journal of Experimental Pathology 
64:644-654. 
Exley,M., C.Terhorst, and T.Wileman. 1991. Structure, assembly and intracellular 
transport of the T cell receptor for antigen. Seminars in Immunology 3:283-297. 
Exley,M., T.Wileman, B.Mueller, and C.Terhorst. 1995. Evidence for multivalent 
structure of T-cell antigen receptor complex. Molecular Immunology 32:829-839. 
Fahey,J.L., H.Prince, M.Weaver, J.Groopman, B.Visscher, K.Schwartz, and RDetels. 
1984. Quantitative changes in T-helper or T-suppressor/cytotoxic lymphocyte subsets 
269 
that distinguish acquired immune deficiency syndrome from other Immune subset 
disorders. American Journal of Medicine 76:95-100. 
Falconer,D.S. 1989. Introduction to quantitative genetics. Longman Press, London and 
New York. 
Falk,K., O.Rotzschke, S.Stevanovic, G.lung, and H.G.Rammensee. 1991. Allele specific 
motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature 
351 :290-296. 
Farm Animal Welfare Council. 1997. Report on the Welfare of Dairy Cattle. 
Farnsworth, R. I. 1987. Indications of contagious and environmental mastitis pathogens 
in a dairy herd. Proceedings of the 26th Annual Meeting of the National Mastitis 
Council, 151-155. 
Fearon,D.T. and R.M.Locksley. 1996. Elements of immunity - The instructive role of 
innate immunity in the acquired immune response. Science 272:50-54. 
Feingold,N., I.Feingold, D.Mouton, Y.Bouthillier, C.Stiffel, and G.Biozzi. 1976. 
Polygenic regulation of antibody synthesis to sheep erythrocytes in the mouse: a genetic 
analysis. European Journal of Immunology 6:43-51. 
Ferens,W.A., W.L.Goff,· W.C.Davis, L.K.Fox, C.Deobald, M.I.Hamilton, and 
G.A.Bohach. 1998. Induction of type 2 cytokines by a staphylococcal enterotoxin 
superantigen. Journal of Natural Toxins 7:193-213. 
Ferens,W.A., W.C.Davis, M.I.Hamilton, y'H.Park, C.F.Deobald, L.Fox, and G.Bohach. 
1998. Activation of bovine lymphocyte subpopulations by staphylococcal enterotoxin C. 
Infection and Immunity 66:573-580. 
Ferrick,D.A., M.D.Schrenzel, T.Muvania, B.Hsieh, W.G.Ferlin, and H.Lepper. 1995. 
Differential production of interferon-y and interleukin-4 in response to Th-l and Th-2 
stimulating pathogens by yo T cells in vitro. Nature 373:255-257. 
270 
Ferrick,D.A, M.D.Schrenzel, T.Mulvania, B.Hsieh, W.G.Ferlin, and H.Lepper. 1995. 
Differential production of interferon-gamma and interleukin-4 in response to Thl-
stimulating and Th2-stimulating pathogens by gamma-delta T -cells in vivo. Nature 
373:255-257. 
Filippsen,L.F., P.Valentinweigand, H.Blobel, K.T.Preissner, and G.S.Chihatwai. 1990. 
Role of complement s protein (Vitronectin) In adherence of Streptococcus dysgalactiae 
to bovine epithelial cells. American Journal of Veterinary Research 51:861-865. 
Fitzpatrick, J. L. Antigen uptake, presentation and immune responses in the bovine 
mammary gland. 1992. PhD Thesis University of Bristol. 
Fitzpatrick,J.L., P.J.Cripps, AW.Hill, P.W.Bland, and C.R.Stokes. 1992. MHC class-IT 
expression in the bovine mammary gland. Veterinary Immunology and Immunopathology 
32:13-23. 
Fitzpatrick,J.L., N.AWilliams, M.Bailey, P.W.Bland, and C.R.Stokes. 1995. 
Presentation of soluble and bacterial antigens by milk derived cells to unprimed bovine 
T-cells in vitro. Veterinary Immunology and Immunopathology 46:251-266. 
Fitzpatrick, J. L., Young, F. J., Eckersall, D., Logue, D. N., Knight, C. J., and Nolan, A 
1998. Recognising and controlling pain and inflammation in mastitis. British Mastitis 
Conference, 36-44. 
Flamand,V., V.Donckier, F.x.Demoor, ALeMoine, P.Matthys, M.L.Vanderhaeghen, 
Y.Tagawa, Y.lwakura, ABilliau, D.Abramowicz, and M.Goldman. 1998. Cutting edge: 
CD40 ligation prevents neonatal induction of transplantation tolerance. Journal of 
Immunology 160:4666-4669. 
Fleischer,B. and H.Schrezenmeirer. 1988. T-cell stimulation by staphylococcal 
enterotoxins - clonally variable response and requirement for Major Histocompatibility 
Complex class-IT molecules on accessory or target cells. Journal of Experimental 
Medicine 167: 1697 -1707. 
271 
Fleischer,B., H.Schrezenmeirer, and P.Conradt. 1989. T lymphocyte activation by 
staphylococcal enterotoxins: role of class II molecules and T cell surface structures. 
Cellular Immunology 120:92-101. 
Fong,T.AT. and T.RMosmann. 1990. Alloreactive murine CD8+ T-cell clones secrete 
the Thl pattern of cytokines. Journal of Immunology 144:1744-1752. 
Fong,T.AT. and T.RMosmann. 1989. The role of IFN-gamma in delayed type 
hypersensitivity mediated by Thl clones. Journal of Immunology 143:2887-2893. 
Fox ,L.K., S.T.Chester, J.W.Hallberg, S.C.Nickerson, J.W.Pankey, and L.D.Weaver. 
1995. Survey of intramammary infections in dairy heifers at breeding age and first 
parturition. Journal of Dairy Science 78:1619-1628. 
Foy,T.M., AAruffo, J.Bajorath, J.E.Buhlmann, and RJ.Noelle. 1996. Immune regulation 
by CD40 and its ligand GP39. Annual Review of Immunology 14:591-617. 
Fraser,D.C., S.Craigmile, J.D.M.Campbell, R.A.Oliver, D.J.Brown, G.C.Russell, 
R.L.Spooner, and EJ.Glass. 1996. Functional expression of a cattle MHC class II DR-
like antigen on mouse L cells. Immunogenetics 43:296-303. 
Freedman,AS., G.Freeman, J.C.Horowitz, J.Daley, and L.M.Nadler. 1987. B7, a cell 
restricted B-cell-restricted antigen that identifies preactivated B-cells. Journal of 
Immunology 139:3260-3267. 
Freeman,G.J., AS.Freedman, J.M.Segil, G.Lee, J.F.Whitman, and L.M.Nadler. 1989. 
B7, a new member of the Ig superfamily with unique expression on activated and 
neoplastic B-cells. Journal of Immunology 143:2714-2722. 
Freeman,GJ., G.S.Gray, C.D.Gimmi, D.B.Lombard, L.J.zhou, M.White, J.D.Fingeroth, 
J.G.Gribben, and L.M.Nadler. 1991. Structure, expression, and T-cell costimulatory 
activity of the murine homolog of the human B-Iymphocyte activation antigen-B7. 
Journal of Experimental Medicine 174:625-631. 
272 
Freeman,G.J., F.Borriello, R.J.Hodes, H.Reiser, J.G.Gribben, J.W.Ng, J.Kim, 
J.M.Goldberg, K.Hathcock, G.Laszlo, L.ALombard, S.Wang, G.S.Gray, L.M.Nadler, 
and A.H.Sharpe. 1993. Murine B7-2, an alternative CTLA4 counter receptor that 
costimulates T-cell proliferation and interleukin-2 production. Journal of Experimental 
Medicine 178:2185-2192. 
Freeman,G.J., V.ABoussiotis, AAnumanthan, G.M.Bernstein, X.Y.Ke, P.D.Rennert, 
G.S.Gray, J.G.Gribben, and L.M.Nadler. 1995. B7-l and B7-2 do not deliver identical 
costimulatory signals, since B7-2 but not B7-l preferentially costimulates the initial 
production of IL-4. Immunity 2:523-532. 
Fries,R., R.Hediger, and G.Stranzinger. 1986. Tentative chromosomal localization of the 
bovine Major Histocompatibility Complex by in situ hybridization. Animal Genetics 
17:287-294. 
Fruchtmann,R., G.Uhlenbruck, D.O.Schmid, and S.Cwik. 1977. Characterization of T-
and B-Iymphocytes in cattle. Zentralbl Veterinaermed 24:486-496. 
Fukunaga,R., Y.Seto, S.Mizushima, and S.Nagata. 1990. Three different messenger 
RNAs encoding human granulocyte colony-stimulating factor receptor. Proceedings of 
The National Academy of Sciences of The United States of America 87:8702-8706. 
Gairola,C. and H.H.Tai. 1985. Selective inhibition of leukotriene B4 biosynthesis in rat 
pulmonary alveolar macrophages by dietary selenium deficiency. Biochemical and 
Biophysical Research Communications 132:397-403. 
Garcia,K.C., M.Degano, R.L.Stanfield, ABrunmark, M.R.Jackson, P.APeterson, 
L.Teyton, and I.AWilson. 1996. An alpha beta T cell receptor structure at 2.5A and its 
orientation in the TCR-MHC complex. Science 274:209-219. 
Garrett,T.J., M.ASaper, P.J.Bjorkman, J.L.Strominger, and D.C.Wiley. 1989. Specificity 
pockets for the side chains of peptide antigens in HLA-aw68. Nature 342:692-696. 
273 
Gaubin,M., M.Autiero, RHoulgatte, S.Basmaciogullari, e.Auffray, and 
D.PiatierTonneau. 1996. Molecular basis of T lymphocyte CD4 antigen functions. 
European Journal of Clinical Chemistry and Clinical Biochemistry 34:723-728. 
Gavora,J.S. and J.L.Spencer. 1983. Breeding for immune responsiveness and disease 
resistance. Animal Blood Groups and Biochemical Genetics 14: 159-180. 
Gay,e.C. 1965. Escherichia coli and neonatal disease of calves. Bacteriology Reviews 
29:75-101. 
Gay,D., P.Maddon, RSekaly, M.ATalle, M.Godfrey, E.Long, G.Goldstein, L.Chess, 
R.Axel, J.Kappler, and P.Marrack. 1987. Functional interaction between human T-cell 
protein CD4 and the Major Histocompatibility Complex HLA-DR antigen. Nature 
328:626-629. 
Gearing,AJ., D.Metcalf, J.G.Moore, and N.ANicola. 1989. Elevated levels of GM-CSF 
and IL-l in the serum, peritoneal and pleural cavities of GM-CSF transgenic mice. 
Immunology 67:216-220. 
Geldermann,H. 1975. Investigations on inheritance of quantitative characters in animals 
by gene markers. Theoretical and Applied Genetics 46:319-330. 
Gelfand,E.W., L.P.Landwehr, B.Ested, and B.Mazer. 1996. Intravenous immune 
globulin: An alternative therapy in steroid dependent allergic diseases. Clinical and 
Experimental Immunology 104:61-66. 
Gelhaus,A, L.Schnittger, D.Mehlitz, RD.Horstmann, and e.G. Meyer. 1995. Sequence 
and PCR-RFLP analysis of 14 novel BoLA-DRB3 alleles. Animal Genetics 26: 147-153. . 
Gilbert,RO., y'T.Grohn, e.L.Guard, V.Surman, N.Neilsen, and D.O.Slauson. 1993. 
Impaired postpartum neutrophil function in cows which retain foetal membranes. 
Research in Veterinary Science 55: 15-19. 
274 
Gilliespie,B.E., B.MJayarao, H.H.Dowlen, and S.P.Oliver. 1999. Analysis and 
frequency of bovine lymphocyte antigen DRB3.2 alleles in Jersey cows. Journal of Dairy 
Science 82:2049-2053. 
Gillis,S., K.ASmith, and P.Wauters. 1980. Biochemical characterization of lymphocyte 
regulatory molecules. II. Purification of a class of rant and human lymphokines. Journal 
of Immunology 124:1954-1962. 
Giraudo,J.A, ACalzolari, H.Rampone, ARampone, AT.Giraudo, C.Bogni, 
A.Larriestra, and RNagel. 1997. Field trials of a vaccine against bovine mastitis .1. 
Evaluation in heifers. Journal of Dairy Science 80:845-853. 
Giri,S.N., G.H.Stabenfeldt, T.AMoseley, T.W.Graham, M.L.Bruss, RH.Bondurant, 
J.S.Cullor, and B.I.Osbum. 1991. Role of eicosanoids in abortion and its prevention by 
treatment with flunixin meglumine in cows during the 1st trimester of pregnancy. 
Journal of Veterinary Medicine Series A-Zentralblatt Fur Veterinaermedizin Reihe A-
Physiology Pathology Clinical Medicine 38:445-459. 
Glass,E.J. and RL.Spooner. 1989. Requirement for MHC class II positive accessory cells 
in an antigen specific bovine T cell repsonse. Research in Veterinary Science 46: 196-
201. 
Glass,E.J., RAOliver, and RL.Spooner. 1991. Bovine T cells recognize antigen in 
association with MHC class II haplotypes defined by one-dimensional isoelectric 
focusing. Immunology 72:380-385. 
Glass,E.J., RAOliver, J.L.Williams, and P.Millar. 1992. Alloreactive T-cell recognition 
of bovine Major Histocompatibility Complex class II products defined by one 
dimensional isoelectric focusing. Animal Genetics 23:97-111. 
Glass,E.J. and P.Millar. 1994. Induction of effective cross reactive immunity by FMDV 
peptides is critically dependent upon specific MHC-peptide-T-cell interactions. 
Immunology 82: 1-8. 
275 
Goddeeris,B.M., W.I.Morrison, J.Naessens, and G.Magonduj. 1987. The bovine 
autologous mixed leucocyte reaction: a proliferative response of non T -cells under the 
control of monocytes. Immunobiology 176:47-62. 
Goldblum,RM., S.Ahlstedt, B.Carlsson, L.AHanson, U.Jodal, G.Lidin-Janson, and 
ASohl-Akerlund. 1975. Antibody forming cells in human colostrum after oral 
immunisation. Nature 257:797-798. 
Goldstein,J.S., T.Chen, M.Brunswick, H.Mostowsky, and S.Kozlowski. 1998. Purified 
MHC class I and peptide complexes activate naive CD8(+) T cells independently of the 
CD281B7 and LFA-1IICAM-1 costimulatory interactions. Journal of Immunology 
160:3180-3187. 
Gordon,W.G., J.Ziegler, and J.J.Basch. 1962. Isolation of an iron binding protein from 
cows milk. Biochemica et Biophysica Acta 60:410-411. 
Gowans,J.L. and E.J.Knight. 1964. The route of recirculation of lymphocytes in the rat. 
Proc.Soc.London 159:257-282. 
Graf,D., S.Muller, U.Korthauer, C.Vankooten, C.Weise, and RAKroczek. 1995. A 
soluble form of trap (CD40 ligand) Is rapidly released after T-cell activation. European 
Journal of Immunology 25: 1749-1754. 
Greenberger,M.J., S.L.Kunkel, RM.Strieter, N.W.Lukacs, J.Bramson, J.Gauldie, 
F.L.Graham, M.Hitt, J.M.Danforth, and T.J.Standiford. 1996. IL-12 gene therapy 
protects mice in lethal Klebsiella pneumonia. Journal of Immunology 157:3006-3012. 
Gregersen,P.K., J.Silver, and RWinchester. 1987. The shared epitope hypothesis. AN 
approach to understanding the molecular genetics of susceptibility to rheumatoid 
arthritis. Journal of Rheumatoid Arthritis 30: 1205-1213. 
Grey,H.M. and RChesnut. 1985. Antigen processing and presentation to T-cells. 
Immunology Today 6:101-106. 
276 
Groenen,M.M., J.J.Vanderpoel, RM.Dijkhof, and M.J.Giphart. 1990. The nucleotide 
sequence of bovine MHC class-II DQB and DRB genes. Immunogenetics 31:37-44. 
Groenen,M.M., J.J.Vanderpoel, RM.Dijkhof, and MJ.Giphart. 1989. Cloning of the 
bovine Major Histocompatibility Complex class-II genes. Animal Genetics 20:267-278. 
Grootenhuis,G. 1981. Mastitis prevention by selection of sires. Veterinary Record 
108:258-260. 
Grosz,M.D., J.E.Womack, and L.C.Skow. 1992. Syntenic conservation of HSP70 genes 
in cattle and humans. Genomics 14:863-868. 
Gruber,M.F., J.M.Bjomdahl, S.Nakamura, and S.M.Fu. 1989. Anti-CD45 inhibition of 
human B-cell proliferation depends on the nature of activation signals and the state of B-
cell activation - a study with anti-IgM and anti-CDw40 antibodies. Journal of 
Immunology 142:4144-4152. 
Gudding,R, J.S.McDonald, and N.F.Cheville. 1984. Pathogenesis of Staphylococcus 
aureus mastitis - bacteriologic, histologic, and ultrastructural pathologic findings. 
American Journal of Veterinary Research 45:2525-2531. 
Guidry,A.J., MJ.Paape, and J.K.L.Pearson. 1975. Effects of estrus and exogenous 
estrogen on circulating neutrophils and milk somatic cell concentration, neutrophil 
phagocytosis, and occurrence of clinical mastitis in cows. American Journal of 
Veterinary Research 36: 1555-1560. 
Gurish,M.F., N.Ghildyal, H.P.McNeil, K.F.Austen, S.Gillis, and RL.Stevens. 
Differential expression of secretory granule proteases in mouse mast cells exposed to 
interleukin-3 and c-kit ligand. Journal of Experimental Medicine 175: 1003-1012. 
Haas,W., P.Pereira, and S.Tonegawa. 1993. Gamma delta T-cells. Annual Review of 
Immunology 11:637-685. 
277 
Hajek,V. and E.Marsalek. 1971. The differentiation of pathogenic staphlococci and a 
suggestion for their taxonomic classification. Zentralbl. Bakteriol. Parasitendk. 217: 176-
182. 
Hall,J.G., B.Morris, G.D.Moreno, and M.Bessis. 1967. The ultra structure and function 
of the cells in lymph nodes following antigenic challenge. Journal of Experimental 
Medicine 125:91-101. 
HanbyFlarida,M.D., OJ.Trask, TJ.Yang, and C.L.Baldwin. 1996. Modulation ofWC1, a 
lineage specific cell surface molecule of gamma/delta T cells, augments cellular 
proliferation. Immunology 88:116-123. 
Hanke,J.H., M.F.Brown, M.S.Pollack, and RRRich. 1985. Class-II determinants 
recognized by TNP-specific cloned human T-cell lines. Human Immunology 14:59-76. 
Hannet,l., F.Erkelleryuksel, P.Lydyard, V.Deneys, and M.Debruyere. 1992. 
Developmental and maturational changes in human blood lymphocyte sUbpopulations. 
Immunology Today 13:215-218. 
Harding,C.V. 1996. Class II antigen processing: analysis of compartments and functions. 
Critical Reviews in Immunology 16:13-29. 
Harding,F.A., J.G.Mcarthur, J.A.Gross, D.H.Raulet, and J.P.Allison. 1992. CD28-
mediated signaling co-stimulates murine T -cells and prevents induction of anergy in T-
cell clones. Nature 356:607-609. 
Harding,F.A. and J.P.Allison. 1993. CD28-B7 interactions allow the induction of CD8+ 
cytotoxic T -lymphocytes in the absence of exogenous help. Journal of Experimental 
Medicine 177:1791-1796. 
Harmon,RJ., F.L.Schanbacher, L.C.Ferguson, and K.L.Smith. 1975. Concentrations of 
lactoferrin in milk of normal lactating cows and changes occurring during mastitis. 
American Journal Veterinary Research 36: 1001-1007. 
278 
Hannon,RJ. 1994. Physiology of mastitis and factors affecting somatic cell counts. 
Journal of Dairy Science 77:2103-2112. 
Harp,J.A and H.W.Moon. 1988. Lymphocyte localization in lymph nodes of swine -
changes induced by lactation. Veterinary Immunology and Immunopathology 18:219-
227. 
Harp,J.A, B.APesch, and P.L.Runnels. 1990. Extravasation of lymphocytes via 
paracortical venules in sheep lymph nodes - visualization using an intracellular 
fluorescent label. Veterinary Immunology and Immunopathology 24: 159-167. 
Harp,J.A, M.E.Kehrli, D.J.Hurley, RAWilson, and T.C.Boone. 1991. Numbers and 
percent of T lymphocytes in bovine peripheral blood during the periparturient period. 
Veterinary Immunology and Immunopathology 28:29-35. 
Harp,J.A and B.J.Nonnecke. 1986. Regulation of mitogenic responses by bovine milk 
leukocytes. Veterinary Immunology and Immunopathology 11:215-224. 
Harp,J.A and H.W.Moon. 1987. Lymphocyte localization in lymph nodes of pubescent, 
prepartum, and postpartum sheep. Veterinary Immunology and Immunopathology 
15:297-310. 
Harp,J.A, P.L.Runnels, and B.APesch. 1988. Lymphocyte recirculation in cattle: 
patterns of localization by mammary and mesenteric lymph node lymphocytes. 
Veterinary Immunology and Immunopathology 20:31-39. 
Harp,J.A, M.E.Kehrli, D.J.Hurley, RAWilson, and T.C.Boone. 1991. Numbers and 
percent of T lymphocytes in bovine peripheral blood during the peri parturient period. 
Veterinary Immunology and Immunopathology 28:29-35. 
Harvey,J. and AGilmour. 1985. Application of current methods for isolation and 
identification of staphylococci in raw bovine milk. Journal of Applied Bacteriology 
59:207-221. 
279 
Hathcock,K.S., G.Laszlo, H.B.Dickler, J.Bradshaw, P.Linsley, and RJ.Hodes. 1993. 
Identification of an alternative CTLA-4 ligand costimulatory for T-cell activation. 
Science 262:905-907. 
Hayashi,S., S.AJohnston, and ATakashima. 2000. Induction of Th2-directed immune 
responses by IL-4 transduced dendritic cells in mice. Vaccine 18:3097-3105. 
Heald,C.W. 1979. Morphometric study of experimentally induced Staphylococcus bovis 
mastitis in the cow. American Journal of Veterinary Research 40: 1294-1298. 
Heemels,M.T. and H.Ploegh. 1995. Generation, translocation, and presentation of mhc 
class-I restricted peptides. Annual Review of Biochemistry 64:463-491. 
Hein,W.R and C.RMackay. 1991. Prominence of gamma delta T-cells in the ruminant 
immune system. Immunology Today 12:30-34. 
Hein,W.R 1994. Ontogeny of T cells. In Cell mediated Immunity in Ruminants. 
B.M.L.Goddeeris and W.I.Morrison editors. CRC Press, London 19-35. 
Hellstrom,U., M.L.Dillner, S.Hammarstrom, and P.Perlmann. 1976. The interaction of 
nonmitogenic and mitogenic lectins with T lymphocytes: association of cellular receptor 
sites. Scandanavian Journal of Immunology 5:45-54. 
Hendrick,AM., B.J.Gormus, and S.H.Leech. 1985. Comparison of peripheral blood 
lymphocyte C3 receptor capping properties in patients with chronic lymphocytic 
leukemia and lymphoma. Cancer 56:1538-1542. 
Hepkema,B.G., M.G.J.Tilanus, H.J.Blankert, G.AAAlbers, M.C.GrosfeldStulemeyer, 
and E.J.Hensen. 1993. A high recombination frequency within the chicken Major 
Histocompatibility (B) Complex. Animal Genetics 24:389-391. 
Hermann,P., C.Vankooten, C.Gaillard, J.Banchereau, and D.Blanchard. 1995. CD40 
ligand positive CD8( +) T-cell clones allow B-cell growth and differentiation. European 
Journal of Immunology 25:2972-2977. 
280 
HemandezCaselles, T., M.MartinezEsparza, AI.Lazarovits, and P .Aparicio. 1996. 
Specific regulation of VLA-4 and alpha(4)beta(7) integrin expression on human activated 
T lymphocytes. Journal of Immunology 156:3668-3677. 
Heumann,AM. and C.Stiffel. 1978. Immune responsiveness of high and low antibody 
producing lines of mice against an antigen non-cross-reacting with the selection antigen. 
Annual Review of Immunology 129:13-27. 
Heuven,H.M., H.Bovenhuis, and R.D.Politiek. 1988. Inheritance of somatic cell count 
and its genetic relationship with milk yield in different parities. Livestock Production 
Science 18:115-127. 
Heyen,D.W., J.I.Weller, M.Ron, M.Band, J.E.Beever, E.Feldmesser, Y.Da, 
G.R.Wiggans, P.M.VanRaden, and H.ALewin. 1999. A genome scan for QTL 
influencing milk production and health traits in dairy cattle. Physiological Genomics 
1:165-175. 
Hibbitt,K.G., C.B.Cole, and B.Reiter. 1969. Antimicrobial proteins isolated from the teat 
canal of the cow. Journal of General Microbiology 56:371-365. 
Higginbotham,J.N. and S.B.Pruett. 1994. Assessment of the correlation between nitrite 
concentration and listericidal activity in cultures of resident and elicited murine 
macrophages. Clinical and Experimental Immunology 97: 100-106. 
Hill,A.W. 1981. Factors influencing the outcome of Escherichia coli mastitis in the dairy 
cow. Research in Veterinary Science 31:107-112. 
Hillerton, J. 1996. Cell count recovery from mastitits. British Mastitis Conference , 13-
19. 
Hillerton, J. 1998. Mastitis treatment - a welfare issue. British Mastitis Conference, 3-8. 
1998. 
Hillerton,J.E. 1987. Summer mastitis - vector transmission or not. Parasitology Today 
3: 121-123. 
281 
Hillerton,J.E., AJ.Bramley, and C.AWatson. 1987. The epidemiology of summer 
mastitis - a survey of clinical cases. British Veterinary Journal 143:520-530. 
Hillerton,J.E., J.H.West, and M.H.Shearn. 1992. The cost of summer mastitis. Veterinary 
Record 131:315-317. 
Hines,H.C., F.R.Allaire, and M.M.Michalak. 1986. Association of bovine lymphocyte 
antigens with milk fat percentage differences. Journal of Dairy Science 69:3148-3150. 
Hines,T.G., N.L.Jacobson, D.C.Beitz, and E.T.Littledike. 1986. Effects of dietary 
calcium, vitamin-D3, and com supplementation on growth performance and mineral 
metabolism in young goats fed whole milk diets. Journal of Dairy Science 69:2868-2876. 
Hirano,T., S.Akira, T.Taga, and T.Kishimoto. 1990. Biological and clinical aspects of 
interleukin-6. Immunology Today 11:443-449. 
Hirvonen,J., S.Pyorala, AHeinasuo, and H.Jousimiessomer. 1994. Penicillin-G and 
penicillin-G tinidazole treatment of experimentally induced summer mastitis - effect on 
elimination rates of bacteria and outcome of the disease. Veterinary Microbiology 
42:307-315. 
Hisatsune,T., AEnomoto, K.Nishijima, Y.Minai, Y.Asano, T.Tada, and S.Kaminogawa. 
1990. CD8+ suppressor T-cell clone capable of inhibiting the antigen T-cell and anti-T-
cell receptor induced proliferation of Th clones without cytolytic activity. Journal of 
Immunology 145:2421-2426. 
Hogan,J.s., W.P.Weiss, and K.L.Smith. 1993. Role of vitamin-E and selenium in host 
defense against mastitis. Journal of Dairy Science 76:2795-2803. 
Hohenboken,W.D. 1987. Heritability and repeatability. G.Simms, editor. 77-119. 
Holdaway,RJ., C.W.Holmes, and I.J.Steffert. 1996. A comparison of indirect methods 
for diagnosis of subclinical intramammary infection in lactating dairy cows .3. Prediction 
of the incidence of infections and the critical threshold value for somatic cell count from 
282 
the herd's bulk milk somatic cell count. Australian Journal of Dairy Technology 51:79-
82. 
Holsti,M.A, I.Mcarthur, I.P.Allison, and D.H.Raulet. 1994. Role of IL-6, IL-l, and 
CD28 signaling in responses of mouse CD4( +) T -cells to immobilized anti-TCR 
monoclonal antibody. Journal of Immunology 152: 1618-1628. 
Holter,W., M.Schwarz, ACerwenka, and W.Knapp. 1996. The role of CD2 as a regulator 
of human T-cell cytokine production. Immunological Reviews 153: 107-122. 
Honkanen-Buzalski,T., T.Katila, and M.Sandholm. 1981. Milk antitrypsin activity during 
clinical and experimental bovine mastitis. Acta Veterinaria Scandinavica 22:360-368. 
Hood,L., M.Steinmetz, R.Goodenow, K.Eakle, D.Fisher, I.Kobori, B.Malissen, 
M.Malissen, M.McMillan, I.McNicholas, AOm, M.Pecht, B.T.Sher, L.Smith, 
IStroynowski, H.SUN, AWinoto, and M.Zuniga. 1982. Genes of the Major 
Histocompatibility Complex. Cold Spring Harbor Symposia On Quantitative Biology 
47:1051-1065. 
Hooper,D.C. and R.B.Taylor. 1987. Specific helper T-cell reactivity against autologous 
erythrocytes implies that self tolerance need not depend on clonal deletion. European 
Journal of Immunology 17:797-802. 
Hooper,D.C., D.H.Chantry, and W.D.Billington. 1987. Murine pregnancy associated 
modulations in lymphocyte reactivity to mitogens - identification of the cell populations 
affected. Journal of Reproductive Immunology 11 :273-286. 
Houssiau,F.A, P.G.Coulie, D.Olive, and I.Vansnick. 1988. Synergistic activation of 
human T -cells by interleukin-l and interleukin-6. European Journal of Immunology 
18:653-656. 
Houssiau,F.A, P.G.Coulie, and I.Vansnick. 1989. Distinct roles of IL-l and IL-6 in 
human T-cell activation. Journal of Immunology 143:2520-2524. 
283 
Howard,C.J., P.Sopp, and K.R.Parsons. 1992. L-selectin expression differentiates T-cells 
isolated from different lymphoid-tissues in cattle but does not correlate with memory. 
Immunology 77:228-234. 
Howard,C.J., M.C.Clarke, P.Sopp, and J.Brownlie. 1992. Immunity to bovine virus 
diarrhea virus in calves - the role of different T-cell subpopulations analyzed by specific 
depletion in vivo with monoclonal antibodies. Veterinary Immunology and 
Immunopathology 32:303-314. 
Howard,C.J., P.Sopp, K.R.Parsons, and J.Finch. 1989. In vivo depletion of BoT4 (CD4) 
And of non-T4ff8 lymphocyte subsets in cattle with monoclonal antibodies. European 
Journal of Immunology 19:757-764. 
Howard,C.J., P.Sopp, K.R.Parsons, DJ.Mckeever, E.N.Taracha, B.V.Jones, 
N.D.Machugh, and W.I.Morrison. 1991. Distinction of naive and memory BoCD4 
lymphocytes in calves with a monoclonal antibody, cc76, to a restricted determinant of 
the bovine leukocyte common antigen, CD45. European Journal of Immunology 
21:2219-2226. 
Howard,C.J. and W.I.Morrison. 1991. Leukocyte antigens in cattle, sheep and goats -
results of comparison tests - introduction. Veterinary Immunology and Immunopathology 
27:19-20. 
Howard,C.J. and J.C.Hope. 2000. Dendritic cells, implications on function from studies 
of the afferent lymph veiled cell. Veterinary Immunology and Immunopathology 77:1-13. 
Howe,P.E. 1921. An effect of the ingestion of colostrum upon the composition of the 
blood in newborn calves. Journal of Biological Chemistry 49: 115. 
Hsieh,C.S., A.B.Heimberger, J.S.Gold, A.Ogarra, and K.M.Murphy. 1992. Differential 
regulation of T -helper phenotype development by interleukin-4 and interleukin-10 in an 
alpha-beta-T -cell-receptor transgenic system. Proceedings of The National Academy of 
Sciences of The United States of America 89:6065-6069. 
284 
Hunt,D.F., R.A.Henderson, J.Shabanowitz, K.Sakaguchi, H.Michel, N.Sevilir, A.L.Cox, 
E.Appella, and V.H.Engelhard. 1992. Characterization of peptides bound to the class I 
MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-1263. 
Husband,A.J. 1982. Kinetics of extravasation and redistribution of IgA specific antibody 
containing cells in the intestine. Journal of Immunology 128:1355-1359. 
Huston,D.P., A.F.Kavanaugh, P.W.Rohane, and M.M.Huston. 1991. Immunoglobulin 
deficiency syndromes and therapy. Journal of Allergy and Clinical Immunology 87:1-17. 
Hyatt,J.M., D.E.Nix, C.W.Stratton, and J.J.Schentag. 1995. In vitro pharmacodynamics 
of piperacillin, piperacillin-tazobactam, and ciprofioxacin alone and in combination 
against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and 
Pseudomonas aeruginosa. Antimicrobial agents and Chemotherapy 39: 1711-1716. 
Ingulli,E., A.Mondino, A.Khoruts, and M.K.Jenkins. 1997. In vivo detection of dendritic 
cell antigen presentation to CD4(+) T cells. Journal of Experimental Medicine 185:2133-
2141. 
Interbull. 1996. Sire evaluation procedures for non-dairy production and growth and beef 
production traits practised in various countries. Interbull evaluation services 13:33-41. 
Interbull. 1996. Sire evaluation procedures for non-dairy production and growth and beef 
production traits practised in various countries. Interbull evaluation services 13: 129-139. 
Interbull. 1996. Sire evaluation procedures for non-dairy production and growth and beef 
production traits practised in various countries. Interbull evaluation services 13:153-158. 
Ishikawa,H., T.Shirahata, and K.Hasegawa. 1994. Interferon-gamma production of 
mitogen stimulated peripheral lymphocytes in prenatal cows. Journal of Veterinary 
Medical Science 56:735-738. 
Ismail,H.I., Y.Hashimoto, Y.Kon, A.Konno, H.Yamazoe, and T.Iwanaga. 1996. The 
distribution of immunoglobulin containing cells and T lymphocyte subpopulations in the 
285 
mouse mammary gland: A morphometric and immunohistochemical study. Biomedical 
Research Tokyo 17:105-113. 
Ito,T. and M.Komada. 1996. Demonstration by reverse transcription polymerase chain 
reaction of multiple cytokine rnRNA expression in bovine alveolar macrophages and 
peripheral blood mononuclear cells. Research in Veterinary Science 60:94-96. 
Jain,N.C. 1979. Common mammary pathogens and factors in infection and mastitis. 
Journal of Dairy Science 62: 128-134. 
Jameson,S.c., K.A.Hogquist, and M.J.Bevan. 1995. Positive selection of thymocytes. 
Annual Review of Immunology 13:93-126. 
Janeway,c.A., BJones, and A.Hayday. 1988. Specificity and function of T-cells bearing 
gamma delta receptors. Immunology Today 9:73-76. 
Janeway,c.A. and P.Golstein. 1992. Lymphocyte activation and effector functions - a 
return to intimacy. Current Opinion in Immunology 4:241-245. 
Jensen,D.L. and R.J.Eberhart. 1975. Macrophages in bovine milk. American Journal of 
Veterinary Research 36:619-624. 
Jensen,D.L. and R.J.Eberhart. 1981. Total and differential cell counts in secretions of the 
nonlactating bovine mammary gland. American Journal of Veterinary Research 42:743-
747. 
Johnson,P., L.Greenbaum, K.Bottomly, and I.S.Trowbridge. 1989. Identification of the 
alternatively spliced exons of murine CD45 (T200) Required for reactivity with b220 and 
other t200 restricted antibodies. Journal of Experimental Medicine 169: 1179-1184. 
Jones,W.P., L.B.Hansen, and H.Chester-Jones. 1994. Response of health care to selection 
for milk yield of dairy cattle. Journal of Dairy Science 77:3137-3152. 
286 
Joseph,S.B., K.T.Miner, and M.Croft. 1998. Augmentation of naive, Th1 and Th2 
effector CD4 responses by IL-6, IL-1 and TNF. European Journal of Immunology 
28:277-289. 
June,e.H., J.A.Ledbetter, P.S.Linsley, and e.B.Thompson. 1990. Role of the CD28 
receptor in T-cell activation. Immunology Today 11:211-216. 
Justement,L.B., V.K.Brown, and J.J.Lin. 1994. Regulation of B-cell activation by CD45 -
a question of mechanism. Immunology Today 15:399-406. 
Jutila,M.A., E.L.Berg, T.K.Kishimoto, L.J.Picker, RF.Bargatze, D.K.Bishop, e.G.Orosz, 
N.W.Wu, and E.C.Butcher. 1989. Inflammation induced endothelial cell adhesion to 
lymphocytes, neutrophils, and monocytes. Role of homing receptors and other adhesion 
molecules. Transplantation 48:727-731. 
Kalish,RS. and S.F.Schlossman. 1985. The lymphocyte-T4 in AIDS. New England 
Journal of Medicine 313: 112-113. 
Kato,K., M.Koyanagi, H.Okada, T.Takanashi, Y.W.Wong, A.F.Williams, K.Okumura, 
and H.Yagita. 1992. CD48 is a counter receptor for mouse CD2 and is involved in T-cell 
activation. Journal of Experimental Medicine 176: 1241-1249. 
Kawamura,T. and M.Furue. 1995. Comparative analysis of B7-1 and B7-2 expression in 
Langerhans cells - differential regulation by T -helper type-1 and T -helper type-2 
cytokines. European Journal of Immunology 25:1913-1917. 
Kean,RP., W.E.Briles, A.Cahaner, A.E.Freeman, and S.J.Lamont. 1994. Differences in 
Major Histocompatibility Complex frequencies after multitrait, divergent selection for 
immunocompetence. Poultry Science 73:7-17. 
Kehrli,M.E., B.J.Nonnecke, and J.A.Roth. 1989. Alterations in bovine neutrophil 
function during the periparturient period (a). American Journal of Veterinary Research 
50:207-214. 
287 
Kehrli,M.E. and J.P.Goff. 1989. Periparturient hypocalcemia in cows - effects on 
peripheral blood neutrophil and lymphocyte function (b). Journal of Dairy Science 
72: 1188-1196. 
Kehrli,M.E., J.P.Goff, M.G.Stevens, and T.C.Boone. 1991. Effects of granulocyte 
colony-stimulating factor administration to peri parturient cows on neutrophils and 
bacterial shedding. Journal of Dairy Science 74:2448-2458. 
Kehrli,M.E., J.S.Cullor, and S.C.Nickerson. 1991. Immunobiology of hematopoietic 
colony-stimulating factors - potential application to disease prevention in the bovine. 
Journal of Dairy Science 74:4399-4412. 
Kelley,K.W. 1980. Stress and immune function: a bibliographic review. Annuales 
Recherche Veterinaire 11:445-478. 
Kelm,S.C., J.C.Detilleux, AE.Freeman, M.E.Kehrli, AB.Dietz, L.K.Fox, J.E.Butler, 
I.Kasckovics, and D.H.Kelley. 1997. Genetic association between parameters of innate 
immunity and measures of mastitis in periparturent Holstein cattle. Journal of Dairy 
Science 80:1767-1775. 
Kenny,K., R.F.Reiser, F.D.Bastidacorcuera, and N.L.Norcross. 1993. Production of 
enterotoxins and toxic shock syndrome toxin by bovine mammary isolates of 
Staphylococcus aureus. Journal of Clinical Microbiology 31:706-707. 
Kent,G.M. and F.H.S.Newbould. 1969. Phagocytosis and related phenomena in PMN 
leucocytes from cows milk. Canadian Journal of Comparative Medicine 33:214-219. 
Kiener,P.A, P.M.Davis, G.C.Starling, C.Mehlin, S.J.K1ebanoff, J.ALedbetter, and 
W.C.Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in 
human monocytes and macrophages. Journal of Experimental Medicine 185:1511-1516. 
Kiessling,R. and O.Haller. 1978. Natural killer cells in the mouse: an alternative immune 
surveillance mechanism? Contempary Topics of Immunobiolo gy 8: 171-201. 
288 
Kim,S.K., D.S.Reed, S.Olson, MJ.Schnell, J.K.Rose, P.AMorton, and L.Lefrancois. 
1998. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific 
environmental and costimulatory signals. Proceedings of The National Academy of 
Sciences of The United States of America 95:10814-10819. 
Kimpton,W.G., E.AWashington, and Rn.P.Cahill. 1989. Recirculation of lymphocyte 
subsets (CD5+, CD4+, CD8+, T19+ and B-cells) through fetal lymph nodes. Immunology 
68:575-579. 
Kimpton,W.G., E.AWashington, and Rn.P.Cahill. 1990. Nonrandom migration of 
CD4+, CD8+, yB+, T19+, and B-cells between blood and lymph draining ileal and 
prescapular lymph nodes in the sheep fetus. International Immunology 2:937-943. 
Kimura,K., J.P.Goff, M.E.Kehrli, and J.AHarp. 1999. Phenotype analysis of peripheral 
blood mononuclear cells in periparturient dairy cows. Journal of Dairy Science 82:315-
319. 
Kirby,W.M.M. 1944. Extraction of a highly potent penicillin inactivator from penicillin 
resistant staphylococci. Science 99:452-453. 
Kishihara,K., J.Penninger, V.AWallace, T.M.Kundig, K.Kawai, AWakeham, E.Timms, 
K.Pfeffer, P.S.Ohashi, M.L.Thomas, C.Purlonger, C.J.Paige, and T.W.Mak. 1993. 
Normal B-Iymphocyte development but impaired T-cell maturation in CD45 exon 6 
protein tyrosine phosphatase deficient mice. Cell 74: 143-156. 
Kishimoto,C., J.T.Kumick, J.T.Pallon, c.S.Crumpacker, and W.H.Abelmann. 1989. 
Characteristics of lymphocytes cultured from murine viral myocarditis specimens - a 
preliminary and technical report. Journal of The American College of Cardiology 
14:799-802. 
Kishimoto,C. and W.H.Abelmann. 1989. Monoclonal antibody therapy for prevention of 
acute Coxsackie virus B3 myocarditis in mice. Circulation 79: 1300-1308. 
289 
Klein,1. 1975. Biology of the mouse Histocompatability-2 Complex; principles of 
immunogenetics applied to a single system. Springer Verlag, New York. 
Klein,1. 1986. Natural History of the Major Histocompatability Complex. Wiley 
Interscience Publications, John Wiley and Sons Inc., New York. 
Klein,1. and F.Figueroa. 1986. Evolution of the Major Histocompatibility Complex. CRc 
Critical Reviews in Immunology 6:295-386. 
Klein,J.S. and V.Horejsi. 1999. Immunology 2nd edition. Blackwell Science Ltd, London. 
Kohl,S., L.S.Loo, and L.K.Pickering. 1981. Protection of neonatal mice against herpes 
simplex viral infection by human antibody and leukocytes from adult, but not neonatal 
humans. Journal of Immunology 127: 1273-1275. 
Koldeweij,E., U.Emanuelson, and L.Janson. 1999. Relation of milk production loss to 
milk somatic cell count. Acta Veterinaria Scandinavica 40:47-56. 
Koller,L.D., S.A.Mulhem, N.C.Frankel, M.G.Steven, and J.R.Williams. 1987. Immune 
dysfunction in rats fed a diet deficient in copper. American Journal of Clinical Nutrition 
45:997-1006. 
Kong,Y.Y., K.Kishihara, H.Sumichika, T.Nakamura, M.Kaneko, and K.Nomoto. 1995. 
Differential requirements of CD45 for lymphocyte development and function. European 
Journal of Immunology 25:3431-3436. 
Kong,Y.Y., K.Kishihara, H.Yoshida, T.W.Mak, and K.Nomoto. 1995. Generation of T-
cells with differential responses to alloantigens in CD45 ex on 6 deficient mice. Journal 
of Immunology 154:5725-5735. 
Korman,A.J., J.M.Boss, T.Spies, R.Sorrentino, K.Okada, and J.L.Strominger. 1985. 
Genetic complexity and expression of human class-IT histocompatibility antigens. 
Immunological Reviews 85:45-86. 
290 
Kortbeekjacobs,N. and H.Vanderdonk. 1981. Messenger RNA from porcine colostral and 
milk cells coding for specific antibodies in response to orally administered Escherichia 
coli strains. Veterinary Immunology and Immunopathology 2:441-451. 
Kossaibati,M.A. and RJ.Esslemont. 1997. The costs of production diseases in dairy 
herds in England. Veterinary Journal 154:41-51. 
Kotzin,B.L., D.Y.M.Leung, J.Kappler, and P.Marrack. 1993. Superantigens and their 
potential role in human disease. Advances in Immunology 54:99-166. 
Kovarik,J. and C.A.Siegrist. 1998. Optimization of vaccine responses in early life: The 
role of delivery systems and immunomodulators. Immunology and Cell Biology 76:222-
236. 
Kowalski,J.J. and D.T.Berman. 1971. Immunobiological activity of cell wall antigens of 
Staphylococcus aureus. Infection and Immunity 4:205-211. 
Kraal ,G. and RE.Mebius. 1997. High endothelial venules: Lymphocyte traffic control 
and controlled traffic. Advances in Immunology 65:347-395. 
Kremer,W.DJ., E.N.NoordhuizenStassen, F.J.Grommers, Y.H.Schukken, RHeeringa, 
and Brand A. 1993. Severity of experimental Escherichia coli mastitis in ketonemic and 
nonketonemic dairy cows. Journal of Dairy Science 76:3428-3446. 
Kristensen,F., B.Kristensen, and S.Lazary. 1982. The lymphocyte stimulation test in 
veterinary immunology. Veterinary Immunology and Immunopathology 3:203-277. 
Kristensson,K., L.Kristensen, C.K.Borrebaeck, and RCarlsson. 1994. Activation of 
human CD4( + )45Ra( +) T -cells using B-cells as accessory cells. Immunology Letters 
39:223-229. 
Krummel,M.P' and J.P.Allison. 1995. CD28 and CTLA-4 have opposing effects on the 
response of T -cells to stimulation. Journal of Experimental Medicine 182:459-465. 
291 
Kuhlman,P., V.T.Moy, B.ALollo, and AABrian. 1991. The accessory function of 
murine Intercellular-Adhesion Molecule-l in T -lymphocyte activation - contributions of 
adhesion and coactivation. Journal of Immunology 146: 1773-1782. 
Kummerle-Deschner,J., H.G.Scheel-Walter, and c.P.Speer. 1997. G-CSF therapy in a 
neonate with alloimmune neutrocytopenia. ZeitschriJt Fur Geburtshilfe Und 
Neonatologie 201:273-276. 
Kummerle-Deschner,1.B., M.K.Hoffmann, D.Niethammer, and G.E.Dannecker. 1998. 
Pediatric rheumatology: autoimmune mechanisms and therapeutic strategies. 
Immunology Today 19:250-253. 
Lam,T.J.G.M., J.H.Van Vliet, Y.H.Schukken, F.J.Grommers, AVan Velden-Russcher, 
H.W.Barkema, and ABrand. 1997. The effect of discontinuation of postmilking teat 
disinfection in low SCC herds. 1. Incidence of clinical mastitis. Veterinary Quarterly 
19:41-47. 
Lamb,J.R, J.N.Woody, RJ.Hartzman, and D.D.Eckels. 1982. In vitro influenza virus 
specific antibody production in man - antigen-specific and HLA restricted induction of 
helper activity mediated by cloned human T -lymphocytes. Journal of Immunology 
129:1465-1470. 
Lamb,J.R, D.D.Eckels, P.Lake, AH.Johnson, and RJ.Hartzman. 1982. Antigen specific 
humanT-lymphocytes clones induction, antigen specificity, and MHC restriction of 
influenza virus immune clones. Journal of Immunology 128:233-238. 
Lamont,S.J. 1989. The chicken Major Histocompatibility Complex in disease resistance. 
Journal of Dairy Science 72: 1328-1333. 
Lamont,S.J. 1998. Impact of genetics on disease resistance. Poultry Science 77: 1111-
1118. 
Lan,H.Y., D.J.Nikolicpaterson, W.Mu, and RC.Atkins. 1995. Local macrophage 
proliferation in multinucleated giant cell and granuloma formation in experimental 
Goodpastures syndrome. American Journal of Pathology 147: 1214-1220. 
292 
Larsen,B., N.E.Jensen, P.Madsen, S.M.Nielsen, O.Klastrup, and P.S.Madsen. 1985. 
Association of the M-blood group system with bovine mastitis. Animal Blood Groups 
and Biochemical Genetics 16:165-173. 
Lascelles,A.K. 1979. The immune system on the ruminant mammary gland and its role in 
the control of mastitis. Journal of Dairy Science 62: 154-167. 
Lawman,M.J., P.Griebel, D.L.Hutchings, W.C.Davis, J.Heise, L.Qualtiere, and 
L.A.Babuick. 1987. Generation of IL-2 dependent bovine cytotoxic T lymphocyte clones 
reactive against BHV -1 infected target cells: loss of genetic restriction and virus 
specificity. Viral Immunology 1: 163-176. 
Lawman,M.J., P.D.Lawman, and C.E.Bagwell. 1992. Ex vivo expansion and 
differentiation of hematopoietic stem cells. Journal of Haematotherapy 1 :251-259. 
Lawrence,M.B. and T.A.Springer. 1993. Neutrophils roll on E-selectin. Journal of 
Immunology 151:6338-6346. 
Lazary,S., H.Gerber, P.A.Glatt, and R.Straub. 1985. Equine leukocyte antigens in sarcoid 
affected horses. Equine Veterinary Journal 17:283-286. 
Lee,C.S. and P.M.Outteridge. 1976. The identification and ultrastructure of macrophages 
from the mammary gland of the ewe. Australian Journal of Experimental Biology 
Medical Science 54:43-55. 
Lee,C.S., T.B.P.Wooding, and P.Kemp. 1980. Identification, properties and differential 
count of cell populations using electron microscopy of dry cows' secretions, colostrum 
and milk from normal cows. Journal of Dairy Research 47:39-50. 
Lee,J.c. 1996. The prospects for developing a vaccine against Staphylococcus aureus. 
Trends in Microbiology 4: 162-166. 
Legates,J.E. and C.D.Grinnells. 1952. Genetic relationships in resistance to mastitis in 
dairy cattle. Journal of Dairy Science 35:829-833. 
293 
Leibold,W., G.Janotte, H.H.Peter, R. A. Gatti , and S.Just. 1980. Spontaneous cell 
mediated cytotoxicity (SCMC) in various mammalian species and chickens: selective 
reaction pattern and different mechanisms of spontaneous cell mediated cytotoxicity and 
generation of HLA unrelated cytotoxic effector cells during MLC in vitro. Scandanavian 
Journal of Immunology 11 :203-222. 
Lemaire,L.C.J.M., SJ.H.vanDeventer, JJ.B.VanLanschot, J.Meenan, and D.J.Gouma. 
1998. Phenotypical characterization of cells in the thoracic duct of patients with and 
without systemic inflammatory response syndrome and multiple organ failure. 
Scandinavian Journal of Immunology 47:69-75. 
Lessa,E.P. 1993. Analysis of DNA sequence variation at population level by polymerase 
chain reaction and denaturing gradient gel electrophoresis. Methods in Enzymology 
224:327-367. 
Leung,D.Y.M. 1997. Immunologic basis of chronic allergic diseases: Clinical messages 
from the laboratory bench. Pediatric Research 42:559-568. 
Leung,D.M. 1997. Atopic dermatitis: Immunobiology and treatment with immune 
modulators. Clinical and Experimental Immunology 107:25-30. 
Lewin,H.A., W.C.Davis, and D.Bernoco. 1985. Monoclonal antibodies that distinguish 
bovine T-Iymphocytes and B-Iymphocytes. Veterinary Immunology and 
Immunopathology 9:87-102. 
Lewin,H.A. and D.Bernoco. 1986. Evidence for BoLA linked resistance and 
susceptibility to subclinical progression of bovine leukemia virus infection. Animal 
Genetics 17: 197 -207. 
Lewin,H.A. 1988. Association between BoLA-A locus alleles and subclinical 
progression of bovine leukemia-virus infection. Animal Genetics 19:55-57. 
Lewin,H.A., M.C.Wu, J.A.Stewart, and T.J.Nolan. 1988. Association between BoLA and 
subclinical bovine leukemia virus infection in a herd of Holstein-Friesian cows. 
Immunogenetics 27:338-344. 
294 
Lewin,H.A. 1989. Disease resistance and immune response genes in cattle - strategies for 
their detection and evidence of their existence. Journal of Dairy Science 72: 1334-1348. 
Lewin,H.A. 1996. Genetic organization, polymorphism, and function of the bovine 
Major Histocompatability Complex. In The Major Histocompatibility Complex Region 
of Domestic Animal Species. L.B.Schook and S.J.Lamont, editors. CRC Press, 65-98. 
Lewin,H.A., G.C.Russell, and E.J.Glass. 1999. Comparative organization and function of 
the Major Histocompatibility Complex of domesticated cattle. Immunological Reviews 
167:145-158. 
Ley,K. and T.F.Tedder. 1995. Leukocyte interactions with vascular endothelium - new 
insights into selectin mediated attachment and rolling. Journal of Immunology 155:525-
528. 
Li,H.M., A.Llera, E.L.Ma1chiodi, and RA.Mariuzza. 1999. The structural basis of T cell 
activation by superantigens. Annual Review of Immunology 17:435-466. 
Licence,S.T., W.C.Davis, M.M.Carr, and RM.Binns. 1995. The behavior of monoclonal 
antibodies in the first international pig CD workshop reacting with gamma delta null T-
lymphocytes in the blood of slablb line pigs. Veterinary Immunology and 
Immunopathology 47:253-271. 
Lieberman,R, W.E.Paul, W.Humphrey, and J.H.Stimpfling. 1972. H-2 linked immune 
response (Ir) genes. Independent loci for Ir-IgG and Ir-IgA genes. Journal of 
Experimental Medicine 136:1231-1240. 
Lin,Y., L.Xia, J.D.Turner, and X.Zhao. 1995. Morphologic observation of neutrophil 
diapedesis across bovine mammary gland epithelium in vitro. American Journal of 
Veterinary Research 56:203-207. 
Lindsten,T., C.R.June, J.A.Ledbetter, G.Stella, and C.B.Thompson. 1989. Regulation of 
lymphokine messenger RNA stability by a surface mediated T-cell activation pathway. 
Science 244:339-343. 
295 
Linsley,P.S., E.AClark, and J.ALedbetter. 1990. T-cell antigen CD28 mediates adhesion 
with B-cells by interacting with activation antigen B7IBB-l. Proceedings of The 
National Academy of Sciences of The United States of America 87 :5031-5035. 
Linsley,P.S., W.Brady, M.Umes, L.S.Grosmaire, N.K.Damle, and J.ALedbetter. 1991. 
CTLA-4 is a 2nd receptor for the B-cell activation antigen-B7. Journal of Experimental 
Medicine 174:561-569. 
Linsley,P.S., W.Brady, L.Grosmaire, A Aruffo, N.K.Damle, and J.ALedbetter. 1991. 
Binding of the B-cell activation antigen B7 to CD28 costimulates T-cell proliferation and 
interleukin-2 messenger RNA accumulation. Journal of Experimental Medicine 173:721-
730. 
Linsley,P.S. and J.ALedbetter. 1993. The role of the CD28 receptor during T-cell 
responses to antigen. Annual Review of Immunology 11: 191-212. 
Linzell,J.L. and M.Peaker. 1974. Changes in colostrum composition and in the 
permeability of the mammary epithelium at about the time of parturition in the goat. 
Journal of Physiology 243:129-151. 
Liu,C.C., P.M.Persechini, and J.D.E.Young. 1995. Perforin and lymphocyte mediated 
cytolysis. Immunological Reviews 146:145-175. 
Liu,Y.J., D.Y.Mason, G.D.Johnson, S.Abbots, C.D.Gregory, D.L.Hardie, J.Gordon, and 
I.C.M.MacLennan. 1991. Germinal center cells express bcl-2 protein after activation by 
signals which prevent their entry into apoptosis. European Journal of Immunology 
21: 1905-1910. 
Liu,Z., Y.K.Sun, Y.P.xi, B.Hong, P.E.Harris, E.F.Reed, and N.Suciu-Foca. 1993. 
Limited usage of T cell receptor V beta genes by allopeptide specific T cells. Journal of 
Immunology 150:3180-3186. 
Lloyd,J.B., H.S.Gill, and AJ.Husband. 1995. The effect of storage on 
immunophenotyping of sheep peripheral blood lymphocytes by flow cytometry. 
Veterinary Immunology and Immunopathology 47: 135-142. 
296 
I 
Loeffler,D.A. and N.L.Norcross. 1987. Use of enzyme linked immunosorbent assay to 
measure bovine milk and serum antibodies to alpha-toxin, beta-toxin, and capsular 
antigens of Staphylococcus aureus. Veterinary Immunology and Immunopathology 
14:145-156. 
Logue, D. N., Gunn, J., and Chaplin, S. 1995. Milk Quality, Mastitis and Somatic Cell 
Counts controlling your bulk tank somatic cell count. Proceedings of British Mastitis 
Conference, Stoneleigh. 
Lund, T. and Jensen, J. 1996. Genetic and phenotypic parameters for clinical mastitis, 
somatic cell production deviance and protein yield in dairy cattle. Proceedings of the 
47th Annual Meeting of the European Association of Animal Producers 4. 
Lunden,A., S.Sigurdardottir, I.Edforslilja, B.Danell, J.Rendel, and L.Andersson. 1990. 
The relationship between bovine Major Histocompatibility Complex class-II 
polymorphism and disease studied by use of bull breeding values. Animal Genetics 
21:221-232. 
Lunden,A., S.Sigurdardottir, and L.Andersson. 1991. Restriction Fragment Length 
Polymorphism of bovine T cell receptor beta genes. Animal Genetics 22:497-501. 
Lunney,J.K. 1994. Current status of the swine leukocyte antigen complex. Veterinary 
Immunology and Immunopathology 43:19-28. 
Lutji,V. and S.J.Black. 1991. Cellular interactions regulating the invitro response of 
bovine lymphocytes to ovalbumin. Veterinary Immunology and Immunopathology 
28:275-288. 
Lutji,V. and S.J.Black. 1992. Analysis of pokeweed mitogen-induced in vitro 
proliferation and antibody responses of bovine lymphocytes. Research in Veterinary 
Science 52:236-242. 
Luxembourg,A.T., A.Brunmark, Y.Kong, M.R.Jackson, P.A.Peterson, J.Sprent, and 
Z.L.Cai. 1998. Requirements for stimulating naive CD8( +) T cells via signal 1 alone. 
Journal of Immunology 161 :5226-5235. 
297 
MacHugh,D.E., RT.Loftus, D.G.Bradley, P.M.Sharp, and P.Cunnigham. 1994. 
Microsatellite DNA variation within and among European cattle breeds. Proceedings of 
the Royal Society of London Series B-Biological Sciences 256:25-31. 
Machugh,N.D. and P.Sopp. 1991. Bovine CD8 (BoCD8). Veterinary Immunology and 
Immunopathology 27 :65-69. 
Machugh,N.D., J.K.Mburu, M.J.Carol, C.RWyatt, J.A.Orden, and W.C.Davis. 1997. 
Identification of two distinct subsets of bovine gamma delta T cells with unique cell 
surface phenotype and tissue distribution. Immunology 92:340-345. 
Mackay,C.R, J.F.Maddox, and M.RBrandon. 1986. Thymocyte subpopulations during 
early fetal development in sheep. Journal of Immunology 136:1592-1599. 
Mackay,C.R, W.RHein, M.H.Brown, and P.Matzinger. 1988. Unusual expression of 
CD2 in sheep - implications for T-cell. European Journal of Immunology 18:1681-1688. 
Mackay,C.R and W.RHein. 1989. A large proportion of bovine T cells express the yo T 
cell receptor and show a distinct tissue distribution and surface phenotype. International 
Immunology 1 :540-545. 
Mackay,C.R, W.L.Marston, and L.Dudler. 1990. Naive and memory T-cells show 
distinct pathways of lymphocyte recirculation. Journal of Experimental Medicine 
171: 80 1-817. 
Mackay,C.R and W.RHein. 1990. Analysis of gamma delta T-cells in ruminants reveals 
further heterogeneity in gamma delta T-cell features and function among species. 
Research in Immunology 141:611-614. 
Mackay,C.R and W.RHein. 1991. Marked variations in gamma delta T-cell numbers 
and distribution throughout the life of sheep. Current Topics in Microbiology and 
Immunology 173:107-111. 
298 
Mackay,C.R., W.L.Marston, L.Dudler, O.Spertini, T.F.Tedder, and W.R.Hein. 1992. 
Tissue specific migration pathways by phenotypically distinct subpopulations of memory 
T-cells. European Journal of Immunology 22:887-895. 
Mackay,C.R. 1993. Immunological memory. Advances in Immunology 53:217-265. 
Mackenzie,D.D.S. and A.K.Lascelles. 1968. The transfer of 131-I-Iabeled 
immunoglobulins and serum albumin from blood into milk of lactating ewes. Australian 
Journal of Experimental Medical Science 46:285-294. 
Madden,D.R., J.c.Gorga, J.L.Strominger, and D.C.Wiley. 1991. The structure of HLA-
B27 reveals nonamer self peptides bound in an extended conformation. Nature 353:321-
325. 
Madden,D.R., J.c.Gorga, J.L.Strominger, and D.C.Wiley. 1992. The 3-dimensional 
structure of HLA-B27 at 2.1 Angstrom resolution suggests a general mechanism for tight 
peptide binding to MHC. Cell 70: 1035-1048. 
Maddox,J.F., C.R.Mackay, and M.R.Brandon. 1987. Ontogeny of ovine lymphocytes .1. 
An immunohistological study on the development of T -lymphocytes in the sheep embryo 
and fetal thymus. Immunology 62:97-105. 
Madsen,M., G.H.Sorensen, and S.A.Nielsen. 1991. Studies on the possible role of cattle 
nuisance flies, especially Hydrotaea irritans, in the transmission of summer mastitis in 
Denmark. Medical and Veterinary Entomology 5:421-429. 
Maeda,M., N.Murayama, H.lshii, N.Uryu, M.Ota, K.Tsuju, and H.lnoko. 1989. A simple 
and rapid method for HLA-DQAl genotyping by digestion of PCR-amplified DNA with 
allele specific restriction endonuc1eases. Tissue Antigens 34:290-298. 
Maillard,J.C., C.Renard, P.Chardon, I.Chantal, and A.Bensaid. 1999. Characterization of 
18 new BoLA-DRB3 alleles. Animal Genetics 30:200-203. 
299 
Makaya, P. V. 1996. Distribution of common mastitis pathogens and the use of 
bacteriological typing methods as epdemiological tools in mastitis control. 1996. PhD 
thesis, The Royal Veterinary and Agricultural University, Copehhagan, Denmark. 
Mallard,B.A, B.N.Wilkie, and B.W.Kennedy. 1989. Genetic and other effects on 
antibody and cell mediated immune response in swine leukocyte antigen (SLA) defined 
miniature pigs. Animal Genetics 20: 167 -178. 
Mallard,B.A, B.N.Wilkie, B.W.Kennedy, and M.Quinton. 1992. Use of estimated 
breeding values in a selection index to breed Yorkshire pigs for high and low immune 
and innate resistance factors. Animal Biotechnology 3:257. 
Marello,K.L., A Gallagher, D.J.Mckeever, RL.Spooner, and G.C.Russell. 1995. 
Expression of mUltiple DQB genes in Bos indicus cattle. Animal Genetics 26:345-349. 
Markert,M.L., D.S.Hummell, H.M.Rosenblatt, S.E.Schiff, T.O.Harville, L.W.Williams, 
RI.Schiff, and R.H.Buckley. 1998. Complete DiGeorge syndrome: Persistence of 
profound immunodeficiency. Journal of Pediatrics 132: 15-21. 
Marrack,P. and J.Kappler. 1997. Positive selection of thymocytes bearing alpha beta T 
cell receptors. Current Opinion in Immunology 9:250-255. 
Martin,A, E.ADunnington, W.B.Gross, W.E.Briles, RW.Briles, and P.B.Siegei. 1990. 
Production traits and alloantigen systems in lines of chickens selected for high or low 
antibody responses to sheep erythrocytes. Poultry Science 69:871-878. 
Mason,D. and F.Powrie. 1990. Memory CD4+ T -cells in man form 2 distinct 
subpopulations, defined by their expression of isoforms of the leukocyte common 
antigen, CD45. Immunology 70:427-433. 
Masson,P.L. and J.F.Heremans. 1966. Studies on lactoferrin, the iron binding protein of 
secretions. Protides Biological Fluids Proceedings Colloq.Bruges 14: 115-124. 
300 
Matsunaga,T., S.Kamata, N.Kakiichi, and K.Uchida. 1993. Characteristics of 
Staphylococcus aureus isolated from peracute, acute and chronic bovine mastitis. Journal 
of Veterinary Medical Science 55:297-300. 
Mazerolles,F., C.Auffray, and AFischer. 1991. Down regulation of T-cell adhesion by 
CD4. Human Immunology 31 :40-46. 
McClure,S.J., W.R.Hein, K. Yamaguchi , L.Dudler, M.F.Beya, and M.Miyasaka. 1989. 
Ontogeny morphology and tissue distribution of a unique subset of CD4- CD8- sheep T 
lymphocytes. Immunology and Cell Biology 67:215-221. 
McCole,D.F., M.L.Doherty, P.R.Torgerson, and AW.Baird. 1998. Local immune 
responses in the colon from cattle infected with Fasciola hepatica. International Journal 
of Parasitology 28:1733-1737. 
McDevitt,H.O. and B.Benacerraf. 1968. Genetic control of specific immune responses. 
Advances in Immunology 11':31-74. 
McDevitt,H.O., B.D.Deak, D.C.Shreffler, J.Klein, J.H.Stimpfling, and G.D.Snell. 1972. 
Genetic control of the immune response. Mapping of the Ir-l locus. Journal of 
Experimental Medicine 135:1259-1278. 
McDonald,B.S. and J.S.McDonald. 1976. Streptococci isolated from bovine 
intramammary infections. American Journal of Veterinary Research 37:377-381. 
McDonald,J.S. and AJ.Anderson. 1981. Antibiotic sensitivity of Staphylococcus aureus 
and CNS isolated from infected bovine mammary glands. Cornell Veterinary 71:391-
396. 
McDonald,J.S. 1984. Streptococcal and staphylococcal mastitis. Veterinary Clinics of 
North America-Large Animal Practice 6:269-285. 
McEwan,S.c., W.D.Black, and AH.Meek. 1991. Antibiotic residue prevention methods. 
Farm management and occurrence of antibiotic residues in milk. Journal of Dairy 
Science 74:2128-2137. 
301 
McGuirk,B. 1998. Bull proofs for somatic cell counts. Holstein-Friesian Journal 
May:52-53. 
McKenzie,Re., T.S.Rafferty, and G.J.Beckett. 1998. Selenium: An essential element for 
immune function. Immunology Today 19:342-345. 
Mejdell,e.M., O.Lie, H.Solbu, E.F.Arnet, and RL.Spooner. 1994. Association of Major 
Histocompatibility Complex antigens (BoLA-A) With AI bull progeny test results for 
mastitis, ketosis and fertility in norwegian cattle. Animal Genetics 25:99-104. 
Menzies,F.D., Bryson,D.G., McCallion,T., Matthews,D.1. 1995. A study of mortality 
among suckler and dairy cows in Northern Ireland in 1992. Veterinary Record 137:531-
536. 
Meredith,D., A.H.Elser, B.Wolf, L.RSoma, W.J.Donawick, and S.Lazary. 1986. Equine 
leukocyte antigens - relationships with sarcoid tumors and laminitis in 2 pure breeds. 
Immunogenetics 23:221-225. 
Metcalf,D., e.G.Begley, and N.A.Nicola. 1985. The proliferative effects of human GM-
CSF-alpha and GM-CSF-beta and murine G-CSF in microwell cultures of fractionated 
human marrow cells. Leukemia Research 9:521-527. 
Metcalf,D. 1985. The granulocyte macrophage colony stimulating factors. Cell 43:5-6. 
Meuer,S.e., RE.Hussey, M.Fabbi, D.Fox, O.Acuto, K.A.Fitzgerald, J.C.Hodgdon, 
J.P.Protentis, S.F.Schlossman, and E.L.Reinherz. 1984. An alternative pathway of T-cell 
activation - a functional role for the 50kd TIl sheep erythrocyte receptor protein. Cell 
36:897-906. 
Meyer,F., S.Gloger-Hock, S.Cwik, G.Eberhart, D.O.Schmid, and B.Senft. 1989. Bovine 
Lymphocyte Antigen (BoLA). Zuchtungskunde 61:28-40. 
Michie,e.A., A.Mc1ean, e.A1cock, and P.L.Beverley. 1992. Life span of human 
lymphocyte subsets defined by CD45 isoforms. Nature 360:264-265. 
302 
Mieschier,S., M.Schreyer, C.B arras , P.Capasso, and V.VonFliedner. 1990. Sparse 
distribution of gamma delta T -lymphocytes around human epithelial tumors 
predominantly infiltrated by primed memory T -cells. Cancer Immunology 
Immunotherapy 32: 81-87. 
Migita,K. and AOchi. 1993. The fate of anergic T-cells in vivo. Journal of Immunology 
150:763-770. 
Milks,L.C., G.P.Conyers, and E.B.Cramer. 1986. The effect of neutrophil migration on 
epithelial permeability. Journal of Cell Biology 103:2729-2738. 
Miller,B.A, RF.Reiser, and M.S.Bergdoll. 1978. Detection of staphylococcal 
enterotoxins A, B, C, D, and E in foods by radioimnunoassay, using staphyloccal cells 
containing protein A as immunoadsorbent. Applied Environmental Biology 36:421-426. 
Miller,RH., M.J.Paape, and L.A.Fulton. 1991. Variation in milk somatic cells of heifers 
at first calving. Journal of Dairy Science 74:3782-3790. 
Milleredge,M. and G.Splitter. 1986. Patterns of bovine T cell mediated immune 
responses to bovine herpesvirus-I. Veterinary Immunology and Immunopathology 
13:301-319. 
Milner,P., K.L.Page, AW.Walton, and J.E.Hillerton. 1996. Detection of clinical mastitis 
by changes in electrical conductivity of foremilk before visible changes in milk. Journal 
of Dairy Science 79:83-86. 
Miltenburg,J.D., D.deLange, AP.P.Crauwels, J.H.Bongers, M.J.M.Tielen, 
Y.H.Schukken, and ARW.Elbers. 1996. Incidence of clinical mastitis in a random 
sample of dairy herds in the southern Netherlands. Veterinary Record 139:204-207. 
Mirsky,M.L., C.AOlmstead, Y.Da, and H.ALewin. 1996. The prevalence of proviral 
bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of 
infection. Journal of Virology 70:2178-2183. 
303 
Miyasaka,M. and Z.Tmka. 1986. Lymphocyte migration and differentiation in a large 
animal model the sheep. Immunological Reviews 91:87-114. 
Miyasaka,M., RPabst, L.Dudler, M.Cooper, and K.Yamaguchi. 1990. Characterization 
of lymphatic and venous emigrants from the thymus. Thymus 16:29-43. 
Mocci,S. and RL.Coffman. 1995. Induction of a Th2 population from a polarized 
leishmania specific Thl population by in vitro culture with IL-4. Journal of Immunology 
154:3779-3787. 
Mokhtarian,F., D.Shirazian, L.Morgante, A.Miller, D.Grob, and E.Lichstein. 1997. 
Influenza virus vaccination of patients with multiple sclerosis. Multiple Sclerosis 3:243-
247. 
Monardes,H.G. and J.F.Hayes. 1985. Genetic and phenotypic relationships between 
lactation cell counts and milk yield and composition of Holstein cows. Journal of Dairy 
Science 68:1250-1256. 
Moon,H.W. and J.S.MacDonald. 1983. Antibody response of cows to Escherichia coli 
pilus antigen K99 after oral vaccination with live or dead bacteria. American Journal of 
Veterinary Research 44:493-496. 
Moore,M.W., F.RCarbone, and MJ.Bevan. 1988. Introduction of soluble protein into the 
class-I pathway of antigen processing and presentation. Cell 54:777-785. 
Morafo,V., S.Rath, M.L.Thomas, and J.M.Durdik. 1999. Induction of a germinal center 
phenotype in B cells in vitro by a Th2 cell line. Cellular Immunology 198:77-86. 
Morimoto,C., N.L.Letvin, A.W.Boyd, M.Hagan, H.M.Brown, M.M.Kornacki, and 
S.F.Schlossman. 1985. The isolation and characterization of the human helper inducer T-
cell subset. Journal of Immunology 134:3762-3769. 
Morland,C.M., J.Fear, G.McNab, RJoplin, and D.H.Adams. 1997. Promotion of 
leukocyte transendothelial cell migration by chemokines derived from human biliary 
304 
epithelial cells in vitro. Proceedings of the Association of American Physicians 109:372-
382. 
Morrison,L.A., V.L.Braciale, and T.J.Braciale. 1988. Antigen form influences induction 
and frequency of influenza specific class-I and class-IT MHC restricted cytolytic T-
lymphocytes. Journal of Immunology 141 :363-368. 
Morrison,W.1. and W.C.Davis. 1991. Differentiation antigens expressed predominantly 
on CD4- and CD8- T-Iymphocytes (WCl, WC2). Veterinary Immunology and 
Immunopathology 27:71-76. 
MorrowTesch,J., N.Woollen, and L.Hahn. 1996. Response of gamma delta T-
lymphocytes to heat stress in Bos taurus and Bos indicus crossbred cattle. Journal of 
Thermal Biology 21:101-108. 
Mosmann,T.R and S.Sad. 1996. The expanding universe ofT-cell subsets: Thl, Th2 and 
more. Immunology Today 17:138-146. 
Mosmann,T.R, H.M.Cherwinski, M.W.Bond, M.A.Giedlin, and RL.Coffman. 1986. 2 
Types of murine helper T-cell clone .1. Definition according to profiles of lymphokine 
activities and secreted proteins. Journal of Immunology 136:2348-2357. 
Mrode,RA., GJ.T.Swanson, and M.S.Winters. 1998. Genetic parameters and 
evaluations for somatic cell counts and its. Animal Science 66:569-576. 
Mrode,RA., GJ.T.Swanson, and C.M.Lindberg. 2000. Genetic correlations of somatic 
cell count and conformation traits with herd life in dairy breeds, with an application to 
national genetic evaluations for herd life in the United Kingdom. Livestock Production 
Science 65:119-130. 
Mugglicockett,N.E. and RT.Stone. 1988. Identification of genetic variation in the bovine 
Major Histocompatibility Complex DRB-like genes using sequenced bovine genomic 
probes. Animal Genetics 19:213-225. 
305 
Mugglicockett,N.E. and R.T.Stone. 1989. Partial nucleotide sequence of a bovine Major 
Histocompatibility class-II DRB-like gene. Animal Genetics 20:361-369. 
Mugglicockett,N.E. and R.T.Stone. 1991. Restriction fragment length polymorphisms in 
bovine Major Histocompatibility Complex class-II beta chain genes using bovine ex on 
containing hybridization probes. Animal Genetics 22: 123-136. 
Munson,S.H., M.T.Tremaine, M.J.Betley, and R.AWe1ch. 1998. Identification and 
characterization of staphylococcal enterotoxin types G and I from Staphylococcus 
aureus. Infection and Immunity 66:3337-3348. 
Muraille,E., T.DeSmedt, F.Andris, B.Pajak, M.Armant, J.Urbain, M.Moser, and O.Leo. 
1997. Staphylococcal enterotoxin B· induces an early and transient state of 
immunosuppression characterized by V-beta unrestricted T cell unresponsiveness and 
defective antigen presenting cell functions. Journal of Immunology 158:2638-2647. 
Murphy,F.A, O.Aalund, J.W.Osebold, and E.J.Carroll. 1964. Gamma globulins of 
bovine lacteal secretions. Archives in Biochemistry and Biophysiology 108:230-239. 
Muscoplat,C.C., I.Alhaji, D.W.Johnson, K.APomeroy, J.M.Olson, V.L.Larson, 
J.B.Stevens, and D.K.Sorensen. 1974. Characteristics of lymphocyte responses to 
phytomitogens: comparison of responses of lymphocytes from normal and lymphocytotic 
cows. American Journal of Veterinary Research 35: 1053-1055. 
Musoke,AJ., F.R.Rurangirwa, and V.M.Nantulya. 1987. Biological properties of bovine 
immunoglobulins and systemic antibody responses. In The Ruminant immune system in 
health and disease. I.W.Morrison editor. Cambridge University Press, Cambridge 393. 
Myers,R.M., V.C.Sheffield, and D.R.Cox. 1988. Dectection of single base changes in 
DNA: ribonuclease cleavage and denaturing gradient gel electrophoresis. In Genome 
Analysis: A Practical Approach. K.Davis, editor. IRL Press, Oxford, 95-139. 
Naessens,J., J.Newson, N.D.McHugh, C.J.Howard, K.Parsons, and B.Jones. 1990. 
Characterization of a bovine leukocyte differentiation antigen of 145,000MW restricted 
to B-Iymphocytes. Immunology 69:525-530. 
306 
Naessens,J. and C.J.Howard. 1991. Monoclonal antibodies reacting with bovine B-cells 
(BoWC3, BoWC4 and BoWC5). Veterinary Immunology and Immunopathology 27:77-
85. 
Nagahata,H., AOgawa, Y.Sanada, H.Noda, and S.Yamamoto. 1992. Peripartum changes 
in antibody producing capability of lymphocytes from dairy cows. Veterinary Quarterly 
14:39-40. 
Nagi,A.M. and L.ABabiuk. 1989. Characterization of surface markers of bovine gut 
mucosal leukocytes. Veterinary Immunology and Immunopathology 22:1-14. 
Nagy,Z.P., C.N.Boxevanis, N.lshii, and J.Klein. 1981. Ia antigens as restriction molecule 
in Ir-gene controlled T-cell proliferation. Immunological Reviews 60:59-83. 
Nash,D.L., G.W.Rogers, J.B.Cooper, G.L.Hargrove, J.F.Keown, and L.B.Hansen. 2000. 
Heritability of clinical mastitis incidnece and relationships with sire transmitting abilities 
for somatic cell score, udder type traits, productive life, and protein yield. Journal of 
Dairy Science 83:2350-2360. 
Nashar,T.O., M.R.Williams, PJ.Brown, P.J.Cripps, and C.R.Stokes. 1990. Fate and 
uptake of soluble and particulate antigens in the preparturient bovine mammary gland. 
Veterinary Immunology and Immunopathology 26: 125-141. 
Nasir,L., M.Ndiaye, C.Seely, and M.J.Stear. 1997. Sequence polymorphism in the bovine 
Major Histocompatability Complex DQB loci. Animal Genetics 28:441-445. 
NavarroJ.A, M.R.Caro, J.seva, M.C.Rosillo, M.AGomez, and M.C.Gallego. 1996. 
Study of lymphocyte subpopulations in peripheral blood and secondary lymphoid organs 
in the goat using monoclonal antibodies to surface markers of bovine lymphocytes. 
Veterinary Immunology and Immunopathology 51:147-156. 
Ndiweni,N. and J.M.Finch. 1999. Effects of in vitro supplementation with ex. tocopherol 
and selenium on bovine neutrophil functions: implications for resistance to mastitis. 
Veterinary Immunology and Immunopathology 51:67-78. 
307 
Neta,R and J.J.Oppenheim. 1988. Why should internists be interested in interleukin-1. 
Annals of Internal Medicine 109:1-3. 
Newbould,F.H.S. 1973. The effect of added serum and glucose and some inherent 
factors, on phagocytosis in vitro by milk leucocytes from several cows. Canadian 
Journal of Comparative Medicine 37:189-194. 
Newby,T.J. and F.J.Bourne. 1977. The nature of the local immune system of the bovine 
mammary gland. Journal of Immunology 118:461-465. 
Newell,M.K., L.J.Haughn, C.RMaroun, and M.H.Julius. 1990. Death of mature T-cells 
by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347:286-289. 
Nicholson,J.K.A., B.M.Jones, and G.D.Cross. 1984. Comparison ofT and B cell analyses 
on fresh and aged blood. Journal of Immunological Methods 73:29-40. 
Nickerson,S.C. and C.W.Heald. 1981. Histopathologic response of the bovine mammary 
gland to experimentally induced Staphylococcus aureus infection. American Journal of 
Veterinary Research 42:1351-1355. 
Nickerson,S.c. 1985. Immune mechanisms of the bovine udder - an overview. Journal of 
the American Veterinary Medical Association 187:41-45. 
Nickerson,S.c., P.E.Baker, and P.Trinidad. 1989. Local immunostimulation of the 
bovine mammary gland with interleukin-2. Journal of Dairy Science 72: 1764-1773. 
Nickerson,S.c., W.E.Owens, RL.Boddie, and N.T.Boddie. 1992. The effect of chronic 
immunostimulation of the nonlactating bovine mammary gland with interleukin-2, 
pokeweed mitogen, and lipopolysaccharide. Journal of Dairy Science 75:3339-3351. 
Nickerson,S.c., W.E.Owens, and RL.Boddie. 1993. Effect of a Staphylococcus aureus 
bacterin on serum antibody, new infection, and mammary histology in nonlactating 
dairy-cows. Journal of Dairy Science 76: 1290-1297. 
308 
Nickerson,S.c., W.E.Owens, L.K.Fox, C.C.Scheifinger, T.RShryock, and T.E.Spike. 
1999. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus 
mastitis at drying off. Journal of Dairy Science 82:696-703. 
Nilsson,P.R, S.E.Marsh, I.Joosten, M.G.B.Nieuwland, E.J.Hensen, 
M.C.GrosfeldStulemeyer, S.Mikko, AGelhaus, and G.T.Schreuder. 1997. The specificity 
of anti-HLA class II monoclonal antibodies in cattle. European Journal of 
Immunogenetics 24:211-223. 
. 
Nonnecke,B.J. and M.E.Kehrli. 1985. Isolation of mononuclear cells from bovine milk 
by continuous flow and density gradient centrifugation - response of cells to mitogens. 
American Journal of Veterinary Research 46:1259-1262. 
Nonnecke,B.J. and J.AHarp. 1985. Effect of chronic staphylococcal mastitis on 
mitogenic responses of bovine lymphocytes. Journal of Dairy Science 68:3323-3328. 
Nonnecke,B.J., L.AElsken, and M.E.Kehrli. 1986. Local and systemic immune response 
in the cow after intramammary vaccination during lactation. Veterinary Immunology and 
Immunopathology 11:31-44. 
Nonnecke,B.J. and J.AHarp. 1989. Function and regulation of lymphocyte mediated 
immune responses - relevance to bovine mastitis. Journal of Dairy Science 72: 1313-
1327. 
Nonoyama,S., L.APenix, C.P.Edwards, D.B.Lewis, S.Ito, AAruffo, C.B.Wilson, and 
H.D.Ochs. 1995. Diminished expression of CD40 ligand by activated neonatal T-cells. 
Journal of Clinical Investigation 95:66-75. 
Norcross,N.L. 1977. Immune response of the mammary gland and role of immunization 
in mastitis control. Journal of the American Veterinary Medical Association 170: 1228-
1233. 
Norton,S.D., L.Zuckerman, K.B.Urdahl, RShefner, J.Miller, and M.K.Jenkins. 1992. 
The CD28 ligand, B7, enhances II...,-2 production by providing a costimulatory signal to 
T-cells. Journal of Immunology 149:1556-1561. 
309 
Oddgeirsson,O., S.P.Simpson, A.l.G.Morgan, D.S.Ross, and R.L.Spooner. 1988. 
Relationship between the bovine Major Histocompatibility Complex (BoLA), 
Erythrocyte markers and susceptibility to mastitis in Icelandic cattle. Animal Genetics 
19:11-16. 
Ohmann,H.B., W.C.Davis, and L.A.Babiuk. 1986. Surface antigen expression by bovine 
alveolar macrophages - functional correlation and influence of interferons in vivo and in 
vitro. Immunobiology 171:125-142. 
Oliver,S.P. and K.L.Srnith. 1982. Nonantibiotic approach in control of bovine mastitis 
during the dry period. Journal of Dairy Science 65:2119-2124. 
Oliver,S.P. and T.Bushe. 1987. Growth inhibition of Escherichia coli and Klebsiella 
pneumoniae during involution of the bovine mammary gland - relation to secretion 
composition. American Journal of Veterinary Research 48:1669-1673. 
Oliver,S.P. and L.M.Sordillo. 1988. Udder health in the periparturient period. Journal of 
Dairy Science 71:2584-2606. 
Oliver,S.P. 1988. Frequency of isolation of environmental mastitis causing pathogens 
and incidence of new intramammary infection during the nonlactating period. American 
Journal of Veterinary Research 49:1789-1793. 
Olsen,J.C., E.P.Casman, E.F.Baer, and J.E.Stone. 1970. Enterotoxigenicity of 
Staphylcoccus aureus cultures isolated from acute cases of bovine mastitis. Applied 
M icrobiolo gy 204: 605-607. 
Oppenheim,J.J. 1994. Summary of the fifth conference on the molecular mechanisms and 
physiological activities of cytokines. Journal of Leukocyte Biology 56:687-691. 
Oppenheimermarks,N., L.S.Davis, D.T.Bogue, J.Ramberg, and P.E.Lipsky. 1991. 
Differential utilization of ICAM-l and VCAM-l during the adhesion and 
transendothelial migration of human T-Iymphocytes. Journal of Immunology 147:2913-
2921. 
310 
Orden,J.A., D.CID, M.E.Blanco, J.A.R.S.Quiteria, E.Gomezlucia, and R.Delafuente. 
1992. Enterotoxin and toxic shock syndrome toxin-l production by staphylococci 
isolated from mastitis in sheep. Apmis 100: 132-134. 
Orden,J.A., J.Goyache, J.Hemandez, A.Domenech, G.Suarez, and E.Gomezlucia. 1992. 
Detection of enterotoxins and TSST -1 secreted by Staphylococcus aureus isolated from 
ruminant mastitis - comparison of ELISA and immunoblot. Journal of Applied 
Bacteriology 72:486-489. 
OReilly,K.L. and G.A.Splitter. 1991. Analysis of workshop antibodies to null cells on a 
non-T lymphocyte non-B lymphocyte population. Veterinary Immunology and 
Immunopathology 27:231-234. 
Orlikowsky,T., Z.Q.Wang, A.Dudhane, H.Horowitz, B.Conti, and M.Hoffmann. 1996. 
The cell surface marker phenotype of macrophages from HIV -1 infected subjects reflects 
an IL-10 enriched and IFN-gamma deprived donor environment. Journal of Interferon 
and Cytokine Research 16:957-962. 
Orlikowsky,T., Z.Q.Wang, A.Dudhane, H.Horowitz, G.Riethmuller, and M.K.Hoffmann. 
1997. Cytotoxic monocytes in the blood of HIV type-1 infected subjects destroy targeted 
T cells in a CD95 dependent fashion. Aids Research and Human Retroviruses 13:953-
960. 
Osteras,O., S.W.Martin, and V.L.Edge. 1999. Possible risk factors associated with 
penicillin resistant strains of Staphylococcus aureus from bovine subclinical mastitis in 
---early lactation. Journal of Dairy Science 82:927-938. 
O'Suilleabhain,C., S.T.O'Sullivan, J.L.Kelly, J.Lederer, J.A.Mannick, and M.L.Rodrick. 
1996. Interleukin-12 treatment restores normal resistance to bacterial challenge after bum 
injury. Surgery 120:290-296. 
O'Sullivan,S.T., J.A.Lederer, A.F.Horgan, Dh.L.Chin, J.A.Mannick, and M.L.Rodrick. 
1995. Major injury leads to predominance of the T-helper-2 lymphocyte phenotype and 
311 
diminished interleukin-12 production associated with decreased resistance to infection. 
Annals of Surgery 222:482-492. 
Outteridge,P.M. and C.S.Lees. 1988. The defence mechanisms of the mammary gland of 
domestic ruminants. Progress in Veterinary Microbiology Immunology 4:165-169. 
Owens,W.E. and J.L.Watts. 1987. Effects of milk on activity of antimicrobics against 
Staphylococcus aureus isolated from bovine udders. Journal of Dairy Science 70: 1946-
1951. 
Owens,W.E. 1988. Evaluation of various antibiotics for induction of L-forms from 
Staphylococcus aureus strains isolated from bovine mastitis. Journal of Clinical 
Microbiology 26:2187-2190. 
Oyaizu,N., Y.Adachi, F.Hashimoto, T.W.McCloskey, N.Hosaka, N.Kayagaki, H.Yagita, 
and S.Pahwa. 1997. Monocytes express fas ligand upon CD4 cross linking and induce 
CD4( +) T cells apoptosis - A possible mechanism of bystander cell death in HIV 
infection. Journal of Immunology 158:2456-2463. 
Oyaizu,N., N.Kayagaki, H.Yagita, S.Pahwa, and Y.Ik:awa. 1997. Requirement of cell-cell 
contact in the induction of jurkat T cell apoptosis: The membrane anchored but not 
soluble form of Fas-L can trigger anti-CD3 induced apoptosis in jurkat T cells. 
Biochemical and Biophysical Research Communications 238:670-675. 
Paape,M.J. and A.J.Guidry. 1977. Effects of fat and casein on intracellular killing of 
Staphylcoccus aureus by milk leucocytes. Proceedings Social and Experimental 
Biological Medicine 155:588-593. 
Paape,M.J., W.P.Wergin, and A.J.Guidry. 1981. Phagocytic defence of the ruminant 
mammary gland. Advances in Experimental Medical Biology 137:555-578. 
Paape,MJ., G.Ziv, and R.H.Miller. 1986. Update on the use of intramammary devices in 
the control of mastitis. Proceedings of the 25th Annual Meeting of the National Mastitis 
Council 87-103. 
312 
Paape,M.J., A.J.Guidry, N.CJain, and RH.Miller. 1991. Leucocytic defence 
mechanisms in the udder. Flemish Veterinary Journal 62:95-109. 
Palmer,C., M.Thurmond, J.Picanso, A.W.Brewer, and D.Bemoco. 1987. Susceptibility of 
cattle to bovine leukemia virus infection associated with BoLA type. Proceedings of the 
91 st Annual Meeting of U. S.Animal Health Association, Salt Lake City 218-228. 
Pankey,J.W., W.N.Philpot, and RL.Boddie. 1983. Efficacy of low concentration 
iodophor teat dips against Staphylococcus aureus. Journal of Dairy Science 66: 155-160. 
Pankey,J.W., W.N.Philpot, RL.Boddie, and J.L.Watts. 1983. Evaluation of 9 teat dip 
formulations under experimental challenge to Staphylococcus aureus and Streptococcus 
agalactiae. Journal of Dairy Science 66:161-167. 
Pankey,J.W., N.T.Boddie, J.L.Watts, and S.C.Nickerson. 1985. Evaluation of protein-A 
and a commercial bacterin as vaccines against Staphylococcus aureus mastitis by 
experimental challenge. Journal of Dairy Science 68:726-731. 
Pankey,J.W. 1989. Hygiene at milking time in the prevention of bovine mastitis. British 
Veterinary Journal 145:401-409. 
Parham,P. and T.Ohta. 1996. Population biology of antigen presentation by MHC class I 
molecules. Science 272:67-74. 
Park,C.E. and RSzabo. 1986. Evaluation of the reversed passive latex agglutination 
(RPLA) Test kits for detection of staphylococcal enterotoxin-A, enterotoxin-B, 
enterotoxin-C, and enterotoxin-D in foods. Canadian Journal of Microbiology 32:723-
727. 
Park,Y.H., L.K.Fox, MJ.Hamilton, and W.C.Davis. 1992. Bovine mononuclear 
leukocyte subpopulations in peripheral blood and mammary gland secretions during 
lactation. Journal of Dairy Science 75:998-1006. 
Park,Y.H., L.K.Fox, M.J.Hamilton, and W.C.Davis. 1993. Suppression of proliferative 
response of BoCD4+ T -lymphocytes by activated BoCD8+ T -lymphocytes in the 
313 
mammary gland of cows with Staphylococcus aureus mastitis. Veterinary Immunology 
and Immunopathology 36:137-151. 
Parmely,M.J., AE.Beer, and R.E.Billingham. 1976. In vitro studies on the T-Iymphocyte 
population of human milk. Journal of Experimental Medicine 144:358-370. 
Parmely,M.J. and AE.Beer. 1977. Colostral cell mediated immunity and the concept of a 
common secretory immune system. Journal of Dairy Science 60:655-665. 
Parra,E., A.G.Wingren, G.Hedlund, T.Kalland, and M.Dohlsten. 1997. The role of B7-1 
and LFA-3 in costimulation of CD8(+) T cells. Journal of Immunology 158:637-642. 
Parry,S.L., J.Hasbold, M.Holman, and G.G.B.Klaus. 1994. Hypercross linking surface 
IgM or IgD receptors on mature B-cells induces apoptosis that is reversed by 
costimulation with IL-4 and anti-CD40. Journal of Immunology 152:2821-2829. 
Parsons,K.R., C.J.Howard, B.V.Jones, and P.Sopp. 1989. Investigation of bovine gut 
associated lymphoid tissue (GALT) Using monoclonal antibodies against bovine 
lymphocytes. Veterinary Pathology 26:396-408. 
Pattison,I.H. and I.M.Smith. 1953. The histology of experimental Streptococcus 
dysgalactiae mastitis in goats. Journal Pathology and Bacteriology 66:247-250. 
Paul,W.E., I.Green, and B.Benacerraf. 1968. Genetic control of the immune response to 
phaten poly-L-Iysine conjugates. Journal of the Reticuloendothelial Society 5:282-293. 
Paul,W.E. and R.ASeder. 1994. Lymphocyte responses and cytokines. Cell 76:241-251. 
Pearson,L.D., M.W.Simpson-Morgan, and B.Morris. 1976. Lymphopoiesis and 
lymphocyte recirculation in the sheep fetus. Journal of Experimental Medicine 143:167-
186. 
Pedersen, P. S., Madsen, J. A, Haesxhen, W., and Neave, F. K. 1981. Laboratory 
methods for use in mastitis work. International Dairy Federation, Brussels, Belgium, 21-
22. 
314 
Peelman,L.J., P.Chardon, M.Vaiman, M.Mattheeuws, AVanZeveren, AVandeWeghe, 
Y.Bouquet, and R.D.Campbell. 1996. A detailed physical map of the porcine Major 
Histocompatibility Complex (MHC) class III region: Comparison with human and mouse 
MHC class III regions. Mammalian Genome 7:363-367. 
Pereira,M.L., L.D.Heneine, E.J.Santos, L.S.Carmo, J.L.Pereira, and M.S.Bergdoll. 1997. 
Prevention of non specific reactions on reversed passive latex agglutination assay 
(RPLA) for detecting low amounts of staphylococcal enterotoxin. Review of 
Latinoamerican Microbiology 39:57-63. 
PerezMelgosa,M., D.Hollenbaugh, and C.B.Wilson. 1999. Cutting edge: CD40 ligand is 
a limiting factor in the humoral response to T-cell dependent antigens. Journal of 
Immunology 163:1123-1127. 
Perraudin,J.P., TorchiaT.E., and D.B.Wetlaufer. 1983. Multiple parameter kinetic studies 
of the oxidative folding of reduced lysozyme. Journal Biological Chemistry 10: 11834-
11839. 
Persson,K., I.G.Colditz, P.Flapper, N.AF.Franklin, and H.F.Seow. 1996. Cytokine-
induced inflammation in the ovine teat and udder. Veterinary Immunology and 
Immunopathology 53:73-85. 
Pescovitz,M.D., M.ALowman, and D.H.Sachs. 1988. Expression of T-cell associated 
antigens by porcine natural killer cells. Immunology 65:267-271. 
Petroff,M.G., K.M.Coggeshall, L.S.Jones, and J.L.Pate. 1997. Bovine luteal cells elicit 
Major Histocompatibility Complex class-II dependent T-cell proliferation. Biology of 
Reproduction 57:887-893. 
Philipsson,J., G.Ral, and B.Berglund. 1995. Somatic cell counts as a selection criterion 
for mastitis resistance. Livestock Production Science 41: 195-200. 
Philpot, W. N. 1975. Prevention of Infection - hygiene. International Dairy Federation, 
Brussels, Belgium, 156-164. 
315 
Picker,L.J., L.W.M.M.Terstappen, L.S.Rott, P.RStreeter, H.Stein, and E.C.Butcher. 
1990. Differential expression of homing associated adhesion molecules by T-cell subsets 
in man. Journal of Immunology 145:3247-3255. 
Picker,L.J. and E.C.Butcher. 1992. Physiological and molecular mechanisms of 
lymphocyte homing. Annual Review of Immunology 10:561-591. 
Picker,L.J. 1994. Control of lymphocyte homing. Current Opinion in Immunology 6:394-
406. 
Pierce,S.K., E.S.Metcalf, and N.RKlinman. 1979. Factors affecting the triggering of the 
B-cell repertoire. In Cells of immunoglobulin synthesis. B.Pemis and H.J.Vogel, editors. 
253-271. 
Pierrce,A.E. and A.Feinstein. 1965. Biophysical and immunological studies on bovine 
immunoglobulins with evidence for selective transport within the mammary gland from 
maternal plasma to colostrum. Immunology 8: 106-123. 
Pierre,P., S.J.Turley, E.Gatti, M.Hull, J.Meltzer, A.Mirza, K.Inaba, RM.Steinman, and 
I.Mellman. 1997. Developmental regulation of MHC class IT transport in mouse dendritic 
cells. Nature 388:787-792. 
Pieters,J. 2000. MHC class-IT restricted antigen processing and presentation. Advances in 
Immunology 75: 159-208. 
Pieters,R 2000. The popliteal lymph node assay in predictive testing for autoimmunity. 
Toxicology Letters 112:453-459. 
Pilling,D., A.N.Akbar, P.A.Bacon, and M.Salmon. 1996. CD4(+) CD45RA(+) T cells 
from adults respond to recall antigens after CD28 ligation. International Immunology 
8: 1737-1742. 
Pinard,M.H. and A.1.Vanderzijpp. 1993. Effects of Major Histocompatibility Complex 
on antibody response in Fl and F2 crosses of chicken lines. Genetics Selection Evolution 
25:283-296. 
316 
Pingel,J.T. and M.L.Thomas. 1989. Evidence that the leukocyte common antigen is 
required for antigen induced T-Iymphocyte proliferation. Cell 58:1055-1065. 
Pinto,A. and F.Ferguson. 1988. Characteristics of Yorkshire swine natural killer cells. 
Veterinary Immunology and Immunopathology 20: 15-29. 
Pinto,M., M.Torten, and S.C.Birnbaum. 1978. Suppression of the in vivo humoral and 
cellular immune response by staphylococcal enterotoxin B (SEB). Transplantation 
25:320-323. 
Plebanski,M., M.Saunders, S.S.Burtles, S.Crowe, and D.C.Hooper. 1992. Primary and 
secondary human in vitro T-cell responses to soluble antigens are mediated by subsets 
bearing different CD45 isoforms. Immunology 75:86-91. 
Politis,l., Z.xin, B.W.McBride, and J.H.Burton. 1991. Examination of chemotactic 
properties of bovine mammary macrophages. Canadian Journal of Veterinary Research-
Revue Canadienne De Recherche Veterinaire 55:321-324. 
Poso,J. and E.A.Mantysaari. 1996. Relationships between clinical mastitis, somatic cell 
score, and production for the first three lactations of Finnish Ayrshire cattle. Journal of 
Dairy Science 79: 1284-1291. 
Postle,D.S., M.Rogunsky, and B.Poutrel. 1978. Induced staphylococcal infections in the 
bovine mammary gland. American Journal of Veterinary Research 39:29-35. 
Powis,SJ., Ar.M.Townsend, E.V.Deverson, J.Bastin, G.W.Butcher, and J.C.Howard. 
1991. Restoration of antigen presentation to the mutant cell line mRNA by an MHC 
linked transporter. Nature 354:528-531. 
Powrie,F. and R.L.Coffman. 1993. Cytokine regulation of T-cell function - potential for 
therapeutic intervention. Immunology Today 14:270-274. 
Prescott,J.P. and J.D.Baggott. 1988. Bovine mastitis, antimicrobial therapy. In Veterinary 
Medicine. Blackwell Scientific Publications, Chicago 321-331. 
317 
Preston,P.M., C.G.D.Brown, L.Bellsakyi, W.Richardson, and AS anderson. 1992. 
Tropical theileriosis in Bos taurus and Bos taurus cross Bos indicus calves - response to 
infection with graded doses of sporozoites of Theileria annulata. Research in Veterinary 
Science 53:230-243. 
Price,V., D.Mochizuki, C.J.March, D.Cosman, M.C.Deeley, R.K1inke, W.Clevenger, 
S.Gillis, P.E.Baker, and D.Urdal. 1987. Expression, purification and characterization of 
recombinant murine granulocyte macrophage colony-stimulating factor and bovine 
interleukin-2 from yeast. Gene 55:287-293. 
Prince,H.E. and L.Arens. 1986. Effect of storage on lymphocyte surface markers in 
whole blood units. Transplantation 41:235-238. 
Puel,A., p.c.Groot, M.G.Lathrop, P.Demant, and D.Mouton. 1995. Mapping of genes 
controlling quantitative antibody production in biozzi mice. Journal of Immunology 
154:5799-5805. 
Pyorala,S., H.Jousimiessomer, and M.Mero. 1992. Clinical, bacteriological and 
therapeutic aspects of bovine mastitis caused by aerobic and anaerobic pathogens. British 
Veterinary Journal 148:54-62. 
Rabinovsky,E.D. and T.J.Yang. 1986. Production and characterization of a bovine T-cell 
specific monoclonal antibody identifying a mature differentiation antigen. Journal of 
Immunology 136:609-615. 
Ranger,AM., M.P.Das, V.K.Kuchroo, and L.H.Glimcher. 1996. B7-2 (CD86) is essential 
for the development of IL-4-producing T cells. International Immunology 8: 1549-1560. 
Rask,L., AK.Jonsson, AC.Svensson, K.Gustafsson, and L.Andersson. 1991. The 
structure of human MHC class-II genes. Autoimmunity 8:237-244. 
Rasmussen,M.D., D.M.Galton, and L.G.Petersson. 1991. Effects of prernilking teat 
preparation on spores of anaerobes, bacteria, and iodine residues in milk. Journal of 
Dairy Science 74:2472-2478. 
318 
Raymond,C. and B.N.Wilkie. 1998. Natural killer cell frequency and function in pigs 
selectively bred for high or low antibody and cell mediated immune response: Response 
to vaccination with modified live transmissible gastroenteritis virus. Natural Immunity 
16: 18-26. 
Reents,R, JJamrozik, L.RSchaeffer, and J.M.Dekkers. 1995. Estimation of genetic 
parameters for test day records of somatic cell. Journal of Dairy Science 78:2847-2857. 
Reeves,J.H. and H.W.Renshaw. 1978. Surface membrane markers on bovine peripheral 
blood lymphocytes. American Journal of Veterinary Research 39:917-923. 
Reid,P.A and C.Watts. 1990. Cycling of cell surface MHC glycoproteins through 
primaquine sensitive intracellular compartments. Nature 346:655-657. 
Reid,W.B. and BJ.Wilson. 1959. A study of the staphylococci associated with the bovine 
udder. American Journal of Veterinary Research 20:825-831. 
Reiner,S.L. and RASeder. 1995. T-helper cell differentiation in immune response. 
Current Opinion in Immunology 7:360-366. 
Reinhardt,T.A, J.RStabel, and J.P.Goff. 1999. 1,25-Dihydroxyvitamin D-3 enhances 
milk antibody titers to Escherichia coli J5 vaccine. Journal of Dairy Science 82: 1904-
1909. 
Reiter,B. 1978. Review of the progress of Dairy Science: antimicrobial systems in milk. 
Journal of Dairy Research 45: 131-147. 
Rellahan,B.L., L.AJones, AM.Kruisbeek, AM.Fry, and L.AMatis. 1990. In vivo 
induction of anergy in peripheral v-beta-8+ T-cells by staphylococcal enterotoxin-B. 
Journal of Experimental Medicine 172: 1091-1100. 
Rendel,J.M. and ARobertson. 1950. Some aspects of longevity in dairy cows. Empire 
Journal of Experimental Agriculture 18:49-56. 
319 
Ridge,J.P., F.DiRosa, and P.Matzinger. 1998. A conditioned dendritic cell can be a 
temporal bridge between a CD4(+) T-helper and a T-killer cell. Nature 393:474-478. 
Risco,C.A., G.A.Donovan, and J.Hernandez. 1999. Clinical mastitis associated with 
abortion in dairy cows. Journal of Dairy Science 82:1684-1689. 
Rivas,A.L., F.W.Quimby, O.Coksaygan, L.Olmstead, and D.H.Lein. 2000. Longitudinal 
evaluation of CD4+ and CD8+ peripheral blood and mammary gland lymphocytes in cows 
experimentally inoculated with Staphylococcus aureus. Canadian Journal of Veterinary 
Research-Revue Canadienne De Recherche Veterinaire 64:232-237. 
Roder,J.C., S.Argov, M.Klein, c.Petersson, R.Kiessling, K.Andersson, and M.Hansson. 
1980. Target-effector cell interaction in the natural killer cell system. V. Energy 
requirements, membrane integrity, and the possible involvement of lysosomal enzymes. 
Immunology 1980 40: 107 -116. 
Rogers,G.W., G.L.Hargrove, T.J.Lawlor, and J.L.Ebersole. 1991. Correlations among 
linear type traits and somatic cell counts. Journal of Dairy Science 74: 1087-1091. 
Rogers,G.W. 1993. Index selection using milk yield, somatic cell score, udder depth. 
Journal of Dairy Science 76:664-670. 
Rogers,G.W., G.Banos, U.Sander Nielsen, and J.Philipsson. 1998. Genetic correlation 
among somatic cell scores, productive life, and type traits from the United States and 
udder health measures from Denmark and Sweden. Journal of Dairy Science 81: 1445-
1453. 
Rogers,P.R., C.Dubey, and S.L.Swain. 2000. Qualitative changes accompany memory T 
cell generation: faster, more effective responses at lower dose of antigen. Journal of 
Immunology 164:2338-2346. 
Romagnani,S. 1994. Lymphokine production by human T-cells in disease states. Annual 
Review of Immunology 12:227-257. 
320 
Rook,G.W., RHemandezpando, and S.L.Lightman. 1994. Hormones, peripherally 
activated prohormones and regulation of the Th1ffh2 balance. Immunology Today 
15:301-303. 
Rooke,R, C.Waltzinger, C.Benoist, and D.Mathis. 1997. Targeted complementation of 
MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 
7: 123-134. 
Roth,J.A, M.L.Kaeberle, and W.H.Hsu. 1982. Effect of estradiol and progesterone on 
lymphocyte and neutrophil functions in steers. Infection and Immunity 35:997-1002. 
Roth,J.A and D.E.Frank. 1989. Recombinant bovine interferon-gamma as an 
immunomodulator in dexamethasone treated and nontreated cattle. Journal of Inteiferon 
Research 9:143-151. 
Rotzschke,O., K.Falk, K.Deres, H.Schild, M.Norda, J.Metzger, G.Jung, and 
H.G.Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as 
recognized by cytotoxic T-cells. Nature 348:252-254. 
Rouse,B.T. and L.ABabiuk. 1974. Host defense mechanisms against infectious bovine 
rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. 
Infection and Immunity 10:681-687. 
Roy,M., T.Waldschmidt, A Aruffo , J.ALedbetter, and RJ.Noelle. 1993. The regulation 
of the expression of GP39, the CD40 ligand, on normal and cloned CD4+ T-cells. 
Journal of Immunology 151:2497-2510. 
Rudd,C.E., J.M.Trevillyan, J.D.Dasgupta, L.L.Wong, and S.F.Schlossman. 1988. The 
CD4 receptor is complexed in detergent lysates to a protein- tyrosine kinase (Pp58) from 
human T-Iymphocytes. Proceedings of The National Academy of Sciences of the United 
States of America 85:5190-5194. 
Rudensky,AY., P.Prestonhurlburt, S.C.Hong, ABarlow, and C.AJaneway. 1991. 
Sequence analysis of peptides bound to MHC class-II molecules. Nature 353:622-627. 
321 
Russell,G.C., K.L.Marello, A. Gallagher, D.l.Mckeever, and RL.Spooner. 1994. 
Amplification and sequencing of expressed DRB second exons from Bos indicus. 
Immunogenetics 39:432-436. 
Russell,G.C., C.l.Davies, and L.Andersson. 1997. BoLA class II nucleotide sequences, 
1996; report of the ISAG BoLA Nomenclature Committee. Animal Genetics 28: 169-180. 
Russell,M.W., B.E.Brooker, and B.Reiter. 1976. Inhibition of the bactericidal activity of 
bovine polymorphonuclear leucocytes and related systems by casein. Research in 
Veterinary Science 20:30-35. 
Saalmuller,A. and MJ.Reddehase. 1988. Immune system of swine - dissection of 
mononuclear leukocyte subpopulations by means of 2-colour cytofluorometric analysis. 
Research in Veterinary Science 45:311-316. 
Saiki,R.K., D.H.Gelfand, S.Stoffel, SJ.Scharf, RHiguchi, G.T.Hom, K.B.Mullis, and 
H.A.Erlich. 1988. Primer directed enzymatic amplification of DNA with a thermostable 
DNA polymerase. Science 239:487-491. 
Sakamoto,S., T.Okanoue, Y.ltoh, K.Sakamoto, K.Nishioji, Y.Nakagawa, N.Yoshida, 
T.Yoshikawa, and K.Kashima. 1997. Intercellular adhesion molecule-l and CD18 are 
involved in neutrophil adhesion and its cytotoxicity to cultured sinusoidal endothelial 
cells in rats. Hepatology 26:658-663. 
Sallusto,F., D.Lenig, C.RMackay, and A.Lanzavecchia. 1998. Flexible programs of 
chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. 
Journal of Experimental Medicine 187:875-883. 
Salmon,M., D.Pilling, N.l.Borthwick, N.Viner, G.lanossy, P.A.Bacon, and A.N.Akbar. 
1994. The progressive differentiation of primed T -cells is associated with an increasing 
susceptibility to apoptosis. European Journal of Immunology 24:892-899. 
Samantaray,S.N., Y.Bhattacharyulu, and B.S.Gill. 1980. Immunisation of claves against 
bovine tropical theileriosis (Theileria annulata) with graded doses of sporozoites and 
irradiated sporozoites. International Journal For Parasitology 10:355-258. 
322 
Sanchez,M.S. and J.L.Watts. 1999. Enhancement of the activity of novobiocin against 
Escherichia coli by lactoferrin. Journal of Dairy Science 82:494-499. 
Sanders,M.E., M.W.Makgoba, S.O.Sharrow, D.Stephany, T.A.Springer, H.A.Young, and 
S.Shaw. 1988. Human-memory T-Iymphocytes express increased levels of 3 cell-
adhesion molecules (LFA-3, CD2, and LFA-l) and 3 other molecules (UCHLl, CDw29, 
and PGD-l) and have enhanced lPN-gamma production. Journal of Immunology 
140: 1401-1407. 
Sandholm,M. and T.Mattila. 1985. Merits of different indirect test in mastitis detection 
(Cell counting, NAGase, BSA, antitrypsin). Kieler Milchwirtschaftliche 
Forschungsberichte 37:334-339. 
Saper,M.A., P.J.Bjorkman, and D.C.Wiley. 1991. Refined structure of the human 
histocompatibility antigen HLA-A2 at 2.6A resolution. Journal of Molecular Biology 
219:277-319. 
Sasaki,M., C.L.Davis, and B.L.Larson. 1976. Production and turnover of IgG 1 and IgG2 
immunoglobulins in the bovine around parturition. Journal of Dairy Science 59:2046-
2055. 
Sattentau,Q.J. and R.A.Weiss. 1988. The CD4 antigen - physiological ligand and HIV 
receptor. Cell 52:631-633. 
Schaechter,M., G.Medoff, and B.Eisenstein. 1993. Mechanism of microbial disease 2nd 
edition. M.Schaechter, G.Medoff, and B.Eisenstein, editors. Williams and Wilkins, 
Baltimore. 
Schalm,O.W., EJ.Carroll, and N.C.Jain. 1971. Bovine Mastitis. Lea and Febiger, 
Philadelphia. 
Schalm,O.W., J.Lasmanis, and N.C.Jain. 1976. Conversion of chronic staphylococcal 
mastitis to acute gangrenous mastitis after neutropenia in blood and bone marrow 
produced by an equine anti bovine leucocyte serum. American Journal Veterinary 
Research 37:885-890. 
323 
Schenning,L., D.Larhammar, P.Bill, K.Wiman, AK.Jonsson, L.Rask, and P.APeterson. 
1984. Both alpha-chains and beta-chains of HLA-DC class-II histocompatibility antigens 
display extensive polymorphism in their amino terminal domains. EMBO Journal 3:447-
452. 
Schierman,L. and AW.Nordskog. 1961. Relationship of blood type to histocompatibility 
in chickens. Science 134: 1008-1009. 
Schore,C.E., B.I.Osbum, D.E.Jasper, and D.E.Tyler. 1981. B-Iymphocytes and T-
lymphocytes in the bovine mammary gland rosette. Veterinary Immunology and 
Immunopathology 2:561-569. 
Schrooten,c., H.Bovenhuis, W.Coppieters, and J.M.Vanarendonk. 2000. Whole genome 
scan to detect quantitative trait loci for conformation and functional traits in dairy cattle. 
Journal of Dairy Science 83:795-806. 
Schukken,Y.H., H.N.Erb, P.M.Sears, and R.D.Smith. 1988. Ecologic study of the risk 
factors for environmental mastitis in cows. American Journal of Veterinary Research 
49:766-769. 
Schukken,Y.H., F.J.Grommers, D.Van der Geer, H.N.Erb, and ABrand. 1990. Risk 
factors for clinical mastitis in herds with a low bulk milk Sec. Data and risk factors for 
all cases. Journal of Dairy Science 77:3463-3471. 
Schukken,Y.H., B.AMallard, J.C.M.Dekkers, K.E.Leslie, and M.J.Stear. 1994. Genetic 
impact on the risk of intramammary infection following Staphylococcus aureus 
challenge. Journal of Dairy Science 77:639-647. 
Schultze,W.D. and M.J.Paape. 1984. Effect on outcome of intramammary challenge 
exposure with Staphylococcus aureus of somatic cell concentration and presence of an 
intramammary device. American Journal of Veterinary Research 45:420-423. 
Schultze,W.D. and AJ.Bramley. 1985. Effect of reaming the papillary duct of cows teats 
on keratin removal and penetrability of the duct to implanted Escherichia coli endotoxin. 
Journal of Dairy Research 52:361-368. 
324 
Schumacher,T.M., M.H.Debruijn, L.N.Vemie, W.M.Kast, C.M.Melief, J.J.Neefjes, and 
H.L.Ploegh. 1991. Peptide selection by MHC class-I molecules. Nature 350:703-706. 
Schutz,M.M., L.B.Hansen, G.RSteuemagel, J.K.Reneau, and A.L.Kuck. 1990. Genetic 
parameters for somatic cells, protein, and fat in milk of. Journal of Dairy Science 73:494-
502. 
Schutz,M.M., P.M.VanRaden, P.J.Boettcher, and L.B.Hansen. 1993. Relationship of 
somatic cell score and linear type trait evaluations. Journal of Dairy Science 76:658-663. 
Schutz,M.M., P.M.VanRaden, and G.RWiggans. 1994. Genetic variation in lactation 
means of somatic cell scores for 6 breeds of dairy cattle. Journal of Dairy Science 
77:284-293. 
Schwartz,R 1986. Immune response (Ir) genes of the murine Major Histocompatibility 
Complex. Advances in Immunology 38:31-201. 
Scollay,RG., E.C.Butcher, and I.L.Weissman. 1980. Thymus cell migration. 
Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Journal 
of Leukocyte Biology 10:210-218. 
Scott, H. M., Sargeant, J. M., and Ireland, M. J. 1996. Efficacy of an Re-17 mutant 
Salmonella typhimurium coreantigen vaccine under field conditions. Proceedings of the 
XIX World Buiatrics Congress, 281-284. 
Sears,P.M. and L.E.Heider. 1981. Identification of mastitis pathogens - a laboratory 
procedure for the veterinary practitioner. Modern Veterinary Practice 62:531-536. 
Seder,RA. and W.E.Paui. 1994. Acquisition of lymphokine producing phenotype by 
CD4+ T-cells. Annual Review of Immunology 12:635-673. 
Seelig,L.L. 1980. Dynamics of leukocytes in rat mammary epithelium during pregnancy 
and lactation. Biology of Reproduction 22: 1211-1217. 
325 
Semple,J.W., D.Allen, W.Chang, P.Castaldi, and 1.Freedman. 1993. Rapid separatoin of 
CD4+and CD19+ lymphocyte populations from human peripheral blood by a magnetic 
activated cell sorter (MACS). Cytometry 14:955-960 
Sepulveda,H., ACerwenka, T.Morgan, and R.W.Dutton. 1999. CD28, IL-2 independent 
costimulatory pathways for CD8 T lymphocyte activation. Journal of Immunology 
163: 1133-1142. 
Sette,A, S.Buus, S.Colon, 1.ASmith, C.Miles, and H.M.Grey. 1987. Structural 
characteristics of an antigen required for its interaction with Ia and recognition by T-
cells. Nature 328:395-399. 
Seykora,AJ. and B.T.McDaniei. 1986. Genetics statistics and relationships of teat and 
udder traits. Journal of Dairy Science 69:2395-2407. 
ShaferWeaver,K.A and L.M.Sordillo. 1996. Enhancing bactericidal activity of bovine 
lymphoid cells during the periparturient period. Journal of Dairy Science 79:1347-1352. 
ShaferWeaver,K.A, G.M.Pighetti, and L.M.Sordillo. 1996. Diminished mammary gland 
lymphocyte functions parallel shifts in trafficking patterns during the postpartum period. 
Proceedings of the Society for Experimental Biology and Medicine 212:271-279. 
ShaferWeaver,K.A and L.M.Sordillo. 1997. Bovine CD8( +) suppressor lymphocytes 
alter immune responsiveness during the postpartum period. Veterinary Immunology and 
Immunopathology 56:53-64. 
ShaferWeaver,K.A, C.M.Corl, and L.M.Sordillo. 1999. Shifts in bovine CD4(+) 
subpopulations increase T-helper-2 compared with T-helper-1 effector cells during the 
postpartum period. Journal of Dairy Science 82: 1696-1706. 
Sharif,S., B.AMallard, B.N.Wilkie, 1.M.Sargeant, H.M.Scott, 1.C.M.Dekkers, and 
K.E.Leslie. 1998. Associations of the bovine Major Histocompatibility Complex DRB3 
(BoLA-DRB3) alleles with occurence of disease and milk somatic cell score in Canadian 
dairy cattle (b). Animal Genetics 29:185-193. 
326 
Sharif,S., B.AMallard, B.N.Wilkie, 1.M.Sargeant, H.M.Scott, 1.C.M.Dekkers, and 
K.E.Leslie. 1998. Associations of the bovine Major Histocompatibility Complex DRB3 
(BoLA-DRB3) with production traits in Canadian dairy cattle (a). Animal Genetics 
30:157-160. 
Shield,C.F., P.Marlett, ASmith, L.Gunter, and G.Goldstein. 1983. Stability of human 
lymphocyte differentiation antigens when stored at room temperature. Journal of 
Immunological Methods 62:347-352. 
Shook,G.E. 1989. Selection for disease resistance. Journal of Dairy Science 72: 1349-
1362. 
Shook,G.E. 1993. Genetic improvement of mastitis through selection on somatic cell 
count. Veterinary Clinics of North America-Food Animal Practice 9:563-581. 
Shortman,K., D.Vremec, and M.Egerton. 1991. The kinetics of T-cell antigen receptor 
expression by subgroups of CD4+8+ thymocytes - delineation of CD4+8+32+ 
thymocytes as post-selection intermediates leading to mature T -cells. Journal of 
Experimental Medicine 173:323-332. 
Shpigel,N.Y., R.Chen, M.Winkler, ASaran, G.Ziv, and F.Longo. 1994. 
Antiinflammatory ketoprofen in the treatment of field cases of bovine mastitis. Research 
in Veterinary Science 56:62-68. 
Shreffler,D.C. and C.S.David. 1975. The H-2 Major Histocompatability Complex and the 
I immune response region; genetic variation, function and organisation. Advances in 
Immunology 20:125-195. 
Shuster,D.E., M.E.Kehrli, and M.G.Stevens. 1993. Cytokine production during endotoxin 
induced mastitis in lactating dairy cows. American Journal of Veterinary Research 
54:80-85. 
Sigurdardottir,S., ALunden, and L.Andersson. 1988. Restriction fragment length 
polymorphism of DQ and DR class II genes of the bovine Major Histocompatibility 
Complex. Animal Genetics 19:133-150. 
327 
Sigurdardottir,S., C.Borsch, KGustafsson, and L.Andersson. 1991. Cloning and 
sequence analysis of 14 DRB alleles of the bovine Major Histocompatibility Complex by 
using the polymerase chain reaction. Animal Genetics 22: 199-209. 
Sigurdardottir,S., C.Borsch, KGustaffsson, and L.Andersson. 1992. Gene duplications 
and sequence polymorphism of bovine class II DQB genes. Immunogenetics 35:205-213. 
Singer,KH., S.M.Denning, L.P.Whichard, and B.F.Haynes. 1990. Thymocyte LFA-l 
and thymic epithelial cell ICAM-l molecules mediate binding of activated human 
thymocytes to thymic epithelial cells. Journal of Immunology 144:2931-2939. 
Sinigaglia,F. and J.Hammer. 1994. Rules for peptide binding to MHC class-II molecules. 
APMIS 102:241-248. 
Siqueira,M., M.B.Esteves, O.M.Ibanez, V. A. Ferreira, O.A.Sant'Anna, M.H.Reis, and 
G.Biozzi. 1977. Nonspecific genetic regulation of antibody responsiveness in the mouse. 
European Journal of Immunology 7: 195-203. 
Sischo,W.M., L.E.Heider, G.Y.Miller, and D.A.Moore. 1993. Prevalence of contagious 
pathogens of bovine mastitis and use of mastitis control practices. Journal of The 
American Veterinary Medical Association 202:595-600. 
Sitte,K, IJ.East, M.F.Lavin, and E.C.Jazwinska. 1995. Identification and 
characterization of new BoLA-DRB3 alleles by heteroduplex analysis and direct 
sequencing. Animal Genetics 26:413-417. 
Skow,L.C., J.E.Womack, J.M.Petresh, and W.L.Miller. 1988. Syntenic mapping of the 
genes for 21 steroid hydroxylase, alpha-a crystallin, and class-I bovine leukocyte antigen 
in cattle. DNA-A Journal of Molecular & Cellular Biology 7:143-149. 
Smith,B.P. 1986. Understanding the role of endotoxins in Gram negative septicemia. 
Food and Animal Practise 2: 1148-1155. 
Smith,J.W. and R.D.Schultz. 1977. Mitogen and antigen responsive milk lymphocytes. 
Cellular Immunology 29: 165-173. 
328 
Smith,KA., P.E.Baker, S.Gillis, and F.W.Ruscetti. 1980. Functional and molecular 
characteristics of T-Cell Growth Factor. Molecular Immunology 17:579-589. 
Smith,KL., J.H.Harrison, D.D.Hancock, D.A.Todhunter, and H.RConrad. 1984. Effect 
of vitamin-E and selenium supplementation on incidence of clinical mastitis and duration 
of clinical symptoms. Journal of Dairy Science 67: 1293-1300. 
Smith,KL., H.RConrad, B.A.Amiet, and D.A.Todhunter. 1985. Incidence of 
environmental mastitis as influenced by dietary vitamin-E and selenium. Kieler 
Milchwirtschaftliche Forschungsberichte 37:482-486. 
Smith,KL. and J.S.Hogan. 1993. Environmental mastitis. Veterinary Clinics of North 
America-Food Animal Practice 9:489-498. 
Smith,S.H., M.H.Brown, D.Rowe, RE.Callard, and P.L.Beverley. 1986. Functional 
subsets of human helper inducer cells defined by a new monoclonal antibody, UCHLl. 
Immunology 58:63-70. 
Smits,J.E.G. and D.L.Godson. 1996. Assessment of humoral immune response in mink 
(Mustela vison): Antibody production and detection. Journal of Wildlife Diseases 
32:358-361. 
Snell,G.D. 1958. Histocompatibility genes of the mouse. II. Production and analysis of 
isogenic resistant lines. Journal of the National Cancer Institute 21 :843-877. 
Soder,KJ. and L.A.Holden. 1999. Lymphocyte proliferation response of lactating dairy 
cows fed varying concentrations of rumen protected methionine. Journal of Dairy 
Science 82: 1935-1942. 
Sol,J., O.C.Sampimon, J.J.Snoep, and Y.H.Schukken. 1994. Factors associated with 
bacteriological cure after dry cow treatment of subclinical staphylococcal mastitis with 
antibiotics. Journal of Dairy Science 77:75-79. 
329 
Solbu,H. 1983. Disease recording in Norwegian dairy cattle .1. Disease incidences and 
non-genetic effects on mastitis, ketosis and milk fever. Journal of Animal Breeding and 
Genetics 100:139-157. 
Sopp,P. and C.J.Howard. 1996. Investigation of PC36 (BoCD45R). Veterinary 
Immunology and Immunopathology 52:271-274. 
Sordillo,L.M., S.C.Nickerson, R.M.Akers, and S.P.Oliver. 1987. Secretion composition 
during bovine mammary involution and the relationship with mastitis. International 
Journal of Biochemistry 19: 1165-1172. 
Sordillo,L.M. and S.C.Nickerson. 1988. Morphometric changes in the bovine mammary 
gland during involution and lactogenesis. American Journal Veterinary Research 
49: 1112-1120. 
Sordillo,L.M., M.Campos, and L.A.Babiuk. 1991. Antibacterial activity of bovine 
mammary gland lymphocytes following treatment with interleukin-2. Journal of Dairy 
Science 74:3370-3375. 
Sordillo,L.M., M.J.Redmond, M.Campos, L.Warren, and L.A.Babiuk. 1991. Cytokine 
activity in bovine mammary-gland secretions during the periparturient period. Canadian 
Journal of Veterinary Research-Revue Canadienne De Recherche Veterinaire :298-301. 
Sordillo,L.M., M.Snider, H.Hughes, G.Afseth, M.Campos, and L.A.Babiuk. 1991. 
Pathological changes in bovine mammary glands following intramammary infusion of 
recombinant interleukin-2. Journal of Dairy Science 74:4164-4174. 
Sordillo,L.M., G.Afseth, G.Davies, and L.A.Babiuk. 1992. Effects of recombinant 
granulocyte macrophage colony-stimulating factor on bovine peripheral blood and 
mammary gland neutrophil function in vitro. Canadian Journal of Veterinary Research-
Revue Canadienne De Recherche Veterinaire 56:16-21. 
Sordillo,L.M., K.ShaferWeaver, and D.DeRosa. 1997. Immunobiology of the mammary 
gland. Journal of Dairy Science 80:1851-1865. 
330 
Sparshott,S.M., E.B.Bell, and S.RSarawar. 1991. CD45R CD4 T-cell subset 
reconstituted nude rats - subset-dependent survival of recipients and bidirectional isoform 
switching. European Journal of Immunology 21 :993-1000. 
Sperling,A.!. and J.ABluestone. 1996. The complexities of T-cell co-stimulation: CD28 
and beyond. Immunological Reviews 153:155-182. 
Sperling,A.!., J.AAuger, B.D.Ehst, I.C.Rulifson, C.B.Thompson, and J.ABluestone. 
1996. CD28IB7 interactions deliver a unique signal to naive T cells that regulates cell 
survival but not early proliferation. Journal of Immunology 157:3909-3917. 
Spiegelberg,H.L. 1974. Biological activities of immunoglobulins of different classes and 
subclasses. Advances in Immunology 19:259. 
Spies, T. and RDemars. 1991. Restored expression of Major Histocompatibility Complex 
class-I molecules by gene transfer of a putative peptide transporter. Nature 351 :323-324. 
Spitznagel,J.K. 1983. Microbial interactions with neutrophils. Reviews of Infectious 
Diseases 5:S806-S822. 
Spooner,R, AMorgan, D.Sales, P.Simpson, H.Solbu, and O.Lie. 1988. MHC 
associations with mastitis. Animal Genetics 19:57-58. 
Spooner,RL., H.Leveziel, F.Grosclaude, RAOliver, and M.Vaiman. 1978. Evidence for 
a possible Major Histocompatibility Complex (BoLA) in cattle. Journal of 
Immunogenetics 5:325-346. 
Spooner,RL., RAOliver, D.I.Sales, C.M.McCoubrey, P.Millar, AG.Morgan, 
B.Amorena, E.Bailey, D.Bernoco, M.Brandon, RW.Bull, J.Caldwell, S.Cwik, van Dam 
RH., J.Dodd, B.Gahne, F.Grosclaude, J.G.Hall, H.Hines, H.Leveziel, M.J.Newman, 
M.J.Stear, W.H.Stone, and M.Vaiman. 1979. Joint report of the 1st International Bovine 
Lymphocyte Antigen (BoLA) Workshop. Animal Blood Groups and Biochemical 
Genetics 10:63-86. 
331 
Spour,E.F., T.Leemhuis, LJenski, RRedmond, D.Fillak, and J.Jansen. 1990. 
Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive 
T lymphocytes. Clinical and Experimental Immunology 80:114-121. 
Sprent,J., E.K.Gao, and S.RWebb. 1990. T-cell reactivity to MHC molecules - immunity 
versus tolerance. Science 248: 1357-1363. 
Springer,T.A 1994. Traffic signals for lymphocyte recirculation and leukocyte 
emigration - the multistep paradigm. Cell 76:301-314. 
Spurzem,J.R, a.Sacco, G.ARossi, J.D.Beckmann, and S.I.Rennard. 1992. Regulation of 
Major Histocompatibility Complex class-II gene expression on bovine bronchial 
epithelial-cells. Journal of Laboratory and Clinical Medicine 120:94-102. 
Stadler,B.M., F.Kristensen, and AL.de Weck. 1980. Thymocyte activation by cytokines: 
Direct assessment of GO-G 1 transition by flow cytometry. Cellular Immunology 55:436-
443. 
Starkenburg,RJ., L.B.Hansen, M.E.Kehrli, and H.Chester-Jones. 1997. Frequencies and 
effects of alternative DRB3.2 alleles of bovine lymphocyte antigen for Holsteins in milk 
selection and control lines. Journal of Dairy Science 80:3411-3419. 
Stear,M.J., TJ.Tierney, F.C.Baldock, S.C.Brown, F.W.Nicholas, and T.H.Rudder. 1988. 
Failure to find an association between class-I antigens of the bovine Major 
Histocompatibility system and fecal worm egg counts. International Journal For 
Parasitology 18:859-861. 
Stear,M.J., F.W.Nicholas, S.C.Brown, and RG.Holroyd. 1989. Class-I antigens of the 
bovine Major Histocompatibility system and resistance to the cattle tick (Boophilus 
microplus) assessed in 3 different seasons. Veterinary Parasitology 31:303-315. 
Steeber,D.A, N.E.Green, S.Sato, and T.F.Tedder. 1996. Lymphocyte migration in L-
selectin deficient mice - altered subset migration and aging of the immune system. 
Journal of Immunology 157:1096-1106. 
332 
Steeg,P.S., RN.Moore, H.MJohnson, and JJ.Oppenheim. 1982. Regulation of murine 
macrophage la-antigen expression by a lymphokine with immune interferon activity. 
Journal of Experimental Medicine 156: 1780-1793. 
Steinbeck,M.J., D.S.A.Webb, and J.A.Roth. 1989. Role for arachidonic acid metabolism 
and protein synthesis in recombinant bovine interferon-gamma - induced activation of 
bovine neutrophils. Journal of Leukocyte Biology 46:450-460. 
Steinman,RM. and Z.A.Cohn. 1973. Identification of a novel cell type in peripheral 
lymphoid organs of mice. I. Morphology, quantitation, and tissue distribution. Journal of 
Experimental Medicine 137:1142-1162. 
Steinman,RM. and M.D.Witmer. 1978. Lymphoid dendritic cells are potent stimulators 
of the primary mixed leukocyte reaction in mice. Proceedings of the National Academy 
of Sciences of the United States of America 75:5132-5136. 
Steinman,RM. 1991. The dendritic cell system and its role in immunogenicity. Annual 
Review of Immunology 9:271-296. 
Steinmann,G.G. and H.K.Mullerhermelink. 1984. Immunohistological demonstration of 
terminal transferase (Tdt) in the age involuted human thymus. Immunobiology 166:45-
52. 
Stem,L.J., J.H.Brown, T.S.Jaradetzky, J.c.Gorga, RG.Urban, J.L.Strominger, and 
D.C.Wiley. 1994. Crystal-structure of the human class-II MHC protein HLA-DRI 
complexed with an influenza virus peptide. Nature 368:215-221. 
Stevens,M.G. and S.C.Olsen. 1994. In vitro effects of live and killed Brucella abortus on 
bovine cytokine and prostaglandin E(2) production. Veterinary Immunology and 
Immunopathology 40: 149-161. 
Stevens,M.G., L.K.Wilson, and L.J.Gershwin. 1992. Isolation and characterization of an 
IL-l dependent IL-4 producing bovine CD4+ T-cell clone. Cellular Immunology 
140:453-467. 
333 
Stiffel,C., M.Liacopoulos-Briot, C.Decreusefond, and F.Lambert. 1977. Genetic selection 
of mice for quantitative responsiveness of lymphocytes to phytohemagglutinin. European 
Journal of Immunology 7:291-297. 
Stout,R.D., J.Suttles, J.C.xu, I.S.Grewal, and R.AFlavell. 1996. Impaired T cell-
mediated macrophage activation in CD40 ligand deficient mice. Journal of Immunology 
156:8-11. 
Streuli,M., T.Matsuyama, C.Morimoto, S.F.Schlossman, and H.Saito. 1987. 
Identification of the sequence required for expression of the Th4 epitope on the human 
leukocyte common antigens. Journal of Experimental Medicine 166:1567-1572. 
Streuli,M., C.Morimoto, M.Schrieber, S.F.Schlossman, and H.Saito. 1988. 
Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse 
cell lines that express individual human leukocyte common antigens. Journal of 
Immunology 141:3910-3914. 
Sulimova,G.E., I.G.Udina, G.O.Shaikhaev, and I.AZakharov. 1995. DNA polymorphism 
at the BoLA-DRB3 gene of cattle in relation to resistance and susceptibility to leukemia. 
Genetika 31: 1294-1299. 
Sunshine,G.H., D.P.Gold, H.H.Wortis, P.Marrack, and J.W.Kappler. 1983. Mouse spleen 
dendritic cells present soluble-antigens to antigen specific T-cell hybridomas. Journal of 
Experimental Medicine 158:1745-1750. 
Suriyasathaporn,W., Y.H.Schukken, M.Nielsen, and ABrand. 2000. Low Somatic Cell 
Count: a Risk Factor for Subsequent Clinical Mastitis in a Dairy herd. Journal of Dairy 
Science 83:1248-1255. 
Sutra,L. and B.Poutrel. 1994. Virulence factors involved in the pathogenesis of bovine 
intramammary infection due to Staphylococcus aureus. Journal of Medical Microbiology 
40:79-89. 
Swain,S.L. 1983. T-cell subsets and the recognition of MHC class. Immunological 
Reviews 74:129-142. 
334 
Swain,S.L. 1991. Regulation of the development of helper T-cell subsets. Immunologic 
Research 10: 177 -182. 
Swain,S.L. 1991. Lymphokines and the immune response - the central role of 
interleukin-2. Current Opinion in Immunology 3:304-310. 
Swain,S.L. 1993. ll...-4 dictates T-cell differentiation. Research in Immunology 144:616-
620. 
Swain,S.L., M.Croft, C.Dubey, L.Haynes, P.Rogers, X.H.Zhang, and L.M.Bradley. 1996. 
From naive to memory T cells. Immunological Reviews 150:143-167. 
Tait,B.D. and L.C.Harrison. 1991. The Major Histocompatibility Complex and insulin 
dependent diabetes mellitus - overview. Baillieres Clinical Endocrinology and 
Metabolism 5:211-228. 
Takeda,S., H.R.Rodewald, H.Arakawa, H.Bluethmann, and T.Shimizu. 1996. MHC class 
II molecules are not required for survival of newly generated CD4( +) T cells, but affect 
their long-term life span. Immunity 5:217-228. 
Takeuchi,S., K.Ishiguro, M.lkegami, T.Kaidoh, and Y.Hayakawa. 1998. Production of 
toxic shock syndrome toxin by Staphylococcus aureus isolated from mastitic cows' milk 
and farm bulk milk. Veterinary Microbiology 59:251-258. 
Tam,Y.K., G.Maki, B.Miyagawa, B.Hennemann, T.Tonn, and H.G.K1ingemann. 1999. 
Characterization of genetically altered, interleukin-2 independent natural killer cell lines 
suitable for adoptive cellular immunotherapy. Human Gene Therapy 10: 1359-1373. 
Tan,L., M.H.Andersen, T.Elliott, and J.S.Haurum. 1997. An improved assembly assay 
for peptide binding to HLA-B*2705 and H-2K(k) class I MHC molecules. Journal of 
Immunological Methods 209:25-36. 
Tanaka,Y., C.T.Morita, E.Nieves, M.B.Brenner, and B.R.Bloom. 1995. Natural and 
synthetic nonpeptide antigens recognized by human gamma delta T -cells. Nature 
375: 155-158. 
335 
Tanaka,Y., L.Ardouin, A.Gillet, S.Y.Lin, A.Magnan, B.Malissen, and M.Malissen. 1995. 
Early T-cell development in CD3 deficient mice. Immunological Reviews 148:171-199. 
Tang,M.K., D.A.Steeber, X.Q.Zhang, and T.F.Tedder. 1998. Intrinsic differences in L-
selectin expression levels affect T and B lymphocyte subset specific recirculation 
pathways. Journal of Immunology 160:5113-5121. 
Tao,W., RDougherty, PJohnston, and W.Pickett. 1993. Recombinant bovine GM-CSF 
primes superoxide production but not degranulation induced by recombinant bovine 
interleukin-l-beta in bovine neutrophils. Journal of Leukocyte Biology 53:679-684. 
Targowski,S.P. and D.T.Berman. 1975. Leukocyte response of bovine mammary gland to 
injection of killed cells and cell walls of Staphylococcus aureus. American Journal of 
Veterinary Research 36:1561-1565. 
Tatini,S.R, J.JJezeski, J.C.Olson, and E.P.Casman. 1971. Factors influencing the 
production of staphylococcal enterotoxin A in milk. Journal of Dairy Science 54:312-
320. 
Taylor,B.C., K.Y.Choi, RJ.Scibienski, P.F.Moore, and J.L.Stott. 1993. Differential 
expression of bovine MHC class-II antigens identified by monoclonal antibodies. Journal 
of Leukocyte Biology 53:479-489. 
Taylor,B.C., J.D.Dellinger, and J.S.Cullor. 1994. Bovine milk lymphocytes display the 
phenotype of memory T cells and are predominately CD8+. Cellular Immunology 
156:245-253. 
Teale,A., M.Agaba, S.Clapcott, A.Gelhaus, C.Haley, O.Hanotte, RHorstmann, F. Iraqi , 
S.Kemp, P.Nilsson, M.Schwerin, K.Sekikawa, M.Soller, Y.Sugimoto, and J.Womack. 
1999. Resistance to trypanosomosis: of markers, genes and mechanisms. Archiv Fur 
Tierzucht-Archives of Animal Breeding 42:36-41. 
336 
Terry,L.A., M.H.Brown, and P.L.Beverley. 1988. The monoclonal antibody, UCHLl, 
recognizes a 180,000 MW component of the human leukocyte common antigen, CD45. 
Immunology 64:331-336. 
Thomas,G. 1987. Summer mastitis: a workshop in the Community Program for the 
Coordination of Agricultural Research. Commission of the European Communities. 
Coordination Agricultural Research, Current Topics in Veterinary Medicine and Animal 
Science 45. 
Thomas,L.H., W.Haider, A.W.Hill, and RS.Cook. 1994. Pathological findings of 
experimentally induced Streptococcus uberis infection in the mammary gland of cows. 
American Journal of Veterinary Research 55:1723-1728. 
Thomson,G., W.P.Robinson, M.K.Kuhner, SJoe, MJ.MacDonald, J.L.Gottschall, 
J.Barbosa, S.S.Rich, J.Bertrams, M.P.Baur, J.Partanen, B.D.Tait, E.Schober, W.RMayr, 
J.Ludvigsson, B.Lindblom, N.RFarid, C.Thomson, and I.Deschamps. 1988. Genetic 
heterogeneity, modes of inheritance, and risk estimates for a joint study of caucasians 
with insulin dependent diabetes mellitus. American Journal of Human Genetics 43:799-
816. 
Tiercy,J.M., C.Morel, A.C.Freidel, F. Zwahlen , L.Gebuhrer, H.Betuel, M.Jeannet, and 
B.Mach. 1991. Selection of unrelated donors for bone marrow transplantation is 
improved by HLA class II genotyping with oligonucleotide hybridization. Proceedings of 
The National Academy of Sciences of The United States of America 88:7121-7125. 
Tizard,1. 1992. General principles of vaccination and vaccines. In Veterinary 
Immunology: an introduction, 4th edition. WB Saunders Co, Philadelphia. 
Tjoelker,L.W., B.P.Chew, T.S.Tanaka, and L.RDaniel. 1988. Bovine vitamin-A and 
beta-carotene intake and lactational status .1. Responsiveness of peripheral blood 
polymorphonuclear leukocytes to vitamin-A and beta-carotene challenge in vitro. 
Journal of Dairy Science 71:3112-3119. 
337 
Todd,l., M.Fishaut, F.Kapral, and T.We1ch. 1978. Toxin shock syndrome associated with 
phage group-I staphylococci. Lancet 25: 1116-1118. 
Todhunter,D.A., K.L.Smith, l.S.Hogan, and L.Nelson. 1991. Intramammary challenge 
with Escherichia coli following immunization with a curli producing Escherichia coli. 
Journal of Dairy Science 74:819-825. 
Todhunter,D.A., K.L.Srnith, and l.S.Hogan. 1995. Environmental streptococcal 
intramammary infections of the bovine mammary gland. Journal of Dairy Science 
78:2366-2374. 
Tonks,N.K., H.Charbonneau, C.D.Diltz, E.H.Fischer, and K.A.Walsh. 1988. 
Demonstration that the leukocyte common antigen CD45 is a protein tyrosine 
phosphatase. Biochemistry 27:8696-8701. 
Torre,P.M. and S.P.Oliver. 1988. Changes in blastogenic activity of bovine blood 
mononuclear cells throughout the nonlactating period. Journal of Dairy Science 71: 1078-
1084. 
Torre,P.M., P.K.Konur, and S.P.Oliver. 1992. Proliferative response of mammary gland 
mononuclear cells to recombinant bovine interleukin-2. Veterinary Immunology and 
Immunopathology 32:351-358. 
Tosato,G. and K.D.Jones. 1990. Interleukin-1 induces interleukin-6 production in 
peripheral blood monocytes. Blood 75: 1305-1310. 
Tough,D.F. and l.Sprent. 1994. Turnover of naIve phenotype and memory phenotype T-
cells. Journal of Experimental Medicine 179:1127-1135. 
Townsend,A., T.Elliott, V.Cerundolo, L.Foster, B.Barber, and A.Tse. 1990. Assembly of 
MHC class-I molecules analyzed in vitro. Cell 62:285-295. 
Trnka,Z. and Rn.P.Cahill. 1980. Aspects of the immune response in single lymph nodes. 
Allergy 16:245-259. 
338 
Trowsdale,J. and A.Kelly. 1985. The human HLA class-II alpha-chain gene DZ-alpha is 
distinct from genes in the DP-subregion, DQ-subregion and DR-subregions. EMBO 
Journal 4:2231-2237. 
Turner,R.J. and J.M.Finch. 1990. Immunological malfunctions associated with low 
selenium vitamin-E diets in lambs. Journal of Comparative Pathology 102:99-109. 
Tyler,J.W., R.C.Wilson, and P.Dowling. 1992. Treatment of subclinical mastitis. 
Veterinary Clinics of North America Food Animal Practice 8:17-28. 
Tyler,J.W., J.S.Cullor, R.J.Erskine, W.L.Smith, J.Dellinger, and K.McClure. 1992. Milk 
antimicrobial drug residue assay results in cattle with experimental, endotoxin induced 
mastitis. Journal of the American Veterinary Medical Association 201: 1378-1384. 
Uchiyama,T., S.Saito, H.Inoko, X.J.Yan, K.Imanishi, M.Araake, and H.lgarashi. 1990. 
Relative activities of distinct isotypes of murine and human Major Histocompatibility 
Complex class-II molecules in binding toxic shock syndrome toxin-l and determination 
of CD antigens expressed on T -cells generated upon stimulation by the toxin. Infection 
and Immunity 58:3877-3882. 
Underdown,B.J. and K.J.Dorrington. 1974. Studies on the structural and conformational 
basis for the relative resistance of serum and secretory IgA to proteolysis. Journal of 
Immunology 112:949-959. 
Uryu,N., M.Maeda, M.Ota, K.Tsuji, and H.Inoko. 1990. A simple and rapid method for 
HLA-DRB and HLA-DQB typing by digestion of PCR amplified DNA with allele 
specific restriction endonucleases. Tissue Antigens 35:20-31. 
Vaiman,M., C.Renard, P.LaFage, J.Ameteau, and P.Nizza. 1970. Evidence for a 
histocompatibility system in swine (SLA). Transplantation 10: 155-164. 
van Arendonk,J.A.M. 1985. Studies on the replacement policies in dairy cattle. II. 
Optimum policy and influence of changes in production and prices. Livestock Production 
Science 13:101-121. 
339 
van Eijk,MJ.T., J.A.Stewart-Haynes, and H.A.Lewin. 1992. Extensive polymorphism of 
the BoLA-DRB3 gene distinguished by PCR-RFLP. Animal Genetics 23:483-496. 
van Haeringen,W.A., P.S.Gwakisa, S.Mikko, E.Eythorsdottir, L.E.Holm, I.Olsaker, 
P.M.Outteridge, and L.Andersson. 1999. Heterozygosity excess at the cattle DRB locus 
revealed by large scale genotyping of two closely linked microsatellites. Animal Genetics 
30:169-176. 
van Kampen,c. and B.A.Mallard. 1997. Effects of peripartum stress and health on 
circulating bovine lymphocyte subsets. Veterinary Immunology and Immunopathology 
59:79-91. 
van Lierop,M.J.C., P.R.Nilsson, J.P.A.Wagenaar, J.M.van Noort, J.D.M.Campbell, 
E.J.Glass, I.Joosten, and E.J.Hensen. 1995. The influence of MHC polymorphism on the 
selection of T-cell determinants of FMDV in cattle. Immunology 84:79-85. 
van Werven,T. 1999. The role of leucocytes in bovine Escherichia coli mastitis. Ph.D 
Thesis University of Utrecht. 
Vanbleek,G.M. and S.G.Nathenson. 1990. Isolation of an endogenously processed 
immunodominant viral peptide from the class-I H-2kb molecule. Nature 348:213-216. 
VanEenennaam,A.1., J.S.Cullor, L.Perani, 1.A.Gardner, W.L.Smith, J.Dellinger, and 
W.M.Guterbock. 1993. Evaluation of milk antibiotic residue screening tests in cattle with 
naturally occurring clinical mastitis. Journal of Dairy Science 76:3041-3053. 
VanElsas,A., C.Aamoudse, C.E.vanderMinne, C.W.vanderSpek, N.Brouwenstijn, 
S.Osanto, and P.I.Schrier. 1997. Transfection of IL-2 augments CTL response to human 
melanoma cells in vitro: Immunological characterization of a melanoma vaccine. Journal 
of Immunotherapy 20:343-353. 
Vankooten,c. and J.Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and 
other cells. Current Opinion in Immunology 9:330-337. 
340 
Vankooten,c. and J.Banchereau. 1997. Functional role of CD40 and its ligand. 
International Archives of Allergy and Immunology 113:393-399. 
Vanlierop,M.J.C., J.M.Vannoort, J.P.A.Wagenaar, V.P.M.G.Rutten, J.Langeveld, 
RH.Meloen, and EJ.Hensen. 1994. T-cell stimulatory fragments of foot and mouth 
disease virus released by mild treatment with cathepsin-D. Journal of General Virology 
75:2937-2946. 
VanMiert,A.S.J.P.A.M. 1991. Acute phase response and non-cellular defense 
mechanisms. Flemish Veterinary Journal 62:69. 
VanNeerven,J., J.E.Coligan, and F.Koning. 1990. Structural comparison of alpha-beta 
and gamma delta T-cell receptor CD3 complexes reveals identical subunit interactions 
but distinct cross-linking patterns of T-cell receptor chains. European Journal of 
Immunology 20:2105-2111. 
Vecht,U., G.E.Shook, RD.Politiek, and G.Grootenhuis. 1987. Cell counts in the milk as 
a criterion in breeding dairy cattle showing increased resistance to mastitis. TijdschriJt 
Voor Diergeneeskunde 112:598-604. 
Vecht,U., K.C.H.M.Meijers, and H.J.Wisselink. 1987. Klebsiella pneumoniae mastitis in 
a dairy herd. TijdschriJt Voor Diergeneeskunde 112:653-659. 
Veerkamp,RF., S.Brotherstone, A.W.Stott, and A.W.Hill. 1995. Profit indices for UK 
dairy cattle. Animal Science 61: 189-197. 
Veillette,A., M.A.Bookman, E.M.Horak, L.E.Samelson, and J.B.Bolen. 1989. Signal 
transduction through the CD4 receptor involves the activation of the internal membrane 
tyrosine protein kinase p561ck. Nature 338:257-259. 
Vella,A.T., T.Mitchell, B.Groth, P.S.Linsley, J.M.Green, C.B.Thompson, J.W.Kappler, 
and P .Marrack. 1997. CD28 engagement and proinflammatory cytokines contribute to T 
cell expansion and long term survival in vivo. Journal of Immunology 158:4714-4720. 
341 
Vidard,L., T.Roger, G.Pham, 1.Couderc, Y.Bouthillier, 1.C.Mevel, D.Mouton, and 
M.Seman. 1990. Polymorphism of TCRB and TCRG genes in biozzi mice - segregation 
analysis of a new TCRG haplotype with antibody responsiveness. Immunogenetics 
32:27-33. 
Vink,A., C.Uyttenhove, P.Wauters, and 1.Vansnick. 1990. Accessory factors involved in 
murine T-cell activation - distinct roles of interleukin-6, interleukin-1 and tumor-necrosis 
factor. European Journal of Immunology 20: 1-6. 
Vonboehmer,H. 1988. The developmental biology of T -lymphocytes. Annual Review of 
Immunology 6:309-326. 
Vonboehmer,H. and P.Kisielow. 1990. Self-nonself discrimination by T-cells. Science 
248: 1369-1373. 
Waage,S., T.Mork, A. Roros , D.Aasland, A.Hunshamar, and S.A.Odegaard. 1999. 
Bacteria associated with clinical mastitis in dairy heifers. Journal of Dairy Science 
82:712-719. 
Ward,P.D., C.Adlam, A.C.McCartney, and 1.P.Arbuthnott. 1979. A histopathological 
study of the effects of highly purified staphylocccal alpha and beta toxins on lactating 
mammary gland and skin of the rabbit. Journal of Comparative Pathology 89: 169-177. 
Washington,E.A., W.G.Kimpton, and R.P.Cahill. 1992. Changes in the distribution of 
alpha-beta and gamma delta T -cells in blood and in lymph nodes from fetal and postnatal 
lambs. Developmental and Comparative Immunology 16:493-501. 
Washington,E.A., M.Katerelos, R.P.Cahill, and W.G.Kimpton. 1994. Differences in the 
tissue specific homing of alpha-beta and gamma delta T -cells to gut and peripheral lymph 
nodes. International Immunology 6:1891-1897. 
Waterhouse,P., L.E.M.Marengere, H.W.Mittrucker, and T.W.Mak. 1996. CTLA-4, a 
negative regulator ofT-lymphocyte activation. Immunological Reviews 153:183-207. 
342 
Watkins,D.I., I.AShadduck, C.E.Rudd, M.E.Stone, H.ALewin, and N.L.Letvin. 1989. 
Isoelectric focusing of bovine Major Histocompatibility Complex class II molecules. 
European Journal of Immunology 19:567-570. 
Watson,D.L. and AKLascelles. 1973. Mechanisms of transfer of immunoglobulins into 
mammary secretions of ewes. Australian Journal of Experimental Biology 51:247-254. 
Watson,D.L. 1992. Vaccination against experimental staphylococcal mastitis in dairy 
heifers. Research in Veterinary Science 53:346-353. 
Watson,D.L., M.L.McColl, and H.I.Davies. 1996. Field trial of a staphylococcal mastitis 
vaccine in dairy herds: Clinical, subclinical and microbiological assessments. Australian 
Veterinary Journal 74:447-450. 
Watts,c. 1997. Immunology - Inside the gearbox of the dendritic cell. Nature 388:724-
725. 
Weaver,C.T. and E.R.Unanue. 1990. The costimulatory function of antigen presenting 
cells. Immunology Today 11 :49-55. 
Weber,C. 1991. Unexpected behavior of H2Kb mutant DNAs in denaturing gradient gel 
electrophoresis. Nucleic Acid Research 19:3331-3335. 
Webster,l. 1993. Understanding the dairy cow 2nd edition. Blackwell Scientific 
Publications, Oxford. 
Wegener,AM.K, F.Letourneur, A Hoevelera, T.Brocker, F.Luton, and B.Malissen. 
1992. The T-cell receptor/CD3 complex is composed of at least 2 autonomous 
transduction modules. Cell 68:83-95. 
Weiblen,B.J., KDebell, and C.R.Valeri. 1983. Acquired immunodeficiency of blood 
stored overnight. New England Journal of Medicine 309:793. 
343 
Weigel,KA., A.E.Freeman, M.E.Kehrli, Stear M.J., and D.H.Kelley. 1990. Association 
of class I bovine lymphocyte antigen complex alleles with health and production traits in 
dairy cattle. Journal of Dairy Science 73:2538-2546. 
Weiss,W.P., J.s.Hogan, KL.Smith, and KH.Hoblet. 1990. Relationships among 
selenium, vitamin-E, and mammary-gland health in commercial dairy herds. Journal of 
Dairy Science 73:381-390. 
Weiss,W.P., D.A.Todhunter, J.S.Hogan, and KL.Smith. 1990. Effect of duration of 
supplementation of selenium and vitamin-E on periparturient dairy cows. Journal of 
Dairy Science 73:3187-3194. 
Weller,1.1., A.Saran, and Y.Zeliger. 1992. Genetic and environmental relationships 
among somatic cell count. Journal of Dairy Science 75:2532-2540. 
Werdelin,O. 1987. T-cells recognize antigen alone and not MHC molecules. Immunology 
Today 8:80-84. 
Wesen,D.P. and L.H.Shultz. 1970. Effectiveness of a post milking teat dip in preventing 
new udder infections. Journal of Dairy Science 53:1391-1403. 
White,J., A. Herman , A.M.Pullen, R.Kubo, J.W.Kappler, and P.Marrack. 1989. The v-
beta specific superantigen staphylococcal enterotoxin-B stimulation of mature T-cells 
and clonal deletion in neonatal mice. Cell 56:27-35. 
Wiedemann,B. and M.Kresken. 1984. The incidence and development of resistance in 
Staphylococcus aureus from 3 European countries. Journal of Antimicrobial 
Chemotherapy 14:27-34. 
Wieneke,A.A. and R.J.Gilbert. 1987. Comparison of 4 methods for the detection of 
staphylococcal enterotoxin in foods from outbreaks of food poisoning. International 
Journal of Food Microbiology 4:135-143. 
344 
Wijngaard,P.L., M.J.Metzelaar, N.D.Machugh, W.I.Morrison, and H.C.Clevers. 1992. 
Molecular characterization of the WC1 antigen expressed specifically on bovine CD4-
CD8- gamma delta T lymphocytes. Journal of Immunology 149:3273-3277. 
Wilesmith,J.W., P.G.Francis, and C.D.Wilson. 1986. Incidence of clinical mastitis in a 
cohort of British dairy herds. Veterinary Record 118: 199-204. 
Williams,J.L., P.Brown, and RL.Spooner. 1988. Approach to MHC polymorphism in 
cattle. Animal Genetics 19:36-38. 
Williams,J.M., D.Deloria, J.A.Hansen, C.A.Dinarello, RLoertscher, H.M.Shapiro, and 
T.B.Strom. 1985. The events of primary T-cell activation can be staged by use of 
sepharose-bound anti-T3 (64.1) Monoclonal antibody and purified interleukin-1. Journal 
of Immunology 135:2249-2255. 
Williams,M.N.V., N.Pande, S.Nair, M.Mohan, and J.Bennett. 1991. Restriction fragment 
length polymorphism analysis of polymerase chain reaction products amplified from 
mapped loci of rice (Oryza sativa L) Genomic DNA. Theoretical and Applied Genetics 
82:489-498. 
Wilson,C.D. and M.S.Richards. 1980. A survey of mastitis in the British dairy herd. 
Veterinary Record 106:431-435. 
Wilson,RA., J.A.Linn, and RJ.Eberhart. 1986. A study of bovine T-cell subsets in the 
blood and mammary gland secretions during the dry period. Veterinary Immunology and 
Immunopathology 13: 151-164. 
Wiman,K., B.Curman, U.Firsyn, L.Klereskog, U.Tjemlund-Malmnas, L.Rask, L.Tragard, 
and P.A.Peterson. 1978. Occurence of Ia antigens on tissues of non-lymphoid origin. 
Nature 276:711-713. 
Winker,H., P.Reuland, J.Muller, S.Weller, and U.Feine. 1988. Leukocyte scintigraphy 
with TC-99M-HMPAO in the diagnosis of bone inflammations - early results. 
Nuklearmedizin 27:121-126. 
345 
Wirth,J.l., P.1.Fraker, and F.Kierszenbaum. 1984. Changes in the levels of marker 
expression by mononuclear phagocytes in zinc deficient mice. Journal of Nutrition 
114: 1826-1833. 
Wood,AC., I.Todd, ACockayne, and 1.P.Arbuthnott. 1991. Staphylococcal enterotoxins 
and the immune system. FEMS Microbiology Immunology 76:121-134. 
WU,M.C., RD.Shanks, and H.ALewin. 1989. Milk and fat production in dairy cattle 
influenced by advanced sub-clinical bovine leukemia infection. Proceedings of the 
National Academy of Sciences of the United States of America 86:993-996. 
Wubbolts,R, M.FemandezBorja, and 1.Neefjes. 1997. MHC class II molecules: 
Transport pathways for antigen presentation. Trends in Cell Biology 7:115-118. 
Wyatt,C.R, C.Madruga, C.Cluff, S.Parish, M.l.Hamilton, W.Goff, and W.C.Davis. 1994. 
Differential distribution of gamma delta T-cell receptor lymphocyte subpopulations in 
blood and spleen of young and adult cattle. Veterinary Immunology and 
Immunopathology 40:187-199. 
Wyatt,C.R, E.l.Brackett, L.E.Perryman, N.D.Machugh, and W.C.Davis. 1995. 
Identification of "1'0 T lymphocytes subsets that populate calf ileal mucosa after birth. 
Veterinary Immunology and Immunopathology 52:91-103. 
Wyatt,C.R, E.l.Brackett, L.E.Perryman, and W.C.Davis. 1996. Identification of gamma 
delta T lymphocyte subsets that populate calf ileal mucosa after birth. Veterinary 
Immunology and Immunopathology 52:91-103. 
XU,A.L., M.l.T.van Eijk, C.Park, and H.ALewin. 1993. Polymorphism in BoLA-DRB3 
exon 2 correlates with resistance to persistent lymphocytosis caused by bovine leukemia 
virus. Journal of Immunology 151 :6977-6985. 
Yamaguchi,T., M.Hiratsuka, K.Asai, K.Kai, and K.Kumagai. 1999. Differential 
distribution of T lymphocyte subpopulations in the bovine mammary gland during 
lactation. Journal of Dairy Science 82: 1459-1464. 
346 
Yanagi,Y., Y.Yoshikai, K. Leggett , S.P.Clark, LAleksander, and T.W.Mak. 1984. A 
human Tcell-specific cDNA clone encodes a protein having extensive homology to 
immunoglobulin chains. Nature 308: 145-149. 
Yanagi,Y., A.Chan, B.Chin, M.Minden, and T.W.Mak. 1985. Analysis of cDNA clones 
specific for human T -cells and the alpha-chains and beta-chains of the T-cell receptor 
heterodimer from a human T-cell line. Proceedings of the National Academy of Sciences 
of the United States of America 82:3430-3434. 
Yancey,R.J. 1993. Recent advances in bovine vaccine technology. Journal of Dairy 
Science 76:2418-2436. 
Yang,H. and R.M.E.Parkhouse. 1996. Phenotypic classification of porcine lymphocyte 
subpopulations in blood and lymphoid tissues. Immunology 89:76-83. 
Yang,T.J. 1981. Identification of bovine T- and B-Iymphocyte subpopulations by 
immunofluorescence surface marker analysis. American Journal of Veterinary Research 
42:755-757. 
Yang,T.J., J.F.Mather, and E.D.Rabinovsky. 1988. Changes in subpopulations of 
lymphocytes in peripheral blood, and supramammary and prescapular lymph nodes of 
cows with mastitis and normal cows. Veterinary Immunology and Immunopathology 
18:279-285. 
Yang,T.J., C.L.Baldwin, M.Hanbyflarida, J.F.Mather, and E.D.Rabinovsky. 1995. 
Monoclonal antibody BLT-l, specific for the bovine homolog of CD5, reacts with the 
majority of mature T -cells, a subpopulation of B-cells and stimulates T-cell proliferation. 
Developmental and Comparative Immunology 19:337-346. 
Yang,T.J., LA.Ayoub, and M.1.Rewinski. 1997. Lactation stage dependent changes of 
lymphocyte subpopulations in mammary secretions: Inversion of CD4( + )/CD8( +) T cell 
ratios at parturition. American Journal of Reproductive Immunology 37:378-383. 
347 
Yokomizo,Y. and H.lgarashi. 1991. Toxic Shock Syndrome Toxin 1 and enterotoxin 
production by Staphylococcus aureus isolated from bovine mastitis. Clinical 
Microbiology 18:411-412. 
Yokomizo,Y., Y.Mori, Y.Shimoji, S.Shimizu, H.Sentsui, M.Kodama, and H.lgarashi. 
1995. Proliferative response and cytokine production of bovine peripheral blood 
mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic 
shock syndrome toxin-I. Journal of Veterinary Medical Science 57:299-305. 
Yoong,K.F., G.McNab, S.G.Hubscher, and D.H.Adams. 1998. Vascular adhesion 
protein-1 and ICAM-1 support the adhesion of tumor infiltrating lymphocytes to tumor 
endothelium in human hepatocellular carcinoma. Journal of Immunology 160:3978-3988. 
Y ork,I.A. and K.L.Rock. 1996. Antigen processing and presentation by the class I Major 
Histocompatibility Complex. Annual Review of Immunology 14:369-396. 
Young, F. J. 1997. Infection and inflammation in bovine Staphylococcus aureus mastitis. 
M.Sc Thesis, University of Glasgow Veterinary School. 
Zanotti,M., G.Poli, W.Ponti, M.Polli, M.Rocchi, E.Bolzani, M.Longeri, S.Russo, 
H.A.Lewin, and M.T.Vaneijk. 1996. Association of BoLA class II haplotypes with 
subclinical progression of bovine leukaemia virus infection in Holstein-Friesian cattle. 
Animal Genetics 27:337-341. 
Zhou,Y.L., G.F.Lin, M.J.Baarsch, RW.Scamurra, and M.P.Murtaugh. 1994. Interleukin-
4 suppresses inflammatory cytokine gene transcription in porcine macrophages. Journal 
of Leukocyte Biology 56:507-513. 
Zimmerman,B.J., D.C.Anderson, and D.N.Granger. 1992. Neuropeptides promote 
neutrophil adherence to endothelial cell monolayers. American Journal of Physiology 
263 :G678-G682. 
Zinkemagel,RM. and P.C.Doherty. 1974. Restriction of in vitro T cell mediated 
cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic 
system. Nature 248:701-702. 
348 
Zinkemagel,R.M. and P.C.Doherty. 1979. MHC restricted T-cells: studies on the 
biological role of polymorphic major transplantation antigens determining T cell 
restriction-specificity, function and responsiveness. Advances in Immunology 27:221-
292. 
Ziv,G., S.Gordin, G.Bacher, and S.Bemstein. 1973. Concentration and persistence of 
antibiotics in milk following intramammary infusion in cows. Refuah Veterinarith 30:85-
100. 
Ziv,G., M.Shemtov, A.Glickman, M.Winkler, and A.Saran. 1995. Tilmicosin 
antibacterial activity and pharmacokinetics in cows. Journal of Veterinary Pharmacology 
and Therapeutics 18:340-345. 
Zorbas,M. and R.Scollay. 1993. Development of gamma delta Tcells in the thymus. 
European Journal of Immunology 23:1655-1660. 
349 
lGLASGOW UNIVERSITY UHRARY 
